> top > docs > PMC:7534795 > annotations

PMC:7534795 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T1 98936-98941 Body_part denotes blood http://purl.org/sig/ont/fma/fma9670
T2 98953-98958 Body_part denotes blood http://purl.org/sig/ont/fma/fma9670
T3 99200-99205 Body_part denotes heart http://purl.org/sig/ont/fma/fma7088
T4 99210-99223 Body_part denotes blood vessels http://purl.org/sig/ont/fma/fma63183
T5 99210-99215 Body_part denotes blood http://purl.org/sig/ont/fma/fma9670
T6 99499-99507 Body_part denotes cytokine http://purl.org/sig/ont/fma/fma84050
T7 99719-99731 Body_part denotes glycoprotein http://purl.org/sig/ont/fma/fma62925
T8 99750-99757 Body_part denotes tissues http://purl.org/sig/ont/fma/fma9637
T9 99772-99777 Body_part denotes lungs http://purl.org/sig/ont/fma/fma68877
T10 99779-99786 Body_part denotes kidneys http://purl.org/sig/ont/fma/fma7203
T11 99788-99793 Body_part denotes heart http://purl.org/sig/ont/fma/fma7088
T12 99807-99818 Body_part denotes endothelium http://purl.org/sig/ont/fma/fma63916
T13 99917-99938 Body_part denotes cardiovascular system http://purl.org/sig/ont/fma/fma7161
T14 100156-100164 Body_part denotes monocyte http://purl.org/sig/ont/fma/fma62864
T15 100181-100188 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T16 100195-100205 Body_part denotes macrophage http://purl.org/sig/ont/fma/fma63261
T17 100245-100259 Body_part denotes cardiomyocytes http://purl.org/sig/ont/fma/fma14067
T18 100264-100281 Body_part denotes endothelial cells http://purl.org/sig/ont/fma/fma66772
T19 100276-100281 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646
T20 101026-101031 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646
T21 101047-101059 Body_part denotes glycoprotein http://purl.org/sig/ont/fma/fma62925
T22 101141-101153 Body_part denotes cell surface http://purl.org/sig/ont/fma/fma67653
T23 101141-101145 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646
T24 101282-101289 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T25 101612-101616 Body_part denotes lung http://purl.org/sig/ont/fma/fma7195
T26 101621-101643 Body_part denotes cardiovascular systems http://purl.org/sig/ont/fma/fma7161
T27 101854-101862 Body_part denotes cytokine http://purl.org/sig/ont/fma/fma84050
T28 102218-102222 Body_part denotes lung http://purl.org/sig/ont/fma/fma7195
T29 102647-102652 Body_part denotes organ http://purl.org/sig/ont/fma/fma67498
T30 103888-103893 Body_part denotes blood http://purl.org/sig/ont/fma/fma9670
T31 104025-104039 Body_part denotes cell membranes http://purl.org/sig/ont/fma/fma63841
T32 104025-104029 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646
T33 104097-104104 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T34 104934-104942 Body_part denotes cytokine http://purl.org/sig/ont/fma/fma84050
T35 105524-105529 Body_part denotes Heart http://purl.org/sig/ont/fma/fma7088
T36 105598-105603 Body_part denotes Heart http://purl.org/sig/ont/fma/fma7088
T37 106262-106283 Body_part denotes cardiovascular system http://purl.org/sig/ont/fma/fma7161
T38 106303-106308 Body_part denotes blood http://purl.org/sig/ont/fma/fma9670
T39 106381-106386 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646
T40 106394-106399 Body_part denotes heart http://purl.org/sig/ont/fma/fma7088
T41 106451-106460 Body_part denotes cytokines http://purl.org/sig/ont/fma/fma84050
T42 106869-106872 Body_part denotes RNA http://purl.org/sig/ont/fma/fma67095
T43 106925-106929 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646
T44 107149-107152 Body_part denotes DNA http://purl.org/sig/ont/fma/fma74412
T45 107165-107173 Body_part denotes proteins http://purl.org/sig/ont/fma/fma67257
T46 107337-107343 Body_part denotes tissue http://purl.org/sig/ont/fma/fma9637
T47 107799-107804 Body_part denotes lungs http://purl.org/sig/ont/fma/fma68877
T48 107806-107813 Body_part denotes kidneys http://purl.org/sig/ont/fma/fma7203
T49 107822-107843 Body_part denotes cardiovascular system http://purl.org/sig/ont/fma/fma7161
T50 108200-108206 Body_part denotes tissue http://purl.org/sig/ont/fma/fma9637
T51 108230-108242 Body_part denotes right atrium http://purl.org/sig/ont/fma/fma7096
T52 108284-108291 Body_part denotes tissues http://purl.org/sig/ont/fma/fma9637
T53 108774-108780 Body_part denotes tissue http://purl.org/sig/ont/fma/fma9637
T54 109327-109332 Body_part denotes lungs http://purl.org/sig/ont/fma/fma68877
T55 109341-109346 Body_part denotes heart http://purl.org/sig/ont/fma/fma7088
T56 110074-110079 Body_part denotes blood http://purl.org/sig/ont/fma/fma9670
T57 110153-110158 Body_part denotes blood http://purl.org/sig/ont/fma/fma9670
T58 110175-110179 Body_part denotes lung http://purl.org/sig/ont/fma/fma7195
T59 110463-110470 Body_part denotes heparin http://purl.org/sig/ont/fma/fma82839
T60 110723-110730 Body_part denotes heparin http://purl.org/sig/ont/fma/fma82839
T61 110916-110924 Body_part denotes platelet http://purl.org/sig/ont/fma/fma62851
T62 110997-111005 Body_part denotes collagen http://purl.org/sig/ont/fma/fma63891
T63 111175-111183 Body_part denotes platelet http://purl.org/sig/ont/fma/fma62851
T64 111184-111196 Body_part denotes phospholipid http://purl.org/sig/ont/fma/fma82779
T65 111229-111237 Body_part denotes platelet http://purl.org/sig/ont/fma/fma62851
T66 111383-111391 Body_part denotes platelet http://purl.org/sig/ont/fma/fma62851
T67 111411-111419 Body_part denotes platelet http://purl.org/sig/ont/fma/fma62851
T68 111486-111497 Body_part denotes fatty acids http://purl.org/sig/ont/fma/fma82738
T69 111538-111547 Body_part denotes platelets http://purl.org/sig/ont/fma/fma62851
T70 111599-111607 Body_part denotes platelet http://purl.org/sig/ont/fma/fma62851
T71 111799-111807 Body_part denotes platelet http://purl.org/sig/ont/fma/fma62851
T72 111837-111845 Body_part denotes platelet http://purl.org/sig/ont/fma/fma62851
T73 111963-111971 Body_part denotes platelet http://purl.org/sig/ont/fma/fma62851
T74 112173-112181 Body_part denotes platelet http://purl.org/sig/ont/fma/fma62851
T75 112286-112294 Body_part denotes platelet http://purl.org/sig/ont/fma/fma62851
T76 112448-112456 Body_part denotes platelet http://purl.org/sig/ont/fma/fma62851
T77 112664-112669 Body_part denotes Lipid http://purl.org/sig/ont/fma/fma67264
T78 112805-112811 Body_part denotes plasma http://purl.org/sig/ont/fma/fma62970
T79 112855-112860 Body_part denotes heart http://purl.org/sig/ont/fma/fma7088
T80 113262-113267 Body_part denotes serum http://purl.org/sig/ont/fma/fma63083
T81 113436-113447 Body_part denotes lipoprotein http://purl.org/sig/ont/fma/fma63169
T82 113547-113554 Body_part denotes glucose http://purl.org/sig/ont/fma/fma82743
T83 113608-113614 Body_part denotes plasma http://purl.org/sig/ont/fma/fma62970
T84 113615-113622 Body_part denotes glucose http://purl.org/sig/ont/fma/fma82743
T85 113665-113672 Body_part denotes insulin http://purl.org/sig/ont/fma/fma83365
T86 113749-113756 Body_part denotes glucose http://purl.org/sig/ont/fma/fma82743
T87 113858-113882 Body_part denotes high density lipoprotein http://purl.org/sig/ont/fma/fma63171
T88 113896-113899 Body_part denotes HDL http://purl.org/sig/ont/fma/fma63171
T89 114050-114053 Body_part denotes HDL http://purl.org/sig/ont/fma/fma63171
T90 114378-114383 Body_part denotes lipid http://purl.org/sig/ont/fma/fma67264
T91 114449-114454 Body_part denotes lipid http://purl.org/sig/ont/fma/fma67264
T92 114541-114556 Body_part denotes coronary artery http://purl.org/sig/ont/fma/fma49893
T93 114623-114629 Body_part denotes plasma http://purl.org/sig/ont/fma/fma62970
T94 114630-114635 Body_part denotes lipid http://purl.org/sig/ont/fma/fma67264
T95 114719-114724 Body_part denotes lipid http://purl.org/sig/ont/fma/fma67264
T96 114891-114906 Body_part denotes coronary artery http://purl.org/sig/ont/fma/fma49893
T97 115118-115123 Body_part denotes lipid http://purl.org/sig/ont/fma/fma67264
T98 115657-115672 Body_part denotes coronary artery http://purl.org/sig/ont/fma/fma49893
T99 116104-116112 Body_part denotes cytokine http://purl.org/sig/ont/fma/fma84050
T100 117625-117629 Body_part denotes lung http://purl.org/sig/ont/fma/fma7195
T101 118425-118430 Body_part denotes lipid http://purl.org/sig/ont/fma/fma67264
T102 118708-118713 Body_part denotes lipid http://purl.org/sig/ont/fma/fma67264
T103 118750-118755 Body_part denotes lipid http://purl.org/sig/ont/fma/fma67264
T104 118822-118833 Body_part denotes fatty acids http://purl.org/sig/ont/fma/fma82738
T105 118941-118952 Body_part denotes fatty acids http://purl.org/sig/ont/fma/fma82738
T106 118958-118979 Body_part denotes mononuclear leukocyte http://purl.org/sig/ont/fma/fma62855
T107 119076-119081 Body_part denotes lipid http://purl.org/sig/ont/fma/fma67264
T108 119397-119408 Body_part denotes amino acids http://purl.org/sig/ont/fma/fma82739
T109 119410-119417 Body_part denotes glucose http://purl.org/sig/ont/fma/fma82743
T110 119440-119445 Body_part denotes lipid http://purl.org/sig/ont/fma/fma67264
T111 121070-121075 Body_part denotes lungs http://purl.org/sig/ont/fma/fma68877
T112 121107-121112 Body_part denotes organ http://purl.org/sig/ont/fma/fma67498
T113 121188-121193 Body_part denotes organ http://purl.org/sig/ont/fma/fma67498
T114 122640-122650 Body_part denotes macrophage http://purl.org/sig/ont/fma/fma63261
T115 122704-122708 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646
T116 122723-122727 Body_part denotes gene http://purl.org/sig/ont/fma/fma74402
T117 122765-122770 Body_part denotes lipid http://purl.org/sig/ont/fma/fma67264
T118 122910-122915 Body_part denotes heart http://purl.org/sig/ont/fma/fma7088
T65995 24-35 Body_part denotes fatty acids http://purl.org/sig/ont/fma/fma82738
T92948 403-408 Body_part denotes lungs http://purl.org/sig/ont/fma/fma68877
T95529 555-576 Body_part denotes cardiovascular system http://purl.org/sig/ont/fma/fma7161
T52458 1095-1106 Body_part denotes fatty acids http://purl.org/sig/ont/fma/fma82738
T68120 1129-1150 Body_part denotes cardiovascular system http://purl.org/sig/ont/fma/fma7161
T15726 1426-1431 Body_part denotes lipid http://purl.org/sig/ont/fma/fma67264
T43090 2706-2716 Body_part denotes nucleotide http://purl.org/sig/ont/fma/fma82740
T41330 3636-3659 Body_part denotes central nervous systems http://purl.org/sig/ont/fma/fma55675
T72777 3731-3736 Body_part denotes lungs http://purl.org/sig/ont/fma/fma68877
T16084 3766-3784 Body_part denotes organs and systems http://purl.org/sig/ont/fma/fma7149
T80150 3800-3807 Body_part denotes kidneys http://purl.org/sig/ont/fma/fma7203
T68146 3809-3814 Body_part denotes heart http://purl.org/sig/ont/fma/fma7088
T74654 3816-3829 Body_part denotes blood vessels http://purl.org/sig/ont/fma/fma63183
T81920 3816-3821 Body_part denotes blood http://purl.org/sig/ont/fma/fma9670
T8742 3831-3853 Body_part denotes gastrointestinal tract http://purl.org/sig/ont/fma/fma71132
T68419 3858-3863 Body_part denotes brain http://purl.org/sig/ont/fma/fma50801
T63124 4007-4030 Body_part denotes lower respiratory tract http://purl.org/sig/ont/fma/fma45662
T36357 4108-4112 Body_part denotes lung http://purl.org/sig/ont/fma/fma7195
T22313 4200-4205 Body_part denotes heart http://purl.org/sig/ont/fma/fma7088
T26828 5022-5031 Body_part denotes Melatonin http://purl.org/sig/ont/fma/fma74644
T62683 5161-5166 Body_part denotes heart http://purl.org/sig/ont/fma/fma7088
T69623 5230-5243 Body_part denotes interleukin-6 http://purl.org/sig/ont/fma/fma264829
T2300 5376-5384 Body_part denotes cytokine http://purl.org/sig/ont/fma/fma84050
T70564 5699-5704 Body_part denotes organ http://purl.org/sig/ont/fma/fma67498
T71556 6047-6060 Body_part denotes interleukin-1 http://purl.org/sig/ont/fma/fma86583
T41271 6084-6088 Body_part denotes IL-1 http://purl.org/sig/ont/fma/fma86583
T45585 6109-6116 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T90573 6164-6172 Body_part denotes cytokine http://purl.org/sig/ont/fma/fma84050
T84940 6289-6300 Body_part denotes Granulocyte http://purl.org/sig/ont/fma/fma62854
T2963 6301-6311 Body_part denotes macrophage http://purl.org/sig/ont/fma/fma63261
T89453 6342-6345 Body_part denotes CSF http://purl.org/sig/ont/fma/fma20935
T80835 6363-6366 Body_part denotes CSF http://purl.org/sig/ont/fma/fma20935
T16035 6413-6424 Body_part denotes macrophages http://purl.org/sig/ont/fma/fma63261
T75061 6488-6491 Body_part denotes CSF http://purl.org/sig/ont/fma/fma20935
T35610 6539-6542 Body_part denotes CSF http://purl.org/sig/ont/fma/fma20935
T79976 6568-6577 Body_part denotes cytokines http://purl.org/sig/ont/fma/fma84050
T70672 6617-6625 Body_part denotes cytokine http://purl.org/sig/ont/fma/fma84050
T41412 6715-6724 Body_part denotes cytokines http://purl.org/sig/ont/fma/fma84050
T31184 7348-7353 Body_part denotes heart http://purl.org/sig/ont/fma/fma7088
T42589 7741-7762 Body_part denotes endoplasmic reticulum http://purl.org/sig/ont/fma/fma63842
T72751 7764-7766 Body_part denotes ER http://purl.org/sig/ont/fma/fma63842
T4655 7948-7959 Body_part denotes fatty acids http://purl.org/sig/ont/fma/fma82738
T71445 8147-8151 Body_part denotes lung http://purl.org/sig/ont/fma/fma7195
T81880 9621-9631 Body_part denotes troponin I http://purl.org/sig/ont/fma/fma62340
T52416 9621-9629 Body_part denotes troponin http://purl.org/sig/ont/fma/fma62338
T40327 9935-9943 Body_part denotes troponin http://purl.org/sig/ont/fma/fma62338
T73102 10010-10015 Body_part denotes heart http://purl.org/sig/ont/fma/fma7088
T47108 11346-11351 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646
T47317 11920-11928 Body_part denotes cytokine http://purl.org/sig/ont/fma/fma84050
T1995 12170-12178 Body_part denotes Cytokine http://purl.org/sig/ont/fma/fma84050
T45371 12201-12206 Body_part denotes heart http://purl.org/sig/ont/fma/fma7088
T45617 12249-12257 Body_part denotes Cytokine http://purl.org/sig/ont/fma/fma84050
T24494 12381-12395 Body_part denotes cardiomyocytes http://purl.org/sig/ont/fma/fma14067
T3398 13533-13538 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646
T88788 13607-13619 Body_part denotes cell surface http://purl.org/sig/ont/fma/fma67653
T22811 13607-13611 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646
T77558 13769-13778 Body_part denotes cytokines http://purl.org/sig/ont/fma/fma84050
T39426 13781-13789 Body_part denotes Cytokine http://purl.org/sig/ont/fma/fma84050
T46176 13969-13978 Body_part denotes cytokines http://purl.org/sig/ont/fma/fma84050
T75133 13980-13984 Body_part denotes IL-1 http://purl.org/sig/ont/fma/fma86583
T75911 14055-14061 Body_part denotes tissue http://purl.org/sig/ont/fma/fma9637
T73994 14289-14315 Body_part denotes sympathetic nervous system http://purl.org/sig/ont/fma/fma9906
T29906 14574-14582 Body_part denotes platelet http://purl.org/sig/ont/fma/fma62851
T7234 14804-14814 Body_part denotes Fibroblast http://purl.org/sig/ont/fma/fma63877
T47304 14834-14845 Body_part denotes Interleukin http://purl.org/sig/ont/fma/fma86578
T54282 14871-14879 Body_part denotes Monocyte http://purl.org/sig/ont/fma/fma62864
T42464 14896-14903 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T97113 14967-14972 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646
T66341 15019-15026 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T39951 15284-15290 Body_part denotes tissue http://purl.org/sig/ont/fma/fma9637
T79927 15405-15415 Body_part denotes myocardium http://purl.org/sig/ont/fma/fma9462
T80807 15590-15593 Body_part denotes RNA http://purl.org/sig/ont/fma/fma67095
T66311 15640-15645 Body_part denotes heart http://purl.org/sig/ont/fma/fma7088
T12094 15762-15776 Body_part denotes cardiomyocytes http://purl.org/sig/ont/fma/fma14067
T18588 16148-16152 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646
T98401 16206-16210 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646
T41658 16292-16297 Body_part denotes heart http://purl.org/sig/ont/fma/fma7088
T3586 16306-16310 Body_part denotes lung http://purl.org/sig/ont/fma/fma7195
T76363 16664-16670 Body_part denotes tissue http://purl.org/sig/ont/fma/fma9637
T34163 16884-16892 Body_part denotes cytokine http://purl.org/sig/ont/fma/fma84050
T79748 17192-17201 Body_part denotes cytokines http://purl.org/sig/ont/fma/fma84050
T71372 17212-17220 Body_part denotes cytokine http://purl.org/sig/ont/fma/fma84050
T48333 17297-17306 Body_part denotes Cytokines http://purl.org/sig/ont/fma/fma84050
T99663 17596-17601 Body_part denotes organ http://purl.org/sig/ont/fma/fma67498
T68092 17745-17754 Body_part denotes cytokines http://purl.org/sig/ont/fma/fma84050
T25052 17764-17777 Body_part denotes interleukin-6 http://purl.org/sig/ont/fma/fma264829
T67470 17811-17815 Body_part denotes IL-1 http://purl.org/sig/ont/fma/fma86583
T53146 17863-17874 Body_part denotes granulocyte http://purl.org/sig/ont/fma/fma62854
T80241 17875-17885 Body_part denotes macrophage http://purl.org/sig/ont/fma/fma63261
T47092 17913-17923 Body_part denotes fibroblast http://purl.org/sig/ont/fma/fma63877
T62920 17939-17949 Body_part denotes macrophage http://purl.org/sig/ont/fma/fma63261
T53553 17963-17970 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T91620 17980-17988 Body_part denotes platelet http://purl.org/sig/ont/fma/fma62851
T8281 18012-18020 Body_part denotes monocyte http://purl.org/sig/ont/fma/fma62864
T32547 18037-18044 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T79096 18091-18096 Body_part denotes serum http://purl.org/sig/ont/fma/fma63083
T95711 18323-18328 Body_part denotes serum http://purl.org/sig/ont/fma/fma63083
T73887 18329-18337 Body_part denotes cytokine http://purl.org/sig/ont/fma/fma84050
T18274 18500-18505 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646
T77105 18553-18566 Body_part denotes blood vessels http://purl.org/sig/ont/fma/fma63183
T65205 18553-18558 Body_part denotes blood http://purl.org/sig/ont/fma/fma9670
T73050 18611-18620 Body_part denotes monocytes http://purl.org/sig/ont/fma/fma62864
T60965 18622-18633 Body_part denotes macrophages http://purl.org/sig/ont/fma/fma63261
T51778 18638-18649 Body_part denotes neutrophils http://purl.org/sig/ont/fma/fma62860
T44581 18663-18674 Body_part denotes body organs http://purl.org/sig/ont/fma/fma45734
T18123 18663-18667 Body_part denotes body http://purl.org/sig/ont/fma/fma256135
T94371 18791-18799 Body_part denotes cytokine http://purl.org/sig/ont/fma/fma84050
T91287 19301-19309 Body_part denotes cytokine http://purl.org/sig/ont/fma/fma84050
T609 19370-19375 Body_part denotes organ http://purl.org/sig/ont/fma/fma67498
T37058 19542-19550 Body_part denotes cytokine http://purl.org/sig/ont/fma/fma84050
T88926 19677-19682 Body_part denotes serum http://purl.org/sig/ont/fma/fma63083
T96290 20111-20119 Body_part denotes cytokine http://purl.org/sig/ont/fma/fma84050
T24819 20158-20163 Body_part denotes organ http://purl.org/sig/ont/fma/fma67498
T11221 20222-20230 Body_part denotes cytokine http://purl.org/sig/ont/fma/fma84050
T352 20738-20745 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T26125 21091-21099 Body_part denotes cytokine http://purl.org/sig/ont/fma/fma84050
T63021 21510-21514 Body_part denotes lung http://purl.org/sig/ont/fma/fma7195
T53541 21800-21808 Body_part denotes cytokine http://purl.org/sig/ont/fma/fma84050
T119 22628-22636 Body_part denotes cytokine http://purl.org/sig/ont/fma/fma84050
T120 23009-23013 Body_part denotes lung http://purl.org/sig/ont/fma/fma7195
T121 23073-23081 Body_part denotes cytokine http://purl.org/sig/ont/fma/fma84050
T122 23139-23144 Body_part denotes chest http://purl.org/sig/ont/fma/fma9576
T123 23248-23256 Body_part denotes cytokine http://purl.org/sig/ont/fma/fma84050
T124 23286-23290 Body_part denotes IL-1 http://purl.org/sig/ont/fma/fma86583
T125 23605-23609 Body_part denotes lung http://purl.org/sig/ont/fma/fma7195
T126 23980-23984 Body_part denotes lung http://purl.org/sig/ont/fma/fma7195
T127 24600-24613 Body_part denotes immune system http://purl.org/sig/ont/fma/fma9825
T128 24802-24814 Body_part denotes lipoproteins http://purl.org/sig/ont/fma/fma63169
T129 24816-24824 Body_part denotes proteins http://purl.org/sig/ont/fma/fma67257
T130 24995-25000 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646
T131 25069-25076 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T132 25496-25503 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T133 25620-25627 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T134 25970-25979 Body_part denotes cytokines http://purl.org/sig/ont/fma/fma84050
T135 25984-25997 Body_part denotes interleukin-1 http://purl.org/sig/ont/fma/fma86583
T136 26004-26008 Body_part denotes IL-1 http://purl.org/sig/ont/fma/fma86583
T137 26077-26081 Body_part denotes IL-1 http://purl.org/sig/ont/fma/fma86583
T138 26246-26252 Body_part denotes tissue http://purl.org/sig/ont/fma/fma9637
T139 26663-26678 Body_part denotes coronary artery http://purl.org/sig/ont/fma/fma49893
T140 26776-26784 Body_part denotes cytokine http://purl.org/sig/ont/fma/fma84050
T141 26880-26887 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T142 27126-27135 Body_part denotes cytokines http://purl.org/sig/ont/fma/fma84050
T143 27220-27229 Body_part denotes cytokines http://purl.org/sig/ont/fma/fma84050
T144 27403-27407 Body_part denotes IL-1 http://purl.org/sig/ont/fma/fma86583
T145 27884-27889 Body_part denotes serum http://purl.org/sig/ont/fma/fma63083
T146 28879-28887 Body_part denotes cytokine http://purl.org/sig/ont/fma/fma84050
T147 29154-29175 Body_part denotes cardiovascular system http://purl.org/sig/ont/fma/fma7161
T148 29461-29469 Body_part denotes platelet http://purl.org/sig/ont/fma/fma62851
T149 29739-29744 Body_part denotes blood http://purl.org/sig/ont/fma/fma9670
T150 30255-30260 Body_part denotes blood http://purl.org/sig/ont/fma/fma9670
T151 30597-30605 Body_part denotes platelet http://purl.org/sig/ont/fma/fma62851
T152 30748-30755 Body_part denotes Heparin http://purl.org/sig/ont/fma/fma82839
T153 30924-30931 Body_part denotes heparin http://purl.org/sig/ont/fma/fma82839
T154 30940-30947 Body_part denotes heparin http://purl.org/sig/ont/fma/fma82839
T155 30991-30996 Body_part denotes heart http://purl.org/sig/ont/fma/fma7088
T156 31015-31022 Body_part denotes heparin http://purl.org/sig/ont/fma/fma82839
T157 31037-31044 Body_part denotes heparin http://purl.org/sig/ont/fma/fma82839
T158 31110-31117 Body_part denotes heparin http://purl.org/sig/ont/fma/fma82839
T159 31218-31225 Body_part denotes heparin http://purl.org/sig/ont/fma/fma82839
T160 31234-31241 Body_part denotes heparin http://purl.org/sig/ont/fma/fma82839
T161 31406-31413 Body_part denotes Heparin http://purl.org/sig/ont/fma/fma82839
T162 31905-31912 Body_part denotes heparin http://purl.org/sig/ont/fma/fma82839
T163 32247-32249 Body_part denotes h4 http://purl.org/sig/ont/fma/fma84132
T164 32347-32355 Body_part denotes alveolar http://purl.org/sig/ont/fma/fma264783
T165 32418-32428 Body_part denotes lymphocyte http://purl.org/sig/ont/fma/fma62863
T166 32948-32953 Body_part denotes lipid http://purl.org/sig/ont/fma/fma67264
T167 32973-32994 Body_part denotes cardiovascular system http://purl.org/sig/ont/fma/fma7161
T168 33051-33056 Body_part denotes serum http://purl.org/sig/ont/fma/fma63083
T169 33080-33091 Body_part denotes fatty acids http://purl.org/sig/ont/fma/fma82738
T170 33102-33109 Body_part denotes glucose http://purl.org/sig/ont/fma/fma82743
T171 33295-33300 Body_part denotes lipid http://purl.org/sig/ont/fma/fma67264
T172 33687-33692 Body_part denotes lipid http://purl.org/sig/ont/fma/fma67264
T173 33871-33875 Body_part denotes lung http://purl.org/sig/ont/fma/fma7195
T174 34250-34264 Body_part denotes cardiomyocytes http://purl.org/sig/ont/fma/fma14067
T175 34488-34493 Body_part denotes heart http://purl.org/sig/ont/fma/fma7088
T176 34816-34831 Body_part denotes coronary artery http://purl.org/sig/ont/fma/fma49893
T177 36188-36196 Body_part denotes troponin http://purl.org/sig/ont/fma/fma62338
T178 36224-36231 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T179 36482-36490 Body_part denotes troponin http://purl.org/sig/ont/fma/fma62338
T180 38691-38696 Body_part denotes heart http://purl.org/sig/ont/fma/fma7088
T181 38897-38905 Body_part denotes troponin http://purl.org/sig/ont/fma/fma62338
T182 39310-39318 Body_part denotes troponin http://purl.org/sig/ont/fma/fma62338
T183 39522-39530 Body_part denotes cytokine http://purl.org/sig/ont/fma/fma84050
T184 39731-39734 Body_part denotes arm http://purl.org/sig/ont/fma/fma24890
T185 39935-39940 Body_part denotes organ http://purl.org/sig/ont/fma/fma67498
T186 39964-39972 Body_part denotes capsules http://purl.org/sig/ont/fma/fma85272
T187 39997-40002 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646
T188 40132-40140 Body_part denotes cytokine http://purl.org/sig/ont/fma/fma84050
T189 40162-40167 Body_part denotes organ http://purl.org/sig/ont/fma/fma67498
T190 40813-40816 Body_part denotes arm http://purl.org/sig/ont/fma/fma24890
T191 40958-40963 Body_part denotes organ http://purl.org/sig/ont/fma/fma67498
T192 41117-41125 Body_part denotes Cytokine http://purl.org/sig/ont/fma/fma84050
T193 41268-41277 Body_part denotes cytokines http://purl.org/sig/ont/fma/fma84050
T194 41571-41580 Body_part denotes melatonin http://purl.org/sig/ont/fma/fma74644
T195 41689-41698 Body_part denotes Melatonin http://purl.org/sig/ont/fma/fma74644
T196 41956-41964 Body_part denotes cytokine http://purl.org/sig/ont/fma/fma84050
T197 42472-42483 Body_part denotes interleukin http://purl.org/sig/ont/fma/fma86578
T198 42495-42503 Body_part denotes cytokine http://purl.org/sig/ont/fma/fma84050
T199 42561-42569 Body_part denotes cytokine http://purl.org/sig/ont/fma/fma84050
T200 42606-42610 Body_part denotes IL-1 http://purl.org/sig/ont/fma/fma86583
T201 43060-43068 Body_part denotes Cytokine http://purl.org/sig/ont/fma/fma84050
T202 43243-43248 Body_part denotes serum http://purl.org/sig/ont/fma/fma63083
T203 44474-44482 Body_part denotes cytokine http://purl.org/sig/ont/fma/fma84050
T204 44870-44875 Body_part denotes organ http://purl.org/sig/ont/fma/fma67498
T205 45260-45270 Body_part denotes fatty acid http://purl.org/sig/ont/fma/fma82738
T206 45375-45383 Body_part denotes capsules http://purl.org/sig/ont/fma/fma85272
T207 45630-45640 Body_part denotes fatty acid http://purl.org/sig/ont/fma/fma82738
T208 45672-45680 Body_part denotes capsules http://purl.org/sig/ont/fma/fma85272
T209 45773-45781 Body_part denotes cytokine http://purl.org/sig/ont/fma/fma84050
T210 45975-45990 Body_part denotes coronary artery http://purl.org/sig/ont/fma/fma49893
T211 46843-46864 Body_part denotes cardiovascular system http://purl.org/sig/ont/fma/fma7161
T212 47574-47595 Body_part denotes cardiovascular system http://purl.org/sig/ont/fma/fma7161
T213 47966-47970 Body_part denotes lung http://purl.org/sig/ont/fma/fma7195
T214 49398-49421 Body_part denotes upper respiratory tract http://purl.org/sig/ont/fma/fma45661
T215 49509-49514 Body_part denotes blood http://purl.org/sig/ont/fma/fma9670
T216 52011-52022 Body_part denotes fatty acids http://purl.org/sig/ont/fma/fma82738
T217 52058-52069 Body_part denotes fatty acids http://purl.org/sig/ont/fma/fma82738
T218 52096-52107 Body_part denotes fatty acids http://purl.org/sig/ont/fma/fma82738
T219 52235-52239 Body_part denotes body http://purl.org/sig/ont/fma/fma256135
T220 52539-52546 Body_part denotes tissues http://purl.org/sig/ont/fma/fma9637
T221 52719-52730 Body_part denotes fatty acids http://purl.org/sig/ont/fma/fma82738
T222 53379-53383 Body_part denotes body http://purl.org/sig/ont/fma/fma256135
T223 53399-53412 Body_part denotes immune system http://purl.org/sig/ont/fma/fma9825
T224 53508-53519 Body_part denotes fatty acids http://purl.org/sig/ont/fma/fma82738
T225 54170-54177 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T226 54215-54225 Body_part denotes neutrophil http://purl.org/sig/ont/fma/fma62860
T227 54359-54379 Body_part denotes alveolar macrophages http://purl.org/sig/ont/fma/fma83023
T228 54663-54679 Body_part denotes epithelial cells http://purl.org/sig/ont/fma/fma66768
T229 54674-54679 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646
T230 54812-54819 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T231 55074-55079 Body_part denotes lungs http://purl.org/sig/ont/fma/fma68877
T232 55770-55775 Body_part denotes organ http://purl.org/sig/ont/fma/fma67498
T233 56897-56902 Body_part denotes lipid http://purl.org/sig/ont/fma/fma67264
T234 57432-57440 Body_part denotes cytokine http://purl.org/sig/ont/fma/fma84050
T235 58485-58493 Body_part denotes capsules http://purl.org/sig/ont/fma/fma85272
T236 59109-59120 Body_part denotes fatty acids http://purl.org/sig/ont/fma/fma82738
T237 59205-59210 Body_part denotes lipid http://purl.org/sig/ont/fma/fma67264
T238 59768-59774 Body_part denotes plasma http://purl.org/sig/ont/fma/fma62970
T239 60054-60059 Body_part denotes Heart http://purl.org/sig/ont/fma/fma7088
T240 60146-60151 Body_part denotes heart http://purl.org/sig/ont/fma/fma7088
T241 60468-60489 Body_part denotes cardiovascular system http://purl.org/sig/ont/fma/fma7161
T242 60565-60570 Body_part denotes lipid http://purl.org/sig/ont/fma/fma67264
T243 60603-60614 Body_part denotes fatty acids http://purl.org/sig/ont/fma/fma82738
T244 60813-60827 Body_part denotes cell membranes http://purl.org/sig/ont/fma/fma63841
T245 60813-60817 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646
T246 60842-60847 Body_part denotes lipid http://purl.org/sig/ont/fma/fma67264
T247 60896-60905 Body_part denotes organelle http://purl.org/sig/ont/fma/fma63832
T248 61569-61579 Body_part denotes chemokines http://purl.org/sig/ont/fma/fma241981
T249 61581-61590 Body_part denotes cytokines http://purl.org/sig/ont/fma/fma84050
T250 62055-62060 Body_part denotes heart http://purl.org/sig/ont/fma/fma7088
T251 62371-62377 Body_part denotes tissue http://purl.org/sig/ont/fma/fma9637
T252 63417-63423 Body_part denotes tissue http://purl.org/sig/ont/fma/fma9637
T253 63717-63724 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T254 63730-63741 Body_part denotes Interleukin http://purl.org/sig/ont/fma/fma86578
T255 63750-63767 Body_part denotes Mitochondrial DNA http://purl.org/sig/ont/fma/fma67199
T256 63764-63767 Body_part denotes DNA http://purl.org/sig/ont/fma/fma74412
T257 63792-63802 Body_part denotes fatty acid http://purl.org/sig/ont/fma/fma82738
T258 63996-64009 Body_part denotes immune system http://purl.org/sig/ont/fma/fma9825
T259 64538-64547 Body_part denotes cytokines http://purl.org/sig/ont/fma/fma84050
T260 64549-64559 Body_part denotes chemokines http://purl.org/sig/ont/fma/fma241981
T261 64956-64969 Body_part denotes cell membrane http://purl.org/sig/ont/fma/fma63841
T262 64956-64960 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646
T263 65270-65279 Body_part denotes Chemokine http://purl.org/sig/ont/fma/fma241981
T264 65457-65466 Body_part denotes G-protein http://purl.org/sig/ont/fma/fma61788
T265 65489-65500 Body_part denotes Interleukin http://purl.org/sig/ont/fma/fma86578
T266 65561-65571 Body_part denotes fatty acid http://purl.org/sig/ont/fma/fma82738
T267 65633-65638 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646
T268 65685-65692 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T269 65716-65718 Body_part denotes A2 http://purl.org/sig/ont/fma/fma66595
T270 65743-65754 Body_part denotes neutrophils http://purl.org/sig/ont/fma/fma62860
T271 65762-65772 Body_part denotes Peroxisome http://purl.org/sig/ont/fma/fma63845
T272 66043-66053 Body_part denotes macrophage http://purl.org/sig/ont/fma/fma63261
T273 66066-66074 Body_part denotes cytokine http://purl.org/sig/ont/fma/fma84050
T274 66166-66170 Body_part denotes IL-1 http://purl.org/sig/ont/fma/fma86583
T275 66287-66308 Body_part denotes cardiovascular system http://purl.org/sig/ont/fma/fma7161
T276 67156-67162 Body_part denotes plasma http://purl.org/sig/ont/fma/fma62970
T277 67179-67183 Body_part denotes IL-1 http://purl.org/sig/ont/fma/fma86583
T278 67272-67275 Body_part denotes leg http://purl.org/sig/ont/fma/fma24979
T279 67526-67534 Body_part denotes cytokine http://purl.org/sig/ont/fma/fma84050
T280 67547-67551 Body_part denotes IL-1 http://purl.org/sig/ont/fma/fma86583
T281 67652-67661 Body_part denotes cytokines http://purl.org/sig/ont/fma/fma84050
T282 67663-67673 Body_part denotes chemokines http://purl.org/sig/ont/fma/fma241981
T283 67700-67714 Body_part denotes cardiomyocytes http://purl.org/sig/ont/fma/fma14067
T284 67716-67727 Body_part denotes fibroblasts http://purl.org/sig/ont/fma/fma63877
T285 67729-67746 Body_part denotes endothelial cells http://purl.org/sig/ont/fma/fma66772
T286 67741-67746 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646
T287 67748-67757 Body_part denotes monocytes http://purl.org/sig/ont/fma/fma62864
T288 67762-67773 Body_part denotes macrophages http://purl.org/sig/ont/fma/fma63261
T289 68232-68242 Body_part denotes peroxisome http://purl.org/sig/ont/fma/fma63845
T290 68766-68774 Body_part denotes cytokine http://purl.org/sig/ont/fma/fma84050
T291 68993-69002 Body_part denotes G protein http://purl.org/sig/ont/fma/fma61788
T292 69169-69178 Body_part denotes monocytic http://purl.org/sig/ont/fma/fma62864
T293 69189-69194 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646
T294 69223-69234 Body_part denotes macrophages http://purl.org/sig/ont/fma/fma63261
T295 69529-69540 Body_part denotes macrophages http://purl.org/sig/ont/fma/fma63261
T296 69597-69606 Body_part denotes monocytes http://purl.org/sig/ont/fma/fma62864
T297 69649-69660 Body_part denotes macrophages http://purl.org/sig/ont/fma/fma63261
T298 69690-69701 Body_part denotes macrophages http://purl.org/sig/ont/fma/fma63261
T299 69752-69757 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646
T300 69835-69846 Body_part denotes macrophages http://purl.org/sig/ont/fma/fma63261
T301 70023-70029 Body_part denotes tissue http://purl.org/sig/ont/fma/fma9637
T302 70103-70114 Body_part denotes macrophages http://purl.org/sig/ont/fma/fma63261
T303 70122-70132 Body_part denotes myocardium http://purl.org/sig/ont/fma/fma9462
T304 70438-70449 Body_part denotes macrophages http://purl.org/sig/ont/fma/fma63261
T305 70511-70522 Body_part denotes macrophages http://purl.org/sig/ont/fma/fma63261
T306 70550-70560 Body_part denotes chemokines http://purl.org/sig/ont/fma/fma241981
T307 70565-70574 Body_part denotes cytokines http://purl.org/sig/ont/fma/fma84050
T308 70593-70597 Body_part denotes IL-1 http://purl.org/sig/ont/fma/fma86583
T309 70636-70641 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646
T310 70680-70693 Body_part denotes immune system http://purl.org/sig/ont/fma/fma9825
T311 70754-70765 Body_part denotes macrophages http://purl.org/sig/ont/fma/fma63261
T312 71087-71091 Body_part denotes IL-1 http://purl.org/sig/ont/fma/fma86583
T313 71116-71127 Body_part denotes macrophages http://purl.org/sig/ont/fma/fma63261
T314 71373-71382 Body_part denotes cytokines http://purl.org/sig/ont/fma/fma84050
T315 71398-71409 Body_part denotes macrophages http://purl.org/sig/ont/fma/fma63261
T316 71648-71658 Body_part denotes macrophage http://purl.org/sig/ont/fma/fma63261
T317 71659-71663 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646
T318 71708-71719 Body_part denotes macrophages http://purl.org/sig/ont/fma/fma63261
T319 71850-71868 Body_part denotes lipopolysaccharide http://purl.org/sig/ont/fma/fma82785
T320 71870-71873 Body_part denotes LPS http://purl.org/sig/ont/fma/fma82785
T321 71910-71915 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646
T322 71920-71942 Body_part denotes peritoneal macrophages http://purl.org/sig/ont/fma/fma83025
T323 72171-72182 Body_part denotes macrophages http://purl.org/sig/ont/fma/fma63261
T324 72421-72426 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646
T325 72510-72521 Body_part denotes macrophages http://purl.org/sig/ont/fma/fma63261
T326 72584-72601 Body_part denotes cellular membrane http://purl.org/sig/ont/fma/fma63841
T327 72845-72855 Body_part denotes macrophage http://purl.org/sig/ont/fma/fma63261
T328 72856-72860 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646
T329 72885-72896 Body_part denotes macrophages http://purl.org/sig/ont/fma/fma63261
T330 72938-72944 Body_part denotes tissue http://purl.org/sig/ont/fma/fma9637
T331 73076-73089 Body_part denotes immune system http://purl.org/sig/ont/fma/fma9825
T332 73140-73161 Body_part denotes cardiovascular system http://purl.org/sig/ont/fma/fma7161
T333 74130-74135 Body_part denotes lipid http://purl.org/sig/ont/fma/fma67264
T334 74392-74397 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646
T335 74409-74424 Body_part denotes dendritic cells http://purl.org/sig/ont/fma/fma273565
T336 74419-74424 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646
T337 74426-74437 Body_part denotes macrophages http://purl.org/sig/ont/fma/fma63261
T338 74439-74450 Body_part denotes fibroblasts http://purl.org/sig/ont/fma/fma63877
T339 74455-74472 Body_part denotes endothelial cells http://purl.org/sig/ont/fma/fma66772
T340 74467-74472 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646
T341 74616-74622 Body_part denotes tissue http://purl.org/sig/ont/fma/fma9637
T342 74633-74644 Body_part denotes neutrophils http://purl.org/sig/ont/fma/fma62860
T343 74646-74656 Body_part denotes mast cells http://purl.org/sig/ont/fma/fma66784
T344 74651-74656 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646
T345 74661-74672 Body_part denotes macrophages http://purl.org/sig/ont/fma/fma63261
T346 74717-74722 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646
T347 75347-75352 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646
T348 76861-76867 Body_part denotes tissue http://purl.org/sig/ont/fma/fma9637
T349 76908-76914 Body_part denotes tissue http://purl.org/sig/ont/fma/fma9637
T350 77175-77186 Body_part denotes neutrophils http://purl.org/sig/ont/fma/fma62860
T351 77191-77200 Body_part denotes monocytes http://purl.org/sig/ont/fma/fma62864
T22449 77208-77224 Body_part denotes epithelial cells http://purl.org/sig/ont/fma/fma66768
T353 77219-77224 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646
T354 77277-77287 Body_part denotes leukocytes http://purl.org/sig/ont/fma/fma62852
T355 77299-77304 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646
T356 77439-77445 Body_part denotes tissue http://purl.org/sig/ont/fma/fma9637
T357 77459-77470 Body_part denotes neutrophils http://purl.org/sig/ont/fma/fma62860
T358 77531-77542 Body_part denotes neutrophils http://purl.org/sig/ont/fma/fma62860
T359 77602-77611 Body_part denotes chemokine http://purl.org/sig/ont/fma/fma241981
T360 77796-77804 Body_part denotes cytokine http://purl.org/sig/ont/fma/fma84050
T361 77831-77840 Body_part denotes leukocyte http://purl.org/sig/ont/fma/fma62852
T362 77984-77995 Body_part denotes neutrophils http://purl.org/sig/ont/fma/fma62860
T363 78004-78014 Body_part denotes neutrophil http://purl.org/sig/ont/fma/fma62860
T364 78042-78053 Body_part denotes macrophages http://purl.org/sig/ont/fma/fma63261
T365 78088-78097 Body_part denotes chemokine http://purl.org/sig/ont/fma/fma241981
T366 78418-78422 Body_part denotes IL-1 http://purl.org/sig/ont/fma/fma86583
T367 78779-78784 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646
T368 78797-78801 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646
T369 78802-78810 Body_part denotes antibody http://purl.org/sig/ont/fma/fma62871
T370 78836-78840 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646
T371 78863-78871 Body_part denotes antibody http://purl.org/sig/ont/fma/fma62871
T372 78882-78886 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646
T373 79211-79222 Body_part denotes macrophages http://purl.org/sig/ont/fma/fma63261
T374 79358-79368 Body_part denotes macrophage http://purl.org/sig/ont/fma/fma63261
T375 79464-79473 Body_part denotes cytokines http://purl.org/sig/ont/fma/fma84050
T376 79474-79484 Body_part denotes chemokines http://purl.org/sig/ont/fma/fma241981
T377 79514-79523 Body_part denotes chemokine http://purl.org/sig/ont/fma/fma241981
T378 79538-79547 Body_part denotes chemokine http://purl.org/sig/ont/fma/fma241981
T379 79567-79578 Body_part denotes macrophages http://purl.org/sig/ont/fma/fma63261
T380 79601-79605 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646
T381 79689-79700 Body_part denotes macrophages http://purl.org/sig/ont/fma/fma63261
T382 79783-79789 Body_part denotes tissue http://purl.org/sig/ont/fma/fma9637
T383 79917-79927 Body_part denotes macrophage http://purl.org/sig/ont/fma/fma63261
T384 80074-80085 Body_part denotes macrophages http://purl.org/sig/ont/fma/fma63261
T385 80274-80285 Body_part denotes macrophages http://purl.org/sig/ont/fma/fma63261
T386 80296-80301 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646
T387 80774-80777 Body_part denotes LPS http://purl.org/sig/ont/fma/fma82785
T388 80890-80900 Body_part denotes neutrophil http://purl.org/sig/ont/fma/fma62860
T389 80972-80981 Body_part denotes cytokines http://purl.org/sig/ont/fma/fma84050
T390 80987-81007 Body_part denotes alveolar macrophages http://purl.org/sig/ont/fma/fma83023
T391 81300-81309 Body_part denotes cytokines http://purl.org/sig/ont/fma/fma84050
T392 81947-81955 Body_part denotes cytokine http://purl.org/sig/ont/fma/fma84050
T393 82338-82359 Body_part denotes cardiovascular system http://purl.org/sig/ont/fma/fma7161
T394 82782-82788 Body_part denotes tissue http://purl.org/sig/ont/fma/fma9637
T395 83703-83712 Body_part denotes leukocyte http://purl.org/sig/ont/fma/fma62852
T396 83754-83770 Body_part denotes endothelial cell http://purl.org/sig/ont/fma/fma66772
T397 83766-83770 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646
T398 83939-83949 Body_part denotes intestinal http://purl.org/sig/ont/fma/fma7199
T399 83967-83973 Body_part denotes kidney http://purl.org/sig/ont/fma/fma7203
T400 84124-84128 Body_part denotes lung http://purl.org/sig/ont/fma/fma7195
T401 84129-84135 Body_part denotes tissue http://purl.org/sig/ont/fma/fma9637
T402 84182-84186 Body_part denotes lung http://purl.org/sig/ont/fma/fma7195
T403 84598-84609 Body_part denotes spinal cord http://purl.org/sig/ont/fma/fma7647
T404 84724-84734 Body_part denotes fatty acid http://purl.org/sig/ont/fma/fma82738
T405 84943-84946 Body_part denotes LPS http://purl.org/sig/ont/fma/fma82785
T406 85088-85093 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646
T407 85123-85126 Body_part denotes LPS http://purl.org/sig/ont/fma/fma82785
T408 85176-85183 Body_part denotes histone http://purl.org/sig/ont/fma/fma74413
T409 85718-85731 Body_part denotes cell membrane http://purl.org/sig/ont/fma/fma63841
T410 85718-85722 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646
T411 85775-85780 Body_part denotes lipid http://purl.org/sig/ont/fma/fma67264
T412 85795-85799 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646
T413 85842-85854 Body_part denotes phospholipid http://purl.org/sig/ont/fma/fma82779
T414 85971-85976 Body_part denotes lipid http://purl.org/sig/ont/fma/fma67264
T415 86257-86264 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T416 86310-86318 Body_part denotes cytokine http://purl.org/sig/ont/fma/fma84050
T417 86333-86337 Body_part denotes gene http://purl.org/sig/ont/fma/fma74402
T418 86696-86711 Body_part denotes dendritic cells http://purl.org/sig/ont/fma/fma273565
T419 86706-86711 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646
T420 86713-86723 Body_part denotes macrophage http://purl.org/sig/ont/fma/fma63261
T421 86745-86749 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646
T422 87063-87079 Body_part denotes plasma membranes http://purl.org/sig/ont/fma/fma63841
T423 87090-87107 Body_part denotes endothelial cells http://purl.org/sig/ont/fma/fma66772
T424 87102-87107 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646
T425 87138-87150 Body_part denotes phospholipid http://purl.org/sig/ont/fma/fma82779
T426 87226-87230 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646
T427 87281-87294 Body_part denotes phospholipids http://purl.org/sig/ont/fma/fma82779
T428 87373-87378 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646
T429 87387-87396 Body_part denotes monocytes http://purl.org/sig/ont/fma/fma62864
T430 87398-87409 Body_part denotes neutrophils http://purl.org/sig/ont/fma/fma62860
T431 87411-87422 Body_part denotes macrophages http://purl.org/sig/ont/fma/fma63261
T432 87427-87438 Body_part denotes lymphocytes http://purl.org/sig/ont/fma/fma62863
T433 87629-87631 Body_part denotes A2 http://purl.org/sig/ont/fma/fma66595
T434 87654-87667 Body_part denotes cell membrane http://purl.org/sig/ont/fma/fma63841
T435 87654-87658 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646
T436 87932-87945 Body_part denotes cell membrane http://purl.org/sig/ont/fma/fma63841
T437 87932-87936 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646
T438 87969-87973 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646
T439 88273-88286 Body_part denotes phospholipids http://purl.org/sig/ont/fma/fma82779
T440 88583-88594 Body_part denotes body organs http://purl.org/sig/ont/fma/fma45734
T441 88583-88587 Body_part denotes body http://purl.org/sig/ont/fma/fma256135
T442 88639-88660 Body_part denotes cardiovascular system http://purl.org/sig/ont/fma/fma7161
T443 89927-89933 Body_part denotes muscle http://purl.org/sig/ont/fma/fma32558
T444 90865-90874 Body_part denotes cytokines http://purl.org/sig/ont/fma/fma84050
T445 90882-90886 Body_part denotes IL-1 http://purl.org/sig/ont/fma/fma86583
T446 90911-90916 Body_part denotes serum http://purl.org/sig/ont/fma/fma63083
T447 91079-91083 Body_part denotes Shin http://purl.org/sig/ont/fma/fma24985
T448 91276-91298 Body_part denotes mitochondrial membrane http://purl.org/sig/ont/fma/fma66861
T449 91352-91356 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646
T450 91479-91488 Body_part denotes cytokines http://purl.org/sig/ont/fma/fma84050
T451 91790-91793 Body_part denotes RNA http://purl.org/sig/ont/fma/fma67095
T452 91798-91801 Body_part denotes RNA http://purl.org/sig/ont/fma/fma67095
T453 91896-91902 Body_part denotes cell's http://purl.org/sig/ont/fma/fma68646
T454 92040-92046 Body_part denotes cell's http://purl.org/sig/ont/fma/fma68646
T455 92174-92191 Body_part denotes mitochondrial DNA http://purl.org/sig/ont/fma/fma67199
T456 92188-92191 Body_part denotes DNA http://purl.org/sig/ont/fma/fma74412
T457 92207-92214 Body_part denotes cytosol http://purl.org/sig/ont/fma/fma66836
T458 92479-92488 Body_part denotes cytokines http://purl.org/sig/ont/fma/fma84050
T459 92518-92522 Body_part denotes IL-1 http://purl.org/sig/ont/fma/fma86583
T460 92627-92636 Body_part denotes cytokines http://purl.org/sig/ont/fma/fma84050
T461 93246-93268 Body_part denotes mitochondrial membrane http://purl.org/sig/ont/fma/fma66861
T462 93269-93281 Body_part denotes phospholipid http://purl.org/sig/ont/fma/fma82779
T463 94066-94071 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646
T464 94102-94105 Body_part denotes LPS http://purl.org/sig/ont/fma/fma82785
T465 94107-94111 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646
T466 94923-94934 Body_part denotes fatty acids http://purl.org/sig/ont/fma/fma82738
T467 95085-95098 Body_part denotes immune system http://purl.org/sig/ont/fma/fma9825
T468 95284-95289 Body_part denotes lipid http://purl.org/sig/ont/fma/fma67264
T469 95904-95912 Body_part denotes antibody http://purl.org/sig/ont/fma/fma62871
T470 95923-95928 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646
T471 96229-96234 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646
T472 96654-96658 Body_part denotes hand http://purl.org/sig/ont/fma/fma9712
T473 96660-96664 Body_part denotes foot http://purl.org/sig/ont/fma/fma9664
T474 96670-96675 Body_part denotes mouth http://purl.org/sig/ont/fma/fma49184
T475 97104-97108 Body_part denotes body http://purl.org/sig/ont/fma/fma256135
T476 97354-97367 Body_part denotes T lymphocytes http://purl.org/sig/ont/fma/fma62870
T477 97380-97384 Body_part denotes mRNA http://purl.org/sig/ont/fma/fma67122
T478 97583-97588 Body_part denotes serum http://purl.org/sig/ont/fma/fma63083
T479 97589-97605 Body_part denotes immunoglobulin G http://purl.org/sig/ont/fma/fma62872
T480 97610-97614 Body_part denotes lung http://purl.org/sig/ont/fma/fma7195
T481 97615-97631 Body_part denotes immunoglobulin A http://purl.org/sig/ont/fma/fma62874
T482 97726-97730 Body_part denotes lung http://purl.org/sig/ont/fma/fma7195
T483 97733-97737 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646
T484 98087-98091 Body_part denotes body http://purl.org/sig/ont/fma/fma256135

LitCovid-PD-UBERON

Id Subject Object Predicate Lexical cue uberon_id
T1 508-514 Body_part denotes organs http://purl.obolibrary.org/obo/UBERON_0000062
T2 555-576 Body_part denotes cardiovascular system http://purl.obolibrary.org/obo/UBERON_0004535
T3 1129-1150 Body_part denotes cardiovascular system http://purl.obolibrary.org/obo/UBERON_0004535
T4 3636-3659 Body_part denotes central nervous systems http://purl.obolibrary.org/obo/UBERON_0001017
T5 3766-3772 Body_part denotes organs http://purl.obolibrary.org/obo/UBERON_0000062
T6 3809-3829 Body_part denotes heart, blood vessels http://purl.obolibrary.org/obo/UBERON_0003498
T7 3809-3814 Body_part denotes heart http://purl.obolibrary.org/obo/UBERON_0000948
T8 3816-3821 Body_part denotes blood http://purl.obolibrary.org/obo/UBERON_0000178
T9 3822-3829 Body_part denotes vessels http://purl.obolibrary.org/obo/UBERON_0000055
T10 3858-3863 Body_part denotes brain http://purl.obolibrary.org/obo/UBERON_0000955
T11 4007-4030 Body_part denotes lower respiratory tract http://purl.obolibrary.org/obo/UBERON_0001558
T12 4013-4030 Body_part denotes respiratory tract http://purl.obolibrary.org/obo/UBERON_0000065
T13 4108-4112 Body_part denotes lung http://purl.obolibrary.org/obo/UBERON_0002048
T14 4200-4205 Body_part denotes heart http://purl.obolibrary.org/obo/UBERON_0000948
T15 5161-5166 Body_part denotes heart http://purl.obolibrary.org/obo/UBERON_0000948
T16 5699-5704 Body_part denotes organ http://purl.obolibrary.org/obo/UBERON_0000062
T17 7348-7353 Body_part denotes heart http://purl.obolibrary.org/obo/UBERON_0000948
T18 8147-8151 Body_part denotes lung http://purl.obolibrary.org/obo/UBERON_0002048
T19 10010-10015 Body_part denotes heart http://purl.obolibrary.org/obo/UBERON_0000948
T20 12201-12206 Body_part denotes heart http://purl.obolibrary.org/obo/UBERON_0000948
T21 14055-14061 Body_part denotes tissue http://purl.obolibrary.org/obo/UBERON_0000479
T22 14289-14315 Body_part denotes sympathetic nervous system http://purl.obolibrary.org/obo/UBERON_0000013
T23 14301-14315 Body_part denotes nervous system http://purl.obolibrary.org/obo/UBERON_0001016
T24 15284-15290 Body_part denotes tissue http://purl.obolibrary.org/obo/UBERON_0000479
T25 15405-15415 Body_part denotes myocardium http://purl.obolibrary.org/obo/UBERON_0002349
T26 15640-15645 Body_part denotes heart http://purl.obolibrary.org/obo/UBERON_0000948
T27 16292-16297 Body_part denotes heart http://purl.obolibrary.org/obo/UBERON_0000948
T28 16306-16310 Body_part denotes lung http://purl.obolibrary.org/obo/UBERON_0002048
T29 16664-16670 Body_part denotes tissue http://purl.obolibrary.org/obo/UBERON_0000479
T30 16738-16743 Body_part denotes scale http://purl.obolibrary.org/obo/UBERON_0002542
T31 17596-17601 Body_part denotes organ http://purl.obolibrary.org/obo/UBERON_0000062
T32 18091-18096 Body_part denotes serum http://purl.obolibrary.org/obo/UBERON_0001977
T33 18323-18328 Body_part denotes serum http://purl.obolibrary.org/obo/UBERON_0001977
T34 18553-18566 Body_part denotes blood vessels http://purl.obolibrary.org/obo/UBERON_0001981
T35 18553-18558 Body_part denotes blood http://purl.obolibrary.org/obo/UBERON_0000178
T36 18559-18566 Body_part denotes vessels http://purl.obolibrary.org/obo/UBERON_0000055
T37 18668-18674 Body_part denotes organs http://purl.obolibrary.org/obo/UBERON_0000062
T38 19370-19375 Body_part denotes organ http://purl.obolibrary.org/obo/UBERON_0000062
T39 19677-19682 Body_part denotes serum http://purl.obolibrary.org/obo/UBERON_0001977
T40 20158-20163 Body_part denotes organ http://purl.obolibrary.org/obo/UBERON_0000062
T41 21510-21514 Body_part denotes lung http://purl.obolibrary.org/obo/UBERON_0002048
T42 23009-23013 Body_part denotes lung http://purl.obolibrary.org/obo/UBERON_0002048
T43 23139-23144 Body_part denotes chest http://purl.obolibrary.org/obo/UBERON_0001443
T44 23605-23609 Body_part denotes lung http://purl.obolibrary.org/obo/UBERON_0002048
T45 23980-23984 Body_part denotes lung http://purl.obolibrary.org/obo/UBERON_0002048
T46 24600-24613 Body_part denotes immune system http://purl.obolibrary.org/obo/UBERON_0002405
T47 26246-26252 Body_part denotes tissue http://purl.obolibrary.org/obo/UBERON_0000479
T48 26663-26678 Body_part denotes coronary artery http://purl.obolibrary.org/obo/UBERON_0001621
T49 26672-26678 Body_part denotes artery http://purl.obolibrary.org/obo/UBERON_0001637
T50 27884-27889 Body_part denotes serum http://purl.obolibrary.org/obo/UBERON_0001977
T51 29057-29063 Body_part denotes organs http://purl.obolibrary.org/obo/UBERON_0000062
T52 29154-29175 Body_part denotes cardiovascular system http://purl.obolibrary.org/obo/UBERON_0004535
T53 29216-29222 Body_part denotes organs http://purl.obolibrary.org/obo/UBERON_0000062
T54 29739-29744 Body_part denotes blood http://purl.obolibrary.org/obo/UBERON_0000178
T55 30255-30266 Body_part denotes blood clots http://purl.obolibrary.org/obo/UBERON_0010210
T56 30255-30260 Body_part denotes blood http://purl.obolibrary.org/obo/UBERON_0000178
T57 30991-30996 Body_part denotes heart http://purl.obolibrary.org/obo/UBERON_0000948
T58 32973-32994 Body_part denotes cardiovascular system http://purl.obolibrary.org/obo/UBERON_0004535
T59 33051-33056 Body_part denotes serum http://purl.obolibrary.org/obo/UBERON_0001977
T60 33871-33875 Body_part denotes lung http://purl.obolibrary.org/obo/UBERON_0002048
T61 34488-34493 Body_part denotes heart http://purl.obolibrary.org/obo/UBERON_0000948
T62 34816-34831 Body_part denotes coronary artery http://purl.obolibrary.org/obo/UBERON_0001621
T63 34825-34831 Body_part denotes artery http://purl.obolibrary.org/obo/UBERON_0001637
T64 36332-36337 Body_part denotes scale http://purl.obolibrary.org/obo/UBERON_0002542
T65 38691-38696 Body_part denotes heart http://purl.obolibrary.org/obo/UBERON_0000948
T66 39731-39734 Body_part denotes arm http://purl.obolibrary.org/obo/UBERON_0001460
T67 39935-39940 Body_part denotes organ http://purl.obolibrary.org/obo/UBERON_0000062
T68 40162-40167 Body_part denotes organ http://purl.obolibrary.org/obo/UBERON_0000062
T69 40813-40816 Body_part denotes arm http://purl.obolibrary.org/obo/UBERON_0001460
T70 40958-40963 Body_part denotes organ http://purl.obolibrary.org/obo/UBERON_0000062
T71 43243-43248 Body_part denotes serum http://purl.obolibrary.org/obo/UBERON_0001977
T72 43560-43565 Body_part denotes scale http://purl.obolibrary.org/obo/UBERON_0002542
T73 44870-44875 Body_part denotes organ http://purl.obolibrary.org/obo/UBERON_0000062
T74 45975-45990 Body_part denotes coronary artery http://purl.obolibrary.org/obo/UBERON_0001621
T75 45984-45990 Body_part denotes artery http://purl.obolibrary.org/obo/UBERON_0001637
T76 46843-46864 Body_part denotes cardiovascular system http://purl.obolibrary.org/obo/UBERON_0004535
T77 47574-47595 Body_part denotes cardiovascular system http://purl.obolibrary.org/obo/UBERON_0004535
T78 47966-47970 Body_part denotes lung http://purl.obolibrary.org/obo/UBERON_0002048
T79 49398-49421 Body_part denotes upper respiratory tract http://purl.obolibrary.org/obo/UBERON_0001557
T80 49404-49421 Body_part denotes respiratory tract http://purl.obolibrary.org/obo/UBERON_0000065
T81 49509-49514 Body_part denotes blood http://purl.obolibrary.org/obo/UBERON_0000178
T82 51199-51204 Body_part denotes scale http://purl.obolibrary.org/obo/UBERON_0002542
T83 53399-53412 Body_part denotes immune system http://purl.obolibrary.org/obo/UBERON_0002405
T84 55770-55775 Body_part denotes organ http://purl.obolibrary.org/obo/UBERON_0000062
T85 60054-60059 Body_part denotes Heart http://purl.obolibrary.org/obo/UBERON_0000948
T86 60146-60151 Body_part denotes heart http://purl.obolibrary.org/obo/UBERON_0000948
T87 60468-60489 Body_part denotes cardiovascular system http://purl.obolibrary.org/obo/UBERON_0004535
T88 62055-62060 Body_part denotes heart http://purl.obolibrary.org/obo/UBERON_0000948
T89 62371-62377 Body_part denotes tissue http://purl.obolibrary.org/obo/UBERON_0000479
T90 63417-63423 Body_part denotes tissue http://purl.obolibrary.org/obo/UBERON_0000479
T91 63996-64009 Body_part denotes immune system http://purl.obolibrary.org/obo/UBERON_0002405
T92 66287-66308 Body_part denotes cardiovascular system http://purl.obolibrary.org/obo/UBERON_0004535
T93 67272-67275 Body_part denotes leg http://purl.obolibrary.org/obo/UBERON_0000978
T94 70023-70029 Body_part denotes tissue http://purl.obolibrary.org/obo/UBERON_0000479
T95 70122-70132 Body_part denotes myocardium http://purl.obolibrary.org/obo/UBERON_0002349
T96 70680-70693 Body_part denotes immune system http://purl.obolibrary.org/obo/UBERON_0002405
T97 72938-72944 Body_part denotes tissue http://purl.obolibrary.org/obo/UBERON_0000479
T98 73076-73089 Body_part denotes immune system http://purl.obolibrary.org/obo/UBERON_0002405
T99 73140-73161 Body_part denotes cardiovascular system http://purl.obolibrary.org/obo/UBERON_0004535
T100 74616-74622 Body_part denotes tissue http://purl.obolibrary.org/obo/UBERON_0000479
T101 76861-76867 Body_part denotes tissue http://purl.obolibrary.org/obo/UBERON_0000479
T102 76908-76914 Body_part denotes tissue http://purl.obolibrary.org/obo/UBERON_0000479
T103 77439-77445 Body_part denotes tissue http://purl.obolibrary.org/obo/UBERON_0000479
T104 79783-79789 Body_part denotes tissue http://purl.obolibrary.org/obo/UBERON_0000479
T105 82338-82359 Body_part denotes cardiovascular system http://purl.obolibrary.org/obo/UBERON_0004535
T106 82782-82788 Body_part denotes tissue http://purl.obolibrary.org/obo/UBERON_0000479
T107 83967-83973 Body_part denotes kidney http://purl.obolibrary.org/obo/UBERON_0002113
T108 84124-84128 Body_part denotes lung http://purl.obolibrary.org/obo/UBERON_0002048
T109 84129-84135 Body_part denotes tissue http://purl.obolibrary.org/obo/UBERON_0000479
T110 84182-84186 Body_part denotes lung http://purl.obolibrary.org/obo/UBERON_0002048
T111 84598-84609 Body_part denotes spinal cord http://purl.obolibrary.org/obo/UBERON_0002240
T112 88588-88594 Body_part denotes organs http://purl.obolibrary.org/obo/UBERON_0000062
T113 88639-88660 Body_part denotes cardiovascular system http://purl.obolibrary.org/obo/UBERON_0004535
T114 90911-90916 Body_part denotes serum http://purl.obolibrary.org/obo/UBERON_0001977
T115 95085-95098 Body_part denotes immune system http://purl.obolibrary.org/obo/UBERON_0002405
T116 96654-96658 Body_part denotes hand http://purl.obolibrary.org/obo/UBERON_0002398
T117 96660-96664 Body_part denotes foot http://purl.obolibrary.org/obo/UBERON_0002387
T118 96670-96675 Body_part denotes mouth http://purl.obolibrary.org/obo/UBERON_0000165
T119 97583-97588 Body_part denotes serum http://purl.obolibrary.org/obo/UBERON_0001977
T120 97610-97614 Body_part denotes lung http://purl.obolibrary.org/obo/UBERON_0002048
T121 97726-97730 Body_part denotes lung http://purl.obolibrary.org/obo/UBERON_0002048
T122 98936-98941 Body_part denotes blood http://purl.obolibrary.org/obo/UBERON_0000178
T123 98953-98958 Body_part denotes blood http://purl.obolibrary.org/obo/UBERON_0000178
T124 99200-99223 Body_part denotes heart and blood vessels http://purl.obolibrary.org/obo/UBERON_0003498
T125 99200-99205 Body_part denotes heart http://purl.obolibrary.org/obo/UBERON_0000948
T126 99210-99223 Body_part denotes blood vessels http://purl.obolibrary.org/obo/UBERON_0001981
T127 99210-99215 Body_part denotes blood http://purl.obolibrary.org/obo/UBERON_0000178
T128 99216-99223 Body_part denotes vessels http://purl.obolibrary.org/obo/UBERON_0000055
T129 99788-99793 Body_part denotes heart http://purl.obolibrary.org/obo/UBERON_0000948
T130 99807-99818 Body_part denotes endothelium http://purl.obolibrary.org/obo/UBERON_0001986
T131 99917-99938 Body_part denotes cardiovascular system http://purl.obolibrary.org/obo/UBERON_0004535
T132 101612-101616 Body_part denotes lung http://purl.obolibrary.org/obo/UBERON_0002048
T133 101621-101643 Body_part denotes cardiovascular systems http://purl.obolibrary.org/obo/UBERON_0004535
T134 102218-102222 Body_part denotes lung http://purl.obolibrary.org/obo/UBERON_0002048
T135 102647-102652 Body_part denotes organ http://purl.obolibrary.org/obo/UBERON_0000062
T136 103888-103893 Body_part denotes blood http://purl.obolibrary.org/obo/UBERON_0000178
T137 105524-105529 Body_part denotes Heart http://purl.obolibrary.org/obo/UBERON_0000948
T138 105598-105603 Body_part denotes Heart http://purl.obolibrary.org/obo/UBERON_0000948
T139 106262-106283 Body_part denotes cardiovascular system http://purl.obolibrary.org/obo/UBERON_0004535
T140 106303-106308 Body_part denotes blood http://purl.obolibrary.org/obo/UBERON_0000178
T141 106394-106399 Body_part denotes heart http://purl.obolibrary.org/obo/UBERON_0000948
T142 107337-107343 Body_part denotes tissue http://purl.obolibrary.org/obo/UBERON_0000479
T143 107782-107788 Body_part denotes organs http://purl.obolibrary.org/obo/UBERON_0000062
T144 107822-107843 Body_part denotes cardiovascular system http://purl.obolibrary.org/obo/UBERON_0004535
T145 108200-108206 Body_part denotes tissue http://purl.obolibrary.org/obo/UBERON_0000479
T146 108774-108780 Body_part denotes tissue http://purl.obolibrary.org/obo/UBERON_0000479
T147 109341-109346 Body_part denotes heart http://purl.obolibrary.org/obo/UBERON_0000948
T148 110074-110079 Body_part denotes blood http://purl.obolibrary.org/obo/UBERON_0000178
T149 110153-110164 Body_part denotes blood clots http://purl.obolibrary.org/obo/UBERON_0010210
T150 110153-110158 Body_part denotes blood http://purl.obolibrary.org/obo/UBERON_0000178
T151 110175-110179 Body_part denotes lung http://purl.obolibrary.org/obo/UBERON_0002048
T152 112855-112860 Body_part denotes heart http://purl.obolibrary.org/obo/UBERON_0000948
T153 113262-113267 Body_part denotes serum http://purl.obolibrary.org/obo/UBERON_0001977
T154 114541-114556 Body_part denotes coronary artery http://purl.obolibrary.org/obo/UBERON_0001621
T155 114550-114556 Body_part denotes artery http://purl.obolibrary.org/obo/UBERON_0001637
T156 114891-114906 Body_part denotes coronary artery http://purl.obolibrary.org/obo/UBERON_0001621
T157 114900-114906 Body_part denotes artery http://purl.obolibrary.org/obo/UBERON_0001637
T158 115657-115672 Body_part denotes coronary artery http://purl.obolibrary.org/obo/UBERON_0001621
T159 115666-115672 Body_part denotes artery http://purl.obolibrary.org/obo/UBERON_0001637
T160 117625-117629 Body_part denotes lung http://purl.obolibrary.org/obo/UBERON_0002048
T161 121107-121112 Body_part denotes organ http://purl.obolibrary.org/obo/UBERON_0000062
T162 121160-121166 Body_part denotes organs http://purl.obolibrary.org/obo/UBERON_0000062
T163 121188-121193 Body_part denotes organ http://purl.obolibrary.org/obo/UBERON_0000062
T164 122910-122915 Body_part denotes heart http://purl.obolibrary.org/obo/UBERON_0000948

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T1 83-91 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T2 143-167 Disease denotes Coronavirus disease 2019 http://purl.obolibrary.org/obo/MONDO_0100096
T3 169-177 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T4 194-241 Disease denotes Severe Acute Respiratory Syndrome Coronavirus 2 http://purl.obolibrary.org/obo/MONDO_0100096
T5 243-251 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T6 371-379 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T7 615-630 Disease denotes viral infection http://purl.obolibrary.org/obo/MONDO_0005108
T8 621-630 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T9 786-794 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T10 862-870 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T11 989-997 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T12 1256-1268 Disease denotes coagulopathy http://purl.obolibrary.org/obo/MONDO_0001531
T13 1730-1738 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T14 1854-1862 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T15 2050-2087 Disease denotes severe and acute respiratory syndrome http://purl.obolibrary.org/obo/MONDO_0005091
T16 2101-2109 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T17 2233-2241 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T18 2259-2269 Disease denotes infectious http://purl.obolibrary.org/obo/MONDO_0005550
T19 2624-2632 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T20 2672-2680 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T21 2754-2801 Disease denotes severe acute respiratory syndrome coronavirus 2 http://purl.obolibrary.org/obo/MONDO_0100096
T22 2754-2787 Disease denotes severe acute respiratory syndrome http://purl.obolibrary.org/obo/MONDO_0005091
T23 2803-2811 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T24 2982-2990 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T25 3081-3090 Disease denotes pneumonia http://purl.obolibrary.org/obo/MONDO_0005249
T26 3168-3176 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T27 3275-3283 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T28 3698-3706 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T29 3927-3935 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T30 4007-4038 Disease denotes lower respiratory tract disease http://purl.obolibrary.org/obo/MONDO_0000270
T31 4102-4119 Disease denotes acute lung injury http://purl.obolibrary.org/obo/MONDO_0006502|http://purl.obolibrary.org/obo/MONDO_0015796
T33 4113-4119 Disease denotes injury http://purl.obolibrary.org/obo/MONDO_0021178
T34 4121-4124 Disease denotes ALI http://purl.obolibrary.org/obo/MONDO_0006502
T35 4127-4162 Disease denotes acute respiratory distress syndrome http://purl.obolibrary.org/obo/MONDO_0006502
T36 4133-4162 Disease denotes respiratory distress syndrome http://purl.obolibrary.org/obo/MONDO_0009971
T37 4164-4168 Disease denotes ARDS http://purl.obolibrary.org/obo/MONDO_0006502
T38 4171-4190 Disease denotes respiratory failure http://purl.obolibrary.org/obo/MONDO_0021113
T39 4200-4213 Disease denotes heart failure http://purl.obolibrary.org/obo/MONDO_0005252
T40 4215-4217 Disease denotes HF http://purl.obolibrary.org/obo/MONDO_0005252
T41 4223-4244 Disease denotes sudden cardiac arrest http://purl.obolibrary.org/obo/MONDO_0007264
T42 4230-4244 Disease denotes cardiac arrest http://purl.obolibrary.org/obo/MONDO_0000745
T43 4583-4591 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T44 4797-4805 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T45 4977-4985 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T46 5076-5090 Disease denotes cardiomyopathy http://purl.obolibrary.org/obo/MONDO_0004994
T47 5109-5130 Disease denotes myocardial infarction http://purl.obolibrary.org/obo/MONDO_0005068
T48 5132-5146 Disease denotes cardiomyopathy http://purl.obolibrary.org/obo/MONDO_0004994
T49 5148-5175 Disease denotes hypertensive heart diseases http://purl.obolibrary.org/obo/MONDO_0001302
T50 5181-5203 Disease denotes pulmonary hypertension http://purl.obolibrary.org/obo/MONDO_0005149
T51 5191-5203 Disease denotes hypertension http://purl.obolibrary.org/obo/MONDO_0005044
T52 5645-5653 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T53 5736-5742 Disease denotes injury http://purl.obolibrary.org/obo/MONDO_0021178
T54 6427-6435 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T55 6741-6749 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T56 7044-7052 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T57 7193-7201 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T58 7287-7299 Disease denotes hypertension http://purl.obolibrary.org/obo/MONDO_0005044
T59 7301-7316 Disease denotes atherosclerosis http://purl.obolibrary.org/obo/MONDO_0005311
T60 7328-7340 Disease denotes inflammation http://purl.obolibrary.org/obo/MONDO_0021166
T61 7348-7361 Disease denotes heart failure http://purl.obolibrary.org/obo/MONDO_0005252
T62 7371-7383 Disease denotes inflammation http://purl.obolibrary.org/obo/MONDO_0021166
T63 7389-7408 Disease denotes myocardial ischemia http://purl.obolibrary.org/obo/MONDO_0024644
T64 7400-7408 Disease denotes ischemia http://purl.obolibrary.org/obo/MONDO_0005053
T65 7827-7839 Disease denotes inflammation http://purl.obolibrary.org/obo/MONDO_0021166
T66 8041-8049 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T67 8107-8116 Disease denotes pneumonia http://purl.obolibrary.org/obo/MONDO_0005249
T68 8354-8376 Disease denotes cardiovascular disease http://purl.obolibrary.org/obo/MONDO_0004995
T69 8423-8432 Disease denotes pneumonia http://purl.obolibrary.org/obo/MONDO_0005249
T70 8519-8528 Disease denotes pneumonia http://purl.obolibrary.org/obo/MONDO_0005249
T71 8645-8654 Disease denotes pneumonia http://purl.obolibrary.org/obo/MONDO_0005249
T72 8863-8873 Disease denotes infections http://purl.obolibrary.org/obo/MONDO_0005550
T73 8898-8909 Disease denotes hypotension http://purl.obolibrary.org/obo/MONDO_0005468
T74 8931-8935 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T75 8956-8966 Disease denotes arrhythmia http://purl.obolibrary.org/obo/MONDO_0007263
T76 9029-9033 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T77 9092-9101 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T78 9136-9153 Disease denotes acute myocarditis http://purl.obolibrary.org/obo/MONDO_0002815
T79 9142-9153 Disease denotes myocarditis http://purl.obolibrary.org/obo/MONDO_0004496
T80 9249-9257 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T81 9384-9392 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T82 9395-9404 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T83 9483-9491 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T84 9517-9523 Disease denotes injury http://purl.obolibrary.org/obo/MONDO_0021178
T85 9864-9872 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T86 9893-9921 Disease denotes cardiovascular disease (CVD) http://purl.obolibrary.org/obo/MONDO_0004995
T87 9954-9968 Disease denotes cardiac arrest http://purl.obolibrary.org/obo/MONDO_0000745
T88 10001-10023 Disease denotes coronary heart disease http://purl.obolibrary.org/obo/MONDO_0005010
T89 10010-10023 Disease denotes heart disease http://purl.obolibrary.org/obo/MONDO_0005267
T90 10048-10060 Disease denotes hypertension http://purl.obolibrary.org/obo/MONDO_0005044
T91 10158-10166 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T92 10368-10376 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T93 10434-10440 Disease denotes injury http://purl.obolibrary.org/obo/MONDO_0021178
T94 10974-10982 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T95 11015-11026 Disease denotes hypotension http://purl.obolibrary.org/obo/MONDO_0005468
T96 11039-11045 Disease denotes injury http://purl.obolibrary.org/obo/MONDO_0021178
T97 11047-11058 Disease denotes myocarditis http://purl.obolibrary.org/obo/MONDO_0004496
T98 11090-11100 Disease denotes arrhythmia http://purl.obolibrary.org/obo/MONDO_0007263
T99 11105-11107 Disease denotes HF http://purl.obolibrary.org/obo/MONDO_0005252
T100 11260-11268 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T101 11380-11391 Disease denotes myocarditis http://purl.obolibrary.org/obo/MONDO_0004496
T102 11395-11403 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T103 11478-11486 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T104 11671-11679 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T105 11682-11691 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T106 11744-11752 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T107 11794-11802 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T108 11826-11832 Disease denotes injury http://purl.obolibrary.org/obo/MONDO_0021178
T109 11855-11861 Disease denotes injury http://purl.obolibrary.org/obo/MONDO_0021178
T110 11864-11881 Disease denotes Acute myocarditis http://purl.obolibrary.org/obo/MONDO_0002815
T111 11870-11881 Disease denotes myocarditis http://purl.obolibrary.org/obo/MONDO_0004496
T112 11987-11999 Disease denotes Coagulopathy http://purl.obolibrary.org/obo/MONDO_0001531
T113 12008-12010 Disease denotes MI http://purl.obolibrary.org/obo/MONDO_0005068
T114 12013-12025 Disease denotes Hypertension http://purl.obolibrary.org/obo/MONDO_0005044
T115 12098-12114 Disease denotes long QT-syndrome http://purl.obolibrary.org/obo/MONDO_0002442
T116 12116-12134 Disease denotes torsade de pointes http://purl.obolibrary.org/obo/MONDO_0005478
T117 12201-12214 Disease denotes heart failure http://purl.obolibrary.org/obo/MONDO_0005252
T118 12502-12514 Disease denotes hypertension http://purl.obolibrary.org/obo/MONDO_0005044
T119 12561-12569 Disease denotes ischemia http://purl.obolibrary.org/obo/MONDO_0005053
T120 12572-12581 Disease denotes Pneumonia http://purl.obolibrary.org/obo/MONDO_0005249
T121 12683-12691 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T122 12771-12779 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T123 12851-12857 Disease denotes injury http://purl.obolibrary.org/obo/MONDO_0021178
T124 12871-12879 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T125 13015-13025 Disease denotes thrombosis http://purl.obolibrary.org/obo/MONDO_0000831
T126 13173-13182 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T127 13366-13374 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T128 13446-13454 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T129 13495-13499 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T130 13638-13646 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T131 13667-13673 Disease denotes injury http://purl.obolibrary.org/obo/MONDO_0021178
T132 13844-13852 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T133 14083-14091 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T134 14102-14111 Disease denotes pneumonia http://purl.obolibrary.org/obo/MONDO_0005249
T135 14331-14340 Disease denotes pneumonia http://purl.obolibrary.org/obo/MONDO_0005249
T136 14492-14500 Disease denotes ischemia http://purl.obolibrary.org/obo/MONDO_0005053
T137 14502-14510 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T138 14621-14638 Disease denotes venous thrombosis http://purl.obolibrary.org/obo/MONDO_0008559
T139 14628-14638 Disease denotes thrombosis http://purl.obolibrary.org/obo/MONDO_0000831
T140 14658-14666 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T141 14737-14743 Disease denotes injury http://purl.obolibrary.org/obo/MONDO_0021178
T142 15072-15080 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T143 15084-15121 Disease denotes Severe and acute respiratory syndrome http://purl.obolibrary.org/obo/MONDO_0005091
T144 15142-15147 Disease denotes Tumor http://purl.obolibrary.org/obo/MONDO_0005070
T145 15334-15343 Disease denotes pneumonia http://purl.obolibrary.org/obo/MONDO_0005249
T146 15358-15382 Disease denotes Streptococcus pneumoniae http://purl.obolibrary.org/obo/MONDO_0005972
T147 15527-15533 Disease denotes injury http://purl.obolibrary.org/obo/MONDO_0021178
T148 15581-15589 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T149 15668-15672 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T150 15701-15705 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T151 15886-15894 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T152 15923-15932 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T153 15938-15946 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T154 15976-15985 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T155 16011-16019 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T156 16048-16056 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T157 16387-16395 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T158 16459-16467 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T159 16524-16532 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T160 16616-16624 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T161 16697-16703 Disease denotes injury http://purl.obolibrary.org/obo/MONDO_0021178
T162 16820-16829 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T163 16833-16841 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T164 16899-16911 Disease denotes Inflammation http://purl.obolibrary.org/obo/MONDO_0021166
T165 17002-17010 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T166 17023-17031 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T167 17045-17054 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T168 17056-17064 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T169 17067-17076 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T170 17392-17408 Disease denotes viral infections http://purl.obolibrary.org/obo/MONDO_0005108
T171 17628-17634 Disease denotes injury http://purl.obolibrary.org/obo/MONDO_0021178
T172 17648-17656 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T173 17659-17668 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T174 17826-17831 Disease denotes tumor http://purl.obolibrary.org/obo/MONDO_0005070
T175 18100-18108 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T176 18382-18390 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T177 19030-19038 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T178 19192-19200 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T179 19393-19401 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T180 19625-19633 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T181 19634-19644 Disease denotes infections http://purl.obolibrary.org/obo/MONDO_0005550
T182 20342-20350 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T183 21161-21169 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T184 21170-21179 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T185 21637-21645 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T186 22724-22733 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T187 23187-23199 Disease denotes inflammation http://purl.obolibrary.org/obo/MONDO_0021166
T188 23375-23383 Disease denotes diabetes http://purl.obolibrary.org/obo/MONDO_0005015
T189 23385-23392 Disease denotes obesity http://purl.obolibrary.org/obo/MONDO_0011122
T190 23405-23417 Disease denotes hypertension http://purl.obolibrary.org/obo/MONDO_0005044
T191 23776-23788 Disease denotes hypertension http://purl.obolibrary.org/obo/MONDO_0005044
T192 23870-23878 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T193 24013-24025 Disease denotes hypertension http://purl.obolibrary.org/obo/MONDO_0005044
T194 24027-24033 Disease denotes stroke http://purl.obolibrary.org/obo/MONDO_0005098|http://purl.obolibrary.org/obo/MONDO_0011057
T196 24436-24444 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T197 24445-24454 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T198 24622-24638 Disease denotes viral infections http://purl.obolibrary.org/obo/MONDO_0005108
T199 25206-25214 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T200 25336-25339 Disease denotes NOD http://purl.obolibrary.org/obo/MONDO_0007435
T201 26161-26173 Disease denotes inflammation http://purl.obolibrary.org/obo/MONDO_0021166
T202 26525-26537 Disease denotes inflammation http://purl.obolibrary.org/obo/MONDO_0021166
T203 26543-26547 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T204 26553-26563 Disease denotes infections http://purl.obolibrary.org/obo/MONDO_0005550
T205 26565-26577 Disease denotes Inflammation http://purl.obolibrary.org/obo/MONDO_0021166
T206 26632-26647 Disease denotes atherosclerosis http://purl.obolibrary.org/obo/MONDO_0005311
T207 26649-26661 Disease denotes coagulopathy http://purl.obolibrary.org/obo/MONDO_0001531
T208 26663-26686 Disease denotes coronary artery disease http://purl.obolibrary.org/obo/MONDO_0005010
T209 26672-26686 Disease denotes artery disease http://purl.obolibrary.org/obo/MONDO_0000473
T210 26691-26693 Disease denotes HF http://purl.obolibrary.org/obo/MONDO_0005252
T211 26762-26770 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T212 26930-26968 Disease denotes disseminated intravascular coagulation http://purl.obolibrary.org/obo/MONDO_0001243
T213 26986-26996 Disease denotes thrombosis http://purl.obolibrary.org/obo/MONDO_0000831
T214 26998-27014 Disease denotes thrombocytopenia http://purl.obolibrary.org/obo/MONDO_0002049
T215 27166-27168 Disease denotes HF http://purl.obolibrary.org/obo/MONDO_0005252
T216 27451-27468 Disease denotes acute myocarditis http://purl.obolibrary.org/obo/MONDO_0002815
T217 27457-27468 Disease denotes myocarditis http://purl.obolibrary.org/obo/MONDO_0004496
T218 27479-27481 Disease denotes MI http://purl.obolibrary.org/obo/MONDO_0005068
T219 27555-27571 Disease denotes long QT-syndrome http://purl.obolibrary.org/obo/MONDO_0002442
T220 27598-27610 Disease denotes inflammation http://purl.obolibrary.org/obo/MONDO_0021166
T221 27640-27651 Disease denotes arrhythmias http://purl.obolibrary.org/obo/MONDO_0007263
T222 27660-27678 Disease denotes torsade de pointes http://purl.obolibrary.org/obo/MONDO_0005478
T223 27799-27822 Disease denotes acute coronary syndrome http://purl.obolibrary.org/obo/MONDO_0005542
T224 27835-27837 Disease denotes HF http://purl.obolibrary.org/obo/MONDO_0005252
T225 27942-27944 Disease denotes MI http://purl.obolibrary.org/obo/MONDO_0005068
T226 28181-28189 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T227 28291-28297 Disease denotes injury http://purl.obolibrary.org/obo/MONDO_0021178
T228 28434-28442 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T229 28475-28482 Disease denotes obesity http://purl.obolibrary.org/obo/MONDO_0011122
T230 28484-28502 Disease denotes metabolic syndrome http://purl.obolibrary.org/obo/MONDO_0004955
T231 28504-28516 Disease denotes hypertension http://purl.obolibrary.org/obo/MONDO_0005044
T232 28521-28529 Disease denotes diabetes http://purl.obolibrary.org/obo/MONDO_0005015
T233 29005-29013 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T234 29284-29292 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T235 29578-29588 Disease denotes thrombosis http://purl.obolibrary.org/obo/MONDO_0000831
T236 29653-29662 Disease denotes pneumonia http://purl.obolibrary.org/obo/MONDO_0005249
T237 29944-29952 Disease denotes thrombus http://purl.obolibrary.org/obo/MONDO_0000831
T238 30008-30016 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T239 30052-30075 Disease denotes venous thromboembolisms http://purl.obolibrary.org/obo/MONDO_0005399
T240 30102-30114 Disease denotes inflammation http://purl.obolibrary.org/obo/MONDO_0021166
T241 30203-30211 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T242 30212-30221 Disease denotes pneumonia http://purl.obolibrary.org/obo/MONDO_0005249
T243 30255-30266 Disease denotes blood clots http://purl.obolibrary.org/obo/MONDO_0000831
T244 30404-30414 Disease denotes thrombosis http://purl.obolibrary.org/obo/MONDO_0000831
T245 30440-30448 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T246 30574-30592 Disease denotes hypercoagulability http://purl.obolibrary.org/obo/MONDO_0002305
T247 30620-30628 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T248 30798-30810 Disease denotes coagulopathy http://purl.obolibrary.org/obo/MONDO_0001531
T249 30869-30877 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T250 30878-30887 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T251 30971-31004 Disease denotes hypertension and/or heart disease http://purl.obolibrary.org/obo/MONDO_0001302
T252 30971-30983 Disease denotes hypertension http://purl.obolibrary.org/obo/MONDO_0005044
T253 30991-31004 Disease denotes heart disease http://purl.obolibrary.org/obo/MONDO_0005267
T254 31306-31318 Disease denotes coagulopathy http://purl.obolibrary.org/obo/MONDO_0001531
T255 31498-31510 Disease denotes coagulopathy http://purl.obolibrary.org/obo/MONDO_0001531
T256 31644-31663 Disease denotes respiratory failure http://purl.obolibrary.org/obo/MONDO_0021113
T257 31763-31782 Disease denotes respiratory failure http://purl.obolibrary.org/obo/MONDO_0021113
T258 32850-32868 Disease denotes SARS-CoV infection http://purl.obolibrary.org/obo/MONDO_0005091
T259 32859-32868 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T260 33025-33039 Disease denotes hyperlipidemia http://purl.obolibrary.org/obo/MONDO_0021187
T261 33224-33232 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T262 33237-33245 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T263 33410-33418 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T264 33469-33477 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T265 33799-33807 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T266 33809-33817 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T267 34029-34048 Disease denotes myocardial ischemia http://purl.obolibrary.org/obo/MONDO_0024644
T268 34040-34048 Disease denotes ischemia http://purl.obolibrary.org/obo/MONDO_0005053
T269 34347-34356 Disease denotes pneumonia http://purl.obolibrary.org/obo/MONDO_0005249
T270 34748-34756 Disease denotes ischemia http://purl.obolibrary.org/obo/MONDO_0005053
T271 34816-34839 Disease denotes coronary artery disease http://purl.obolibrary.org/obo/MONDO_0005010
T272 34825-34839 Disease denotes artery disease http://purl.obolibrary.org/obo/MONDO_0000473
T273 35181-35192 Disease denotes arrhythmias http://purl.obolibrary.org/obo/MONDO_0007263
T274 35289-35291 Disease denotes HF http://purl.obolibrary.org/obo/MONDO_0005252
T275 35309-35317 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T276 35433-35457 Disease denotes acute coronary syndromes http://purl.obolibrary.org/obo/MONDO_0005542
T277 35459-35469 Disease denotes thrombosis http://purl.obolibrary.org/obo/MONDO_0000831
T278 35471-35490 Disease denotes myocardial ischemia http://purl.obolibrary.org/obo/MONDO_0024644
T279 35482-35490 Disease denotes ischemia http://purl.obolibrary.org/obo/MONDO_0005053
T280 35510-35512 Disease denotes HF http://purl.obolibrary.org/obo/MONDO_0005252
T281 35672-35680 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T282 35780-35788 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T283 35815-35821 Disease denotes injury http://purl.obolibrary.org/obo/MONDO_0021178
T284 35986-35998 Disease denotes inflammation http://purl.obolibrary.org/obo/MONDO_0021166
T285 36628-36636 Disease denotes diarrhea http://purl.obolibrary.org/obo/MONDO_0001673
T286 36836-36844 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T287 36845-36854 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T288 36949-36961 Disease denotes inflammation http://purl.obolibrary.org/obo/MONDO_0021166
T289 37106-37112 Disease denotes injury http://purl.obolibrary.org/obo/MONDO_0021178
T290 37459-37462 Disease denotes ARB http://purl.obolibrary.org/obo/MONDO_0012733
T291 37602-37608 Disease denotes injury http://purl.obolibrary.org/obo/MONDO_0021178
T292 37897-37900 Disease denotes ARB http://purl.obolibrary.org/obo/MONDO_0012733
T293 37924-37932 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T294 37959-37971 Disease denotes hypertension http://purl.obolibrary.org/obo/MONDO_0005044
T295 38040-38052 Disease denotes hypertension http://purl.obolibrary.org/obo/MONDO_0005044
T296 38071-38079 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T297 38166-38169 Disease denotes ARB http://purl.obolibrary.org/obo/MONDO_0012733
T298 38197-38200 Disease denotes ARB http://purl.obolibrary.org/obo/MONDO_0012733
T299 38208-38211 Disease denotes ARB http://purl.obolibrary.org/obo/MONDO_0012733
T300 38229-38241 Disease denotes hypertension http://purl.obolibrary.org/obo/MONDO_0005044
T301 38337-38340 Disease denotes ARB http://purl.obolibrary.org/obo/MONDO_0012733
T302 38397-38400 Disease denotes ARB http://purl.obolibrary.org/obo/MONDO_0012733
T303 38429-38441 Disease denotes hypertension http://purl.obolibrary.org/obo/MONDO_0005044
T304 38549-38555 Disease denotes injury http://purl.obolibrary.org/obo/MONDO_0021178
T305 38594-38597 Disease denotes ARB http://purl.obolibrary.org/obo/MONDO_0012733
T306 38636-38644 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T307 38697-38703 Disease denotes injury http://purl.obolibrary.org/obo/MONDO_0021178
T308 38711-38719 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T309 38720-38732 Disease denotes inflammation http://purl.obolibrary.org/obo/MONDO_0021166
T310 38805-38811 Disease denotes injury http://purl.obolibrary.org/obo/MONDO_0021178
T311 38993-38999 Disease denotes injury http://purl.obolibrary.org/obo/MONDO_0021178
T312 39143-39149 Disease denotes injury http://purl.obolibrary.org/obo/MONDO_0021178
T313 39385-39393 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T314 39555-39561 Disease denotes injury http://purl.obolibrary.org/obo/MONDO_0021178
T315 39575-39583 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T316 39586-39595 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T317 39784-39792 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T318 40419-40426 Disease denotes sterile http://purl.obolibrary.org/obo/MONDO_0005047
T319 41544-41552 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T320 41921-41929 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T321 43038-43046 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T322 43047-43057 Disease denotes infections http://purl.obolibrary.org/obo/MONDO_0005550
T323 43069-43083 Disease denotes storm syndrome http://purl.obolibrary.org/obo/MONDO_0008496
T324 43330-43339 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T325 43410-43432 Disease denotes hospitalized infection http://purl.obolibrary.org/obo/MONDO_0043544
T326 43423-43432 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T327 43948-43956 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T328 43957-43966 Disease denotes pneumonia http://purl.obolibrary.org/obo/MONDO_0005249
T329 44119-44127 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T330 44223-44231 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T331 44719-44722 Disease denotes ARB http://purl.obolibrary.org/obo/MONDO_0012733
T332 44753-44761 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T333 44963-44966 Disease denotes ARB http://purl.obolibrary.org/obo/MONDO_0012733
T334 45014-45022 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T335 45288-45296 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T336 45646-45649 Disease denotes FFA http://purl.obolibrary.org/obo/MONDO_0016776
T337 45957-45969 Disease denotes hypertension http://purl.obolibrary.org/obo/MONDO_0005044
T338 45971-45973 Disease denotes HF http://purl.obolibrary.org/obo/MONDO_0005252
T339 45975-45998 Disease denotes coronary artery disease http://purl.obolibrary.org/obo/MONDO_0005010
T340 45984-45998 Disease denotes artery disease http://purl.obolibrary.org/obo/MONDO_0000473
T341 46000-46003 Disease denotes CAD http://purl.obolibrary.org/obo/MONDO_0005010|http://purl.obolibrary.org/obo/MONDO_0018922
T343 46006-46014 Disease denotes diabetes http://purl.obolibrary.org/obo/MONDO_0005015
T344 46016-46023 Disease denotes obesity http://purl.obolibrary.org/obo/MONDO_0011122
T345 46485-46493 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T346 46606-46614 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T347 46691-46700 Disease denotes pneumonia http://purl.obolibrary.org/obo/MONDO_0005249
T348 46798-46806 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T349 46966-46974 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T350 47103-47111 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T351 47213-47221 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T352 47434-47442 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T353 47637-47645 Disease denotes ischemia http://purl.obolibrary.org/obo/MONDO_0005053
T354 47647-47649 Disease denotes MI http://purl.obolibrary.org/obo/MONDO_0005068
T355 47651-47662 Disease denotes arrhythmias http://purl.obolibrary.org/obo/MONDO_0007263
T356 47667-47669 Disease denotes HF http://purl.obolibrary.org/obo/MONDO_0005252
T357 47830-47848 Disease denotes SARS-CoV infection http://purl.obolibrary.org/obo/MONDO_0005091
T358 47839-47848 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T359 47876-47888 Disease denotes inflammation http://purl.obolibrary.org/obo/MONDO_0021166
T360 47971-47977 Disease denotes injury http://purl.obolibrary.org/obo/MONDO_0021178
T361 47994-48002 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T362 48236-48244 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T363 48754-48776 Disease denotes atrioventricular block http://purl.obolibrary.org/obo/MONDO_0000465
T364 48781-48799 Disease denotes torsade de pointes http://purl.obolibrary.org/obo/MONDO_0005478
T365 48800-48811 Disease denotes arrhythmias http://purl.obolibrary.org/obo/MONDO_0007263
T366 48835-48837 Disease denotes MI http://purl.obolibrary.org/obo/MONDO_0005068
T367 48948-48961 Disease denotes hyperglycemia http://purl.obolibrary.org/obo/MONDO_0002909
T368 48963-48977 Disease denotes hyperlipidemia http://purl.obolibrary.org/obo/MONDO_0021187
T369 48982-48995 Disease denotes lipodystrophy http://purl.obolibrary.org/obo/MONDO_0006573
T370 49248-49256 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T371 49571-49583 Disease denotes hypertension http://purl.obolibrary.org/obo/MONDO_0005044
T372 49585-49605 Disease denotes hypertriglyceridemia http://purl.obolibrary.org/obo/MONDO_0005347
T373 49645-49656 Disease denotes arrhythmias http://purl.obolibrary.org/obo/MONDO_0007263
T374 49658-49660 Disease denotes MI http://purl.obolibrary.org/obo/MONDO_0005068
T375 49665-49679 Disease denotes cardiomyopathy http://purl.obolibrary.org/obo/MONDO_0004994
T376 49929-49937 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T377 50100-50110 Disease denotes infections http://purl.obolibrary.org/obo/MONDO_0005550
T378 50205-50221 Disease denotes hemolytic anemia http://purl.obolibrary.org/obo/MONDO_0003664
T379 50215-50221 Disease denotes anemia http://purl.obolibrary.org/obo/MONDO_0002280
T380 50269-50284 Disease denotes cardiac disease http://purl.obolibrary.org/obo/MONDO_0005267
T381 50317-50319 Disease denotes MI http://purl.obolibrary.org/obo/MONDO_0005068
T382 50450-50458 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T383 50863-50871 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T384 51065-51073 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T385 51323-51331 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T386 51506-51514 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T387 51589-51597 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T388 51776-51784 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T389 51785-51794 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T390 53537-53559 Disease denotes respiratory infections http://purl.obolibrary.org/obo/MONDO_0024355
T391 53686-53689 Disease denotes ALI http://purl.obolibrary.org/obo/MONDO_0006502
T392 53694-53698 Disease denotes ARDS http://purl.obolibrary.org/obo/MONDO_0006502
T393 53751-53759 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T394 54031-54043 Disease denotes inflammation http://purl.obolibrary.org/obo/MONDO_0021166
T395 54567-54570 Disease denotes ALI http://purl.obolibrary.org/obo/MONDO_0006502
T396 54844-54856 Disease denotes inflammation http://purl.obolibrary.org/obo/MONDO_0021166
T397 55106-55122 Disease denotes viral infections http://purl.obolibrary.org/obo/MONDO_0005108
T398 55164-55172 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T399 55252-55255 Disease denotes ALI http://purl.obolibrary.org/obo/MONDO_0006502
T400 55257-55261 Disease denotes ARDS http://purl.obolibrary.org/obo/MONDO_0006502
T401 55923-55926 Disease denotes ALI http://purl.obolibrary.org/obo/MONDO_0006502
T402 55927-55931 Disease denotes ARDS http://purl.obolibrary.org/obo/MONDO_0006502
T403 56537-56541 Disease denotes ARDS http://purl.obolibrary.org/obo/MONDO_0006502
T404 56933-56942 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T405 57400-57408 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T406 57688-57696 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T407 58146-58154 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T408 58306-58314 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T409 58984-58992 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T410 60137-60159 Disease denotes coronary heart disease http://purl.obolibrary.org/obo/MONDO_0005010
T411 60146-60159 Disease denotes heart disease http://purl.obolibrary.org/obo/MONDO_0005267
T412 60178-60180 Disease denotes MI http://purl.obolibrary.org/obo/MONDO_0005068
T413 60242-60244 Disease denotes HF http://purl.obolibrary.org/obo/MONDO_0005252
T414 60723-60731 Disease denotes thrombus http://purl.obolibrary.org/obo/MONDO_0000831
T415 61155-61167 Disease denotes hypertension http://purl.obolibrary.org/obo/MONDO_0005044
T416 61755-61763 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T417 61799-61807 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T418 61829-61832 Disease denotes ALI http://purl.obolibrary.org/obo/MONDO_0006502
T419 61833-61837 Disease denotes ARDS http://purl.obolibrary.org/obo/MONDO_0006502
T420 61888-61902 Disease denotes cardiac arrest http://purl.obolibrary.org/obo/MONDO_0000745
T421 62004-62016 Disease denotes inflammation http://purl.obolibrary.org/obo/MONDO_0021166
T422 62076-62090 Disease denotes cardiomyopathy http://purl.obolibrary.org/obo/MONDO_0004994
T423 62256-62264 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T424 62628-62636 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T425 62724-62732 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T426 63011-63027 Disease denotes viral infections http://purl.obolibrary.org/obo/MONDO_0005108
T427 63450-63462 Disease denotes coagulopathy http://purl.obolibrary.org/obo/MONDO_0001531
T428 63598-63610 Disease denotes inflammation http://purl.obolibrary.org/obo/MONDO_0021166
T429 63637-63645 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T430 63861-63866 Disease denotes Tumor http://purl.obolibrary.org/obo/MONDO_0005070
T431 64036-64048 Disease denotes inflammation http://purl.obolibrary.org/obo/MONDO_0021166
T432 64141-64149 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T433 64397-64405 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T434 65911-65916 Disease denotes Tumor http://purl.obolibrary.org/obo/MONDO_0005070
T435 66229-66241 Disease denotes inflammation http://purl.obolibrary.org/obo/MONDO_0021166
T436 66254-66262 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T437 66429-66437 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T438 66538-66546 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T439 66630-66654 Disease denotes cardiovascular disorders http://purl.obolibrary.org/obo/MONDO_0004995
T440 67276-67282 Disease denotes ulcers http://purl.obolibrary.org/obo/MONDO_0043839
T441 67362-67374 Disease denotes inflammation http://purl.obolibrary.org/obo/MONDO_0021166
T442 68784-68792 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T443 69625-69634 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T444 70005-70010 Disease denotes wound http://purl.obolibrary.org/obo/MONDO_0021178
T445 70151-70159 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T446 70201-70207 Disease denotes injury http://purl.obolibrary.org/obo/MONDO_0021178
T447 70355-70363 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T448 70488-70494 Disease denotes injury http://purl.obolibrary.org/obo/MONDO_0021178
T449 71884-71896 Disease denotes inflammation http://purl.obolibrary.org/obo/MONDO_0021166
T450 72921-72933 Disease denotes inflammation http://purl.obolibrary.org/obo/MONDO_0021166
T451 72958-72967 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T452 73180-73188 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T453 74239-74263 Disease denotes cardiovascular disorders http://purl.obolibrary.org/obo/MONDO_0004995
T454 75172-75184 Disease denotes inflammation http://purl.obolibrary.org/obo/MONDO_0021166
T455 76016-76024 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T456 76720-76732 Disease denotes inflammation http://purl.obolibrary.org/obo/MONDO_0021166
T457 76885-76890 Disease denotes wound http://purl.obolibrary.org/obo/MONDO_0021178
T458 77333-77345 Disease denotes inflammation http://purl.obolibrary.org/obo/MONDO_0021166
T459 78442-78454 Disease denotes hypertension http://purl.obolibrary.org/obo/MONDO_0005044
T460 79091-79100 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T461 79119-79127 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T462 79302-79308 Disease denotes cancer http://purl.obolibrary.org/obo/MONDO_0004992
T463 79394-79400 Disease denotes tumors http://purl.obolibrary.org/obo/MONDO_0005070
T464 79595-79600 Disease denotes tumor http://purl.obolibrary.org/obo/MONDO_0005070
T465 79739-79751 Disease denotes inflammation http://purl.obolibrary.org/obo/MONDO_0021166
T466 80139-80151 Disease denotes inflammation http://purl.obolibrary.org/obo/MONDO_0021166
T467 80339-80348 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T468 80353-80359 Disease denotes injury http://purl.obolibrary.org/obo/MONDO_0021178
T469 80520-80532 Disease denotes inflammation http://purl.obolibrary.org/obo/MONDO_0021166
T470 80583-80586 Disease denotes ALI http://purl.obolibrary.org/obo/MONDO_0006502
T471 80591-80595 Disease denotes ARDS http://purl.obolibrary.org/obo/MONDO_0006502
T472 81125-81134 Disease denotes influenza http://purl.obolibrary.org/obo/MONDO_0005812
T473 81227-81241 Disease denotes viral diseases http://purl.obolibrary.org/obo/MONDO_0005108
T474 81534-81546 Disease denotes inflammation http://purl.obolibrary.org/obo/MONDO_0021166
T475 81603-81611 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T476 81612-81621 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T477 81906-81918 Disease denotes inflammation http://purl.obolibrary.org/obo/MONDO_0021166
T478 81977-81985 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T479 82068-82078 Disease denotes infections http://purl.obolibrary.org/obo/MONDO_0005550
T480 82153-82163 Disease denotes infections http://purl.obolibrary.org/obo/MONDO_0005550
T481 82222-82234 Disease denotes inflammation http://purl.obolibrary.org/obo/MONDO_0021166
T482 82789-82795 Disease denotes injury http://purl.obolibrary.org/obo/MONDO_0021178
T483 82936-82938 Disease denotes MI http://purl.obolibrary.org/obo/MONDO_0005068
T484 82939-82945 Disease denotes injury http://purl.obolibrary.org/obo/MONDO_0021178
T485 83551-83563 Disease denotes inflammation http://purl.obolibrary.org/obo/MONDO_0021166
T486 83930-83938 Disease denotes allergic http://purl.obolibrary.org/obo/MONDO_0004980
T487 83939-83962 Disease denotes intestinal inflammation http://purl.obolibrary.org/obo/MONDO_0002269
T488 83950-83962 Disease denotes inflammation http://purl.obolibrary.org/obo/MONDO_0021166
T489 84102-84114 Disease denotes inflammation http://purl.obolibrary.org/obo/MONDO_0021166
T490 84182-84196 Disease denotes lung carcinoma http://purl.obolibrary.org/obo/MONDO_0005138
T491 84187-84196 Disease denotes carcinoma http://purl.obolibrary.org/obo/MONDO_0004993
T492 84993-84999 Disease denotes injury http://purl.obolibrary.org/obo/MONDO_0021178
T493 85151-85157 Disease denotes injury http://purl.obolibrary.org/obo/MONDO_0021178
T494 85535-85541 Disease denotes injury http://purl.obolibrary.org/obo/MONDO_0021178
T495 85654-85660 Disease denotes injury http://purl.obolibrary.org/obo/MONDO_0021178
T496 85674-85682 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T497 85683-85692 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T498 88511-88519 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T499 89301-89309 Disease denotes diabetes http://purl.obolibrary.org/obo/MONDO_0005015
T500 89345-89365 Disease denotes bacterial infections http://purl.obolibrary.org/obo/MONDO_0005113
T501 89594-89602 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T502 89956-89964 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T503 90487-90493 Disease denotes injury http://purl.obolibrary.org/obo/MONDO_0021178
T504 90507-90515 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T505 90922-90930 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T506 91062-91068 Disease denotes injury http://purl.obolibrary.org/obo/MONDO_0021178
T507 91588-91596 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T508 91607-91616 Disease denotes pneumonia http://purl.obolibrary.org/obo/MONDO_0005249
T509 91817-91825 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T510 92004-92012 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T511 92644-92652 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T512 92726-92738 Disease denotes inflammation http://purl.obolibrary.org/obo/MONDO_0021166
T513 92794-92800 Disease denotes injury http://purl.obolibrary.org/obo/MONDO_0021178
T514 92916-92924 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T515 93476-93503 Disease denotes ischemia reperfusion injury http://purl.obolibrary.org/obo/MONDO_0005203
T516 93476-93484 Disease denotes ischemia http://purl.obolibrary.org/obo/MONDO_0005053
T517 93497-93503 Disease denotes injury http://purl.obolibrary.org/obo/MONDO_0021178
T518 93819-93846 Disease denotes ischemia reperfusion injury http://purl.obolibrary.org/obo/MONDO_0005203
T519 93819-93827 Disease denotes ischemia http://purl.obolibrary.org/obo/MONDO_0005053
T520 93840-93846 Disease denotes injury http://purl.obolibrary.org/obo/MONDO_0021178
T521 94112-94118 Disease denotes injury http://purl.obolibrary.org/obo/MONDO_0021178
T522 94319-94325 Disease denotes injury http://purl.obolibrary.org/obo/MONDO_0021178
T523 94506-94514 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T524 94646-94667 Disease denotes inflammatory diseases http://purl.obolibrary.org/obo/MONDO_0021166
T525 94684-94700 Disease denotes viral infections http://purl.obolibrary.org/obo/MONDO_0005108
T526 95363-95372 Disease denotes influenza http://purl.obolibrary.org/obo/MONDO_0005812
T527 95425-95444 Disease denotes influenza infection http://purl.obolibrary.org/obo/MONDO_0005812
T528 95435-95444 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T529 95564-95573 Disease denotes influenza http://purl.obolibrary.org/obo/MONDO_0005812
T530 95611-95620 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T531 95711-95714 Disease denotes SPM http://purl.obolibrary.org/obo/MONDO_0010400
T532 95770-95784 Disease denotes H1N1 influenza http://purl.obolibrary.org/obo/MONDO_0005460
T533 95775-95784 Disease denotes influenza http://purl.obolibrary.org/obo/MONDO_0005812
T534 96019-96038 Disease denotes influenza infection http://purl.obolibrary.org/obo/MONDO_0005812
T535 96029-96038 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T536 96153-96169 Disease denotes viral infections http://purl.obolibrary.org/obo/MONDO_0005108
T537 96207-96220 Disease denotes neuroblastoma http://purl.obolibrary.org/obo/MONDO_0005072
T538 96249-96253 Disease denotes Zika http://purl.obolibrary.org/obo/MONDO_0018661
T539 96654-96683 Disease denotes hand, foot, and mouth disease http://purl.obolibrary.org/obo/MONDO_0005779
T540 96670-96683 Disease denotes mouth disease http://purl.obolibrary.org/obo/MONDO_0006858
T541 96782-96798 Disease denotes viral infections http://purl.obolibrary.org/obo/MONDO_0005108
T542 97048-97064 Disease denotes viral infections http://purl.obolibrary.org/obo/MONDO_0005108
T543 97169-97183 Disease denotes H1N1 influenza http://purl.obolibrary.org/obo/MONDO_0005460
T544 97174-97183 Disease denotes influenza http://purl.obolibrary.org/obo/MONDO_0005812
T545 97662-97671 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T546 97681-97690 Disease denotes influenza http://purl.obolibrary.org/obo/MONDO_0005812
T547 97932-97941 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T548 98056-98065 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T549 98484-98492 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T550 98689-98697 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T551 98700-98716 Disease denotes viral infections http://purl.obolibrary.org/obo/MONDO_0005108
T552 98815-98823 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T553 99281-99293 Disease denotes hypertension http://purl.obolibrary.org/obo/MONDO_0005044
T554 100088-100100 Disease denotes inflammation http://purl.obolibrary.org/obo/MONDO_0021166
T555 100582-100606 Disease denotes cardiovascular disorders http://purl.obolibrary.org/obo/MONDO_0004995
T556 100808-100820 Disease denotes hypertension http://purl.obolibrary.org/obo/MONDO_0005044
T557 100822-100824 Disease denotes HF http://purl.obolibrary.org/obo/MONDO_0005252
T558 100826-100828 Disease denotes MI http://purl.obolibrary.org/obo/MONDO_0005068
T559 100954-100962 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T560 101063-101071 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T561 101188-101197 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T562 101439-101447 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T563 101870-101882 Disease denotes inflammation http://purl.obolibrary.org/obo/MONDO_0021166
T564 101924-101934 Disease denotes thrombosis http://purl.obolibrary.org/obo/MONDO_0000831
T565 102006-102018 Disease denotes hypertension http://purl.obolibrary.org/obo/MONDO_0005044
T566 102020-102022 Disease denotes HF http://purl.obolibrary.org/obo/MONDO_0005252
T567 102033-102057 Disease denotes cardiovascular disorders http://purl.obolibrary.org/obo/MONDO_0004995
T568 102223-102229 Disease denotes injury http://purl.obolibrary.org/obo/MONDO_0021178
T569 102715-102723 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T570 103337-103345 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T571 104128-104136 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T572 104299-104307 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T573 104310-104319 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T574 104471-104479 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T575 104647-104655 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T576 104784-104792 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T577 104977-104985 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T578 104996-105002 Disease denotes injury http://purl.obolibrary.org/obo/MONDO_0021178
T579 105096-105104 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T580 105119-105131 Disease denotes hypertension http://purl.obolibrary.org/obo/MONDO_0005044
T581 105202-105210 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T582 105414-105422 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T583 105543-105546 Disease denotes AHA http://purl.obolibrary.org/obo/MONDO_0020108
T584 105598-105611 Disease denotes Heart Failure http://purl.obolibrary.org/obo/MONDO_0005252
T585 105828-105836 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T586 105839-105848 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T587 105981-105989 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T588 106038-106047 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T589 106053-106061 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T590 106831-106840 Disease denotes pneumonia http://purl.obolibrary.org/obo/MONDO_0005249
T591 106873-106889 Disease denotes virus infections http://purl.obolibrary.org/obo/MONDO_0005108
T592 106994-107002 Disease denotes acidosis http://purl.obolibrary.org/obo/MONDO_0006022
T593 107344-107350 Disease denotes injury http://purl.obolibrary.org/obo/MONDO_0021178
T594 109101-109109 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T595 109160-109172 Disease denotes inflammation http://purl.obolibrary.org/obo/MONDO_0021166
T596 109486-109498 Disease denotes inflammation http://purl.obolibrary.org/obo/MONDO_0021166
T597 109568-109580 Disease denotes coagulopathy http://purl.obolibrary.org/obo/MONDO_0001531
T598 109610-109618 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T599 109645-109657 Disease denotes coagulopathy http://purl.obolibrary.org/obo/MONDO_0001531
T600 109738-109748 Disease denotes thrombosis http://purl.obolibrary.org/obo/MONDO_0000831
T601 109820-109836 Disease denotes thrombocytopenia http://purl.obolibrary.org/obo/MONDO_0002049
T602 110020-110028 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T603 110153-110164 Disease denotes blood clots http://purl.obolibrary.org/obo/MONDO_0000831
T604 110220-110226 Disease denotes stroke http://purl.obolibrary.org/obo/MONDO_0005098|http://purl.obolibrary.org/obo/MONDO_0011057
T606 110297-110319 Disease denotes venous thromboembolism http://purl.obolibrary.org/obo/MONDO_0005399
T607 110330-110338 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T608 110497-110505 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T609 110508-110517 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T610 110778-110786 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T611 111635-111645 Disease denotes thrombosis http://purl.obolibrary.org/obo/MONDO_0000831
T612 112488-112496 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T613 112612-112624 Disease denotes coagulopathy http://purl.obolibrary.org/obo/MONDO_0001531
T614 112648-112656 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T615 112721-112729 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T616 112766-112774 Disease denotes diabetes http://purl.obolibrary.org/obo/MONDO_0005015
T617 112776-112788 Disease denotes dyslipidemia http://purl.obolibrary.org/obo/MONDO_0002525
T618 112846-112868 Disease denotes coronary heart disease http://purl.obolibrary.org/obo/MONDO_0005010
T619 112855-112868 Disease denotes heart disease http://purl.obolibrary.org/obo/MONDO_0005267
T620 112900-112908 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T621 112957-112961 Disease denotes ARDS http://purl.obolibrary.org/obo/MONDO_0006502
T622 113130-113138 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T623 113361-113369 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T624 113704-113712 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T625 113805-113813 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T626 113814-113823 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T627 113923-113931 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T628 114224-114242 Disease denotes hypercoagulability http://purl.obolibrary.org/obo/MONDO_0002305
T629 114277-114285 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T630 114353-114356 Disease denotes HLD http://purl.obolibrary.org/obo/MONDO_0019046
T631 114417-114425 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T632 114426-114435 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T633 114494-114506 Disease denotes dyslipidemia http://purl.obolibrary.org/obo/MONDO_0002525
T634 114531-114539 Disease denotes diabetes http://purl.obolibrary.org/obo/MONDO_0005015
T635 114541-114564 Disease denotes coronary artery disease http://purl.obolibrary.org/obo/MONDO_0005010
T636 114550-114564 Disease denotes artery disease http://purl.obolibrary.org/obo/MONDO_0000473
T637 114570-114577 Disease denotes obesity http://purl.obolibrary.org/obo/MONDO_0011122
T638 114648-114656 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T639 114857-114865 Disease denotes diabetes http://purl.obolibrary.org/obo/MONDO_0005015
T640 114867-114885 Disease denotes metabolic syndrome http://purl.obolibrary.org/obo/MONDO_0004955
T641 114891-114914 Disease denotes coronary artery disease http://purl.obolibrary.org/obo/MONDO_0005010
T642 114900-114914 Disease denotes artery disease http://purl.obolibrary.org/obo/MONDO_0000473
T643 114961-114969 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T644 115044-115052 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T645 115365-115373 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T646 115475-115483 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T647 115541-115553 Disease denotes dyslipidemia http://purl.obolibrary.org/obo/MONDO_0002525
T648 115657-115680 Disease denotes coronary artery disease http://purl.obolibrary.org/obo/MONDO_0005010
T649 115666-115680 Disease denotes artery disease http://purl.obolibrary.org/obo/MONDO_0000473
T650 115713-115721 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T651 115722-115731 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T652 116157-116202 Disease denotes secondary haemophagocytic lymphohistiocytosis http://purl.obolibrary.org/obo/MONDO_0015542
T653 116323-116343 Disease denotes hypertriglyceridemia http://purl.obolibrary.org/obo/MONDO_0005347
T654 116419-116427 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T655 116480-116489 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T656 116498-116519 Disease denotes respiratory disorders http://purl.obolibrary.org/obo/MONDO_0005087
T657 116705-116713 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T658 117415-117418 Disease denotes ALI http://purl.obolibrary.org/obo/MONDO_0006502
T659 117535-117538 Disease denotes ALI http://purl.obolibrary.org/obo/MONDO_0006502
T660 117630-117642 Disease denotes inflammation http://purl.obolibrary.org/obo/MONDO_0021166
T661 118489-118501 Disease denotes inflammation http://purl.obolibrary.org/obo/MONDO_0021166
T662 119163-119170 Disease denotes colitis http://purl.obolibrary.org/obo/MONDO_0005292
T663 119282-119300 Disease denotes acute pancreatitis http://purl.obolibrary.org/obo/MONDO_0006515
T664 119288-119300 Disease denotes pancreatitis http://purl.obolibrary.org/obo/MONDO_0004982
T665 120259-120267 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T666 120483-120491 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T667 120616-120624 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T668 120840-120848 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T669 121116-121124 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T670 121217-121223 Disease denotes injury http://purl.obolibrary.org/obo/MONDO_0021178
T671 121275-121283 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T672 121426-121434 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T673 121641-121649 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T674 121765-121773 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T675 121980-121988 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T676 122190-122198 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T677 122683-122695 Disease denotes coagulopathy http://purl.obolibrary.org/obo/MONDO_0001531
T678 123113-123121 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T679 123124-123133 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T1 98875-98876 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T2 98936-98941 http://purl.obolibrary.org/obo/UBERON_0000178 denotes blood
T3 98936-98941 http://www.ebi.ac.uk/efo/EFO_0000296 denotes blood
T4 98953-98958 http://purl.obolibrary.org/obo/UBERON_0000178 denotes blood
T5 98953-98958 http://www.ebi.ac.uk/efo/EFO_0000296 denotes blood
T6 99200-99205 http://purl.obolibrary.org/obo/UBERON_0000948 denotes heart
T7 99200-99205 http://purl.obolibrary.org/obo/UBERON_0007100 denotes heart
T8 99200-99205 http://purl.obolibrary.org/obo/UBERON_0015228 denotes heart
T9 99200-99205 http://www.ebi.ac.uk/efo/EFO_0000815 denotes heart
T10 99210-99223 http://purl.obolibrary.org/obo/UBERON_0001981 denotes blood vessels
T11 99210-99223 http://www.ebi.ac.uk/efo/EFO_0000817 denotes blood vessels
T12 99481-99482 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T13 99527-99528 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T14 99569-99576 http://purl.obolibrary.org/obo/NCBITaxon_9577 denotes Gibbons
T15 99692-99693 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T16 99710-99718 http://purl.obolibrary.org/obo/UBERON_0000158 denotes membrane
T17 99772-99777 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lungs
T18 99779-99786 http://purl.obolibrary.org/obo/UBERON_0002113 denotes kidneys
T19 99779-99786 http://www.ebi.ac.uk/efo/EFO_0000927 denotes kidneys
T20 99779-99786 http://www.ebi.ac.uk/efo/EFO_0000929 denotes kidneys
T21 99788-99793 http://purl.obolibrary.org/obo/UBERON_0000948 denotes heart
T22 99788-99793 http://purl.obolibrary.org/obo/UBERON_0007100 denotes heart
T23 99788-99793 http://purl.obolibrary.org/obo/UBERON_0015228 denotes heart
T24 99788-99793 http://www.ebi.ac.uk/efo/EFO_0000815 denotes heart
T25 99807-99818 http://purl.obolibrary.org/obo/UBERON_0001986 denotes endothelium
T26 99917-99938 http://purl.obolibrary.org/obo/UBERON_0004535 denotes cardiovascular system
T27 99917-99938 http://www.ebi.ac.uk/efo/EFO_0000791 denotes cardiovascular system
T28 99975-99979 http://purl.obolibrary.org/obo/CLO_0001185 denotes 2018
T29 100156-100164 http://purl.obolibrary.org/obo/CL_0000576 denotes monocyte
T30 100245-100259 http://purl.obolibrary.org/obo/CL_0000746 denotes cardiomyocytes
T31 100264-100281 http://purl.obolibrary.org/obo/CL_0000115 denotes endothelial cells
T32 100635-100643 http://purl.obolibrary.org/obo/CLO_0001658 denotes activity
T33 100937-100940 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T34 101026-101031 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T35 101141-101145 http://purl.obolibrary.org/obo/GO_0005623 denotes cell
T36 101411-101417 http://purl.obolibrary.org/obo/NCBITaxon_33208 denotes animal
T37 101612-101616 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung
T38 101612-101616 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lung
T39 101621-101643 http://purl.obolibrary.org/obo/UBERON_0004535 denotes cardiovascular systems
T40 101621-101643 http://www.ebi.ac.uk/efo/EFO_0000791 denotes cardiovascular systems
T41 102103-102105 http://purl.obolibrary.org/obo/CLO_0001022 denotes Li
T42 102103-102105 http://purl.obolibrary.org/obo/CLO_0007314 denotes Li
T43 102218-102222 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung
T44 102218-102222 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lung
T45 102277-102285 http://purl.obolibrary.org/obo/CLO_0001658 denotes activity
T46 102647-102652 http://purl.obolibrary.org/obo/UBERON_0003103 denotes organ
T47 103035-103043 http://purl.obolibrary.org/obo/CLO_0001658 denotes activity
T48 103637-103645 http://purl.obolibrary.org/obo/CLO_0001658 denotes activity
T49 103756-103759 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T50 103888-103893 http://purl.obolibrary.org/obo/UBERON_0000178 denotes blood
T51 103888-103893 http://www.ebi.ac.uk/efo/EFO_0000296 denotes blood
T52 104025-104029 http://purl.obolibrary.org/obo/GO_0005623 denotes cell
T53 104030-104039 http://purl.obolibrary.org/obo/UBERON_0000158 denotes membranes
T54 104258-104259 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T55 104582-104590 http://purl.obolibrary.org/obo/CLO_0001658 denotes activity
T56 104932-104933 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T57 105010-105012 http://purl.obolibrary.org/obo/CLO_0001022 denotes Li
T58 105010-105012 http://purl.obolibrary.org/obo/CLO_0007314 denotes Li
T59 105042-105043 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T60 105490-105491 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T61 105524-105529 http://purl.obolibrary.org/obo/UBERON_0000948 denotes Heart
T62 105524-105529 http://purl.obolibrary.org/obo/UBERON_0007100 denotes Heart
T63 105524-105529 http://purl.obolibrary.org/obo/UBERON_0015228 denotes Heart
T64 105524-105529 http://www.ebi.ac.uk/efo/EFO_0000815 denotes Heart
T65 105598-105603 http://purl.obolibrary.org/obo/UBERON_0000948 denotes Heart
T66 105598-105603 http://purl.obolibrary.org/obo/UBERON_0007100 denotes Heart
T67 105598-105603 http://purl.obolibrary.org/obo/UBERON_0015228 denotes Heart
T68 105598-105603 http://www.ebi.ac.uk/efo/EFO_0000815 denotes Heart
T69 105863-105864 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T70 106021-106024 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T71 106136-106137 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T72 106262-106283 http://purl.obolibrary.org/obo/UBERON_0004535 denotes cardiovascular system
T73 106262-106283 http://www.ebi.ac.uk/efo/EFO_0000791 denotes cardiovascular system
T74 106303-106308 http://purl.obolibrary.org/obo/UBERON_0000178 denotes blood
T75 106303-106308 http://www.ebi.ac.uk/efo/EFO_0000296 denotes blood
T76 106381-106386 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T77 106394-106399 http://purl.obolibrary.org/obo/UBERON_0000948 denotes heart
T78 106394-106399 http://purl.obolibrary.org/obo/UBERON_0007100 denotes heart
T79 106394-106399 http://purl.obolibrary.org/obo/UBERON_0015228 denotes heart
T80 106394-106399 http://www.ebi.ac.uk/efo/EFO_0000815 denotes heart
T81 106873-106878 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T82 106925-106929 http://purl.obolibrary.org/obo/GO_0005623 denotes cell
T83 107030-107032 http://purl.obolibrary.org/obo/CLO_0001022 denotes Li
T84 107030-107032 http://purl.obolibrary.org/obo/CLO_0007314 denotes Li
T85 107115-107134 http://purl.obolibrary.org/obo/GO_0005575 denotes cellular components
T86 107293-107303 http://purl.obolibrary.org/obo/CLO_0001658 denotes activation
T87 107403-107407 http://purl.obolibrary.org/obo/CLO_0001185 denotes 2018
T88 107782-107788 http://purl.obolibrary.org/obo/UBERON_0003103 denotes organs
T89 107799-107804 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lungs
T90 107806-107813 http://purl.obolibrary.org/obo/UBERON_0002113 denotes kidneys
T91 107806-107813 http://www.ebi.ac.uk/efo/EFO_0000927 denotes kidneys
T92 107806-107813 http://www.ebi.ac.uk/efo/EFO_0000929 denotes kidneys
T93 107822-107843 http://purl.obolibrary.org/obo/UBERON_0004535 denotes cardiovascular system
T94 107822-107843 http://www.ebi.ac.uk/efo/EFO_0000791 denotes cardiovascular system
T95 108042-108043 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T96 108119-108120 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T97 108394-108402 http://purl.obolibrary.org/obo/CLO_0001658 denotes activity
T98 108630-108638 http://purl.obolibrary.org/obo/UBERON_0000158 denotes membrane
T99 108671-108672 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T100 108751-108759 http://purl.obolibrary.org/obo/CLO_0001658 denotes activity
T101 108870-108875 http://purl.obolibrary.org/obo/CLO_0007836 denotes mouse
T102 108876-108882 http://purl.obolibrary.org/obo/UBERON_0000948 denotes hearts
T103 108876-108882 http://purl.obolibrary.org/obo/UBERON_0007100 denotes hearts
T104 108876-108882 http://purl.obolibrary.org/obo/UBERON_0015228 denotes hearts
T105 108876-108882 http://www.ebi.ac.uk/efo/EFO_0000815 denotes hearts
T106 108985-108995 http://purl.obolibrary.org/obo/CLO_0001658 denotes activities
T107 109327-109332 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lungs
T108 109341-109346 http://purl.obolibrary.org/obo/UBERON_0000948 denotes heart
T109 109341-109346 http://purl.obolibrary.org/obo/UBERON_0007100 denotes heart
T110 109341-109346 http://purl.obolibrary.org/obo/UBERON_0015228 denotes heart
T111 109341-109346 http://www.ebi.ac.uk/efo/EFO_0000815 denotes heart
T112 109658-109661 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T113 109858-109869 http://purl.obolibrary.org/obo/PR_000007299 denotes prothrombin
T114 109993-109994 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T115 110074-110079 http://purl.obolibrary.org/obo/UBERON_0000178 denotes blood
T116 110074-110079 http://www.ebi.ac.uk/efo/EFO_0000296 denotes blood
T117 110089-110095 http://purl.obolibrary.org/obo/CLO_0001751 denotes and 33
T118 110153-110158 http://purl.obolibrary.org/obo/UBERON_0000178 denotes blood
T119 110153-110158 http://www.ebi.ac.uk/efo/EFO_0000296 denotes blood
T120 110175-110179 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung
T121 110175-110179 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lung
T122 110260-110263 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T123 110417-110423 http://purl.obolibrary.org/obo/CLO_0001658 denotes active
T124 110518-110521 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T125 110648-110649 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T126 110925-110935 http://purl.obolibrary.org/obo/CLO_0001658 denotes activating
T127 110997-111005 http://purl.obolibrary.org/obo/CHEBI_3815 denotes collagen
T128 111197-111205 http://purl.obolibrary.org/obo/UBERON_0000158 denotes membrane
T129 111392-111400 http://purl.obolibrary.org/obo/UBERON_0000158 denotes membrane
T130 111503-111504 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T131 111675-111679 http://purl.obolibrary.org/obo/CLO_0001185 denotes 2018
T132 111808-111818 http://purl.obolibrary.org/obo/CLO_0001658 denotes activation
T133 111935-111941 http://purl.obolibrary.org/obo/CLO_0001658 denotes active
T134 111995-111996 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T135 112148-112151 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T136 112182-112192 http://purl.obolibrary.org/obo/CLO_0001658 denotes activation
T137 112230-112231 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T138 112364-112368 http://purl.obolibrary.org/obo/CLO_0001185 denotes 2018
T139 112805-112811 http://purl.obolibrary.org/obo/UBERON_0001969 denotes plasma
T140 112855-112860 http://purl.obolibrary.org/obo/UBERON_0000948 denotes heart
T141 112855-112860 http://purl.obolibrary.org/obo/UBERON_0007100 denotes heart
T142 112855-112860 http://purl.obolibrary.org/obo/UBERON_0015228 denotes heart
T143 112855-112860 http://www.ebi.ac.uk/efo/EFO_0000815 denotes heart
T144 113139-113142 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T145 113349-113350 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T146 113455-113463 http://purl.obolibrary.org/obo/CLO_0001658 denotes activity
T147 113562-113563 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T148 113608-113614 http://purl.obolibrary.org/obo/UBERON_0001969 denotes plasma
T149 113642-113643 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T150 113665-113672 http://purl.obolibrary.org/obo/PR_000009054 denotes insulin
T151 113727-113728 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T152 114363-114364 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T153 114550-114556 http://purl.obolibrary.org/obo/UBERON_0001637 denotes artery
T154 114550-114556 http://www.ebi.ac.uk/efo/EFO_0000814 denotes artery
T155 114623-114629 http://purl.obolibrary.org/obo/UBERON_0001969 denotes plasma
T156 114900-114906 http://purl.obolibrary.org/obo/UBERON_0001637 denotes artery
T157 114900-114906 http://www.ebi.ac.uk/efo/EFO_0000814 denotes artery
T158 115001-115002 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T159 115062-115065 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T160 115195-115196 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T161 115374-115379 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T162 115639-115640 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T163 115666-115672 http://purl.obolibrary.org/obo/UBERON_0001637 denotes artery
T164 115666-115672 http://www.ebi.ac.uk/efo/EFO_0000814 denotes artery
T165 115853-115856 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T166 115878-115879 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T167 116011-116015 http://purl.obolibrary.org/obo/CLO_0001185 denotes 2018
T168 116075-116076 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T169 116102-116103 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T170 116446-116453 http://purl.obolibrary.org/obo/CLO_0009985 denotes focuses
T171 116995-116996 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T172 117192-117193 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T173 117219-117220 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T174 117244-117252 http://purl.obolibrary.org/obo/UBERON_0000158 denotes membrane
T175 117253-117255 http://purl.obolibrary.org/obo/CLO_0001627 denotes AA
T176 117260-117263 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T177 117460-117461 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T178 117625-117629 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung
T179 117625-117629 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lung
T180 117704-117705 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T181 117831-117832 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T182 117940-117941 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T183 118017-118018 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T184 118040-118041 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T185 118310-118314 http://purl.obolibrary.org/obo/NCBITaxon_117565 denotes fish
T186 118452-118456 http://purl.obolibrary.org/obo/NCBITaxon_117565 denotes fish
T187 118583-118587 http://purl.obolibrary.org/obo/CLO_0001185 denotes 2018
T188 118593-118594 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T189 118666-118671 http://purl.obolibrary.org/obo/CLO_0007225 denotes label
T190 118726-118727 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T191 118794-118798 http://purl.obolibrary.org/obo/NCBITaxon_117565 denotes fish
T192 118905-118907 http://purl.obolibrary.org/obo/CLO_0001627 denotes AA
T193 118980-118989 http://purl.obolibrary.org/obo/UBERON_0000158 denotes membranes
T194 119063-119064 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T195 119205-119206 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T196 119422-119425 http://purl.obolibrary.org/obo/UBERON_0001013 denotes fat
T197 119487-119488 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T198 119507-119510 http://purl.obolibrary.org/obo/UBERON_0001013 denotes fat
T199 119551-119555 http://purl.obolibrary.org/obo/NCBITaxon_117565 denotes fish
T200 119602-119606 http://purl.obolibrary.org/obo/NCBITaxon_117565 denotes fish
T201 119628-119629 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T202 119742-119744 http://purl.obolibrary.org/obo/CLO_0001022 denotes Li
T203 119742-119744 http://purl.obolibrary.org/obo/CLO_0007314 denotes Li
T204 119746-119748 http://purl.obolibrary.org/obo/CLO_0001022 denotes Li
T205 119746-119748 http://purl.obolibrary.org/obo/CLO_0007314 denotes Li
T206 119752-119754 http://purl.obolibrary.org/obo/CLO_0001022 denotes Li
T207 119752-119754 http://purl.obolibrary.org/obo/CLO_0007314 denotes Li
T208 119957-119960 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T209 119977-119981 http://purl.obolibrary.org/obo/NCBITaxon_117565 denotes fish
T210 120196-120197 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T211 120310-120313 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T212 120916-120921 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T213 121070-121075 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lungs
T214 121107-121112 http://purl.obolibrary.org/obo/UBERON_0003103 denotes organ
T215 121132-121137 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T216 121160-121166 http://purl.obolibrary.org/obo/UBERON_0003103 denotes organs
T217 121188-121193 http://purl.obolibrary.org/obo/UBERON_0003103 denotes organ
T218 121224-121227 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T219 121242-121243 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T220 121332-121333 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T221 121503-121504 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T222 121822-121831 http://purl.obolibrary.org/obo/SO_0000418 denotes signaling
T223 122335-122341 http://purl.obolibrary.org/obo/CLO_0001658 denotes active
T224 122489-122495 http://purl.obolibrary.org/obo/CLO_0001658 denotes active
T225 122623-122630 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes viruses
T226 122651-122661 http://purl.obolibrary.org/obo/CL_0000234 denotes phagocytic
T227 122704-122708 http://purl.obolibrary.org/obo/GO_0005623 denotes cell
T228 122709-122718 http://purl.obolibrary.org/obo/SO_0000418 denotes signaling
T229 122723-122727 http://purl.obolibrary.org/obo/OGG_0000000002 denotes gene
T230 122819-122820 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T231 122910-122915 http://purl.obolibrary.org/obo/UBERON_0000948 denotes heart
T232 122910-122915 http://purl.obolibrary.org/obo/UBERON_0007100 denotes heart
T233 122910-122915 http://purl.obolibrary.org/obo/UBERON_0015228 denotes heart
T234 122910-122915 http://www.ebi.ac.uk/efo/EFO_0000815 denotes heart
T235 123053-123057 http://purl.obolibrary.org/obo/UBERON_0000473 denotes test
T236 123439-123440 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T98443 50-51 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T97175 256-259 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T31455 277-278 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T84059 403-408 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lungs
T89104 508-514 http://purl.obolibrary.org/obo/UBERON_0003103 denotes organs
T79663 555-576 http://purl.obolibrary.org/obo/UBERON_0004535 denotes cardiovascular system
T44536 555-576 http://www.ebi.ac.uk/efo/EFO_0000791 denotes cardiovascular system
T17496 578-579 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T45959 1032-1035 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T96471 1129-1150 http://purl.obolibrary.org/obo/UBERON_0004535 denotes cardiovascular system
T55834 1129-1150 http://www.ebi.ac.uk/efo/EFO_0000791 denotes cardiovascular system
T94038 1283-1286 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T53704 1398-1399 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T74203 1867-1872 http://purl.obolibrary.org/obo/CLO_0009985 denotes focus
T88816 2530-2537 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes Viruses
T19128 3069-3070 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T18892 3317-3329 http://purl.obolibrary.org/obo/OBI_0000245 denotes Organization
T18621 3333-3334 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T5066 3551-3558 http://purl.obolibrary.org/obo/NCBITaxon_33208 denotes animals
T11010 3563-3569 http://purl.obolibrary.org/obo/NCBITaxon_9606 denotes humans
T91245 3636-3659 http://purl.obolibrary.org/obo/UBERON_0001017 denotes central nervous systems
T41100 3636-3659 http://www.ebi.ac.uk/efo/EFO_0000302 denotes central nervous systems
T28423 3636-3659 http://www.ebi.ac.uk/efo/EFO_0000908 denotes central nervous systems
T54681 3666-3668 http://purl.obolibrary.org/obo/CLO_0001022 denotes Li
T54688 3666-3668 http://purl.obolibrary.org/obo/CLO_0007314 denotes Li
T28843 3731-3736 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lungs
T98322 3766-3784 http://purl.obolibrary.org/obo/UBERON_0000467 denotes organs and systems
T76276 3800-3807 http://purl.obolibrary.org/obo/UBERON_0002113 denotes kidneys
T59650 3800-3807 http://www.ebi.ac.uk/efo/EFO_0000927 denotes kidneys
T46669 3800-3807 http://www.ebi.ac.uk/efo/EFO_0000929 denotes kidneys
T10398 3809-3814 http://purl.obolibrary.org/obo/UBERON_0000948 denotes heart
T37309 3809-3814 http://purl.obolibrary.org/obo/UBERON_0007100 denotes heart
T60359 3809-3814 http://purl.obolibrary.org/obo/UBERON_0015228 denotes heart
T83927 3809-3814 http://www.ebi.ac.uk/efo/EFO_0000815 denotes heart
T95767 3816-3829 http://purl.obolibrary.org/obo/UBERON_0001981 denotes blood vessels
T43385 3816-3829 http://www.ebi.ac.uk/efo/EFO_0000817 denotes blood vessels
T54345 3831-3853 http://purl.obolibrary.org/obo/UBERON_0005409 denotes gastrointestinal tract
T58218 3858-3863 http://purl.obolibrary.org/obo/UBERON_0000955 denotes brain
T72303 3858-3863 http://www.ebi.ac.uk/efo/EFO_0000302 denotes brain
T28712 4007-4030 http://purl.obolibrary.org/obo/UBERON_0001558 denotes lower respiratory tract
T81723 4108-4112 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung
T29985 4108-4112 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lung
T97169 4200-4205 http://purl.obolibrary.org/obo/UBERON_0000948 denotes heart
T97037 4200-4205 http://purl.obolibrary.org/obo/UBERON_0007100 denotes heart
T58825 4200-4205 http://purl.obolibrary.org/obo/UBERON_0015228 denotes heart
T17826 4200-4205 http://www.ebi.ac.uk/efo/EFO_0000815 denotes heart
T25626 4252-4253 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T20269 5093-5096 http://purl.obolibrary.org/obo/CLO_0051582 denotes Has
T32303 5161-5166 http://purl.obolibrary.org/obo/UBERON_0000948 denotes heart
T86034 5161-5166 http://purl.obolibrary.org/obo/UBERON_0007100 denotes heart
T68915 5161-5166 http://purl.obolibrary.org/obo/UBERON_0015228 denotes heart
T41295 5161-5166 http://www.ebi.ac.uk/efo/EFO_0000815 denotes heart
T78016 5230-5243 http://purl.obolibrary.org/obo/PR_000001393 denotes interleukin-6
T85990 5699-5704 http://purl.obolibrary.org/obo/UBERON_0003103 denotes organ
T15304 5899-5908 http://purl.obolibrary.org/obo/SO_0000418 denotes signaling
T98618 6047-6060 http://purl.obolibrary.org/obo/PR_000001091 denotes interleukin-1
T66694 6073-6074 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T23727 6376-6377 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T5199 6400-6409 http://purl.obolibrary.org/obo/SO_0000418 denotes signaling
T73249 7348-7353 http://purl.obolibrary.org/obo/UBERON_0000948 denotes heart
T2074 7348-7353 http://purl.obolibrary.org/obo/UBERON_0007100 denotes heart
T35465 7348-7353 http://purl.obolibrary.org/obo/UBERON_0015228 denotes heart
T11230 7348-7353 http://www.ebi.ac.uk/efo/EFO_0000815 denotes heart
T1364 8147-8151 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung
T63139 8147-8151 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lung
T82303 8165-8166 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T26129 8238-8241 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T35987 8279-8283 http://purl.obolibrary.org/obo/CLO_0001185 denotes 2018
T98888 9044-9046 http://purl.obolibrary.org/obo/CLO_0001022 denotes Li
T96033 9044-9046 http://purl.obolibrary.org/obo/CLO_0007314 denotes Li
T38286 9673-9675 http://purl.obolibrary.org/obo/CLO_0050507 denotes 22
T59930 10010-10015 http://purl.obolibrary.org/obo/UBERON_0000948 denotes heart
T6034 10010-10015 http://purl.obolibrary.org/obo/UBERON_0007100 denotes heart
T53133 10010-10015 http://purl.obolibrary.org/obo/UBERON_0015228 denotes heart
T9658 10010-10015 http://www.ebi.ac.uk/efo/EFO_0000815 denotes heart
T77625 10028-10030 http://purl.obolibrary.org/obo/CLO_0001000 denotes 35
T71983 10555-10558 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T34586 11346-11351 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T12354 11607-11608 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T25178 12201-12206 http://purl.obolibrary.org/obo/UBERON_0000948 denotes heart
T28499 12201-12206 http://purl.obolibrary.org/obo/UBERON_0007100 denotes heart
T22599 12201-12206 http://purl.obolibrary.org/obo/UBERON_0015228 denotes heart
T95058 12201-12206 http://www.ebi.ac.uk/efo/EFO_0000815 denotes heart
T15203 12381-12395 http://purl.obolibrary.org/obo/CL_0000746 denotes cardiomyocytes
T50531 12410-12420 http://purl.obolibrary.org/obo/CLO_0001658 denotes Activation
T11690 12614-12622 http://purl.obolibrary.org/obo/CLO_0001658 denotes activity
T79454 12926-12931 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T59769 13533-13538 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T86299 13607-13611 http://purl.obolibrary.org/obo/GO_0005623 denotes cell
T49434 13938-13948 http://purl.obolibrary.org/obo/CLO_0001658 denotes activation
T83084 13993-13995 http://purl.obolibrary.org/obo/CLO_0050510 denotes 18
T87274 14215-14223 http://purl.obolibrary.org/obo/CLO_0001658 denotes activate
T44105 14271-14281 http://purl.obolibrary.org/obo/CLO_0001658 denotes Activation
T34660 14432-14433 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T93838 14608-14616 http://purl.obolibrary.org/obo/UBERON_0001637 denotes arterial
T73015 14608-14616 http://www.ebi.ac.uk/efo/EFO_0000814 denotes arterial
T80406 14804-14814 http://purl.obolibrary.org/obo/CL_0000057 denotes Fibroblast
T16585 14871-14879 http://purl.obolibrary.org/obo/CL_0000576 denotes Monocyte
T3991 14910-14911 http://purl.obolibrary.org/obo/CLO_0001021 denotes B
T1452 14955-14964 http://purl.obolibrary.org/obo/CLO_0001658 denotes activated
T62771 14965-14972 http://purl.obolibrary.org/obo/CL_0000236 denotes B-cells
T32529 15291-15294 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T68553 15405-15415 http://purl.obolibrary.org/obo/UBERON_0002349 denotes myocardium
T23803 15610-15612 http://purl.obolibrary.org/obo/CLO_0001000 denotes 35
T65875 15634-15639 http://purl.obolibrary.org/obo/NCBITaxon_9606 denotes human
T11260 15640-15645 http://purl.obolibrary.org/obo/UBERON_0000948 denotes heart
T34923 15640-15645 http://purl.obolibrary.org/obo/UBERON_0007100 denotes heart
T55900 15640-15645 http://purl.obolibrary.org/obo/UBERON_0015228 denotes heart
T74365 15640-15645 http://www.ebi.ac.uk/efo/EFO_0000815 denotes heart
T37670 15762-15776 http://purl.obolibrary.org/obo/CL_0000746 denotes cardiomyocytes
T56099 15784-15789 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T90564 15832-15833 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T63917 15866-15871 http://purl.obolibrary.org/obo/NCBITaxon_9606 denotes human
T649 16067-16068 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T85441 16099-16100 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T81427 16148-16152 http://purl.obolibrary.org/obo/GO_0005623 denotes cell
T43208 16206-16210 http://purl.obolibrary.org/obo/GO_0005623 denotes cell
T64659 16292-16297 http://purl.obolibrary.org/obo/UBERON_0000948 denotes heart
T27439 16292-16297 http://purl.obolibrary.org/obo/UBERON_0007100 denotes heart
T19348 16292-16297 http://purl.obolibrary.org/obo/UBERON_0015228 denotes heart
T68420 16292-16297 http://www.ebi.ac.uk/efo/EFO_0000815 denotes heart
T90334 16306-16310 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung
T21446 16306-16310 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lung
T17501 17246-17250 http://purl.obolibrary.org/obo/CLO_0001185 denotes 2018
T46995 17312-17313 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T10805 17422-17425 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T42288 17596-17601 http://purl.obolibrary.org/obo/UBERON_0003103 denotes organ
T42212 17691-17692 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T55059 17764-17777 http://purl.obolibrary.org/obo/PR_000001393 denotes interleukin-6
T70699 17792-17796 http://purl.obolibrary.org/obo/CLO_0053704 denotes IL-8
T28440 17826-17853 http://purl.obolibrary.org/obo/PR_000000134 denotes tumor necrosis factor-alpha
T67030 17913-17923 http://purl.obolibrary.org/obo/CL_0000057 denotes fibroblast
T17877 18012-18020 http://purl.obolibrary.org/obo/CL_0000576 denotes monocyte
T39894 18294-18295 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T61413 18500-18505 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T45103 18553-18566 http://purl.obolibrary.org/obo/UBERON_0001981 denotes blood vessels
T1820 18553-18566 http://www.ebi.ac.uk/efo/EFO_0000817 denotes blood vessels
T31892 18611-18620 http://purl.obolibrary.org/obo/CL_0000576 denotes monocytes
T33982 18668-18674 http://purl.obolibrary.org/obo/UBERON_0003103 denotes organs
T25308 18979-18980 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T38194 19370-19375 http://purl.obolibrary.org/obo/UBERON_0003103 denotes organ
T58949 19647-19649 http://purl.obolibrary.org/obo/CLO_0050510 denotes 18
T48903 19695-19697 http://purl.obolibrary.org/obo/CLO_0001527 denotes 94
T93650 19736-19738 http://purl.obolibrary.org/obo/CLO_0001527 denotes 94
T97130 19758-19761 http://purl.obolibrary.org/obo/CLO_0001382 denotes 4–8
T58937 20067-20068 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T90672 20158-20163 http://purl.obolibrary.org/obo/UBERON_0003103 denotes organ
T42818 20298-20300 http://purl.obolibrary.org/obo/CLO_0050510 denotes 18
T80103 20564-20565 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T37131 20891-20892 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T93220 21263-21266 http://purl.obolibrary.org/obo/CLO_0001382 denotes 4–8
T98454 21510-21514 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung
T73971 21510-21514 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lung
T66738 21854-21857 http://purl.obolibrary.org/obo/CLO_0009952 denotes sat
T88671 21860-21862 http://purl.obolibrary.org/obo/CLO_0001527 denotes 94
T27345 22335-22336 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T39273 22690-22692 http://purl.obolibrary.org/obo/CLO_0050510 denotes 18
T61281 23009-23013 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung
T18574 23009-23013 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lung
T26649 23139-23144 http://www.ebi.ac.uk/efo/EFO_0000965 denotes chest
T12727 23307-23312 http://purl.obolibrary.org/obo/CLO_0007225 denotes label
T68840 23575-23577 http://purl.obolibrary.org/obo/CLO_0053733 denotes 11
T84535 23605-23609 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung
T5134 23605-23609 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lung
T20296 23980-23984 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung
T70879 23980-23984 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lung
T49486 24127-24129 http://purl.obolibrary.org/obo/CLO_0001407 denotes 52
T75011 24600-24613 http://purl.obolibrary.org/obo/UBERON_0002405 denotes immune system
T25023 24778-24783 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T28041 24844-24846 http://purl.obolibrary.org/obo/CLO_0001022 denotes Li
T75144 24844-24846 http://purl.obolibrary.org/obo/CLO_0007314 denotes Li
T76006 24862-24872 http://purl.obolibrary.org/obo/CLO_0001658 denotes Activation
T7517 24983-24992 http://purl.obolibrary.org/obo/CLO_0001658 denotes activated
T84929 24993-25000 http://purl.obolibrary.org/obo/CL_0000236 denotes B cells
T34526 25006-25007 http://purl.obolibrary.org/obo/CLO_0001021 denotes B
T9298 25059-25068 http://purl.obolibrary.org/obo/CLO_0001658 denotes activated
T19420 25130-25131 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T71421 25224-25233 http://purl.obolibrary.org/obo/CLO_0001658 denotes activates
T69486 25242-25243 http://purl.obolibrary.org/obo/CLO_0001021 denotes B
T11591 25479-25480 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T89345 25637-25638 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T94663 25647-25657 http://purl.obolibrary.org/obo/CLO_0001658 denotes activation
T45799 25781-25791 http://purl.obolibrary.org/obo/CLO_0001658 denotes activation
T78339 25873-25879 http://purl.obolibrary.org/obo/CLO_0001658 denotes active
T40183 25984-25997 http://purl.obolibrary.org/obo/PR_000001091 denotes interleukin-1
T58965 26022-26024 http://purl.obolibrary.org/obo/CLO_0050510 denotes 18
T20321 26050-26056 http://purl.obolibrary.org/obo/CLO_0001658 denotes active
T58471 26090-26092 http://purl.obolibrary.org/obo/CLO_0050510 denotes 18
T96331 26118-26119 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T68493 26314-26318 http://purl.obolibrary.org/obo/CLO_0001185 denotes 2018
T65108 26430-26433 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T98364 26672-26678 http://purl.obolibrary.org/obo/UBERON_0001637 denotes artery
T77492 26672-26678 http://www.ebi.ac.uk/efo/EFO_0000814 denotes artery
T2930 26791-26794 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T56894 27035-27040 http://www.ebi.ac.uk/efo/EFO_0000876 denotes limbs
T34655 27182-27183 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T75689 27699-27703 http://purl.obolibrary.org/obo/CLO_0001185 denotes 2018
T16337 27748-27749 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T22517 27900-27904 http://purl.obolibrary.org/obo/CLO_0053704 denotes IL-8
T52712 28056-28057 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T81029 28315-28318 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T24738 28554-28555 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T95009 28599-28600 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T79378 28919-28920 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T78049 29057-29063 http://purl.obolibrary.org/obo/UBERON_0003103 denotes organs
T89636 29154-29175 http://purl.obolibrary.org/obo/UBERON_0004535 denotes cardiovascular system
T94547 29154-29175 http://www.ebi.ac.uk/efo/EFO_0000791 denotes cardiovascular system
T56365 29216-29222 http://purl.obolibrary.org/obo/UBERON_0003103 denotes organs
T87686 29482-29490 http://purl.obolibrary.org/obo/CLO_0001658 denotes activity
T10415 29723-29731 http://purl.obolibrary.org/obo/CLO_0001658 denotes activity
T62132 29739-29744 http://purl.obolibrary.org/obo/UBERON_0000178 denotes blood
T74474 29739-29744 http://www.ebi.ac.uk/efo/EFO_0000296 denotes blood
T61313 29958-29959 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T37890 30039-30047 http://purl.obolibrary.org/obo/UBERON_0001637 denotes arterial
T84372 30039-30047 http://www.ebi.ac.uk/efo/EFO_0000814 denotes arterial
T98744 30157-30158 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T9198 30255-30260 http://purl.obolibrary.org/obo/UBERON_0000178 denotes blood
T87344 30255-30260 http://www.ebi.ac.uk/efo/EFO_0000296 denotes blood
T64675 30606-30616 http://purl.obolibrary.org/obo/CLO_0001658 denotes activation
T92107 30844-30846 http://purl.obolibrary.org/obo/CLO_0050510 denotes 18
T4831 30991-30996 http://purl.obolibrary.org/obo/UBERON_0000948 denotes heart
T34951 30991-30996 http://purl.obolibrary.org/obo/UBERON_0007100 denotes heart
T52443 30991-30996 http://purl.obolibrary.org/obo/UBERON_0015228 denotes heart
T98069 30991-30996 http://www.ebi.ac.uk/efo/EFO_0000815 denotes heart
T25882 31437-31438 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T68940 32244-32246 http://purl.obolibrary.org/obo/CLO_0001382 denotes 48
T29687 32247-32249 http://purl.obolibrary.org/obo/CLO_0003599 denotes h4
T20765 32356-32364 http://purl.obolibrary.org/obo/UBERON_0001637 denotes arterial
T55348 32356-32364 http://www.ebi.ac.uk/efo/EFO_0000814 denotes arterial
T39743 32533-32534 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T33652 32767-32768 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T84691 32973-32994 http://purl.obolibrary.org/obo/UBERON_0004535 denotes cardiovascular system
T4742 32973-32994 http://www.ebi.ac.uk/efo/EFO_0000791 denotes cardiovascular system
T58635 33371-33372 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T95845 33526-33527 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T6069 33552-33553 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T237 33871-33875 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung
T238 33871-33875 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lung
T239 34135-34145 http://purl.obolibrary.org/obo/CLO_0001658 denotes activation
T240 34250-34264 http://purl.obolibrary.org/obo/CL_0000746 denotes cardiomyocytes
T241 34393-34401 http://purl.obolibrary.org/obo/CLO_0001658 denotes activity
T242 34480-34481 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T243 34488-34493 http://purl.obolibrary.org/obo/UBERON_0000948 denotes heart
T244 34488-34493 http://purl.obolibrary.org/obo/UBERON_0007100 denotes heart
T245 34488-34493 http://purl.obolibrary.org/obo/UBERON_0015228 denotes heart
T246 34488-34493 http://www.ebi.ac.uk/efo/EFO_0000815 denotes heart
T247 34588-34589 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T248 34825-34831 http://purl.obolibrary.org/obo/UBERON_0001637 denotes artery
T249 34825-34831 http://www.ebi.ac.uk/efo/EFO_0000814 denotes artery
T250 35208-35212 http://purl.obolibrary.org/obo/CLO_0001185 denotes 2018
T251 36042-36047 http://purl.obolibrary.org/obo/CLO_0007225 denotes label
T252 36715-36716 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T253 37282-37283 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T254 38086-38088 http://purl.obolibrary.org/obo/CLO_0050510 denotes 18
T255 38691-38696 http://purl.obolibrary.org/obo/UBERON_0000948 denotes heart
T256 38691-38696 http://purl.obolibrary.org/obo/UBERON_0007100 denotes heart
T257 38691-38696 http://purl.obolibrary.org/obo/UBERON_0015228 denotes heart
T258 38691-38696 http://www.ebi.ac.uk/efo/EFO_0000815 denotes heart
T259 38956-38965 http://purl.obolibrary.org/obo/BFO_0000030 denotes Objective
T260 39026-39028 http://purl.obolibrary.org/obo/CLO_0001313 denotes 36
T261 39257-39258 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T262 39520-39521 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T263 39731-39734 http://www.ebi.ac.uk/efo/EFO_0001410 denotes arm
T264 39935-39940 http://purl.obolibrary.org/obo/UBERON_0003103 denotes organ
T265 39997-40002 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T266 40162-40167 http://purl.obolibrary.org/obo/UBERON_0003103 denotes organ
T267 40484-40486 http://purl.obolibrary.org/obo/CLO_0001022 denotes Li
T268 40484-40486 http://purl.obolibrary.org/obo/CLO_0007314 denotes Li
T269 40813-40816 http://www.ebi.ac.uk/efo/EFO_0001410 denotes arm
T270 40822-40827 http://purl.obolibrary.org/obo/CLO_0007225 denotes label
T271 40958-40963 http://purl.obolibrary.org/obo/UBERON_0003103 denotes organ
T272 41017-41021 http://purl.obolibrary.org/obo/CLO_0053001 denotes 1–14
T273 41183-41188 http://purl.obolibrary.org/obo/CLO_0007225 denotes label
T274 41426-41427 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T275 42023-42024 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T276 42046-42052 http://purl.obolibrary.org/obo/UBERON_0001005 denotes airway
T277 42094-42095 http://purl.obolibrary.org/obo/CLO_0001021 denotes B
T278 42177-42183 http://purl.obolibrary.org/obo/UBERON_0001005 denotes airway
T279 42926-42928 http://purl.obolibrary.org/obo/CLO_0053733 denotes 11
T280 43899-43909 http://purl.obolibrary.org/obo/SO_0000418 denotes signalling
T281 44870-44875 http://purl.obolibrary.org/obo/UBERON_0003103 denotes organ
T282 45984-45990 http://purl.obolibrary.org/obo/UBERON_0001637 denotes artery
T283 45984-45990 http://www.ebi.ac.uk/efo/EFO_0000814 denotes artery
T284 46230-46232 http://purl.obolibrary.org/obo/CLO_0050509 denotes 27
T285 46756-46764 http://purl.obolibrary.org/obo/CLO_0009985 denotes focusing
T286 46843-46864 http://purl.obolibrary.org/obo/UBERON_0004535 denotes cardiovascular system
T287 46843-46864 http://www.ebi.ac.uk/efo/EFO_0000791 denotes cardiovascular system
T288 47574-47595 http://purl.obolibrary.org/obo/UBERON_0004535 denotes cardiovascular system
T289 47574-47595 http://www.ebi.ac.uk/efo/EFO_0000791 denotes cardiovascular system
T290 47708-47712 http://purl.obolibrary.org/obo/CLO_0001185 denotes 2018
T291 47966-47970 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung
T292 47966-47970 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lung
T293 48148-48154 http://purl.obolibrary.org/obo/UBERON_0000473 denotes tested
T294 48158-48159 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T295 48188-48193 http://purl.obolibrary.org/obo/CLO_0007225 denotes label
T296 49152-49153 http://purl.obolibrary.org/obo/CLO_0001021 denotes b
T297 49337-49338 http://purl.obolibrary.org/obo/CLO_0001021 denotes b
T298 49385-49390 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T299 49509-49514 http://purl.obolibrary.org/obo/UBERON_0000178 denotes blood
T300 49509-49514 http://www.ebi.ac.uk/efo/EFO_0000296 denotes blood
T301 49546-49549 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T302 49768-49773 http://purl.obolibrary.org/obo/CLO_0007225 denotes label
T303 49791-49794 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T304 49813-49817 http://purl.obolibrary.org/obo/UBERON_0000473 denotes test
T305 50171-50174 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T306 50175-50176 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T307 50435-50436 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T308 50467-50472 http://purl.obolibrary.org/obo/CLO_0007225 denotes label
T309 50914-50918 http://purl.obolibrary.org/obo/CLO_0001185 denotes 2018
T310 51054-51058 http://purl.obolibrary.org/obo/UBERON_0000473 denotes test
T311 51430-51431 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T312 51472-51473 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T313 52208-52210 http://purl.obolibrary.org/obo/CLO_0050510 denotes 18
T314 52270-52271 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T315 52803-52807 http://purl.obolibrary.org/obo/NCBITaxon_117565 denotes fish
T316 52925-52927 http://purl.obolibrary.org/obo/CLO_0050510 denotes 18
T317 53049-53051 http://purl.obolibrary.org/obo/CLO_0001627 denotes AA
T318 53103-53107 http://purl.obolibrary.org/obo/CLO_0053799 denotes 4,-5
T319 53349-53358 http://purl.obolibrary.org/obo/SO_0000418 denotes signaling
T320 53399-53412 http://purl.obolibrary.org/obo/UBERON_0002405 denotes immune system
T321 53574-53575 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T322 53588-53593 http://purl.obolibrary.org/obo/NCBITaxon_9606 denotes human
T323 53598-53604 http://purl.obolibrary.org/obo/NCBITaxon_33208 denotes animal
T324 53961-53965 http://purl.obolibrary.org/obo/NCBITaxon_117565 denotes fish
T325 53973-53974 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T326 54126-54127 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T327 54408-54410 http://purl.obolibrary.org/obo/CLO_0001627 denotes AA
T328 54480-54482 http://purl.obolibrary.org/obo/CLO_0002860 denotes E2
T329 54501-54502 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T330 54656-54662 http://purl.obolibrary.org/obo/CLO_0002192 denotes Calu-3
T331 54663-54673 http://purl.obolibrary.org/obo/CL_0000066 denotes epithelial
T332 54674-54679 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T333 55004-55005 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T334 55074-55079 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lungs
T335 55273-55276 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T336 55339-55340 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T337 55721-55722 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T338 55770-55775 http://purl.obolibrary.org/obo/UBERON_0003103 denotes organ
T339 56040-56041 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T340 56065-56066 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T341 56750-56751 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T342 56782-56783 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T343 56888-56892 http://purl.obolibrary.org/obo/NCBITaxon_117565 denotes fish
T344 56990-56991 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T345 57131-57134 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T346 57293-57297 http://purl.obolibrary.org/obo/NCBITaxon_117565 denotes fish
T347 58081-58082 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T348 58195-58200 http://purl.obolibrary.org/obo/CLO_0007225 denotes label
T349 59226-59227 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T350 59768-59774 http://purl.obolibrary.org/obo/UBERON_0001969 denotes plasma
T351 59808-59809 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T352 60054-60059 http://purl.obolibrary.org/obo/UBERON_0000948 denotes Heart
T353 60054-60059 http://purl.obolibrary.org/obo/UBERON_0007100 denotes Heart
T354 60054-60059 http://purl.obolibrary.org/obo/UBERON_0015228 denotes Heart
T355 60054-60059 http://www.ebi.ac.uk/efo/EFO_0000815 denotes Heart
T356 60146-60151 http://purl.obolibrary.org/obo/UBERON_0000948 denotes heart
T357 60146-60151 http://purl.obolibrary.org/obo/UBERON_0007100 denotes heart
T358 60146-60151 http://purl.obolibrary.org/obo/UBERON_0015228 denotes heart
T359 60146-60151 http://www.ebi.ac.uk/efo/EFO_0000815 denotes heart
T360 60169-60170 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T361 60468-60489 http://purl.obolibrary.org/obo/UBERON_0004535 denotes cardiovascular system
T362 60468-60489 http://www.ebi.ac.uk/efo/EFO_0000791 denotes cardiovascular system
T363 60509-60510 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T364 60538-60541 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T365 60542-60543 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T366 60813-60817 http://purl.obolibrary.org/obo/GO_0005623 denotes cell
T367 60818-60827 http://purl.obolibrary.org/obo/UBERON_0000158 denotes membranes
T368 62055-62060 http://purl.obolibrary.org/obo/UBERON_0000948 denotes heart
T369 62055-62060 http://purl.obolibrary.org/obo/UBERON_0007100 denotes heart
T370 62055-62060 http://purl.obolibrary.org/obo/UBERON_0015228 denotes heart
T371 62055-62060 http://www.ebi.ac.uk/efo/EFO_0000815 denotes heart
T372 62107-62111 http://purl.obolibrary.org/obo/CLO_0001185 denotes 2018
T373 62525-62526 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T374 62735-62736 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T375 62850-62851 http://purl.obolibrary.org/obo/CLO_0001021 denotes B
T376 63055-63063 http://purl.obolibrary.org/obo/UBERON_0000158 denotes membrane
T377 63106-63116 http://purl.obolibrary.org/obo/CLO_0001658 denotes activating
T378 63336-63341 http://purl.obolibrary.org/obo/CLO_0037161 denotes (E) N
T379 63559-63560 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T380 63861-63888 http://purl.obolibrary.org/obo/PR_000000134 denotes Tumor necrosis factor alpha
T381 63996-64009 http://purl.obolibrary.org/obo/UBERON_0002405 denotes immune system
T382 64164-64165 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T383 64424-64425 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T384 64485-64486 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T385 64613-64621 http://purl.obolibrary.org/obo/CLO_0001658 denotes activate
T386 64676-64684 http://purl.obolibrary.org/obo/CLO_0001658 denotes activate
T387 64730-64740 http://purl.obolibrary.org/obo/CLO_0001658 denotes activation
T388 64748-64754 http://purl.obolibrary.org/obo/CLO_0001869 denotes B. (B)
T389 64896-64898 http://purl.obolibrary.org/obo/CLO_0001627 denotes AA
T390 64956-64960 http://purl.obolibrary.org/obo/GO_0005623 denotes cell
T391 64961-64969 http://purl.obolibrary.org/obo/UBERON_0000158 denotes membrane
T392 65005-65014 http://purl.obolibrary.org/obo/SO_0000418 denotes signaling
T393 65142-65147 http://purl.obolibrary.org/obo/CLO_0037161 denotes (E) N
T394 65243-65245 http://purl.obolibrary.org/obo/CLO_0001627 denotes AA
T395 65457-65483 http://purl.obolibrary.org/obo/PR_000030035 denotes G-protein coupled receptor
T396 65521-65523 http://purl.obolibrary.org/obo/CLO_0007408 denotes LT
T397 65576-65577 http://purl.obolibrary.org/obo/CLO_0001021 denotes B
T398 65621-65630 http://purl.obolibrary.org/obo/CLO_0001658 denotes activated
T399 65631-65638 http://purl.obolibrary.org/obo/CL_0000236 denotes B-cells
T400 65716-65718 http://purl.obolibrary.org/obo/CLO_0001562 denotes A2
T401 65786-65795 http://purl.obolibrary.org/obo/CLO_0001658 denotes activated
T402 66063-66064 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T403 66086-66096 http://purl.obolibrary.org/obo/CLO_0001658 denotes activation
T404 66200-66201 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T405 66287-66308 http://purl.obolibrary.org/obo/UBERON_0004535 denotes cardiovascular system
T406 66287-66308 http://www.ebi.ac.uk/efo/EFO_0000791 denotes cardiovascular system
T407 66359-66360 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T408 66656-66659 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T409 67035-67036 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T410 67156-67162 http://purl.obolibrary.org/obo/UBERON_0001969 denotes plasma
T411 67272-67275 http://www.ebi.ac.uk/efo/EFO_0001411 denotes leg
T412 67416-67420 http://purl.obolibrary.org/obo/CLO_0001185 denotes 2018
T413 67636-67641 http://purl.obolibrary.org/obo/OGG_0000000002 denotes genes
T414 67700-67714 http://purl.obolibrary.org/obo/CL_0000746 denotes cardiomyocytes
T415 67716-67727 http://purl.obolibrary.org/obo/CL_0000057 denotes fibroblasts
T416 67729-67746 http://purl.obolibrary.org/obo/CL_0000115 denotes endothelial cells
T417 67748-67757 http://purl.obolibrary.org/obo/CL_0000576 denotes monocytes
T418 68056-68057 http://purl.obolibrary.org/obo/CLO_0001021 denotes B
T419 68221-68231 http://purl.obolibrary.org/obo/CLO_0001658 denotes activating
T420 68256-68265 http://purl.obolibrary.org/obo/CLO_0001658 denotes activated
T421 68342-68352 http://purl.obolibrary.org/obo/CLO_0001658 denotes Activation
T422 68396-68406 http://purl.obolibrary.org/obo/CLO_0001658 denotes activation
T423 68414-68415 http://purl.obolibrary.org/obo/CLO_0001021 denotes B
T424 68660-68670 http://purl.obolibrary.org/obo/CLO_0001658 denotes activation
T425 68717-68718 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T426 68834-68835 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T427 68979-68989 http://purl.obolibrary.org/obo/CLO_0001658 denotes activation
T428 68993-69019 http://purl.obolibrary.org/obo/PR_000030035 denotes G protein-coupled receptor
T429 69169-69178 http://purl.obolibrary.org/obo/CL_0000576 denotes monocytic
T430 69189-69194 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T431 69597-69606 http://purl.obolibrary.org/obo/CL_0000576 denotes monocytes
T432 69673-69674 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T433 69736-69738 http://purl.obolibrary.org/obo/CLO_0007448 denotes M1
T434 69736-69738 http://purl.obolibrary.org/obo/CLO_0050175 denotes M1
T435 69752-69757 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T436 69832-69834 http://purl.obolibrary.org/obo/CLO_0007448 denotes M1
T437 69832-69834 http://purl.obolibrary.org/obo/CLO_0050175 denotes M1
T438 69912-69921 http://purl.obolibrary.org/obo/CLO_0001658 denotes activated
T439 70122-70132 http://purl.obolibrary.org/obo/UBERON_0002349 denotes myocardium
T440 70163-70164 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T441 70435-70437 http://purl.obolibrary.org/obo/CLO_0007448 denotes M1
T442 70435-70437 http://purl.obolibrary.org/obo/CLO_0050175 denotes M1
T443 70508-70510 http://purl.obolibrary.org/obo/CLO_0007448 denotes M1
T444 70508-70510 http://purl.obolibrary.org/obo/CLO_0050175 denotes M1
T445 70531-70532 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T446 70614-70622 http://purl.obolibrary.org/obo/CLO_0001658 denotes activate
T447 70636-70641 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T448 70680-70693 http://purl.obolibrary.org/obo/UBERON_0002405 denotes immune system
T449 71000-71006 http://purl.obolibrary.org/obo/CLO_0001658 denotes active
T450 71113-71115 http://purl.obolibrary.org/obo/CLO_0007448 denotes M1
T451 71113-71115 http://purl.obolibrary.org/obo/CLO_0050175 denotes M1
T452 71615-71618 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T453 71659-71669 http://purl.obolibrary.org/obo/CLO_0000031 denotes cell lines
T454 71692-71697 http://purl.obolibrary.org/obo/NCBITaxon_9606 denotes human
T455 71702-71707 http://purl.obolibrary.org/obo/CLO_0007836 denotes mouse
T456 71737-71741 http://purl.obolibrary.org/obo/CLO_0001185 denotes 2018
T457 71910-71915 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T458 71920-71942 http://purl.obolibrary.org/obo/CL_0000581 denotes peritoneal macrophages
T459 72148-72158 http://purl.obolibrary.org/obo/CL_0000234 denotes phagocytic
T460 72190-72193 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T461 72421-72426 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T462 72452-72455 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T463 72487-72497 http://purl.obolibrary.org/obo/CL_0000234 denotes phagocytic
T464 72593-72601 http://purl.obolibrary.org/obo/UBERON_0000158 denotes membrane
T465 72729-72733 http://purl.obolibrary.org/obo/CLO_0001185 denotes 2018
T466 72856-72866 http://purl.obolibrary.org/obo/CLO_0000031 denotes cell lines
T467 72879-72884 http://purl.obolibrary.org/obo/CLO_0007836 denotes mouse
T468 73009-73013 http://purl.obolibrary.org/obo/CLO_0001185 denotes 2018
T469 73076-73089 http://purl.obolibrary.org/obo/UBERON_0002405 denotes immune system
T470 73103-73104 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T471 73140-73161 http://purl.obolibrary.org/obo/UBERON_0004535 denotes cardiovascular system
T472 73140-73161 http://www.ebi.ac.uk/efo/EFO_0000791 denotes cardiovascular system
T473 73625-73629 http://purl.obolibrary.org/obo/CLO_0001185 denotes 2018
T474 73785-73786 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T475 73921-73923 http://purl.obolibrary.org/obo/CLO_0001627 denotes AA
T476 74048-74050 http://purl.obolibrary.org/obo/CLO_0001627 denotes AA
T477 74281-74285 http://purl.obolibrary.org/obo/CLO_0001185 denotes 2018
T478 74392-74397 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T479 74409-74424 http://purl.obolibrary.org/obo/CL_0000451 denotes dendritic cells
T480 74439-74450 http://purl.obolibrary.org/obo/CL_0000057 denotes fibroblasts
T481 74455-74472 http://purl.obolibrary.org/obo/CL_0000115 denotes endothelial cells
T482 74651-74656 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T483 74717-74722 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T484 74767-74768 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T485 74896-74897 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T486 75013-75015 http://purl.obolibrary.org/obo/CLO_0001627 denotes AA
T487 75206-75209 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T488 75325-75333 http://purl.obolibrary.org/obo/NCBITaxon_9606 denotes by human
T489 75347-75352 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T490 75384-75385 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T491 75399-75403 http://purl.obolibrary.org/obo/NCBITaxon_117565 denotes fish
T492 75630-75632 http://purl.obolibrary.org/obo/CLO_0001627 denotes AA
T493 75733-75739 http://purl.obolibrary.org/obo/CLO_0001658 denotes active
T494 77191-77200 http://purl.obolibrary.org/obo/CL_0000576 denotes monocytes
T495 77208-77218 http://purl.obolibrary.org/obo/CL_0000066 denotes epithelial
T496 77219-77224 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T497 77299-77304 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T498 77612-77616 http://purl.obolibrary.org/obo/CLO_0053704 denotes IL-8
T499 77693-77701 http://purl.obolibrary.org/obo/CLO_0001658 denotes activity
T500 77757-77758 http://purl.obolibrary.org/obo/CLO_0001021 denotes B
T501 77759-77769 http://purl.obolibrary.org/obo/CLO_0001658 denotes activation
T502 78098-78107 http://purl.obolibrary.org/obo/SO_0000418 denotes signaling
T503 78231-78232 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T504 78427-78428 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T505 78541-78542 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T506 78599-78600 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T507 78771-78776 http://purl.obolibrary.org/obo/NCBITaxon_9606 denotes human
T508 78777-78784 http://purl.obolibrary.org/obo/CL_0000236 denotes B cells
T509 78795-78801 http://purl.obolibrary.org/obo/CL_0000236 denotes B cell
T510 78834-78840 http://purl.obolibrary.org/obo/CL_0000236 denotes B cell
T511 78882-78886 http://purl.obolibrary.org/obo/GO_0005623 denotes cell
T512 79169-79170 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T513 79508-79512 http://purl.obolibrary.org/obo/CLO_0053704 denotes IL-8
T514 79558-79566 http://purl.obolibrary.org/obo/NCBITaxon_9606 denotes by human
T515 79601-79605 http://purl.obolibrary.org/obo/GO_0005623 denotes cell
T516 79631-79635 http://purl.obolibrary.org/obo/CLO_0001185 denotes 2018
T517 79861-79867 http://purl.obolibrary.org/obo/CLO_0001658 denotes active
T518 79944-79946 http://purl.obolibrary.org/obo/CLO_0007448 denotes M1
T519 79944-79946 http://purl.obolibrary.org/obo/CLO_0050175 denotes M1
T520 80251-80261 http://purl.obolibrary.org/obo/CL_0000234 denotes phagocytic
T521 80296-80301 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T522 80428-80432 http://purl.obolibrary.org/obo/CLO_0001185 denotes 2018
T523 80533-80536 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T524 80566-80572 http://purl.obolibrary.org/obo/NCBITaxon_33208 denotes animal
T525 80658-80662 http://purl.obolibrary.org/obo/CLO_0001185 denotes 2018
T526 80725-80730 http://purl.obolibrary.org/obo/CLO_0007836 denotes mouse
T527 81062-81065 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T528 81344-81354 http://purl.obolibrary.org/obo/CLO_0001658 denotes activities
T529 81413-81415 http://purl.obolibrary.org/obo/CLO_0001627 denotes AA
T530 81510-81511 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T531 81623-81624 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T532 81741-81745 http://purl.obolibrary.org/obo/CLO_0001185 denotes 2018
T533 82338-82359 http://purl.obolibrary.org/obo/UBERON_0004535 denotes cardiovascular system
T534 82338-82359 http://www.ebi.ac.uk/efo/EFO_0000791 denotes cardiovascular system
T535 82904-82905 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T536 82967-82968 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T537 83052-83053 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T538 83194-83198 http://purl.obolibrary.org/obo/CLO_0001185 denotes 2018
T539 83726-83731 http://purl.obolibrary.org/obo/NCBITaxon_9606 denotes human
T540 83754-83770 http://purl.obolibrary.org/obo/CL_0000115 denotes endothelial cell
T541 83939-83949 http://purl.obolibrary.org/obo/UBERON_0000160 denotes intestinal
T542 83939-83949 http://www.ebi.ac.uk/efo/EFO_0000834 denotes intestinal
T543 83967-83973 http://purl.obolibrary.org/obo/UBERON_0002113 denotes kidney
T544 83967-83973 http://www.ebi.ac.uk/efo/EFO_0000927 denotes kidney
T545 83967-83973 http://www.ebi.ac.uk/efo/EFO_0000929 denotes kidney
T546 84000-84005 http://purl.obolibrary.org/obo/CLO_0007836 denotes mouse
T547 84118-84123 http://purl.obolibrary.org/obo/NCBITaxon_9606 denotes human
T548 84124-84128 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung
T549 84124-84128 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lung
T550 84182-84186 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung
T551 84182-84186 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lung
T552 84219-84220 http://purl.obolibrary.org/obo/CLO_0001021 denotes B
T553 84225-84235 http://purl.obolibrary.org/obo/CLO_0001658 denotes activation
T554 84407-84413 http://purl.obolibrary.org/obo/NCBITaxon_33208 denotes animal
T555 84598-84609 http://purl.obolibrary.org/obo/UBERON_0002240 denotes spinal cord
T556 84613-84617 http://purl.obolibrary.org/obo/UBERON_0003101 denotes male
T557 84613-84617 http://www.ebi.ac.uk/efo/EFO_0000970 denotes male
T558 84679-84687 http://purl.obolibrary.org/obo/CLO_0001658 denotes activity
T559 84948-84951 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T560 84952-84953 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T561 85061-85062 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T562 85075-85079 http://purl.obolibrary.org/obo/CLO_0052763 denotes HL-1
T563 85088-85093 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T564 85161-85171 http://purl.obolibrary.org/obo/CLO_0001658 denotes activating
T565 85221-85231 http://purl.obolibrary.org/obo/CLO_0001658 denotes activation
T566 85278-85279 http://purl.obolibrary.org/obo/CLO_0001021 denotes B
T567 85453-85454 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T568 85475-85485 http://purl.obolibrary.org/obo/CLO_0001658 denotes activating
T569 85718-85722 http://purl.obolibrary.org/obo/GO_0005623 denotes cell
T570 85723-85731 http://purl.obolibrary.org/obo/UBERON_0000158 denotes membrane
T571 85793-85799 http://purl.obolibrary.org/obo/CLO_0001020 denotes a cell
T572 85855-85864 http://purl.obolibrary.org/obo/UBERON_0000158 denotes membranes
T573 86073-86081 http://purl.obolibrary.org/obo/UBERON_0000158 denotes membrane
T574 86100-86101 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T575 86157-86165 http://purl.obolibrary.org/obo/UBERON_0000158 denotes membrane
T576 86228-86236 http://purl.obolibrary.org/obo/UBERON_0000158 denotes membrane
T577 86246-86255 http://purl.obolibrary.org/obo/SO_0000418 denotes signaling
T578 86333-86337 http://purl.obolibrary.org/obo/OGG_0000000002 denotes gene
T579 86338-86348 http://purl.obolibrary.org/obo/CLO_0001658 denotes activation
T580 86408-86409 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T581 86696-86711 http://purl.obolibrary.org/obo/CL_0000451 denotes dendritic cells
T582 86743-86749 http://purl.obolibrary.org/obo/CL_0000236 denotes B cell
T583 86763-86773 http://purl.obolibrary.org/obo/CLO_0001658 denotes activation
T584 87063-87069 http://purl.obolibrary.org/obo/UBERON_0001969 denotes plasma
T585 87070-87079 http://purl.obolibrary.org/obo/UBERON_0000158 denotes membranes
T586 87083-87089 http://www.ebi.ac.uk/efo/EFO_0000265 denotes aortic
T587 87090-87107 http://purl.obolibrary.org/obo/CL_0000115 denotes endothelial cells
T588 87151-87159 http://purl.obolibrary.org/obo/UBERON_0000158 denotes membrane
T589 87226-87236 http://purl.obolibrary.org/obo/CL_0000000 denotes cell types
T590 87238-87240 http://purl.obolibrary.org/obo/CLO_0001627 denotes AA
T591 87272-87280 http://purl.obolibrary.org/obo/UBERON_0000158 denotes membrane
T592 87373-87378 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T593 87387-87396 http://purl.obolibrary.org/obo/CL_0000576 denotes monocytes
T594 87453-87454 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T595 87471-87473 http://purl.obolibrary.org/obo/CLO_0001627 denotes AA
T596 87483-87491 http://purl.obolibrary.org/obo/UBERON_0000158 denotes membrane
T597 87502-87510 http://purl.obolibrary.org/obo/UBERON_0000158 denotes membrane
T598 87511-87513 http://purl.obolibrary.org/obo/CLO_0001627 denotes AA
T599 87601-87611 http://purl.obolibrary.org/obo/CLO_0001658 denotes activation
T600 87629-87631 http://purl.obolibrary.org/obo/CLO_0001562 denotes A2
T601 87642-87644 http://purl.obolibrary.org/obo/CLO_0001627 denotes AA
T602 87654-87658 http://purl.obolibrary.org/obo/GO_0005623 denotes cell
T603 87659-87667 http://purl.obolibrary.org/obo/UBERON_0000158 denotes membrane
T604 87905-87907 http://purl.obolibrary.org/obo/CLO_0001627 denotes AA
T605 87932-87936 http://purl.obolibrary.org/obo/GO_0005623 denotes cell
T606 87937-87945 http://purl.obolibrary.org/obo/UBERON_0000158 denotes membrane
T607 87969-87973 http://purl.obolibrary.org/obo/GO_0005623 denotes cell
T608 88287-88290 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T609 88291-88292 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T610 88588-88594 http://purl.obolibrary.org/obo/UBERON_0003103 denotes organs
T611 88639-88660 http://purl.obolibrary.org/obo/UBERON_0004535 denotes cardiovascular system
T612 88639-88660 http://www.ebi.ac.uk/efo/EFO_0000791 denotes cardiovascular system
T613 88674-88675 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T614 88798-88804 http://purl.obolibrary.org/obo/CLO_0007900 denotes Murphy
T615 88833-88834 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T616 88877-88878 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T617 89248-89251 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T618 89367-89370 http://purl.obolibrary.org/obo/CLO_0002421 denotes Cho
T619 89367-89370 http://purl.obolibrary.org/obo/CLO_0052479 denotes Cho
T620 89367-89370 http://purl.obolibrary.org/obo/CLO_0052480 denotes Cho
T621 89367-89370 http://purl.obolibrary.org/obo/CLO_0052483 denotes Cho
T622 89367-89370 http://purl.obolibrary.org/obo/CLO_0052484 denotes Cho
T623 89367-89370 http://purl.obolibrary.org/obo/CLO_0052485 denotes Cho
T624 89417-89421 http://purl.obolibrary.org/obo/CLO_0001185 denotes 2018
T625 89672-89673 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T626 89776-89782 http://purl.obolibrary.org/obo/CLO_0007900 denotes Murphy
T627 89927-89933 http://purl.obolibrary.org/obo/UBERON_0001630 denotes muscle
T628 89927-89933 http://purl.obolibrary.org/obo/UBERON_0005090 denotes muscle
T629 89927-89933 http://www.ebi.ac.uk/efo/EFO_0000801 denotes muscle
T630 89927-89933 http://www.ebi.ac.uk/efo/EFO_0001949 denotes muscle
T631 90069-90070 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T632 90213-90214 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T633 90689-90693 http://purl.obolibrary.org/obo/CLO_0001185 denotes 2018
T634 91218-91226 http://purl.obolibrary.org/obo/CLO_0001658 denotes activity
T635 91290-91298 http://purl.obolibrary.org/obo/UBERON_0000158 denotes membrane
T636 91352-91356 http://purl.obolibrary.org/obo/GO_0005623 denotes cell
T637 91364-91366 http://purl.obolibrary.org/obo/CLO_0001022 denotes Li
T638 91364-91366 http://purl.obolibrary.org/obo/CLO_0007314 denotes Li
T639 91718-91719 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T640 91896-91902 http://purl.obolibrary.org/obo/GO_0005623 denotes cell's
T641 92040-92046 http://purl.obolibrary.org/obo/GO_0005623 denotes cell's
T642 92102-92107 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T643 92428-92438 http://purl.obolibrary.org/obo/CLO_0001658 denotes activation
T644 92682-92683 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T645 92744-92747 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T646 92748-92749 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T647 92843-92844 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T648 93067-93068 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T63948 93206-93207 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T650 93260-93268 http://purl.obolibrary.org/obo/UBERON_0000158 denotes membrane
T651 93459-93460 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T652 93461-93466 http://purl.obolibrary.org/obo/CLO_0007836 denotes mouse
T653 93753-93754 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T654 93934-93935 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T655 94053-94057 http://purl.obolibrary.org/obo/CLO_0052763 denotes HL-1
T656 94066-94071 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T657 94107-94111 http://purl.obolibrary.org/obo/GO_0005623 denotes cell
T658 94723-94727 http://purl.obolibrary.org/obo/CLO_0001185 denotes 2018
T659 94950-94957 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes viruses
T660 95042-95050 http://purl.obolibrary.org/obo/UBERON_0000158 denotes membrane
T661 95064-95072 http://purl.obolibrary.org/obo/CLO_0001658 denotes activate
T662 95085-95098 http://purl.obolibrary.org/obo/UBERON_0002405 denotes immune system
T663 95151-95155 http://purl.obolibrary.org/obo/CLO_0001185 denotes 2018
T664 95333-95341 http://purl.obolibrary.org/obo/CLO_0001658 denotes activity
T665 95373-95374 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T666 95375-95380 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T667 95448-95452 http://purl.obolibrary.org/obo/UBERON_0003101 denotes male
T668 95448-95452 http://www.ebi.ac.uk/efo/EFO_0000970 denotes male
T669 95574-95579 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T670 95709-95710 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T671 95785-95790 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T672 95868-95875 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes viruses
T673 95923-95928 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T674 96221-96228 http://purl.obolibrary.org/obo/CLO_0009015 denotes SH-SY5Y
T675 96221-96228 http://purl.obolibrary.org/obo/CLO_0051795 denotes SH-SY5Y
T676 96221-96228 http://purl.obolibrary.org/obo/CLO_0052135 denotes SH-SY5Y
T677 96221-96228 http://purl.obolibrary.org/obo/CLO_0052139 denotes SH-SY5Y
T678 96221-96228 http://purl.obolibrary.org/obo/CLO_0052141 denotes SH-SY5Y
T679 96229-96234 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T680 96254-96259 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T681 96464-96471 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes viruses
T682 96526-96529 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T683 96670-96675 http://www.ebi.ac.uk/efo/EFO_0000825 denotes mouth
T684 96826-96834 http://purl.obolibrary.org/obo/UBERON_0000158 denotes membrane
T685 96869-96879 http://purl.obolibrary.org/obo/CLO_0001658 denotes activating
T686 97142-97146 http://purl.obolibrary.org/obo/NCBITaxon_117565 denotes fish
T687 97184-97189 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T688 97197-97198 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T689 97349-97352 http://purl.obolibrary.org/obo/CLO_0053438 denotes CD8
T690 97518-97519 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T691 97525-97528 http://purl.obolibrary.org/obo/UBERON_0001013 denotes fat
T692 97610-97614 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung
T693 97610-97614 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lung
T694 97630-97631 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T695 97691-97696 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T696 97709-97710 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T697 97711-97716 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T698 97726-97730 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung
T699 97726-97730 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lung
T700 97731-97737 http://purl.obolibrary.org/obo/CL_0000084 denotes T cell
T701 97797-97798 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T702 97865-97870 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T703 98030-98035 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T704 98367-98371 http://purl.obolibrary.org/obo/NCBITaxon_117565 denotes fish
T705 98436-98442 http://purl.obolibrary.org/obo/NCBITaxon_33208 denotes animal
T706 98495-98500 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T707 98536-98543 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes viruses

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T1 8-35 Chemical denotes polyunsaturated fatty acids http://purl.obolibrary.org/obo/CHEBI_26208
T2 24-35 Chemical denotes fatty acids http://purl.obolibrary.org/obo/CHEBI_35366
T3 30-35 Chemical denotes acids http://purl.obolibrary.org/obo/CHEBI_37527
T4 62-70 Chemical denotes adjuvant http://purl.obolibrary.org/obo/CHEBI_60809
T5 1079-1106 Chemical denotes polyunsaturated fatty acids http://purl.obolibrary.org/obo/CHEBI_26208
T6 1095-1106 Chemical denotes fatty acids http://purl.obolibrary.org/obo/CHEBI_35366
T7 1101-1106 Chemical denotes acids http://purl.obolibrary.org/obo/CHEBI_37527
T8 1112-1116 Chemical denotes PUFA http://purl.obolibrary.org/obo/CHEBI_26208|http://purl.obolibrary.org/obo/CHEBI_76567
T10 1313-1318 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208
T11 1320-1341 Chemical denotes eicosapentaenoic acid http://purl.obolibrary.org/obo/CHEBI_36006
T12 1337-1341 Chemical denotes acid http://purl.obolibrary.org/obo/CHEBI_37527
T13 1343-1346 Chemical denotes EPA http://purl.obolibrary.org/obo/CHEBI_28364|http://purl.obolibrary.org/obo/CHEBI_36006
T15 1352-1372 Chemical denotes docosahexaenoic acid http://purl.obolibrary.org/obo/CHEBI_36005
T16 1368-1372 Chemical denotes acid http://purl.obolibrary.org/obo/CHEBI_37527
T17 1374-1377 Chemical denotes DHA http://purl.obolibrary.org/obo/CHEBI_16016|http://purl.obolibrary.org/obo/CHEBI_28125|http://purl.obolibrary.org/obo/CHEBI_28689|http://purl.obolibrary.org/obo/CHEBI_36005
T21 1400-1405 Chemical denotes group http://purl.obolibrary.org/obo/CHEBI_24433
T22 1426-1431 Chemical denotes lipid http://purl.obolibrary.org/obo/CHEBI_18059
T23 1599-1604 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208
T24 1615-1626 Chemical denotes metabolites http://purl.obolibrary.org/obo/CHEBI_25212
T25 1661-1666 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208
T26 1680-1688 Chemical denotes adjuvant http://purl.obolibrary.org/obo/CHEBI_60809
T27 1941-1946 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208
T28 1957-1968 Chemical denotes metabolites http://purl.obolibrary.org/obo/CHEBI_25212
T29 2706-2716 Chemical denotes nucleotide http://purl.obolibrary.org/obo/CHEBI_36976
T30 3666-3668 Chemical denotes Li http://purl.obolibrary.org/obo/CHEBI_30145
T31 4215-4217 Chemical denotes HF http://purl.obolibrary.org/obo/CHEBI_141438|http://purl.obolibrary.org/obo/CHEBI_29228
T33 4452-4467 Chemical denotes corticosteroids http://purl.obolibrary.org/obo/CHEBI_50858
T34 4469-4478 Chemical denotes antiviral http://purl.obolibrary.org/obo/CHEBI_22587
T35 4889-4898 Chemical denotes Vitamin C http://purl.obolibrary.org/obo/CHEBI_21241|http://purl.obolibrary.org/obo/CHEBI_29073|http://purl.obolibrary.org/obo/CHEBI_38290
T38 4889-4896 Chemical denotes Vitamin http://purl.obolibrary.org/obo/CHEBI_33229
T39 5022-5031 Chemical denotes Melatonin http://purl.obolibrary.org/obo/CHEBI_16796
T40 5264-5266 Chemical denotes IL http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072
T42 5297-5299 Chemical denotes IL http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072
T44 5324-5326 Chemical denotes IL http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072
T46 5404-5406 Chemical denotes IL http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072
T48 5544-5554 Chemical denotes etanercept http://purl.obolibrary.org/obo/CHEBI_4875
T49 5788-5798 Chemical denotes inhibitors http://purl.obolibrary.org/obo/CHEBI_35222
T50 5814-5825 Chemical denotes tofacitinib http://purl.obolibrary.org/obo/CHEBI_71200
T51 5894-5896 Chemical denotes IL http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072
T53 6084-6086 Chemical denotes IL http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072
T55 6098-6108 Chemical denotes antagonist http://purl.obolibrary.org/obo/CHEBI_48706
T56 6109-6116 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T57 6339-6341 Chemical denotes GM http://purl.obolibrary.org/obo/CHEBI_74120
T58 6360-6362 Chemical denotes GM http://purl.obolibrary.org/obo/CHEBI_74120
T59 6485-6487 Chemical denotes GM http://purl.obolibrary.org/obo/CHEBI_74120
T60 6536-6538 Chemical denotes GM http://purl.obolibrary.org/obo/CHEBI_74120
T61 6931-6942 Chemical denotes antagonists http://purl.obolibrary.org/obo/CHEBI_48706
T62 7079-7095 Chemical denotes N-acetylcysteine http://purl.obolibrary.org/obo/CHEBI_28939
T63 7081-7095 Chemical denotes acetylcysteine http://purl.obolibrary.org/obo/CHEBI_22198
T64 7097-7100 Chemical denotes NAC http://purl.obolibrary.org/obo/CHEBI_28939|http://purl.obolibrary.org/obo/CHEBI_7421
T66 7109-7116 Chemical denotes oxidant http://purl.obolibrary.org/obo/CHEBI_63248
T67 7153-7156 Chemical denotes NAC http://purl.obolibrary.org/obo/CHEBI_28939|http://purl.obolibrary.org/obo/CHEBI_7421
T69 7172-7180 Chemical denotes adjuvant http://purl.obolibrary.org/obo/CHEBI_60809
T70 7266-7269 Chemical denotes NAC http://purl.obolibrary.org/obo/CHEBI_28939|http://purl.obolibrary.org/obo/CHEBI_7421
T72 7432-7434 Chemical denotes La http://purl.obolibrary.org/obo/CHEBI_33336
T73 7501-7508 Chemical denotes epoxide http://purl.obolibrary.org/obo/CHEBI_32955
T74 7525-7535 Chemical denotes inhibitors http://purl.obolibrary.org/obo/CHEBI_35222
T75 7538-7563 Chemical denotes Epoxyeicosatrienoic acids http://purl.obolibrary.org/obo/CHEBI_64007
T76 7558-7563 Chemical denotes acids http://purl.obolibrary.org/obo/CHEBI_37527
T77 7565-7569 Chemical denotes EETs http://purl.obolibrary.org/obo/CHEBI_64007
T78 7710-7720 Chemical denotes eicosanoid http://purl.obolibrary.org/obo/CHEBI_23899
T79 7903-7905 Chemical denotes Co http://purl.obolibrary.org/obo/CHEBI_27638
T80 7925-7935 Chemical denotes inhibitors http://purl.obolibrary.org/obo/CHEBI_35222
T81 7940-7959 Chemical denotes omega-3 fatty acids http://purl.obolibrary.org/obo/CHEBI_25681
T82 7948-7959 Chemical denotes fatty acids http://purl.obolibrary.org/obo/CHEBI_35366
T83 7954-7959 Chemical denotes acids http://purl.obolibrary.org/obo/CHEBI_37527
T84 9044-9046 Chemical denotes Li http://purl.obolibrary.org/obo/CHEBI_30145
T85 9545-9548 Chemical denotes ECG http://purl.obolibrary.org/obo/CHEBI_70255
T86 10468-10471 Chemical denotes Guo http://purl.obolibrary.org/obo/CHEBI_16750
T87 11105-11107 Chemical denotes HF http://purl.obolibrary.org/obo/CHEBI_141438|http://purl.obolibrary.org/obo/CHEBI_29228
T89 11129-11132 Chemical denotes Guo http://purl.obolibrary.org/obo/CHEBI_16750
T90 12008-12010 Chemical denotes MI http://purl.obolibrary.org/obo/CHEBI_53620|http://purl.obolibrary.org/obo/CHEBI_74704
T92 12299-12305 Chemical denotes sodium http://purl.obolibrary.org/obo/CHEBI_26708
T93 12310-12315 Chemical denotes water http://purl.obolibrary.org/obo/CHEBI_15377
T94 12537-12543 Chemical denotes oxygen http://purl.obolibrary.org/obo/CHEBI_25805
T95 13081-13084 Chemical denotes Guo http://purl.obolibrary.org/obo/CHEBI_16750
T96 13806-13808 Chemical denotes IL http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072
T98 13980-13982 Chemical denotes IL http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072
T100 13990-13992 Chemical denotes IL http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072
T102 14026-14028 Chemical denotes IL http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072
T104 14196-14199 Chemical denotes ROS http://purl.obolibrary.org/obo/CHEBI_26523
T105 14457-14459 Chemical denotes O2 http://purl.obolibrary.org/obo/CHEBI_15379
T106 14751-14762 Chemical denotes Angiotensin http://purl.obolibrary.org/obo/CHEBI_2719
T107 14790-14797 Chemical denotes Calcium http://purl.obolibrary.org/obo/CHEBI_22984
T108 14830-14832 Chemical denotes IL http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072
T110 14864-14867 Chemical denotes MCP http://purl.obolibrary.org/obo/CHEBI_132592|http://purl.obolibrary.org/obo/CHEBI_50099
T112 14896-14903 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T113 14907-14909 Chemical denotes NF http://purl.obolibrary.org/obo/CHEBI_141424|http://purl.obolibrary.org/obo/CHEBI_25573|http://purl.obolibrary.org/obo/CHEBI_1224
T116 15019-15026 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T117 15030-15032 Chemical denotes O2 http://purl.obolibrary.org/obo/CHEBI_15379
T118 15034-15040 Chemical denotes Oxygen http://purl.obolibrary.org/obo/CHEBI_15379
T119 15042-15045 Chemical denotes ROS http://purl.obolibrary.org/obo/CHEBI_26523
T120 15047-15070 Chemical denotes Reactive oxygen species http://purl.obolibrary.org/obo/CHEBI_26523
T121 15056-15062 Chemical denotes oxygen http://purl.obolibrary.org/obo/CHEBI_25805
T122 16163-16174 Chemical denotes angiotensin http://purl.obolibrary.org/obo/CHEBI_48433
T123 17779-17781 Chemical denotes IL http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072
T125 17786-17788 Chemical denotes IL http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072
T127 17792-17794 Chemical denotes IL http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072
T129 17798-17800 Chemical denotes IL http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072
T131 17804-17806 Chemical denotes IL http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072
T133 17811-17813 Chemical denotes IL http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072
T135 17818-17820 Chemical denotes IL http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072
T137 17848-17853 Chemical denotes alpha http://purl.obolibrary.org/obo/CHEBI_30216
T138 17963-17970 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T139 17973-17978 Chemical denotes alpha http://purl.obolibrary.org/obo/CHEBI_30216
T140 18037-18044 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T141 19537-19539 Chemical denotes IL http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072
T143 19683-19685 Chemical denotes IL http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072
T145 19717-19728 Chemical denotes tocilizumab http://purl.obolibrary.org/obo/CHEBI_64360
T146 19768-19779 Chemical denotes tocilizumab http://purl.obolibrary.org/obo/CHEBI_64360
T147 19910-19921 Chemical denotes tocilizumab http://purl.obolibrary.org/obo/CHEBI_64360
T148 20443-20454 Chemical denotes tocilizumab http://purl.obolibrary.org/obo/CHEBI_64360
T149 20512-20523 Chemical denotes tocilizumab http://purl.obolibrary.org/obo/CHEBI_64360
T150 20738-20745 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T151 21214-21225 Chemical denotes tocilizumab http://purl.obolibrary.org/obo/CHEBI_64360
T152 21283-21294 Chemical denotes tocilizumab http://purl.obolibrary.org/obo/CHEBI_64360
T153 21337-21348 Chemical denotes tocilizumab http://purl.obolibrary.org/obo/CHEBI_64360
T154 21444-21446 Chemical denotes O2 http://purl.obolibrary.org/obo/CHEBI_15379
T155 21493-21495 Chemical denotes IL http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072
T157 21597-21602 Chemical denotes group http://purl.obolibrary.org/obo/CHEBI_24433
T158 21739-21757 Chemical denotes methylprednisolone http://purl.obolibrary.org/obo/CHEBI_6888
T159 21770-21781 Chemical denotes tocilizumab http://purl.obolibrary.org/obo/CHEBI_64360
T160 21851-21853 Chemical denotes O2 http://purl.obolibrary.org/obo/CHEBI_15379
T161 21979-21997 Chemical denotes methylprednisolone http://purl.obolibrary.org/obo/CHEBI_6888
T162 22002-22013 Chemical denotes tocilizumab http://purl.obolibrary.org/obo/CHEBI_64360
T163 22058-22076 Chemical denotes methylprednisolone http://purl.obolibrary.org/obo/CHEBI_6888
T164 22200-22211 Chemical denotes tocilizumab http://purl.obolibrary.org/obo/CHEBI_64360
T165 22794-22805 Chemical denotes ruxolitinib http://purl.obolibrary.org/obo/CHEBI_66919
T166 22897-22906 Chemical denotes vitamin C http://purl.obolibrary.org/obo/CHEBI_21241
T167 22897-22904 Chemical denotes vitamin http://purl.obolibrary.org/obo/CHEBI_33229
T168 23286-23288 Chemical denotes IL http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072
T170 23307-23312 Chemical denotes label http://purl.obolibrary.org/obo/CHEBI_35209
T171 23996-24002 Chemical denotes Cohort http://purl.obolibrary.org/obo/CHEBI_34935
T172 24794-24800 Chemical denotes lipids http://purl.obolibrary.org/obo/CHEBI_18059
T173 24802-24814 Chemical denotes lipoproteins http://purl.obolibrary.org/obo/CHEBI_6495
T174 24816-24824 Chemical denotes proteins http://purl.obolibrary.org/obo/CHEBI_36080
T175 24829-24842 Chemical denotes nucleic acids http://purl.obolibrary.org/obo/CHEBI_33696
T176 24837-24842 Chemical denotes acids http://purl.obolibrary.org/obo/CHEBI_37527
T177 24844-24846 Chemical denotes Li http://purl.obolibrary.org/obo/CHEBI_30145
T178 25002-25004 Chemical denotes NF http://purl.obolibrary.org/obo/CHEBI_141424|http://purl.obolibrary.org/obo/CHEBI_25573|http://purl.obolibrary.org/obo/CHEBI_1224
T181 25010-25020 Chemical denotes interferon http://purl.obolibrary.org/obo/CHEBI_52999
T182 25022-25025 Chemical denotes IFN http://purl.obolibrary.org/obo/CHEBI_52999
T183 25051-25058 Chemical denotes mitogen http://purl.obolibrary.org/obo/CHEBI_52290
T184 25069-25076 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T185 25238-25240 Chemical denotes NF http://purl.obolibrary.org/obo/CHEBI_141424|http://purl.obolibrary.org/obo/CHEBI_25573|http://purl.obolibrary.org/obo/CHEBI_1224
T188 25496-25503 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T189 25620-25627 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T190 25880-25888 Chemical denotes effector http://purl.obolibrary.org/obo/CHEBI_35224
T191 26004-26006 Chemical denotes IL http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072
T193 26019-26021 Chemical denotes IL http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072
T195 26077-26079 Chemical denotes IL http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072
T197 26087-26089 Chemical denotes IL http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072
T199 26189-26191 Chemical denotes IL http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072
T201 26195-26209 Chemical denotes prostaglandins http://purl.obolibrary.org/obo/CHEBI_26333
T202 26214-26226 Chemical denotes leukotrienes http://purl.obolibrary.org/obo/CHEBI_25029
T203 26691-26693 Chemical denotes HF http://purl.obolibrary.org/obo/CHEBI_141438|http://purl.obolibrary.org/obo/CHEBI_29228
T205 26880-26887 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T206 27166-27168 Chemical denotes HF http://purl.obolibrary.org/obo/CHEBI_141438|http://purl.obolibrary.org/obo/CHEBI_29228
T208 27403-27405 Chemical denotes IL http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072
T210 27413-27415 Chemical denotes IL http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072
T212 27479-27481 Chemical denotes MI http://purl.obolibrary.org/obo/CHEBI_53620|http://purl.obolibrary.org/obo/CHEBI_74704
T214 27517-27519 Chemical denotes IL http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072
T216 27728-27730 Chemical denotes IL http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072
T218 27835-27837 Chemical denotes HF http://purl.obolibrary.org/obo/CHEBI_141438|http://purl.obolibrary.org/obo/CHEBI_29228
T220 27900-27902 Chemical denotes IL http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072
T222 27942-27944 Chemical denotes MI http://purl.obolibrary.org/obo/CHEBI_53620|http://purl.obolibrary.org/obo/CHEBI_74704
T224 30427-30432 Chemical denotes drugs http://purl.obolibrary.org/obo/CHEBI_23888
T225 30748-30755 Chemical denotes Heparin http://purl.obolibrary.org/obo/CHEBI_28304
T226 30756-30769 Chemical denotes anticoagulant http://purl.obolibrary.org/obo/CHEBI_50249
T227 30924-30931 Chemical denotes heparin http://purl.obolibrary.org/obo/CHEBI_28304
T228 30940-30947 Chemical denotes heparin http://purl.obolibrary.org/obo/CHEBI_28304
T229 31015-31022 Chemical denotes heparin http://purl.obolibrary.org/obo/CHEBI_28304
T230 31037-31044 Chemical denotes heparin http://purl.obolibrary.org/obo/CHEBI_28304
T231 31110-31117 Chemical denotes heparin http://purl.obolibrary.org/obo/CHEBI_28304
T232 31218-31225 Chemical denotes heparin http://purl.obolibrary.org/obo/CHEBI_28304
T233 31234-31241 Chemical denotes heparin http://purl.obolibrary.org/obo/CHEBI_28304
T234 31406-31413 Chemical denotes Heparin http://purl.obolibrary.org/obo/CHEBI_28304
T235 31595-31608 Chemical denotes anticoagulant http://purl.obolibrary.org/obo/CHEBI_50249
T236 31791-31794 Chemical denotes ASA http://purl.obolibrary.org/obo/CHEBI_15365
T237 31797-31808 Chemical denotes clopidogrel http://purl.obolibrary.org/obo/CHEBI_37941
T238 31811-31820 Chemical denotes tirofiban http://purl.obolibrary.org/obo/CHEBI_9605
T239 31823-31835 Chemical denotes fondaparinux http://purl.obolibrary.org/obo/CHEBI_61033
T240 31905-31912 Chemical denotes heparin http://purl.obolibrary.org/obo/CHEBI_28304
T241 31999-32019 Chemical denotes acetylsalicylic acid http://purl.obolibrary.org/obo/CHEBI_15365
T242 32015-32019 Chemical denotes acid http://purl.obolibrary.org/obo/CHEBI_37527
T243 32021-32024 Chemical denotes ASA http://purl.obolibrary.org/obo/CHEBI_15365
T244 32070-32081 Chemical denotes clopidogrel http://purl.obolibrary.org/obo/CHEBI_37941
T245 32091-32094 Chemical denotes ASA http://purl.obolibrary.org/obo/CHEBI_15365
T246 32099-32110 Chemical denotes clopidogrel http://purl.obolibrary.org/obo/CHEBI_37941
T247 32151-32160 Chemical denotes Tirofiban http://purl.obolibrary.org/obo/CHEBI_9605
T248 32365-32371 Chemical denotes oxygen http://purl.obolibrary.org/obo/CHEBI_25805
T249 32459-32464 Chemical denotes group http://purl.obolibrary.org/obo/CHEBI_24433
T250 32948-32953 Chemical denotes lipid http://purl.obolibrary.org/obo/CHEBI_18059
T251 33080-33091 Chemical denotes fatty acids http://purl.obolibrary.org/obo/CHEBI_35366
T252 33086-33091 Chemical denotes acids http://purl.obolibrary.org/obo/CHEBI_37527
T253 33102-33109 Chemical denotes glucose http://purl.obolibrary.org/obo/CHEBI_17234|http://purl.obolibrary.org/obo/CHEBI_4167
T255 33295-33300 Chemical denotes lipid http://purl.obolibrary.org/obo/CHEBI_18059
T256 33310-33317 Chemical denotes statins http://purl.obolibrary.org/obo/CHEBI_87631
T257 33498-33505 Chemical denotes statins http://purl.obolibrary.org/obo/CHEBI_87631
T258 33687-33707 Chemical denotes lipid-lowering drugs http://purl.obolibrary.org/obo/CHEBI_35679
T259 33687-33692 Chemical denotes lipid http://purl.obolibrary.org/obo/CHEBI_18059
T260 33702-33707 Chemical denotes drugs http://purl.obolibrary.org/obo/CHEBI_23888
T261 34014-34020 Chemical denotes oxygen http://purl.obolibrary.org/obo/CHEBI_25805
T262 34062-34069 Chemical denotes calcium http://purl.obolibrary.org/obo/CHEBI_22984|http://purl.obolibrary.org/obo/CHEBI_29320
T264 34102-34109 Chemical denotes calcium http://purl.obolibrary.org/obo/CHEBI_22984|http://purl.obolibrary.org/obo/CHEBI_29320
T266 34564-34570 Chemical denotes oxygen http://purl.obolibrary.org/obo/CHEBI_25805
T267 34703-34709 Chemical denotes oxygen http://purl.obolibrary.org/obo/CHEBI_25805
T268 34928-34934 Chemical denotes sodium http://purl.obolibrary.org/obo/CHEBI_26708
T269 34939-34944 Chemical denotes water http://purl.obolibrary.org/obo/CHEBI_15377
T270 35289-35291 Chemical denotes HF http://purl.obolibrary.org/obo/CHEBI_141438|http://purl.obolibrary.org/obo/CHEBI_29228
T272 35510-35512 Chemical denotes HF http://purl.obolibrary.org/obo/CHEBI_141438|http://purl.obolibrary.org/obo/CHEBI_29228
T274 35932-35942 Chemical denotes Colchicine http://purl.obolibrary.org/obo/CHEBI_27882
T275 36042-36047 Chemical denotes label http://purl.obolibrary.org/obo/CHEBI_35209
T276 36092-36102 Chemical denotes colchicine http://purl.obolibrary.org/obo/CHEBI_23359
T277 36224-36231 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T278 36340-36350 Chemical denotes Colchicine http://purl.obolibrary.org/obo/CHEBI_27882
T279 36547-36557 Chemical denotes colchicine http://purl.obolibrary.org/obo/CHEBI_23359
T280 36668-36678 Chemical denotes colchicine http://purl.obolibrary.org/obo/CHEBI_23359
T281 36691-36701 Chemical denotes Colchicine http://purl.obolibrary.org/obo/CHEBI_27882
T282 37125-37131 Chemical denotes statin http://purl.obolibrary.org/obo/CHEBI_87631
T283 37154-37160 Chemical denotes statin http://purl.obolibrary.org/obo/CHEBI_87631
T284 37175-37181 Chemical denotes statin http://purl.obolibrary.org/obo/CHEBI_87631
T285 37188-37200 Chemical denotes Atorvastatin http://purl.obolibrary.org/obo/CHEBI_39548
T286 37256-37263 Chemical denotes statins http://purl.obolibrary.org/obo/CHEBI_87631
T287 37309-37321 Chemical denotes atorvastatin http://purl.obolibrary.org/obo/CHEBI_39548
T288 37387-37393 Chemical denotes statin http://purl.obolibrary.org/obo/CHEBI_87631
T289 37486-37492 Chemical denotes statin http://purl.obolibrary.org/obo/CHEBI_87631
T290 37538-37544 Chemical denotes statin http://purl.obolibrary.org/obo/CHEBI_87631
T291 37637-37639 Chemical denotes IL http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072
T293 37656-37662 Chemical denotes statin http://purl.obolibrary.org/obo/CHEBI_87631
T294 37769-37775 Chemical denotes statin http://purl.obolibrary.org/obo/CHEBI_87631
T295 37848-37855 Chemical denotes statins http://purl.obolibrary.org/obo/CHEBI_87631
T296 38349-38354 Chemical denotes group http://purl.obolibrary.org/obo/CHEBI_24433
T297 39048-39055 Chemical denotes statins http://purl.obolibrary.org/obo/CHEBI_87631
T298 39374-39381 Chemical denotes statins http://purl.obolibrary.org/obo/CHEBI_87631
T299 39821-39825 Chemical denotes drug http://purl.obolibrary.org/obo/CHEBI_23888
T300 39838-39851 Chemical denotes dapagliflozin http://purl.obolibrary.org/obo/CHEBI_85078
T301 39854-39865 Chemical denotes ambrisentan http://purl.obolibrary.org/obo/CHEBI_135949
T302 40045-40056 Chemical denotes ambrisentan http://purl.obolibrary.org/obo/CHEBI_135949
T303 40105-40107 Chemical denotes IV http://purl.obolibrary.org/obo/CHEBI_74327
T304 40108-40117 Chemical denotes Vitamin C http://purl.obolibrary.org/obo/CHEBI_21241|http://purl.obolibrary.org/obo/CHEBI_29073|http://purl.obolibrary.org/obo/CHEBI_38290
T307 40108-40115 Chemical denotes Vitamin http://purl.obolibrary.org/obo/CHEBI_33229
T308 40275-40284 Chemical denotes vitamin C http://purl.obolibrary.org/obo/CHEBI_21241
T309 40275-40282 Chemical denotes vitamin http://purl.obolibrary.org/obo/CHEBI_33229
T310 40359-40368 Chemical denotes vitamin C http://purl.obolibrary.org/obo/CHEBI_21241
T311 40359-40366 Chemical denotes vitamin http://purl.obolibrary.org/obo/CHEBI_33229
T312 40427-40432 Chemical denotes water http://purl.obolibrary.org/obo/CHEBI_15377
T313 40484-40486 Chemical denotes Li http://purl.obolibrary.org/obo/CHEBI_30145
T314 40567-40578 Chemical denotes tocilizumab http://purl.obolibrary.org/obo/CHEBI_64360
T315 40822-40827 Chemical denotes label http://purl.obolibrary.org/obo/CHEBI_35209
T316 41183-41188 Chemical denotes label http://purl.obolibrary.org/obo/CHEBI_35209
T317 41215-41226 Chemical denotes polystyrene http://purl.obolibrary.org/obo/CHEBI_53276
T318 41571-41580 Chemical denotes melatonin http://purl.obolibrary.org/obo/CHEBI_16796
T319 41675-41677 Chemical denotes IL http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072
T321 41689-41698 Chemical denotes Melatonin http://purl.obolibrary.org/obo/CHEBI_16796
T322 41937-41939 Chemical denotes IL http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072
T324 42016-42022 Chemical denotes Cohort http://purl.obolibrary.org/obo/CHEBI_34935
T325 42087-42093 Chemical denotes Cohort http://purl.obolibrary.org/obo/CHEBI_34935
T326 42141-42146 Chemical denotes group http://purl.obolibrary.org/obo/CHEBI_24433
T327 42606-42608 Chemical denotes IL http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072
T329 42654-42656 Chemical denotes IL http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072
T331 42725-42727 Chemical denotes IL http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072
T333 42760-42771 Chemical denotes tocilizumab http://purl.obolibrary.org/obo/CHEBI_64360
T334 43249-43251 Chemical denotes IL http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072
T336 43285-43291 Chemical denotes Cohort http://purl.obolibrary.org/obo/CHEBI_34935
T337 43387-43393 Chemical denotes Cohort http://purl.obolibrary.org/obo/CHEBI_34935
T338 43646-43652 Chemical denotes Cohort http://purl.obolibrary.org/obo/CHEBI_34935
T339 43690-43696 Chemical denotes Cohort http://purl.obolibrary.org/obo/CHEBI_34935
T340 43734-43740 Chemical denotes Cohort http://purl.obolibrary.org/obo/CHEBI_34935
T341 43894-43896 Chemical denotes IL http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072
T343 44709-44717 Chemical denotes Losartan http://purl.obolibrary.org/obo/CHEBI_6541
T344 44778-44786 Chemical denotes Losartan http://purl.obolibrary.org/obo/CHEBI_6541
T345 44898-44906 Chemical denotes Losartan http://purl.obolibrary.org/obo/CHEBI_6541
T346 44953-44961 Chemical denotes Losartan http://purl.obolibrary.org/obo/CHEBI_6541
T347 45039-45047 Chemical denotes Losartan http://purl.obolibrary.org/obo/CHEBI_6541
T348 45172-45180 Chemical denotes Losartan http://purl.obolibrary.org/obo/CHEBI_6541
T349 45227-45248 Chemical denotes Eicosapentaenoic acid http://purl.obolibrary.org/obo/CHEBI_28364
T350 45244-45248 Chemical denotes acid http://purl.obolibrary.org/obo/CHEBI_37527
T351 45250-45253 Chemical denotes EPA http://purl.obolibrary.org/obo/CHEBI_28364|http://purl.obolibrary.org/obo/CHEBI_36006
T353 45260-45270 Chemical denotes fatty acid http://purl.obolibrary.org/obo/CHEBI_35366
T354 45266-45270 Chemical denotes acid http://purl.obolibrary.org/obo/CHEBI_37527
T355 45354-45357 Chemical denotes EPA http://purl.obolibrary.org/obo/CHEBI_28364|http://purl.obolibrary.org/obo/CHEBI_36006
T357 45589-45591 Chemical denotes IL http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072
T359 45603-45624 Chemical denotes Eicosapentaenoic acid http://purl.obolibrary.org/obo/CHEBI_28364
T360 45620-45624 Chemical denotes acid http://purl.obolibrary.org/obo/CHEBI_37527
T361 45630-45640 Chemical denotes fatty acid http://purl.obolibrary.org/obo/CHEBI_35366
T362 45636-45640 Chemical denotes acid http://purl.obolibrary.org/obo/CHEBI_37527
T363 45642-45645 Chemical denotes EPA http://purl.obolibrary.org/obo/CHEBI_28364|http://purl.obolibrary.org/obo/CHEBI_36006
T365 45646-45649 Chemical denotes FFA http://purl.obolibrary.org/obo/CHEBI_42638
T366 45745-45755 Chemical denotes Colchicine http://purl.obolibrary.org/obo/CHEBI_27882
T367 45971-45973 Chemical denotes HF http://purl.obolibrary.org/obo/CHEBI_141438|http://purl.obolibrary.org/obo/CHEBI_29228
T369 46032-46042 Chemical denotes Colchicine http://purl.obolibrary.org/obo/CHEBI_27882
T370 46154-46164 Chemical denotes Colchicine http://purl.obolibrary.org/obo/CHEBI_27882
T371 46259-46269 Chemical denotes colchicine http://purl.obolibrary.org/obo/CHEBI_23359
T372 46445-46449 Chemical denotes drug http://purl.obolibrary.org/obo/CHEBI_23888
T373 47227-47264 Chemical denotes non-steroidal anti-inflammatory drugs http://purl.obolibrary.org/obo/CHEBI_35475
T374 47241-47264 Chemical denotes anti-inflammatory drugs http://purl.obolibrary.org/obo/CHEBI_35472
T375 47259-47264 Chemical denotes drugs http://purl.obolibrary.org/obo/CHEBI_23888
T376 47266-47281 Chemical denotes glucocorticoids http://purl.obolibrary.org/obo/CHEBI_24261
T377 47286-47303 Chemical denotes anti-viral agents http://purl.obolibrary.org/obo/CHEBI_22587
T378 47313-47322 Chemical denotes ribavirin http://purl.obolibrary.org/obo/CHEBI_63580
T379 47324-47343 Chemical denotes lopinavir/ritonavir http://purl.obolibrary.org/obo/CHEBI_145924
T380 47324-47333 Chemical denotes lopinavir http://purl.obolibrary.org/obo/CHEBI_31781
T381 47334-47343 Chemical denotes ritonavir http://purl.obolibrary.org/obo/CHEBI_45409
T382 47359-47369 Chemical denotes antibiotic http://purl.obolibrary.org/obo/CHEBI_33281
T383 47370-47382 Chemical denotes azithromycin http://purl.obolibrary.org/obo/CHEBI_2955
T25921 47470-47507 Chemical denotes non-steroidal anti-inflammatory drugs http://purl.obolibrary.org/obo/CHEBI_35475
T98583 47484-47507 Chemical denotes anti-inflammatory drugs http://purl.obolibrary.org/obo/CHEBI_35472
T58985 47502-47507 Chemical denotes drugs http://purl.obolibrary.org/obo/CHEBI_23888
T16721 47512-47527 Chemical denotes glucocorticoids http://purl.obolibrary.org/obo/CHEBI_24261
T86889 47647-47649 Chemical denotes MI http://purl.obolibrary.org/obo/CHEBI_53620|http://purl.obolibrary.org/obo/CHEBI_74704
T57646 47667-47669 Chemical denotes HF http://purl.obolibrary.org/obo/CHEBI_141438|http://purl.obolibrary.org/obo/CHEBI_29228
T9 47747-47762 Chemical denotes corticosteroids http://purl.obolibrary.org/obo/CHEBI_50858
T48644 47935-47950 Chemical denotes corticosteroids http://purl.obolibrary.org/obo/CHEBI_50858
T73219 48097-48113 Chemical denotes antiviral agents http://purl.obolibrary.org/obo/CHEBI_22587
T21496 48114-48137 Chemical denotes lopinavir and ritonavir http://purl.obolibrary.org/obo/CHEBI_145924
T50172 48114-48123 Chemical denotes lopinavir http://purl.obolibrary.org/obo/CHEBI_31781
T14 48128-48137 Chemical denotes ritonavir http://purl.obolibrary.org/obo/CHEBI_45409
T33412 48188-48193 Chemical denotes label http://purl.obolibrary.org/obo/CHEBI_35209
T81685 48293-48302 Chemical denotes lopinavir http://purl.obolibrary.org/obo/CHEBI_31781
T64788 48303-48312 Chemical denotes ritonavir http://purl.obolibrary.org/obo/CHEBI_45409
T18 48368-48377 Chemical denotes lopinavir http://purl.obolibrary.org/obo/CHEBI_31781
T19 48378-48387 Chemical denotes ritonavir http://purl.obolibrary.org/obo/CHEBI_45409
T20 48622-48632 Chemical denotes antivirals http://purl.obolibrary.org/obo/CHEBI_22587
T38571 48710-48712 Chemical denotes PR http://purl.obolibrary.org/obo/CHEBI_73645
T28881 48835-48837 Chemical denotes MI http://purl.obolibrary.org/obo/CHEBI_53620|http://purl.obolibrary.org/obo/CHEBI_74704
T44699 48885-48904 Chemical denotes protease inhibitors http://purl.obolibrary.org/obo/CHEBI_37670|http://purl.obolibrary.org/obo/CHEBI_60258
T29282 48894-48904 Chemical denotes inhibitors http://purl.obolibrary.org/obo/CHEBI_35222
T94759 49489-49491 Chemical denotes IL http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072
T47139 49658-49660 Chemical denotes MI http://purl.obolibrary.org/obo/CHEBI_53620|http://purl.obolibrary.org/obo/CHEBI_74704
T91487 49768-49773 Chemical denotes label http://purl.obolibrary.org/obo/CHEBI_35209
T32 49838-49842 Chemical denotes beta http://purl.obolibrary.org/obo/CHEBI_10545
T59681 49847-49856 Chemical denotes lopinavir http://purl.obolibrary.org/obo/CHEBI_31781
T9440 49857-49866 Chemical denotes ritonavir http://purl.obolibrary.org/obo/CHEBI_45409
T99302 49871-49880 Chemical denotes ribavirin http://purl.obolibrary.org/obo/CHEBI_63580
T36 49965-49974 Chemical denotes antiviral http://purl.obolibrary.org/obo/CHEBI_22587
T37 50161-50170 Chemical denotes ribavirin http://purl.obolibrary.org/obo/CHEBI_63580
T66525 50317-50319 Chemical denotes MI http://purl.obolibrary.org/obo/CHEBI_53620|http://purl.obolibrary.org/obo/CHEBI_74704
T32313 50396-50414 Chemical denotes hydroxychloroquine http://purl.obolibrary.org/obo/CHEBI_5801
T41 50419-50431 Chemical denotes azithromycin http://purl.obolibrary.org/obo/CHEBI_2955
T73104 50467-50472 Chemical denotes label http://purl.obolibrary.org/obo/CHEBI_35209
T43 50681-50693 Chemical denotes azithromycin http://purl.obolibrary.org/obo/CHEBI_2955
T90286 50697-50715 Chemical denotes hydroxychloroquine http://purl.obolibrary.org/obo/CHEBI_5801
T45 50805-50817 Chemical denotes azithromycin http://purl.obolibrary.org/obo/CHEBI_2955
T70102 50835-50853 Chemical denotes hydroxychloroquine http://purl.obolibrary.org/obo/CHEBI_5801
T47 51940-51944 Chemical denotes drug http://purl.obolibrary.org/obo/CHEBI_23888
T35839 51995-52022 Chemical denotes polyunsaturated fatty acids http://purl.obolibrary.org/obo/CHEBI_26208
T37931 52011-52022 Chemical denotes fatty acids http://purl.obolibrary.org/obo/CHEBI_35366
T49251 52017-52022 Chemical denotes acids http://purl.obolibrary.org/obo/CHEBI_37527
T69010 52042-52069 Chemical denotes polyunsaturated fatty acids http://purl.obolibrary.org/obo/CHEBI_26208
T52 52058-52069 Chemical denotes fatty acids http://purl.obolibrary.org/obo/CHEBI_35366
T22565 52064-52069 Chemical denotes acids http://purl.obolibrary.org/obo/CHEBI_37527
T54 52075-52080 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208
T47684 52086-52107 Chemical denotes essential fatty acids http://purl.obolibrary.org/obo/CHEBI_59549
T2181 52096-52107 Chemical denotes fatty acids http://purl.obolibrary.org/obo/CHEBI_35366
T34267 52102-52107 Chemical denotes acids http://purl.obolibrary.org/obo/CHEBI_37527
T1123 52177-52181 Chemical denotes PUFA http://purl.obolibrary.org/obo/CHEBI_26208|http://purl.obolibrary.org/obo/CHEBI_76567
T18159 52187-52201 Chemical denotes linolenic acid http://purl.obolibrary.org/obo/CHEBI_25048|http://purl.obolibrary.org/obo/CHEBI_27432
T92595 52197-52201 Chemical denotes acid http://purl.obolibrary.org/obo/CHEBI_37527
T6817 52203-52206 Chemical denotes ALA http://purl.obolibrary.org/obo/CHEBI_16449|http://purl.obolibrary.org/obo/CHEBI_27432
T65 52208-52212 Chemical denotes 18:3 http://purl.obolibrary.org/obo/CHEBI_25633|http://purl.obolibrary.org/obo/CHEBI_61160
T46099 52241-52244 Chemical denotes ALA http://purl.obolibrary.org/obo/CHEBI_16449|http://purl.obolibrary.org/obo/CHEBI_27432
T15635 52335-52340 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208
T68740 52356-52359 Chemical denotes ALA http://purl.obolibrary.org/obo/CHEBI_16449|http://purl.obolibrary.org/obo/CHEBI_27432
T11482 52380-52401 Chemical denotes eicosapentaenoic acid http://purl.obolibrary.org/obo/CHEBI_36006
T10015 52397-52401 Chemical denotes acid http://purl.obolibrary.org/obo/CHEBI_37527
T4452 52403-52406 Chemical denotes EPA http://purl.obolibrary.org/obo/CHEBI_28364
T10426 52456-52476 Chemical denotes docosahexaenoic acid http://purl.obolibrary.org/obo/CHEBI_36005
T31285 52472-52476 Chemical denotes acid http://purl.obolibrary.org/obo/CHEBI_37527
T18702 52478-52481 Chemical denotes DHA http://purl.obolibrary.org/obo/CHEBI_16016|http://purl.obolibrary.org/obo/CHEBI_28125|http://purl.obolibrary.org/obo/CHEBI_28689|http://purl.obolibrary.org/obo/CHEBI_36005
T8852 52483-52486 Chemical denotes C22 http://purl.obolibrary.org/obo/CHEBI_87145
T43627 52520-52525 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208
T52698 52691-52694 Chemical denotes ALA http://purl.obolibrary.org/obo/CHEBI_16449|http://purl.obolibrary.org/obo/CHEBI_27432
T89908 52719-52730 Chemical denotes fatty acids http://purl.obolibrary.org/obo/CHEBI_35366
T95104 52725-52730 Chemical denotes acids http://purl.obolibrary.org/obo/CHEBI_37527
T17223 52906-52919 Chemical denotes linoleic acid http://purl.obolibrary.org/obo/CHEBI_17351
T88 52915-52919 Chemical denotes acid http://purl.obolibrary.org/obo/CHEBI_37527
T91031 52921-52923 Chemical denotes LA http://purl.obolibrary.org/obo/CHEBI_17351|http://purl.obolibrary.org/obo/CHEBI_73527
T91 52925-52929 Chemical denotes 18:2 http://purl.obolibrary.org/obo/CHEBI_24993|http://purl.obolibrary.org/obo/CHEBI_25627
T38867 52989-52994 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208
T36453 52996-52998 Chemical denotes LA http://purl.obolibrary.org/obo/CHEBI_17351|http://purl.obolibrary.org/obo/CHEBI_73527
T38709 53031-53047 Chemical denotes arachidonic acid http://purl.obolibrary.org/obo/CHEBI_15843
T97 53043-53047 Chemical denotes acid http://purl.obolibrary.org/obo/CHEBI_37527
T21399 53049-53051 Chemical denotes AA http://purl.obolibrary.org/obo/CHEBI_15843|http://purl.obolibrary.org/obo/CHEBI_72816
T80167 53138-53143 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208
T101 53197-53202 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208
T81083 53208-53213 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208
T103 53262-53266 Chemical denotes PUFA http://purl.obolibrary.org/obo/CHEBI_26208|http://purl.obolibrary.org/obo/CHEBI_76567
T18055 53275-53286 Chemical denotes metabolites http://purl.obolibrary.org/obo/CHEBI_25212
T69018 53307-53317 Chemical denotes metabolite http://purl.obolibrary.org/obo/CHEBI_25212
T23524 53492-53519 Chemical denotes polyunsaturated fatty acids http://purl.obolibrary.org/obo/CHEBI_26208
T56225 53508-53519 Chemical denotes fatty acids http://purl.obolibrary.org/obo/CHEBI_35366
T109 53514-53519 Chemical denotes acids http://purl.obolibrary.org/obo/CHEBI_37527
T28674 53657-53660 Chemical denotes EPA http://purl.obolibrary.org/obo/CHEBI_28364
T111 53665-53668 Chemical denotes DHA http://purl.obolibrary.org/obo/CHEBI_16016|http://purl.obolibrary.org/obo/CHEBI_28125|http://purl.obolibrary.org/obo/CHEBI_28689|http://purl.obolibrary.org/obo/CHEBI_36005
T115 53989-53994 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208
T40184 54108-54112 Chemical denotes PUFA http://purl.obolibrary.org/obo/CHEBI_26208|http://purl.obolibrary.org/obo/CHEBI_76567
T98365 54170-54177 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T69798 54268-54272 Chemical denotes PUFA http://purl.obolibrary.org/obo/CHEBI_26208|http://purl.obolibrary.org/obo/CHEBI_76567
T19581 54408-54410 Chemical denotes AA http://purl.obolibrary.org/obo/CHEBI_15843|http://purl.obolibrary.org/obo/CHEBI_72816
T97574 54419-54430 Chemical denotes metabolites http://purl.obolibrary.org/obo/CHEBI_25212
T124 54440-54454 Chemical denotes thromboxane B2 http://purl.obolibrary.org/obo/CHEBI_28728|http://purl.obolibrary.org/obo/CHEBI_90696
T126 54440-54451 Chemical denotes thromboxane http://purl.obolibrary.org/obo/CHEBI_26995
T46793 54452-54454 Chemical denotes B2 http://purl.obolibrary.org/obo/CHEBI_51707
T128 54456-54460 Chemical denotes TxB2 http://purl.obolibrary.org/obo/CHEBI_28728
T24179 54466-54482 Chemical denotes prostaglandin E2 http://purl.obolibrary.org/obo/CHEBI_15551|http://purl.obolibrary.org/obo/CHEBI_606564
T89104 54466-54479 Chemical denotes prostaglandin http://purl.obolibrary.org/obo/CHEBI_26333
T132 54484-54488 Chemical denotes PGE2 http://purl.obolibrary.org/obo/CHEBI_15551
T39359 54528-54533 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208
T134 54543-54548 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208
T65891 54705-54707 Chemical denotes RV http://purl.obolibrary.org/obo/CHEBI_73823
T136 54715-54717 Chemical denotes RV http://purl.obolibrary.org/obo/CHEBI_73823
T85105 54746-54749 Chemical denotes DHA http://purl.obolibrary.org/obo/CHEBI_16016|http://purl.obolibrary.org/obo/CHEBI_28125|http://purl.obolibrary.org/obo/CHEBI_28689|http://purl.obolibrary.org/obo/CHEBI_36005
T55489 54787-54789 Chemical denotes IL http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072
T39288 54812-54819 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T144 54833-54835 Chemical denotes RV http://purl.obolibrary.org/obo/CHEBI_73823
T82265 54993-54998 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208
T96746 55230-55235 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208
T97226 55360-55363 Chemical denotes EPA http://purl.obolibrary.org/obo/CHEBI_28364
T94168 55367-55381 Chemical denotes linolenic acid http://purl.obolibrary.org/obo/CHEBI_25048|http://purl.obolibrary.org/obo/CHEBI_27432
T26064 55377-55381 Chemical denotes acid http://purl.obolibrary.org/obo/CHEBI_37527
T66493 55386-55398 Chemical denotes antioxidants http://purl.obolibrary.org/obo/CHEBI_22586
T46970 55938-55941 Chemical denotes EPA http://purl.obolibrary.org/obo/CHEBI_28364
T82421 55948-55962 Chemical denotes linolenic acid http://purl.obolibrary.org/obo/CHEBI_25048|http://purl.obolibrary.org/obo/CHEBI_27432
T50755 55958-55962 Chemical denotes acid http://purl.obolibrary.org/obo/CHEBI_37527
T156 56077-56080 Chemical denotes EPA http://purl.obolibrary.org/obo/CHEBI_28364
T77128 56085-56088 Chemical denotes DHA http://purl.obolibrary.org/obo/CHEBI_16016|http://purl.obolibrary.org/obo/CHEBI_28125|http://purl.obolibrary.org/obo/CHEBI_28689|http://purl.obolibrary.org/obo/CHEBI_36005
T41697 56111-56124 Chemical denotes ascorbic acid http://purl.obolibrary.org/obo/CHEBI_22652|http://purl.obolibrary.org/obo/CHEBI_29073
T20638 56120-56124 Chemical denotes acid http://purl.obolibrary.org/obo/CHEBI_37527
T74301 56139-56149 Chemical denotes tocopherol http://purl.obolibrary.org/obo/CHEBI_27013
T94909 56163-56171 Chemical denotes selenium http://purl.obolibrary.org/obo/CHEBI_27568
T92357 56292-56294 Chemical denotes IL http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072
T75303 56491-56495 Chemical denotes PUFA http://purl.obolibrary.org/obo/CHEBI_26208|http://purl.obolibrary.org/obo/CHEBI_76567
T65248 56897-56902 Chemical denotes lipid http://purl.obolibrary.org/obo/CHEBI_18059
T84237 57110-57114 Chemical denotes PUFA http://purl.obolibrary.org/obo/CHEBI_26208|http://purl.obolibrary.org/obo/CHEBI_76567
T43172 57347-57350 Chemical denotes EPA http://purl.obolibrary.org/obo/CHEBI_28364
T97134 57355-57358 Chemical denotes DHA http://purl.obolibrary.org/obo/CHEBI_16016|http://purl.obolibrary.org/obo/CHEBI_28125|http://purl.obolibrary.org/obo/CHEBI_28689|http://purl.obolibrary.org/obo/CHEBI_36005
T46084 57604-57609 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208
T179 57930-57935 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208
T180 58195-58200 Chemical denotes label http://purl.obolibrary.org/obo/CHEBI_35209
T60396 58260-58265 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208
T23982 58399-58404 Chemical denotes group http://purl.obolibrary.org/obo/CHEBI_24433
T29687 58481-58484 Chemical denotes EPA http://purl.obolibrary.org/obo/CHEBI_28364
T96930 58572-58575 Chemical denotes EPA http://purl.obolibrary.org/obo/CHEBI_28364
T15357 58609-58615 Chemical denotes oxygen http://purl.obolibrary.org/obo/CHEBI_25805
T186 58655-58657 Chemical denotes IL http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072
T65020 58888-58894 Chemical denotes lipids http://purl.obolibrary.org/obo/CHEBI_18059
T4064 59093-59120 Chemical denotes polyunsaturated fatty acids http://purl.obolibrary.org/obo/CHEBI_26208
T7626 59109-59120 Chemical denotes fatty acids http://purl.obolibrary.org/obo/CHEBI_35366
T71651 59115-59120 Chemical denotes acids http://purl.obolibrary.org/obo/CHEBI_37527
T192 59125-59130 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208
T79903 59176-59187 Chemical denotes metabolites http://purl.obolibrary.org/obo/CHEBI_25212
T194 59205-59210 Chemical denotes lipid http://purl.obolibrary.org/obo/CHEBI_18059
T2816 59211-59220 Chemical denotes molecules http://purl.obolibrary.org/obo/CHEBI_25367
T196 59489-59494 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208
T81765 59789-59793 Chemical denotes PUFA http://purl.obolibrary.org/obo/CHEBI_26208|http://purl.obolibrary.org/obo/CHEBI_76567
T42008 60011-60016 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208
T200 60178-60180 Chemical denotes MI http://purl.obolibrary.org/obo/CHEBI_53620|http://purl.obolibrary.org/obo/CHEBI_74704
T80020 60242-60244 Chemical denotes HF http://purl.obolibrary.org/obo/CHEBI_141438|http://purl.obolibrary.org/obo/CHEBI_29228
T204 60380-60385 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208
T90720 60532-60537 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208
T82402 60565-60570 Chemical denotes lipid http://purl.obolibrary.org/obo/CHEBI_18059
T207 60593-60614 Chemical denotes saturated fatty acids http://purl.obolibrary.org/obo/CHEBI_26607
T64756 60603-60614 Chemical denotes fatty acids http://purl.obolibrary.org/obo/CHEBI_35366
T209 60609-60614 Chemical denotes acids http://purl.obolibrary.org/obo/CHEBI_37527
T24989 60628-60640 Chemical denotes triglyceride http://purl.obolibrary.org/obo/CHEBI_17855
T211 60796-60801 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208
T37262 60842-60847 Chemical denotes lipid http://purl.obolibrary.org/obo/CHEBI_18059
T213 61371-61376 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208
T13324 61387-61398 Chemical denotes metabolites http://purl.obolibrary.org/obo/CHEBI_25212
T215 61518-61523 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208
T30067 61617-61628 Chemical denotes metabolites http://purl.obolibrary.org/obo/CHEBI_25212
T217 61646-61651 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208
T38525 61731-61736 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208
T219 61970-61975 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208
T88776 62170-62175 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208
T221 62312-62323 Chemical denotes antioxidant http://purl.obolibrary.org/obo/CHEBI_22586
T72282 62458-62463 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208
T223 62474-62485 Chemical denotes metabolites http://purl.obolibrary.org/obo/CHEBI_25212
T79067 62508-62513 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208
T5044 62538-62546 Chemical denotes adjuvant http://purl.obolibrary.org/obo/CHEBI_60809
T80175 62700-62705 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208
T24234 62742-62747 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208
T7018 62857-62862 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208
T98746 62972-62977 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208
T70497 63178-63183 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208
T32324 63344-63349 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208
T84667 63358-63369 Chemical denotes antioxidant http://purl.obolibrary.org/obo/CHEBI_22586
T12453 63433-63438 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208
T24148 63508-63520 Chemical denotes triglyceride http://purl.obolibrary.org/obo/CHEBI_17855
T15454 63544-63549 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208
T67393 63652-63663 Chemical denotes Angiotensin http://purl.obolibrary.org/obo/CHEBI_2719
T14430 63688-63699 Chemical denotes Angiotensin http://purl.obolibrary.org/obo/CHEBI_2719
T31050 63717-63724 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T10144 63726-63728 Chemical denotes IL http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072
T4756 63764-63767 Chemical denotes DNA http://purl.obolibrary.org/obo/CHEBI_16991
T24904 63769-63773 Chemical denotes PUFA http://purl.obolibrary.org/obo/CHEBI_26208|http://purl.obolibrary.org/obo/CHEBI_76567
T70192 63780-63802 Chemical denotes unsaturated fatty acid http://purl.obolibrary.org/obo/CHEBI_27208
T55358 63792-63802 Chemical denotes fatty acid http://purl.obolibrary.org/obo/CHEBI_35366
T92131 63798-63802 Chemical denotes acid http://purl.obolibrary.org/obo/CHEBI_37527
T82150 63804-63807 Chemical denotes ROS http://purl.obolibrary.org/obo/CHEBI_26523
T62728 63809-63832 Chemical denotes Reactive oxygen species http://purl.obolibrary.org/obo/CHEBI_26523
T4591 63818-63824 Chemical denotes oxygen http://purl.obolibrary.org/obo/CHEBI_25805
T61931 63883-63888 Chemical denotes alpha http://purl.obolibrary.org/obo/CHEBI_30216
T3853 63890-63892 Chemical denotes TX http://purl.obolibrary.org/obo/CHEBI_26995
T97296 63953-63958 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208
T91966 64477-64482 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208
T254 64492-64497 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208
T25762 64573-64582 Chemical denotes molecules http://purl.obolibrary.org/obo/CHEBI_25367
T2516 64744-64746 Chemical denotes NF http://purl.obolibrary.org/obo/CHEBI_141424|http://purl.obolibrary.org/obo/CHEBI_25573|http://purl.obolibrary.org/obo/CHEBI_1224
T90528 64759-64764 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208
T92881 64808-64811 Chemical denotes LTs http://purl.obolibrary.org/obo/CHEBI_25029
T67923 64859-64864 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208
T52402 64881-64886 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208
T263 64896-64898 Chemical denotes AA http://purl.obolibrary.org/obo/CHEBI_15843|http://purl.obolibrary.org/obo/CHEBI_72816
T265 64940-64944 Chemical denotes PUFA http://purl.obolibrary.org/obo/CHEBI_26208|http://purl.obolibrary.org/obo/CHEBI_76567
T41515 65024-65029 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208
T49437 65031-65034 Chemical denotes DHA http://purl.obolibrary.org/obo/CHEBI_16016|http://purl.obolibrary.org/obo/CHEBI_28125|http://purl.obolibrary.org/obo/CHEBI_28689|http://purl.obolibrary.org/obo/CHEBI_36005
T8273 65039-65042 Chemical denotes EPA http://purl.obolibrary.org/obo/CHEBI_28364
T273 65063-65066 Chemical denotes CYP http://purl.obolibrary.org/obo/CHEBI_38559
T15459 65150-65155 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208
T98235 65188-65192 Chemical denotes SPMs http://purl.obolibrary.org/obo/CHEBI_140399
T61651 65243-65245 Chemical denotes AA http://purl.obolibrary.org/obo/CHEBI_15843|http://purl.obolibrary.org/obo/CHEBI_72816
T10468 65247-65263 Chemical denotes Arachidonic acid http://purl.obolibrary.org/obo/CHEBI_15843
T33326 65259-65263 Chemical denotes acid http://purl.obolibrary.org/obo/CHEBI_37527
T93741 65265-65268 Chemical denotes CCL http://purl.obolibrary.org/obo/CHEBI_3478
T49022 65280-65286 Chemical denotes ligand http://purl.obolibrary.org/obo/CHEBI_52214
T32999 65309-65312 Chemical denotes CYP http://purl.obolibrary.org/obo/CHEBI_38559
T44466 65314-65324 Chemical denotes Cytochrome http://purl.obolibrary.org/obo/CHEBI_4056
T12742 65331-65334 Chemical denotes DHA http://purl.obolibrary.org/obo/CHEBI_16016|http://purl.obolibrary.org/obo/CHEBI_28125|http://purl.obolibrary.org/obo/CHEBI_28689|http://purl.obolibrary.org/obo/CHEBI_36005
T92319 65336-65356 Chemical denotes Docosahexaenoic acid http://purl.obolibrary.org/obo/CHEBI_28125
T3064 65352-65356 Chemical denotes acid http://purl.obolibrary.org/obo/CHEBI_37527
T14197 65363-65389 Chemical denotes Epoxydocosapentaenoic acid http://purl.obolibrary.org/obo/CHEBI_72654
T66732 65385-65389 Chemical denotes acid http://purl.obolibrary.org/obo/CHEBI_37527
T292 65391-65394 Chemical denotes EEQ http://purl.obolibrary.org/obo/CHEBI_144559|http://purl.obolibrary.org/obo/CHEBI_72852
T45166 65396-65422 Chemical denotes Epoxyeicosatetraenoic acid http://purl.obolibrary.org/obo/CHEBI_72852
T89769 65418-65422 Chemical denotes acid http://purl.obolibrary.org/obo/CHEBI_37527
T46951 65424-65427 Chemical denotes EPA http://purl.obolibrary.org/obo/CHEBI_28364
T32094 65429-65450 Chemical denotes Eicosapentaenoic acid http://purl.obolibrary.org/obo/CHEBI_28364
T89321 65446-65450 Chemical denotes acid http://purl.obolibrary.org/obo/CHEBI_37527
T33506 65452-65455 Chemical denotes GRP http://purl.obolibrary.org/obo/CHEBI_144473|http://purl.obolibrary.org/obo/CHEBI_80328
T56126 65459-65466 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T51846 65485-65487 Chemical denotes IL http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072
T77398 65521-65523 Chemical denotes LT http://purl.obolibrary.org/obo/CHEBI_73589
T305 65525-65536 Chemical denotes Leukotriene http://purl.obolibrary.org/obo/CHEBI_25029
T306 65538-65542 Chemical denotes PUFA http://purl.obolibrary.org/obo/CHEBI_26208|http://purl.obolibrary.org/obo/CHEBI_76567
T47314 65549-65571 Chemical denotes unsaturated fatty acid http://purl.obolibrary.org/obo/CHEBI_27208
T64064 65561-65571 Chemical denotes fatty acid http://purl.obolibrary.org/obo/CHEBI_35366
T11513 65567-65571 Chemical denotes acid http://purl.obolibrary.org/obo/CHEBI_37527
T26774 65573-65575 Chemical denotes NF http://purl.obolibrary.org/obo/CHEBI_141424|http://purl.obolibrary.org/obo/CHEBI_25573|http://purl.obolibrary.org/obo/CHEBI_1224
T12903 65685-65692 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T14656 65806-65809 Chemical denotes ROS http://purl.obolibrary.org/obo/CHEBI_26523
T89630 65811-65834 Chemical denotes Reactive oxygen species http://purl.obolibrary.org/obo/CHEBI_26523
T21274 65820-65826 Chemical denotes oxygen http://purl.obolibrary.org/obo/CHEBI_25805
T1686 65836-65840 Chemical denotes SPMs http://purl.obolibrary.org/obo/CHEBI_140399
T80333 65842-65877 Chemical denotes Specialized pro-resolving mediators http://purl.obolibrary.org/obo/CHEBI_140399
T320 65948-65953 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208
T16455 66166-66168 Chemical denotes IL http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072
T323 66183-66185 Chemical denotes IL http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072
T26290 66529-66534 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208
T68666 66561-66572 Chemical denotes application http://purl.obolibrary.org/obo/CHEBI_33232
T34991 66580-66585 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208
T328 66802-66807 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208
T96546 67084-67088 Chemical denotes PUFA http://purl.obolibrary.org/obo/CHEBI_26208|http://purl.obolibrary.org/obo/CHEBI_76567
T12271 67116-67119 Chemical denotes EPA http://purl.obolibrary.org/obo/CHEBI_28364
T332 67134-67137 Chemical denotes DHA http://purl.obolibrary.org/obo/CHEBI_16016|http://purl.obolibrary.org/obo/CHEBI_28125|http://purl.obolibrary.org/obo/CHEBI_28689|http://purl.obolibrary.org/obo/CHEBI_36005
T29542 67173-67175 Chemical denotes IL http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072
T70242 67179-67181 Chemical denotes IL http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072
T99746 67298-67303 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208
T68956 67453-67458 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208
T342 67541-67543 Chemical denotes IL http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072
T4887 67547-67549 Chemical denotes IL http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072
T51017 67568-67573 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208
T45152 67687-67696 Chemical denotes molecules http://purl.obolibrary.org/obo/CHEBI_25367
T51487 68052-68054 Chemical denotes NF http://purl.obolibrary.org/obo/CHEBI_141424|http://purl.obolibrary.org/obo/CHEBI_25573|http://purl.obolibrary.org/obo/CHEBI_1224
T79422 68410-68412 Chemical denotes NF http://purl.obolibrary.org/obo/CHEBI_141424|http://purl.obolibrary.org/obo/CHEBI_25573|http://purl.obolibrary.org/obo/CHEBI_1224
T57263 68449-68456 Chemical denotes nucleus http://purl.obolibrary.org/obo/CHEBI_33252
T83398 68691-68699 Chemical denotes agonists http://purl.obolibrary.org/obo/CHEBI_48705
T356 68817-68822 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208
T14067 68964-68969 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208
T358 68995-69002 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T9960 69138-69143 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208
T73075 69356-69360 Chemical denotes PUFA http://purl.obolibrary.org/obo/CHEBI_26208|http://purl.obolibrary.org/obo/CHEBI_76567
T13559 69441-69446 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208
T88420 69736-69738 Chemical denotes M1 http://purl.obolibrary.org/obo/CHEBI_51079|http://purl.obolibrary.org/obo/CHEBI_139019|http://purl.obolibrary.org/obo/CHEBI_140152|http://purl.obolibrary.org/obo/CHEBI_34826
T13921 69832-69834 Chemical denotes M1 http://purl.obolibrary.org/obo/CHEBI_51079|http://purl.obolibrary.org/obo/CHEBI_139019|http://purl.obolibrary.org/obo/CHEBI_140152|http://purl.obolibrary.org/obo/CHEBI_34826
T7583 69936-69938 Chemical denotes M2 http://purl.obolibrary.org/obo/CHEBI_34827|http://purl.obolibrary.org/obo/CHEBI_51112
T73384 69959-69961 Chemical denotes IL http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072
T46560 70435-70437 Chemical denotes M1 http://purl.obolibrary.org/obo/CHEBI_51079|http://purl.obolibrary.org/obo/CHEBI_139019|http://purl.obolibrary.org/obo/CHEBI_140152|http://purl.obolibrary.org/obo/CHEBI_34826
T40164 70508-70510 Chemical denotes M1 http://purl.obolibrary.org/obo/CHEBI_51079|http://purl.obolibrary.org/obo/CHEBI_139019|http://purl.obolibrary.org/obo/CHEBI_140152|http://purl.obolibrary.org/obo/CHEBI_34826
T26987 70593-70595 Chemical denotes IL http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072
T385 70751-70753 Chemical denotes M2 http://purl.obolibrary.org/obo/CHEBI_34827|http://purl.obolibrary.org/obo/CHEBI_51112
T387 70968-70973 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208
T388 71007-71018 Chemical denotes metabolites http://purl.obolibrary.org/obo/CHEBI_25212
T389 71087-71089 Chemical denotes IL http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072
T391 71105-71107 Chemical denotes IL http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072
T393 71113-71115 Chemical denotes M1 http://purl.obolibrary.org/obo/CHEBI_51079|http://purl.obolibrary.org/obo/CHEBI_139019|http://purl.obolibrary.org/obo/CHEBI_140152|http://purl.obolibrary.org/obo/CHEBI_34826
T397 71250-71255 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208
T398 71552-71555 Chemical denotes EPA http://purl.obolibrary.org/obo/CHEBI_28364
T399 71560-71563 Chemical denotes DHA http://purl.obolibrary.org/obo/CHEBI_16016|http://purl.obolibrary.org/obo/CHEBI_28125|http://purl.obolibrary.org/obo/CHEBI_28689|http://purl.obolibrary.org/obo/CHEBI_36005
T403 71828-71839 Chemical denotes metabolites http://purl.obolibrary.org/obo/CHEBI_25212
T404 71843-71846 Chemical denotes ALA http://purl.obolibrary.org/obo/CHEBI_16449|http://purl.obolibrary.org/obo/CHEBI_27432
T406 71850-71868 Chemical denotes lipopolysaccharide http://purl.obolibrary.org/obo/CHEBI_16412
T407 71870-71873 Chemical denotes LPS http://purl.obolibrary.org/obo/CHEBI_16412|http://purl.obolibrary.org/obo/CHEBI_52603|http://purl.obolibrary.org/obo/CHEBI_89981
T410 72005-72016 Chemical denotes metabolites http://purl.obolibrary.org/obo/CHEBI_25212
T411 72125-72130 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208
T412 72231-72238 Chemical denotes zymosan http://purl.obolibrary.org/obo/CHEBI_37671
T413 72531-72535 Chemical denotes PUFA http://purl.obolibrary.org/obo/CHEBI_26208|http://purl.obolibrary.org/obo/CHEBI_76567
T415 72667-72672 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208
T416 72793-72798 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208
T417 72826-72828 Chemical denotes M2 http://purl.obolibrary.org/obo/CHEBI_34827|http://purl.obolibrary.org/obo/CHEBI_51112
T419 73063-73068 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208
T420 73339-73350 Chemical denotes metabolites http://purl.obolibrary.org/obo/CHEBI_25212
T421 73358-73363 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208
T422 73439-73450 Chemical denotes metabolites http://purl.obolibrary.org/obo/CHEBI_25212
T423 73470-73475 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208
T424 73662-73667 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208
T425 73834-73845 Chemical denotes metabolites http://purl.obolibrary.org/obo/CHEBI_25212
T426 73898-73902 Chemical denotes PUFA http://purl.obolibrary.org/obo/CHEBI_26208|http://purl.obolibrary.org/obo/CHEBI_76567
T428 73903-73919 Chemical denotes arachidonic acid http://purl.obolibrary.org/obo/CHEBI_15843
T429 73915-73919 Chemical denotes acid http://purl.obolibrary.org/obo/CHEBI_37527
T430 73921-73923 Chemical denotes AA http://purl.obolibrary.org/obo/CHEBI_15843|http://purl.obolibrary.org/obo/CHEBI_72816
T432 73944-73958 Chemical denotes prostaglandins http://purl.obolibrary.org/obo/CHEBI_26333
T433 73960-73963 Chemical denotes PGs http://purl.obolibrary.org/obo/CHEBI_26333
T434 73985-73997 Chemical denotes thromboxanes http://purl.obolibrary.org/obo/CHEBI_26995
T435 73999-74001 Chemical denotes TX http://purl.obolibrary.org/obo/CHEBI_26995
T436 74048-74050 Chemical denotes AA http://purl.obolibrary.org/obo/CHEBI_15843|http://purl.obolibrary.org/obo/CHEBI_72816
T438 74067-74079 Chemical denotes leukotrienes http://purl.obolibrary.org/obo/CHEBI_25029
T439 74081-74084 Chemical denotes LTs http://purl.obolibrary.org/obo/CHEBI_25029
T440 74117-74122 Chemical denotes acids http://purl.obolibrary.org/obo/CHEBI_37527
T441 74130-74135 Chemical denotes lipid http://purl.obolibrary.org/obo/CHEBI_18059
T442 74369-74373 Chemical denotes PGE2 http://purl.obolibrary.org/obo/CHEBI_15551
T443 74474-74478 Chemical denotes PGE2 http://purl.obolibrary.org/obo/CHEBI_15551
T444 74745-74750 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208
T445 74848-74851 Chemical denotes PGs http://purl.obolibrary.org/obo/CHEBI_26333
T446 74881-74884 Chemical denotes LTs http://purl.obolibrary.org/obo/CHEBI_25029
T447 74949-74960 Chemical denotes metabolites http://purl.obolibrary.org/obo/CHEBI_25212
T448 74982-74992 Chemical denotes metabolite http://purl.obolibrary.org/obo/CHEBI_25212
T449 75013-75015 Chemical denotes AA http://purl.obolibrary.org/obo/CHEBI_15843|http://purl.obolibrary.org/obo/CHEBI_72816
T451 75087-75098 Chemical denotes eicosanoids http://purl.obolibrary.org/obo/CHEBI_23899
T452 75311-75315 Chemical denotes PGE2 http://purl.obolibrary.org/obo/CHEBI_15551
T453 75320-75324 Chemical denotes LTB4 http://purl.obolibrary.org/obo/CHEBI_15647
T454 75581-75586 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208
T455 75630-75632 Chemical denotes AA http://purl.obolibrary.org/obo/CHEBI_15843|http://purl.obolibrary.org/obo/CHEBI_72816
T457 75658-75669 Chemical denotes metabolites http://purl.obolibrary.org/obo/CHEBI_25212
T458 75964-75969 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208
T459 76072-76077 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208
T460 76086-76121 Chemical denotes specialized pro-resolving mediators http://purl.obolibrary.org/obo/CHEBI_140399
T461 76123-76127 Chemical denotes SPMs http://purl.obolibrary.org/obo/CHEBI_140399
T462 76147-76152 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208
T463 76176-76181 Chemical denotes group http://purl.obolibrary.org/obo/CHEBI_24433
T464 76192-76227 Chemical denotes specialized pro-resolving mediators http://purl.obolibrary.org/obo/CHEBI_140399
T465 76229-76233 Chemical denotes SPMs http://purl.obolibrary.org/obo/CHEBI_140399
T466 76249-76258 Chemical denotes resolvins http://purl.obolibrary.org/obo/CHEBI_132120
T467 76260-76297 Chemical denotes resolution phase interaction products http://purl.obolibrary.org/obo/CHEBI_132120
T468 76318-76321 Chemical denotes EPA http://purl.obolibrary.org/obo/CHEBI_28364
T469 76333-76337 Chemical denotes RvE1 http://purl.obolibrary.org/obo/CHEBI_81559
T470 76345-76348 Chemical denotes DHA http://purl.obolibrary.org/obo/CHEBI_16016|http://purl.obolibrary.org/obo/CHEBI_28125|http://purl.obolibrary.org/obo/CHEBI_28689|http://purl.obolibrary.org/obo/CHEBI_36005
T474 76360-76364 Chemical denotes RvD1 http://purl.obolibrary.org/obo/CHEBI_81564
T475 76417-76420 Chemical denotes DHA http://purl.obolibrary.org/obo/CHEBI_16016|http://purl.obolibrary.org/obo/CHEBI_28125|http://purl.obolibrary.org/obo/CHEBI_28689|http://purl.obolibrary.org/obo/CHEBI_36005
T479 76547-76558 Chemical denotes metabolites http://purl.obolibrary.org/obo/CHEBI_25212
T480 76678-76682 Chemical denotes SPMs http://purl.obolibrary.org/obo/CHEBI_140399
T481 77097-77106 Chemical denotes resolvins http://purl.obolibrary.org/obo/CHEBI_132120
T482 77421-77430 Chemical denotes resolvins http://purl.obolibrary.org/obo/CHEBI_132120
T483 77612-77614 Chemical denotes IL http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072
T485 77674-77681 Chemical denotes agonist http://purl.obolibrary.org/obo/CHEBI_48705
T486 77682-77692 Chemical denotes antagonist http://purl.obolibrary.org/obo/CHEBI_48706
T487 77705-77709 Chemical denotes RvE1 http://purl.obolibrary.org/obo/CHEBI_81559
T488 77717-77721 Chemical denotes LTB4 http://purl.obolibrary.org/obo/CHEBI_15647
T489 77753-77755 Chemical denotes NF http://purl.obolibrary.org/obo/CHEBI_141424|http://purl.obolibrary.org/obo/CHEBI_25573|http://purl.obolibrary.org/obo/CHEBI_1224
T492 77938-77961 Chemical denotes reactive oxygen species http://purl.obolibrary.org/obo/CHEBI_26523
T493 77947-77953 Chemical denotes oxygen http://purl.obolibrary.org/obo/CHEBI_25805
T494 77963-77966 Chemical denotes ROS http://purl.obolibrary.org/obo/CHEBI_26523
T495 78252-78255 Chemical denotes DHA http://purl.obolibrary.org/obo/CHEBI_16016|http://purl.obolibrary.org/obo/CHEBI_28125|http://purl.obolibrary.org/obo/CHEBI_28689|http://purl.obolibrary.org/obo/CHEBI_36005
T499 78260-78274 Chemical denotes monoglycerides http://purl.obolibrary.org/obo/CHEBI_17408
T500 78325-78329 Chemical denotes RvD3 http://purl.obolibrary.org/obo/CHEBI_138648
T501 78401-78403 Chemical denotes IL http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072
T503 78418-78420 Chemical denotes IL http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072
T505 78551-78555 Chemical denotes SPMs http://purl.obolibrary.org/obo/CHEBI_140399
T506 78644-78671 Chemical denotes hydroxydocosahexaenoic acid http://purl.obolibrary.org/obo/CHEBI_72790
T507 78667-78671 Chemical denotes acid http://purl.obolibrary.org/obo/CHEBI_37527
T508 78673-78680 Chemical denotes 17-HDHA http://purl.obolibrary.org/obo/CHEBI_72637
T509 78713-78717 Chemical denotes SPMs http://purl.obolibrary.org/obo/CHEBI_140399
T510 78719-78723 Chemical denotes RvD1 http://purl.obolibrary.org/obo/CHEBI_81564
T511 78729-78733 Chemical denotes RvD1 http://purl.obolibrary.org/obo/CHEBI_81564
T512 78753-78755 Chemical denotes IL http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072
T514 78984-78988 Chemical denotes SPMs http://purl.obolibrary.org/obo/CHEBI_140399
T515 79014-79023 Chemical denotes adjuvants http://purl.obolibrary.org/obo/CHEBI_60809
T516 79061-79070 Chemical denotes molecules http://purl.obolibrary.org/obo/CHEBI_25367
T517 79253-79257 Chemical denotes RvD1 http://purl.obolibrary.org/obo/CHEBI_81564
T518 79267-79271 Chemical denotes RvE1 http://purl.obolibrary.org/obo/CHEBI_81559
T519 79408-79417 Chemical denotes resolvins http://purl.obolibrary.org/obo/CHEBI_132120
T520 79502-79504 Chemical denotes IL http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072
T522 79508-79510 Chemical denotes IL http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072
T524 79524-79530 Chemical denotes ligand http://purl.obolibrary.org/obo/CHEBI_52214
T525 79538-79556 Chemical denotes chemokine ligand 5 http://purl.obolibrary.org/obo/CHEBI_138180
T526 79548-79554 Chemical denotes ligand http://purl.obolibrary.org/obo/CHEBI_52214
T527 79665-79673 Chemical denotes sulfides http://purl.obolibrary.org/obo/CHEBI_16385|http://purl.obolibrary.org/obo/CHEBI_46717
T529 79896-79899 Chemical denotes DHA http://purl.obolibrary.org/obo/CHEBI_16016|http://purl.obolibrary.org/obo/CHEBI_28125|http://purl.obolibrary.org/obo/CHEBI_28689|http://purl.obolibrary.org/obo/CHEBI_36005
T533 79944-79946 Chemical denotes M1 http://purl.obolibrary.org/obo/CHEBI_51079|http://purl.obolibrary.org/obo/CHEBI_139019|http://purl.obolibrary.org/obo/CHEBI_140152|http://purl.obolibrary.org/obo/CHEBI_34826
T537 79969-79971 Chemical denotes M2 http://purl.obolibrary.org/obo/CHEBI_34827|http://purl.obolibrary.org/obo/CHEBI_51112
T539 80071-80073 Chemical denotes M2 http://purl.obolibrary.org/obo/CHEBI_34827|http://purl.obolibrary.org/obo/CHEBI_51112
T541 80094-80103 Chemical denotes resolvins http://purl.obolibrary.org/obo/CHEBI_132120
T542 80489-80498 Chemical denotes resolvins http://purl.obolibrary.org/obo/CHEBI_132120
T543 80774-80777 Chemical denotes LPS http://purl.obolibrary.org/obo/CHEBI_16412|http://purl.obolibrary.org/obo/CHEBI_52603|http://purl.obolibrary.org/obo/CHEBI_89981
T546 80824-80833 Chemical denotes molecules http://purl.obolibrary.org/obo/CHEBI_25367
T547 81321-81323 Chemical denotes IL http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072
T549 81413-81415 Chemical denotes AA http://purl.obolibrary.org/obo/CHEBI_15843|http://purl.obolibrary.org/obo/CHEBI_72816
T551 81417-81420 Chemical denotes EPA http://purl.obolibrary.org/obo/CHEBI_28364
T552 81425-81428 Chemical denotes DHA http://purl.obolibrary.org/obo/CHEBI_16016|http://purl.obolibrary.org/obo/CHEBI_28125|http://purl.obolibrary.org/obo/CHEBI_28689|http://purl.obolibrary.org/obo/CHEBI_36005
T556 81451-81453 Chemical denotes LA http://purl.obolibrary.org/obo/CHEBI_17351|http://purl.obolibrary.org/obo/CHEBI_73527
T558 81458-81461 Chemical denotes ALA http://purl.obolibrary.org/obo/CHEBI_16449|http://purl.obolibrary.org/obo/CHEBI_27432
T560 81569-81571 Chemical denotes IL http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072
T562 81639-81642 Chemical denotes EPA http://purl.obolibrary.org/obo/CHEBI_28364
T563 81647-81650 Chemical denotes DHA http://purl.obolibrary.org/obo/CHEBI_16016|http://purl.obolibrary.org/obo/CHEBI_28125|http://purl.obolibrary.org/obo/CHEBI_28689|http://purl.obolibrary.org/obo/CHEBI_36005
T567 81690-81699 Chemical denotes resolvins http://purl.obolibrary.org/obo/CHEBI_132120
T568 81772-81777 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208
T569 81791-81802 Chemical denotes metabolites http://purl.obolibrary.org/obo/CHEBI_25212
T570 81804-81813 Chemical denotes resolvins http://purl.obolibrary.org/obo/CHEBI_132120
T571 81880-81882 Chemical denotes IL http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072
T573 82037-82041 Chemical denotes PUFA http://purl.obolibrary.org/obo/CHEBI_26208|http://purl.obolibrary.org/obo/CHEBI_76567
T575 82181-82184 Chemical denotes CYP http://purl.obolibrary.org/obo/CHEBI_38559
T576 82194-82205 Chemical denotes metabolites http://purl.obolibrary.org/obo/CHEBI_25212
T577 82290-82305 Chemical denotes cytochrome P450 http://purl.obolibrary.org/obo/CHEBI_38559
T578 82290-82300 Chemical denotes cytochrome http://purl.obolibrary.org/obo/CHEBI_4056
T579 82307-82310 Chemical denotes CYP http://purl.obolibrary.org/obo/CHEBI_38559
T580 82372-82375 Chemical denotes EPA http://purl.obolibrary.org/obo/CHEBI_28364
T581 82397-82424 Chemical denotes epoxyeicosatetraenoic acids http://purl.obolibrary.org/obo/CHEBI_72852
T582 82419-82424 Chemical denotes acids http://purl.obolibrary.org/obo/CHEBI_37527
T583 82454-82463 Chemical denotes 17,18-EEQ http://purl.obolibrary.org/obo/CHEBI_72853
T584 82460-82463 Chemical denotes EEQ http://purl.obolibrary.org/obo/CHEBI_144559|http://purl.obolibrary.org/obo/CHEBI_72852
T586 82469-82472 Chemical denotes DHA http://purl.obolibrary.org/obo/CHEBI_16016|http://purl.obolibrary.org/obo/CHEBI_28125|http://purl.obolibrary.org/obo/CHEBI_28689|http://purl.obolibrary.org/obo/CHEBI_36005
T590 82494-82521 Chemical denotes epoxydocosapentaenoic acids http://purl.obolibrary.org/obo/CHEBI_72654
T591 82516-82521 Chemical denotes acids http://purl.obolibrary.org/obo/CHEBI_37527
T592 82559-82568 Chemical denotes 19,20-EDP http://purl.obolibrary.org/obo/CHEBI_72653
T593 82682-82691 Chemical denotes 17,18-EEQ http://purl.obolibrary.org/obo/CHEBI_72853
T594 82688-82691 Chemical denotes EEQ http://purl.obolibrary.org/obo/CHEBI_144559|http://purl.obolibrary.org/obo/CHEBI_72852
T596 82696-82705 Chemical denotes 19,20-EDP http://purl.obolibrary.org/obo/CHEBI_72653
T597 82755-82760 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208
T598 82848-82850 Chemical denotes Lu http://purl.obolibrary.org/obo/CHEBI_33382
T599 82910-82914 Chemical denotes PUFA http://purl.obolibrary.org/obo/CHEBI_26208|http://purl.obolibrary.org/obo/CHEBI_76567
T601 82936-82938 Chemical denotes MI http://purl.obolibrary.org/obo/CHEBI_53620|http://purl.obolibrary.org/obo/CHEBI_74704
T603 82980-82990 Chemical denotes eicosanoid http://purl.obolibrary.org/obo/CHEBI_23899
T604 83030-83040 Chemical denotes metabolite http://purl.obolibrary.org/obo/CHEBI_25212
T605 83115-83124 Chemical denotes 19,20-EDP http://purl.obolibrary.org/obo/CHEBI_72653
T606 83129-83138 Chemical denotes 17,18-EEQ http://purl.obolibrary.org/obo/CHEBI_72853
T607 83135-83138 Chemical denotes EEQ http://purl.obolibrary.org/obo/CHEBI_144559|http://purl.obolibrary.org/obo/CHEBI_72852
T609 83175-83179 Chemical denotes PGE2 http://purl.obolibrary.org/obo/CHEBI_15551
T610 83237-83242 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208
T611 83436-83439 Chemical denotes CYP http://purl.obolibrary.org/obo/CHEBI_38559
T612 83448-83453 Chemical denotes epoxy http://purl.obolibrary.org/obo/CHEBI_30721
T613 83454-83465 Chemical denotes metabolites http://purl.obolibrary.org/obo/CHEBI_25212
T614 83534-83541 Chemical denotes retinal http://purl.obolibrary.org/obo/CHEBI_15035
T615 83593-83602 Chemical denotes 19,20-EDP http://purl.obolibrary.org/obo/CHEBI_72653
T616 83636-83644 Chemical denotes molecule http://purl.obolibrary.org/obo/CHEBI_25367
T617 83672-83680 Chemical denotes molecule http://purl.obolibrary.org/obo/CHEBI_25367
T618 83732-83739 Chemical denotes retinal http://purl.obolibrary.org/obo/CHEBI_15035
T619 83890-83899 Chemical denotes 17,18-EEQ http://purl.obolibrary.org/obo/CHEBI_72853
T620 83896-83899 Chemical denotes EEQ http://purl.obolibrary.org/obo/CHEBI_144559|http://purl.obolibrary.org/obo/CHEBI_72852
T622 83904-83913 Chemical denotes 19,20-EDP http://purl.obolibrary.org/obo/CHEBI_72653
T623 84059-84068 Chemical denotes 17,18-EEQ http://purl.obolibrary.org/obo/CHEBI_72853
T624 84065-84068 Chemical denotes EEQ http://purl.obolibrary.org/obo/CHEBI_144559|http://purl.obolibrary.org/obo/CHEBI_72852
T626 84215-84217 Chemical denotes NF http://purl.obolibrary.org/obo/CHEBI_141424|http://purl.obolibrary.org/obo/CHEBI_25573|http://purl.obolibrary.org/obo/CHEBI_1224
T629 84360-84363 Chemical denotes DHA http://purl.obolibrary.org/obo/CHEBI_16016|http://purl.obolibrary.org/obo/CHEBI_28125|http://purl.obolibrary.org/obo/CHEBI_28689|http://purl.obolibrary.org/obo/CHEBI_36005
T633 84364-84372 Chemical denotes epoxides http://purl.obolibrary.org/obo/CHEBI_32955
T634 84515-84518 Chemical denotes DHA http://purl.obolibrary.org/obo/CHEBI_16016|http://purl.obolibrary.org/obo/CHEBI_28125|http://purl.obolibrary.org/obo/CHEBI_28689|http://purl.obolibrary.org/obo/CHEBI_36005
T638 84519-84527 Chemical denotes epoxides http://purl.obolibrary.org/obo/CHEBI_32955
T639 84570-84581 Chemical denotes carrageenan http://purl.obolibrary.org/obo/CHEBI_3435
T640 84613-84617 Chemical denotes male http://purl.obolibrary.org/obo/CHEBI_30780
T641 84724-84734 Chemical denotes fatty acid http://purl.obolibrary.org/obo/CHEBI_35366
T642 84730-84734 Chemical denotes acid http://purl.obolibrary.org/obo/CHEBI_37527
T643 84735-84738 Chemical denotes DHA http://purl.obolibrary.org/obo/CHEBI_16016|http://purl.obolibrary.org/obo/CHEBI_28125|http://purl.obolibrary.org/obo/CHEBI_28689|http://purl.obolibrary.org/obo/CHEBI_36005
T647 84761-84766 Chemical denotes diols http://purl.obolibrary.org/obo/CHEBI_23824
T648 84943-84946 Chemical denotes LPS http://purl.obolibrary.org/obo/CHEBI_16412|http://purl.obolibrary.org/obo/CHEBI_52603|http://purl.obolibrary.org/obo/CHEBI_89981
T651 85075-85077 Chemical denotes HL http://purl.obolibrary.org/obo/CHEBI_5729
T652 85095-85104 Chemical denotes 19,20-EDP http://purl.obolibrary.org/obo/CHEBI_72653
T653 85123-85126 Chemical denotes LPS http://purl.obolibrary.org/obo/CHEBI_16412|http://purl.obolibrary.org/obo/CHEBI_52603|http://purl.obolibrary.org/obo/CHEBI_89981
T656 85176-85183 Chemical denotes histone http://purl.obolibrary.org/obo/CHEBI_15358
T657 85274-85276 Chemical denotes NF http://purl.obolibrary.org/obo/CHEBI_141424|http://purl.obolibrary.org/obo/CHEBI_25573|http://purl.obolibrary.org/obo/CHEBI_1224
T660 85407-85410 Chemical denotes CYP http://purl.obolibrary.org/obo/CHEBI_38559
T661 85423-85434 Chemical denotes metabolites http://purl.obolibrary.org/obo/CHEBI_25212
T662 85442-85447 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208
T663 85706-85711 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208
T664 85775-85780 Chemical denotes lipid http://purl.obolibrary.org/obo/CHEBI_18059
T665 85805-85810 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208
T666 85842-85854 Chemical denotes phospholipid http://purl.obolibrary.org/obo/CHEBI_16247
T667 85914-85919 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208
T668 85971-85976 Chemical denotes lipid http://purl.obolibrary.org/obo/CHEBI_18059
T669 86062-86067 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208
T670 86257-86264 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T671 86302-86308 Chemical denotes lipids http://purl.obolibrary.org/obo/CHEBI_18059
T672 86639-86644 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208
T673 86987-86990 Chemical denotes DHA http://purl.obolibrary.org/obo/CHEBI_16016|http://purl.obolibrary.org/obo/CHEBI_28125|http://purl.obolibrary.org/obo/CHEBI_28689|http://purl.obolibrary.org/obo/CHEBI_36005
T677 87017-87020 Chemical denotes EPA http://purl.obolibrary.org/obo/CHEBI_28364
T678 87038-87043 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208
T679 87048-87059 Chemical denotes cholesterol http://purl.obolibrary.org/obo/CHEBI_16113
T680 87138-87150 Chemical denotes phospholipid http://purl.obolibrary.org/obo/CHEBI_16247
T681 87238-87240 Chemical denotes AA http://purl.obolibrary.org/obo/CHEBI_15843|http://purl.obolibrary.org/obo/CHEBI_72816
T683 87264-87268 Chemical denotes PUFA http://purl.obolibrary.org/obo/CHEBI_26208|http://purl.obolibrary.org/obo/CHEBI_76567
T685 87281-87294 Chemical denotes phospholipids http://purl.obolibrary.org/obo/CHEBI_16247
T686 87471-87473 Chemical denotes AA http://purl.obolibrary.org/obo/CHEBI_15843|http://purl.obolibrary.org/obo/CHEBI_72816
T688 87511-87513 Chemical denotes AA http://purl.obolibrary.org/obo/CHEBI_15843|http://purl.obolibrary.org/obo/CHEBI_72816
T690 87642-87644 Chemical denotes AA http://purl.obolibrary.org/obo/CHEBI_15843|http://purl.obolibrary.org/obo/CHEBI_72816
T692 87730-87741 Chemical denotes metabolites http://purl.obolibrary.org/obo/CHEBI_25212
T693 87870-87875 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208
T694 87905-87907 Chemical denotes AA http://purl.obolibrary.org/obo/CHEBI_15843|http://purl.obolibrary.org/obo/CHEBI_72816
T696 87913-87916 Chemical denotes EPA http://purl.obolibrary.org/obo/CHEBI_28364
T697 87921-87924 Chemical denotes DHA http://purl.obolibrary.org/obo/CHEBI_16016|http://purl.obolibrary.org/obo/CHEBI_28125|http://purl.obolibrary.org/obo/CHEBI_28689|http://purl.obolibrary.org/obo/CHEBI_36005
T701 88097-88107 Chemical denotes metabolite http://purl.obolibrary.org/obo/CHEBI_25212
T702 88238-88243 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208
T703 88253-88256 Chemical denotes EPA http://purl.obolibrary.org/obo/CHEBI_28364
T704 88261-88264 Chemical denotes DHA http://purl.obolibrary.org/obo/CHEBI_16016|http://purl.obolibrary.org/obo/CHEBI_28125|http://purl.obolibrary.org/obo/CHEBI_28689|http://purl.obolibrary.org/obo/CHEBI_36005
T708 88273-88286 Chemical denotes phospholipids http://purl.obolibrary.org/obo/CHEBI_16247
T709 88423-88428 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208
T710 90882-90884 Chemical denotes IL http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072
T712 90892-90894 Chemical denotes IL http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072
T714 91001-91004 Chemical denotes ATP http://purl.obolibrary.org/obo/CHEBI_15422|http://purl.obolibrary.org/obo/CHEBI_30616
T716 91034-91037 Chemical denotes ROS http://purl.obolibrary.org/obo/CHEBI_26523
T717 91147-91149 Chemical denotes IL http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072
T719 91179-91182 Chemical denotes ROS http://purl.obolibrary.org/obo/CHEBI_26523
T720 91234-91242 Chemical denotes electron http://purl.obolibrary.org/obo/CHEBI_10545
T721 91364-91366 Chemical denotes Li http://purl.obolibrary.org/obo/CHEBI_30145
T722 91639-91646 Chemical denotes calcium http://purl.obolibrary.org/obo/CHEBI_22984|http://purl.obolibrary.org/obo/CHEBI_29320
T724 92188-92191 Chemical denotes DNA http://purl.obolibrary.org/obo/CHEBI_16991
T725 92196-92199 Chemical denotes ROS http://purl.obolibrary.org/obo/CHEBI_26523
T726 92518-92520 Chemical denotes IL http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072
T728 92528-92530 Chemical denotes IL http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072
T730 92996-93000 Chemical denotes PUFA http://purl.obolibrary.org/obo/CHEBI_26208|http://purl.obolibrary.org/obo/CHEBI_76567
T732 93023-93034 Chemical denotes metabolites http://purl.obolibrary.org/obo/CHEBI_25212
T733 93187-93192 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208
T734 93269-93281 Chemical denotes phospholipid http://purl.obolibrary.org/obo/CHEBI_16247
T735 93353-93356 Chemical denotes ATP http://purl.obolibrary.org/obo/CHEBI_15422|http://purl.obolibrary.org/obo/CHEBI_30616
T737 93510-93513 Chemical denotes DHA http://purl.obolibrary.org/obo/CHEBI_16016|http://purl.obolibrary.org/obo/CHEBI_28125|http://purl.obolibrary.org/obo/CHEBI_28689|http://purl.obolibrary.org/obo/CHEBI_36005
T741 93522-93527 Chemical denotes epoxy http://purl.obolibrary.org/obo/CHEBI_30721
T742 93528-93538 Chemical denotes metabolite http://purl.obolibrary.org/obo/CHEBI_25212
T743 93540-93549 Chemical denotes 19,20-EDP http://purl.obolibrary.org/obo/CHEBI_72653
T744 93902-93909 Chemical denotes oxidant http://purl.obolibrary.org/obo/CHEBI_63248
T745 94033-94042 Chemical denotes 19,20-EDP http://purl.obolibrary.org/obo/CHEBI_72653
T746 94053-94055 Chemical denotes HL http://purl.obolibrary.org/obo/CHEBI_5729
T747 94102-94105 Chemical denotes LPS http://purl.obolibrary.org/obo/CHEBI_16412|http://purl.obolibrary.org/obo/CHEBI_52603|http://purl.obolibrary.org/obo/CHEBI_89981
T750 94223-94228 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208
T751 94239-94250 Chemical denotes metabolites http://purl.obolibrary.org/obo/CHEBI_25212
T752 94557-94562 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208
T753 94590-94593 Chemical denotes EPA http://purl.obolibrary.org/obo/CHEBI_28364
T754 94598-94601 Chemical denotes DHA http://purl.obolibrary.org/obo/CHEBI_16016|http://purl.obolibrary.org/obo/CHEBI_28125|http://purl.obolibrary.org/obo/CHEBI_28689|http://purl.obolibrary.org/obo/CHEBI_36005
T758 94884-94887 Chemical denotes EPA http://purl.obolibrary.org/obo/CHEBI_28364
T759 94889-94892 Chemical denotes DHA http://purl.obolibrary.org/obo/CHEBI_16016|http://purl.obolibrary.org/obo/CHEBI_28125|http://purl.obolibrary.org/obo/CHEBI_28689|http://purl.obolibrary.org/obo/CHEBI_36005
T763 94911-94934 Chemical denotes unsaturated fatty acids http://purl.obolibrary.org/obo/CHEBI_27208
T764 94923-94934 Chemical denotes fatty acids http://purl.obolibrary.org/obo/CHEBI_35366
T765 94929-94934 Chemical denotes acids http://purl.obolibrary.org/obo/CHEBI_37527
T766 95271-95275 Chemical denotes PUFA http://purl.obolibrary.org/obo/CHEBI_26208|http://purl.obolibrary.org/obo/CHEBI_76567
T768 95284-95289 Chemical denotes lipid http://purl.obolibrary.org/obo/CHEBI_18059
T769 95300-95312 Chemical denotes protectin D1 http://purl.obolibrary.org/obo/CHEBI_138655
T770 95323-95332 Chemical denotes antiviral http://purl.obolibrary.org/obo/CHEBI_22587
T771 95448-95452 Chemical denotes male http://purl.obolibrary.org/obo/CHEBI_30780
T772 95524-95536 Chemical denotes protectin D1 http://purl.obolibrary.org/obo/CHEBI_138655
T773 95700-95707 Chemical denotes 17-HDHA http://purl.obolibrary.org/obo/CHEBI_72637
T774 95711-95714 Chemical denotes SPM http://purl.obolibrary.org/obo/CHEBI_140399
T775 95728-95731 Chemical denotes DHA http://purl.obolibrary.org/obo/CHEBI_16016|http://purl.obolibrary.org/obo/CHEBI_28125|http://purl.obolibrary.org/obo/CHEBI_28689|http://purl.obolibrary.org/obo/CHEBI_36005
T779 95811-95818 Chemical denotes 17-HDHA http://purl.obolibrary.org/obo/CHEBI_72637
T780 96139-96144 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208
T781 96186-96189 Chemical denotes DHA http://purl.obolibrary.org/obo/CHEBI_16016|http://purl.obolibrary.org/obo/CHEBI_28125|http://purl.obolibrary.org/obo/CHEBI_28689|http://purl.obolibrary.org/obo/CHEBI_36005
T785 96221-96223 Chemical denotes SH http://purl.obolibrary.org/obo/CHEBI_29312|http://purl.obolibrary.org/obo/CHEBI_73651
T787 96417-96422 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208
T788 96541-96544 Chemical denotes EPA http://purl.obolibrary.org/obo/CHEBI_28364
T789 96549-96552 Chemical denotes DHA http://purl.obolibrary.org/obo/CHEBI_16016|http://purl.obolibrary.org/obo/CHEBI_28125|http://purl.obolibrary.org/obo/CHEBI_28689|http://purl.obolibrary.org/obo/CHEBI_36005
T793 96743-96748 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208
T96243 96979-96982 Chemical denotes EPA http://purl.obolibrary.org/obo/CHEBI_28364
T22183 96987-96990 Chemical denotes DHA http://purl.obolibrary.org/obo/CHEBI_16016|http://purl.obolibrary.org/obo/CHEBI_28125|http://purl.obolibrary.org/obo/CHEBI_28689|http://purl.obolibrary.org/obo/CHEBI_36005
T42974 97422-97424 Chemical denotes IL http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072
T8535 97542-97545 Chemical denotes EPA http://purl.obolibrary.org/obo/CHEBI_28364
T36312 97550-97553 Chemical denotes DHA http://purl.obolibrary.org/obo/CHEBI_16016|http://purl.obolibrary.org/obo/CHEBI_28125|http://purl.obolibrary.org/obo/CHEBI_28689|http://purl.obolibrary.org/obo/CHEBI_36005
T70467 97812-97815 Chemical denotes EPA http://purl.obolibrary.org/obo/CHEBI_28364
T10664 97820-97823 Chemical denotes DHA http://purl.obolibrary.org/obo/CHEBI_16016|http://purl.obolibrary.org/obo/CHEBI_28125|http://purl.obolibrary.org/obo/CHEBI_28689|http://purl.obolibrary.org/obo/CHEBI_36005
T57308 97985-97989 Chemical denotes PUFA http://purl.obolibrary.org/obo/CHEBI_26208|http://purl.obolibrary.org/obo/CHEBI_76567
T86035 98122-98127 Chemical denotes group http://purl.obolibrary.org/obo/CHEBI_24433
T31343 98630-98633 Chemical denotes EPA http://purl.obolibrary.org/obo/CHEBI_28364
T37898 98638-98641 Chemical denotes DHA http://purl.obolibrary.org/obo/CHEBI_16016|http://purl.obolibrary.org/obo/CHEBI_28125|http://purl.obolibrary.org/obo/CHEBI_28689|http://purl.obolibrary.org/obo/CHEBI_36005
T3472 98736-98741 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208
T27939 98766-98777 Chemical denotes angiotensin http://purl.obolibrary.org/obo/CHEBI_48433
T6936 98778-98789 Chemical denotes aldosterone http://purl.obolibrary.org/obo/CHEBI_27584|http://purl.obolibrary.org/obo/CHEBI_30834
T7499 98834-98845 Chemical denotes angiotensin http://purl.obolibrary.org/obo/CHEBI_48433
T78890 98846-98857 Chemical denotes aldosterone http://purl.obolibrary.org/obo/CHEBI_27584|http://purl.obolibrary.org/obo/CHEBI_30834
T63803 98978-98989 Chemical denotes angiotensin http://purl.obolibrary.org/obo/CHEBI_48433
T28595 99018-99029 Chemical denotes angiotensin http://purl.obolibrary.org/obo/CHEBI_48433
T98359 99082-99096 Chemical denotes angiotensin II http://purl.obolibrary.org/obo/CHEBI_2719|http://purl.obolibrary.org/obo/CHEBI_48432|http://purl.obolibrary.org/obo/CHEBI_58506
T10416 99082-99093 Chemical denotes angiotensin http://purl.obolibrary.org/obo/CHEBI_48433
T26343 99094-99096 Chemical denotes II http://purl.obolibrary.org/obo/CHEBI_74067
T17402 99102-99104 Chemical denotes II http://purl.obolibrary.org/obo/CHEBI_74067
T58284 99160-99162 Chemical denotes II http://purl.obolibrary.org/obo/CHEBI_74067
T59649 99170-99181 Chemical denotes angiotensin http://purl.obolibrary.org/obo/CHEBI_48433
T82369 99326-99329 Chemical denotes ROS http://purl.obolibrary.org/obo/CHEBI_26523
T75644 99467-99469 Chemical denotes II http://purl.obolibrary.org/obo/CHEBI_74067
T85120 99719-99731 Chemical denotes glycoprotein http://purl.obolibrary.org/obo/CHEBI_17089
T80947 99846-99848 Chemical denotes II http://purl.obolibrary.org/obo/CHEBI_74067
T84439 99864-99875 Chemical denotes vasodilator http://purl.obolibrary.org/obo/CHEBI_35620
T27213 99876-99887 Chemical denotes angiotensin http://purl.obolibrary.org/obo/CHEBI_48433
T45768 99966-99968 Chemical denotes II http://purl.obolibrary.org/obo/CHEBI_74067
T96191 100122-100124 Chemical denotes IL http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072
T78534 100146-100154 Chemical denotes molecule http://purl.obolibrary.org/obo/CHEBI_25367
T73533 100181-100188 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T51196 100496-100498 Chemical denotes II http://purl.obolibrary.org/obo/CHEBI_74067
T87718 100736-100742 Chemical denotes sodium http://purl.obolibrary.org/obo/CHEBI_26708
T60659 100822-100824 Chemical denotes HF http://purl.obolibrary.org/obo/CHEBI_141438|http://purl.obolibrary.org/obo/CHEBI_29228
T89389 100826-100828 Chemical denotes MI http://purl.obolibrary.org/obo/CHEBI_53620|http://purl.obolibrary.org/obo/CHEBI_74704
T98010 101047-101059 Chemical denotes glycoprotein http://purl.obolibrary.org/obo/CHEBI_17089
T7184 101282-101289 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T76586 101810-101824 Chemical denotes angiotensin II http://purl.obolibrary.org/obo/CHEBI_2719|http://purl.obolibrary.org/obo/CHEBI_48432|http://purl.obolibrary.org/obo/CHEBI_58506
T40913 101810-101821 Chemical denotes angiotensin http://purl.obolibrary.org/obo/CHEBI_48433
T16555 101822-101824 Chemical denotes II http://purl.obolibrary.org/obo/CHEBI_74067
T42493 102020-102022 Chemical denotes HF http://purl.obolibrary.org/obo/CHEBI_141438|http://purl.obolibrary.org/obo/CHEBI_29228
T88031 102103-102105 Chemical denotes Li http://purl.obolibrary.org/obo/CHEBI_30145
T37525 102171-102173 Chemical denotes II http://purl.obolibrary.org/obo/CHEBI_74067
T71 102751-102765 Chemical denotes ACE inhibitors http://purl.obolibrary.org/obo/CHEBI_35457
T14183 102755-102765 Chemical denotes inhibitors http://purl.obolibrary.org/obo/CHEBI_35222
T61185 102880-102894 Chemical denotes ACE inhibitors http://purl.obolibrary.org/obo/CHEBI_35457
T22919 102884-102894 Chemical denotes inhibitors http://purl.obolibrary.org/obo/CHEBI_35222
T66918 102962-102976 Chemical denotes ACE inhibitors http://purl.obolibrary.org/obo/CHEBI_35457
T15471 102966-102976 Chemical denotes inhibitors http://purl.obolibrary.org/obo/CHEBI_35222
T68170 103140-103142 Chemical denotes II http://purl.obolibrary.org/obo/CHEBI_74067
T90032 103273-103281 Chemical denotes effector http://purl.obolibrary.org/obo/CHEBI_35224
T78320 103421-103426 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208
T6147 103479-103481 Chemical denotes II http://purl.obolibrary.org/obo/CHEBI_74067
T2532 103547-103552 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208
T57170 103586-103597 Chemical denotes metabolites http://purl.obolibrary.org/obo/CHEBI_25212
T65017 103671-103685 Chemical denotes angiotensin II http://purl.obolibrary.org/obo/CHEBI_2719|http://purl.obolibrary.org/obo/CHEBI_48432|http://purl.obolibrary.org/obo/CHEBI_58506
T91030 103671-103682 Chemical denotes angiotensin http://purl.obolibrary.org/obo/CHEBI_48433
T61660 103683-103685 Chemical denotes II http://purl.obolibrary.org/obo/CHEBI_74067
T96103 103819-103823 Chemical denotes PUFA http://purl.obolibrary.org/obo/CHEBI_26208|http://purl.obolibrary.org/obo/CHEBI_76567
T74515 103877-103879 Chemical denotes II http://purl.obolibrary.org/obo/CHEBI_74067
T61134 104010-104015 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208
T84182 104097-104104 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T23531 104279-104284 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208
T46108 104354-104362 Chemical denotes adjuvant http://purl.obolibrary.org/obo/CHEBI_60809
T25304 104450-104452 Chemical denotes II http://purl.obolibrary.org/obo/CHEBI_74067
T8642 104734-104748 Chemical denotes ACE inhibitors http://purl.obolibrary.org/obo/CHEBI_35457
T64765 104738-104748 Chemical denotes inhibitors http://purl.obolibrary.org/obo/CHEBI_35222
T98256 105010-105012 Chemical denotes Li http://purl.obolibrary.org/obo/CHEBI_30145
T99 105138-105152 Chemical denotes ACE inhibitors http://purl.obolibrary.org/obo/CHEBI_35457
T58213 105142-105152 Chemical denotes inhibitors http://purl.obolibrary.org/obo/CHEBI_35222
T47825 105237-105251 Chemical denotes ACE inhibitors http://purl.obolibrary.org/obo/CHEBI_35457
T12352 105241-105251 Chemical denotes inhibitors http://purl.obolibrary.org/obo/CHEBI_35222
T22206 105363-105372 Chemical denotes inhibitor http://purl.obolibrary.org/obo/CHEBI_35222
T31919 105543-105546 Chemical denotes AHA http://purl.obolibrary.org/obo/CHEBI_27777
T30574 105585-105588 Chemical denotes ACC http://purl.obolibrary.org/obo/CHEBI_18053|http://purl.obolibrary.org/obo/CHEBI_30526
T36552 105668-105681 Chemical denotes ACE inhibitor http://purl.obolibrary.org/obo/CHEBI_35457
T48816 105672-105681 Chemical denotes inhibitor http://purl.obolibrary.org/obo/CHEBI_35222
T31232 105781-105783 Chemical denotes II http://purl.obolibrary.org/obo/CHEBI_74067
T61607 106193-106195 Chemical denotes II http://purl.obolibrary.org/obo/CHEBI_74067
T49059 106210-106212 Chemical denotes II http://purl.obolibrary.org/obo/CHEBI_74067
T61540 106708-106722 Chemical denotes ACE inhibitors http://purl.obolibrary.org/obo/CHEBI_35457
T46668 106712-106722 Chemical denotes inhibitors http://purl.obolibrary.org/obo/CHEBI_35222
T114 106737-106742 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208
T45701 106789-106794 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208
T41367 106808-106815 Chemical denotes oxidant http://purl.obolibrary.org/obo/CHEBI_63248
T40351 107025-107028 Chemical denotes ROS http://purl.obolibrary.org/obo/CHEBI_26523
T36964 107030-107032 Chemical denotes Li http://purl.obolibrary.org/obo/CHEBI_30145
T2473 107073-107076 Chemical denotes ROS http://purl.obolibrary.org/obo/CHEBI_26523
T14290 107149-107152 Chemical denotes DNA http://purl.obolibrary.org/obo/CHEBI_16991
T56355 107154-107160 Chemical denotes lipids http://purl.obolibrary.org/obo/CHEBI_18059
T32112 107165-107173 Chemical denotes proteins http://purl.obolibrary.org/obo/CHEBI_36080
T56548 107189-107192 Chemical denotes ROS http://purl.obolibrary.org/obo/CHEBI_26523
T62076 107217-107228 Chemical denotes antioxidant http://purl.obolibrary.org/obo/CHEBI_22586
T53447 107462-107467 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208
T20113 107481-107488 Chemical denotes oxidant http://purl.obolibrary.org/obo/CHEBI_63248
T75385 107550-107557 Chemical denotes oxidant http://purl.obolibrary.org/obo/CHEBI_63248
T10034 107572-107582 Chemical denotes superoxide http://purl.obolibrary.org/obo/CHEBI_18421
T68730 107613-107620 Chemical denotes oxidant http://purl.obolibrary.org/obo/CHEBI_63248
T130 107635-107647 Chemical denotes nitric oxide http://purl.obolibrary.org/obo/CHEBI_16480
T27375 107642-107647 Chemical denotes oxide http://purl.obolibrary.org/obo/CHEBI_25741|http://purl.obolibrary.org/obo/CHEBI_29356
T51423 107703-107711 Chemical denotes radicals http://purl.obolibrary.org/obo/CHEBI_26519
T92608 107740-107745 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208
T5976 108072-108077 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208
T31276 108089-108092 Chemical denotes EPA http://purl.obolibrary.org/obo/CHEBI_28364
T36770 108097-108100 Chemical denotes DHA http://purl.obolibrary.org/obo/CHEBI_16016|http://purl.obolibrary.org/obo/CHEBI_28125|http://purl.obolibrary.org/obo/CHEBI_28689|http://purl.obolibrary.org/obo/CHEBI_36005
T72412 108101-108106 Chemical denotes ethyl http://purl.obolibrary.org/obo/CHEBI_37807|http://purl.obolibrary.org/obo/CHEBI_62801
T78199 108107-108113 Chemical denotes esters http://purl.obolibrary.org/obo/CHEBI_35701
T96256 108334-108345 Chemical denotes antioxidant http://purl.obolibrary.org/obo/CHEBI_22586
T82340 108410-108422 Chemical denotes antioxidants http://purl.obolibrary.org/obo/CHEBI_22586
T78968 108431-108442 Chemical denotes glutathione http://purl.obolibrary.org/obo/CHEBI_16856|http://purl.obolibrary.org/obo/CHEBI_57925
T9746 108457-108468 Chemical denotes glutathione http://purl.obolibrary.org/obo/CHEBI_16856|http://purl.obolibrary.org/obo/CHEBI_57925
T97438 108483-108488 Chemical denotes NADPH http://purl.obolibrary.org/obo/CHEBI_16474|http://purl.obolibrary.org/obo/CHEBI_57783
T8438 108489-108496 Chemical denotes quinone http://purl.obolibrary.org/obo/CHEBI_36141
T35345 108497-108502 Chemical denotes oxido http://purl.obolibrary.org/obo/CHEBI_29355
T55874 108516-108527 Chemical denotes thioredoxin http://purl.obolibrary.org/obo/CHEBI_15033
T8450 108550-108561 Chemical denotes glutathione http://purl.obolibrary.org/obo/CHEBI_16856|http://purl.obolibrary.org/obo/CHEBI_57925
T53406 108652-108661 Chemical denotes monoamine http://purl.obolibrary.org/obo/CHEBI_63534
T34181 108698-108701 Chemical denotes ROS http://purl.obolibrary.org/obo/CHEBI_26523
T91270 108799-108803 Chemical denotes PUFA http://purl.obolibrary.org/obo/CHEBI_26208|http://purl.obolibrary.org/obo/CHEBI_76567
T25405 108897-108900 Chemical denotes DHA http://purl.obolibrary.org/obo/CHEBI_16016|http://purl.obolibrary.org/obo/CHEBI_28125|http://purl.obolibrary.org/obo/CHEBI_28689|http://purl.obolibrary.org/obo/CHEBI_36005
T17595 109003-109015 Chemical denotes antioxidants http://purl.obolibrary.org/obo/CHEBI_22586
T46979 109016-109027 Chemical denotes thioredoxin http://purl.obolibrary.org/obo/CHEBI_15033
T75823 109034-109045 Chemical denotes thioredoxin http://purl.obolibrary.org/obo/CHEBI_15033
T37150 109221-109227 Chemical denotes oxygen http://purl.obolibrary.org/obo/CHEBI_25805
T169 109268-109271 Chemical denotes ROS http://purl.obolibrary.org/obo/CHEBI_26523
T57145 109396-109401 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208
T83743 109426-109437 Chemical denotes metabolites http://purl.obolibrary.org/obo/CHEBI_25212
T72537 109503-109506 Chemical denotes ROS http://purl.obolibrary.org/obo/CHEBI_26523
T89723 109529-109534 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208
T51375 110424-110435 Chemical denotes application http://purl.obolibrary.org/obo/CHEBI_33232
T91999 110439-110453 Chemical denotes anticoagulants http://purl.obolibrary.org/obo/CHEBI_50249
T86234 110463-110470 Chemical denotes heparin http://purl.obolibrary.org/obo/CHEBI_28304
T21342 110667-110680 Chemical denotes anticoagulant http://purl.obolibrary.org/obo/CHEBI_50249
T64463 110723-110730 Chemical denotes heparin http://purl.obolibrary.org/obo/CHEBI_28304
T40880 110838-110843 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208
T56258 110858-110864 Chemical denotes lipids http://purl.obolibrary.org/obo/CHEBI_18059
T81371 110916-110942 Chemical denotes platelet-activating factor http://purl.obolibrary.org/obo/CHEBI_36707|http://purl.obolibrary.org/obo/CHEBI_44811|http://purl.obolibrary.org/obo/CHEBI_52450
T47565 111011-111020 Chemical denotes adenosine http://purl.obolibrary.org/obo/CHEBI_16335
T76873 111021-111032 Chemical denotes diphosphate http://purl.obolibrary.org/obo/CHEBI_18361|http://purl.obolibrary.org/obo/CHEBI_33019
T187 111159-111164 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208
T49312 111184-111196 Chemical denotes phospholipid http://purl.obolibrary.org/obo/CHEBI_16247
T32750 111360-111363 Chemical denotes EPA http://purl.obolibrary.org/obo/CHEBI_28364
T65550 111368-111371 Chemical denotes DHA http://purl.obolibrary.org/obo/CHEBI_16016|http://purl.obolibrary.org/obo/CHEBI_28125|http://purl.obolibrary.org/obo/CHEBI_28689|http://purl.obolibrary.org/obo/CHEBI_36005
T7485 111486-111497 Chemical denotes fatty acids http://purl.obolibrary.org/obo/CHEBI_35366
T25037 111492-111497 Chemical denotes acids http://purl.obolibrary.org/obo/CHEBI_37527
T8207 111505-111510 Chemical denotes group http://purl.obolibrary.org/obo/CHEBI_24433
T22618 111525-111534 Chemical denotes oxylipins http://purl.obolibrary.org/obo/CHEBI_61121
T198 111771-111774 Chemical denotes EPA http://purl.obolibrary.org/obo/CHEBI_28364
T83821 111923-111926 Chemical denotes EPA http://purl.obolibrary.org/obo/CHEBI_28364
T8746 111947-111950 Chemical denotes DHA http://purl.obolibrary.org/obo/CHEBI_16016|http://purl.obolibrary.org/obo/CHEBI_28125|http://purl.obolibrary.org/obo/CHEBI_28689|http://purl.obolibrary.org/obo/CHEBI_36005
T22584 112021-112024 Chemical denotes DHA http://purl.obolibrary.org/obo/CHEBI_16016|http://purl.obolibrary.org/obo/CHEBI_28125|http://purl.obolibrary.org/obo/CHEBI_28689|http://purl.obolibrary.org/obo/CHEBI_36005
T33066 112054-112058 Chemical denotes PGH2 http://purl.obolibrary.org/obo/CHEBI_15554
T13767 112136-112139 Chemical denotes EPA http://purl.obolibrary.org/obo/CHEBI_28364
T42581 112144-112147 Chemical denotes DHA http://purl.obolibrary.org/obo/CHEBI_16016|http://purl.obolibrary.org/obo/CHEBI_28125|http://purl.obolibrary.org/obo/CHEBI_28689|http://purl.obolibrary.org/obo/CHEBI_36005
T6690 112263-112268 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208
T85648 112377-112390 Chemical denotes anticoagulant http://purl.obolibrary.org/obo/CHEBI_50249
T53245 112409-112414 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208
T17989 112589-112594 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208
T64723 112664-112669 Chemical denotes Lipid http://purl.obolibrary.org/obo/CHEBI_18059
T97641 112697-112702 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208
T73970 112812-112823 Chemical denotes cholesterol http://purl.obolibrary.org/obo/CHEBI_16113
T74997 112828-112841 Chemical denotes triglycerides http://purl.obolibrary.org/obo/CHEBI_17855
T18213 113268-113280 Chemical denotes triglyceride http://purl.obolibrary.org/obo/CHEBI_17855
T91925 113436-113447 Chemical denotes lipoprotein http://purl.obolibrary.org/obo/CHEBI_6495
T98996 113534-113546 Chemical denotes Triglyceride http://purl.obolibrary.org/obo/CHEBI_17855|http://purl.obolibrary.org/obo/CHEBI_88875|http://purl.obolibrary.org/obo/CHEBI_88880|http://purl.obolibrary.org/obo/CHEBI_88881|http://purl.obolibrary.org/obo/CHEBI_88882|http://purl.obolibrary.org/obo/CHEBI_88890|http://purl.obolibrary.org/obo/CHEBI_88891|http://purl.obolibrary.org/obo/CHEBI_88892|http://purl.obolibrary.org/obo/CHEBI_88898|http://purl.obolibrary.org/obo/CHEBI_88899|http://purl.obolibrary.org/obo/CHEBI_88901|http://purl.obolibrary.org/obo/CHEBI_88940|http://purl.obolibrary.org/obo/CHEBI_88941|http://purl.obolibrary.org/obo/CHEBI_88943|http://purl.obolibrary.org/obo/CHEBI_88945|http://purl.obolibrary.org/obo/CHEBI_88946|http://purl.obolibrary.org/obo/CHEBI_88967|http://purl.obolibrary.org/obo/CHEBI_88968|http://purl.obolibrary.org/obo/CHEBI_88970|http://purl.obolibrary.org/obo/CHEBI_88971|http://purl.obolibrary.org/obo/CHEBI_88972|http://purl.obolibrary.org/obo/CHEBI_88973|http://purl.obolibrary.org/obo/CHEBI_88976|http://purl.obolibrary.org/obo/CHEBI_88977|http://purl.obolibrary.org/obo/CHEBI_88978|http://purl.obolibrary.org/obo/CHEBI_88979|http://purl.obolibrary.org/obo/CHEBI_88980|http://purl.obolibrary.org/obo/CHEBI_88982|http://purl.obolibrary.org/obo/CHEBI_88983|http://purl.obolibrary.org/obo/CHEBI_88984|http://purl.obolibrary.org/obo/CHEBI_88985|http://purl.obolibrary.org/obo/CHEBI_88986|http://purl.obolibrary.org/obo/CHEBI_88987|http://purl.obolibrary.org/obo/CHEBI_88993|http://purl.obolibrary.org/obo/CHEBI_88994|http://purl.obolibrary.org/obo/CHEBI_88995|http://purl.obolibrary.org/obo/CHEBI_88997|http://purl.obolibrary.org/obo/CHEBI_88998|http://purl.obolibrary.org/obo/CHEBI_88999|http://purl.obolibrary.org/obo/CHEBI_89001|http://purl.obolibrary.org/obo/CHEBI_89003|http://purl.obolibrary.org/obo/CHEBI_89005|http://purl.obolibrary.org/obo/CHEBI_89011|http://purl.obolibrary.org/obo/CHEBI_89016|http://purl.obolibrary.org/obo/CHEBI_89017|http://purl.obolibrary.org/obo/CHEBI_89018|http://purl.obolibrary.org/obo/CHEBI_89019|http://purl.obolibrary.org/obo/CHEBI_89020|http://purl.obolibrary.org/obo/CHEBI_89021|http://purl.obolibrary.org/obo/CHEBI_89022|http://purl.obolibrary.org/obo/CHEBI_89023|http://purl.obolibrary.org/obo/CHEBI_89024|http://purl.obolibrary.org/obo/CHEBI_89025|http://purl.obolibrary.org/obo/CHEBI_89166|http://purl.obolibrary.org/obo/CHEBI_89754|http://purl.obolibrary.org/obo/CHEBI_89756|http://purl.obolibrary.org/obo/CHEBI_89757|http://purl.obolibrary.org/obo/CHEBI_89758|http://purl.obolibrary.org/obo/CHEBI_89759|http://purl.obolibrary.org/obo/CHEBI_89763|http://purl.obolibrary.org/obo/CHEBI_89764|http://purl.obolibrary.org/obo/CHEBI_89765|http://purl.obolibrary.org/obo/CHEBI_89767|http://purl.obolibrary.org/obo/CHEBI_89768|http://purl.obolibrary.org/obo/CHEBI_89772|http://purl.obolibrary.org/obo/CHEBI_89774|http://purl.obolibrary.org/obo/CHEBI_89775|http://purl.obolibrary.org/obo/CHEBI_89776|http://purl.obolibrary.org/obo/CHEBI_89777|http://purl.obolibrary.org/obo/CHEBI_89779|http://purl.obolibrary.org/obo/CHEBI_89840|http://purl.obolibrary.org/obo/CHEBI_89841|http://purl.obolibrary.org/obo/CHEBI_89842|http://purl.obolibrary.org/obo/CHEBI_89948|http://purl.obolibrary.org/obo/CHEBI_89950|http://purl.obolibrary.org/obo/CHEBI_89952|http://purl.obolibrary.org/obo/CHEBI_89958|http://purl.obolibrary.org/obo/CHEBI_89959|http://purl.obolibrary.org/obo/CHEBI_89960|http://purl.obolibrary.org/obo/CHEBI_89961|http://purl.obolibrary.org/obo/CHEBI_89962|http://purl.obolibrary.org/obo/CHEBI_89971|http://purl.obolibrary.org/obo/CHEBI_90042|http://purl.obolibrary.org/obo/CHEBI_90047|http://purl.obolibrary.org/obo/CHEBI_90048|http://purl.obolibrary.org/obo/CHEBI_90049|http://purl.obolibrary.org/obo/CHEBI_90050|http://purl.obolibrary.org/obo/CHEBI_90051|http://purl.obolibrary.org/obo/CHEBI_90052|http://purl.obolibrary.org/obo/CHEBI_90053|http://purl.obolibrary.org/obo/CHEBI_90054|http://purl.obolibrary.org/obo/CHEBI_90066|http://purl.obolibrary.org/obo/CHEBI_90067|http://purl.obolibrary.org/obo/CHEBI_90069|http://purl.obolibrary.org/obo/CHEBI_90070|http://purl.obolibrary.org/obo/CHEBI_90072|http://purl.obolibrary.org/obo/CHEBI_90073
T96702 113547-113554 Chemical denotes glucose http://purl.obolibrary.org/obo/CHEBI_17234|http://purl.obolibrary.org/obo/CHEBI_4167
T58388 113583-113595 Chemical denotes triglyceride http://purl.obolibrary.org/obo/CHEBI_17855
T77480 113615-113622 Chemical denotes glucose http://purl.obolibrary.org/obo/CHEBI_17234|http://purl.obolibrary.org/obo/CHEBI_4167
T30325 113665-113672 Chemical denotes insulin http://purl.obolibrary.org/obo/CHEBI_145810
T11968 113736-113748 Chemical denotes triglyceride http://purl.obolibrary.org/obo/CHEBI_17855
T61046 113749-113756 Chemical denotes glucose http://purl.obolibrary.org/obo/CHEBI_17234|http://purl.obolibrary.org/obo/CHEBI_4167
T330 113858-113894 Chemical denotes high density lipoprotein cholesterol http://purl.obolibrary.org/obo/CHEBI_47775
T93248 113871-113894 Chemical denotes lipoprotein cholesterol http://purl.obolibrary.org/obo/CHEBI_50404
T21748 113871-113882 Chemical denotes lipoprotein http://purl.obolibrary.org/obo/CHEBI_6495
T78952 113883-113894 Chemical denotes cholesterol http://purl.obolibrary.org/obo/CHEBI_16113
T57600 113896-113899 Chemical denotes HDL http://purl.obolibrary.org/obo/CHEBI_39025
T335 114050-114053 Chemical denotes HDL http://purl.obolibrary.org/obo/CHEBI_39025
T23967 114378-114383 Chemical denotes lipid http://purl.obolibrary.org/obo/CHEBI_18059
T68916 114449-114454 Chemical denotes lipid http://purl.obolibrary.org/obo/CHEBI_18059
T74078 114630-114635 Chemical denotes lipid http://purl.obolibrary.org/obo/CHEBI_18059
T59078 114701-114708 Chemical denotes statins http://purl.obolibrary.org/obo/CHEBI_87631
T14528 114719-114724 Chemical denotes lipid http://purl.obolibrary.org/obo/CHEBI_18059
T11008 115095-115101 Chemical denotes statin http://purl.obolibrary.org/obo/CHEBI_87631
T86145 115118-115139 Chemical denotes lipid-lowering agents http://purl.obolibrary.org/obo/CHEBI_35679
T61093 115118-115123 Chemical denotes lipid http://purl.obolibrary.org/obo/CHEBI_18059
T61139 115239-115245 Chemical denotes statin http://purl.obolibrary.org/obo/CHEBI_87631
T88931 115341-115348 Chemical denotes statins http://purl.obolibrary.org/obo/CHEBI_87631
T4285 115502-115508 Chemical denotes statin http://purl.obolibrary.org/obo/CHEBI_87631
T61043 115594-115606 Chemical denotes triglyceride http://purl.obolibrary.org/obo/CHEBI_17855
T67036 115796-115808 Chemical denotes triglyceride http://purl.obolibrary.org/obo/CHEBI_17855
T15031 115832-115836 Chemical denotes PUFA http://purl.obolibrary.org/obo/CHEBI_26208|http://purl.obolibrary.org/obo/CHEBI_76567
T37395 116053-116066 Chemical denotes triglycerides http://purl.obolibrary.org/obo/CHEBI_17855
T352 116257-116262 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208
T29626 116410-116415 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208
T13949 116681-116686 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208
T75577 116753-116758 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208
T18112 117177-117182 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208
T9659 117253-117255 Chemical denotes AA http://purl.obolibrary.org/obo/CHEBI_15843|http://purl.obolibrary.org/obo/CHEBI_72816
T87532 117317-117322 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208
T22847 117569-117572 Chemical denotes EPA http://purl.obolibrary.org/obo/CHEBI_28364
T22042 117574-117577 Chemical denotes DHA http://purl.obolibrary.org/obo/CHEBI_16016|http://purl.obolibrary.org/obo/CHEBI_28125|http://purl.obolibrary.org/obo/CHEBI_28689|http://purl.obolibrary.org/obo/CHEBI_36005
T29272 117582-117602 Chemical denotes gamma-linolenic acid http://purl.obolibrary.org/obo/CHEBI_28661
T59182 117582-117587 Chemical denotes gamma http://purl.obolibrary.org/obo/CHEBI_30212
T45354 117588-117602 Chemical denotes linolenic acid http://purl.obolibrary.org/obo/CHEBI_25048|http://purl.obolibrary.org/obo/CHEBI_27432
T42730 117598-117602 Chemical denotes acid http://purl.obolibrary.org/obo/CHEBI_37527
T89073 117961-117964 Chemical denotes EPA http://purl.obolibrary.org/obo/CHEBI_28364
T75169 117966-117986 Chemical denotes gamma-linolenic acid http://purl.obolibrary.org/obo/CHEBI_28661
T57701 117966-117971 Chemical denotes gamma http://purl.obolibrary.org/obo/CHEBI_30212
T77926 117972-117986 Chemical denotes linolenic acid http://purl.obolibrary.org/obo/CHEBI_25048|http://purl.obolibrary.org/obo/CHEBI_27432
T98610 117982-117986 Chemical denotes acid http://purl.obolibrary.org/obo/CHEBI_37527
T29143 117991-118003 Chemical denotes antioxidants http://purl.obolibrary.org/obo/CHEBI_22586
T95395 118425-118430 Chemical denotes lipid http://purl.obolibrary.org/obo/CHEBI_18059
T21989 118666-118671 Chemical denotes label http://purl.obolibrary.org/obo/CHEBI_35209
T40851 118700-118702 Chemical denotes FA http://purl.obolibrary.org/obo/CHEBI_39002|http://purl.obolibrary.org/obo/CHEBI_73630
T74427 118708-118713 Chemical denotes lipid http://purl.obolibrary.org/obo/CHEBI_18059
T49893 118750-118755 Chemical denotes lipid http://purl.obolibrary.org/obo/CHEBI_18059
T70821 118818-118833 Chemical denotes n-3 fatty acids http://purl.obolibrary.org/obo/CHEBI_25681
T384 118822-118833 Chemical denotes fatty acids http://purl.obolibrary.org/obo/CHEBI_35366
T85700 118828-118833 Chemical denotes acids http://purl.obolibrary.org/obo/CHEBI_37527
T386 118888-118891 Chemical denotes EPA http://purl.obolibrary.org/obo/CHEBI_28364
T46130 118896-118899 Chemical denotes DHA http://purl.obolibrary.org/obo/CHEBI_16016|http://purl.obolibrary.org/obo/CHEBI_28125|http://purl.obolibrary.org/obo/CHEBI_28689|http://purl.obolibrary.org/obo/CHEBI_36005
T85496 118905-118907 Chemical denotes AA http://purl.obolibrary.org/obo/CHEBI_15843|http://purl.obolibrary.org/obo/CHEBI_72816
T99076 118937-118952 Chemical denotes n-3 fatty acids http://purl.obolibrary.org/obo/CHEBI_25681
T394 118941-118952 Chemical denotes fatty acids http://purl.obolibrary.org/obo/CHEBI_35366
T395 118947-118952 Chemical denotes acids http://purl.obolibrary.org/obo/CHEBI_37527
T396 119076-119081 Chemical denotes lipid http://purl.obolibrary.org/obo/CHEBI_18059
T80999 119107-119111 Chemical denotes PUFA http://purl.obolibrary.org/obo/CHEBI_26208|http://purl.obolibrary.org/obo/CHEBI_76567
T19224 119143-119154 Chemical denotes acetic acid http://purl.obolibrary.org/obo/CHEBI_15366
T400 119150-119154 Chemical denotes acid http://purl.obolibrary.org/obo/CHEBI_37527
T401 119397-119408 Chemical denotes amino acids http://purl.obolibrary.org/obo/CHEBI_33709
T402 119397-119402 Chemical denotes amino http://purl.obolibrary.org/obo/CHEBI_46882
T89665 119403-119408 Chemical denotes acids http://purl.obolibrary.org/obo/CHEBI_37527
T58535 119410-119417 Chemical denotes glucose http://purl.obolibrary.org/obo/CHEBI_17234|http://purl.obolibrary.org/obo/CHEBI_4167
T77699 119440-119445 Chemical denotes lipid http://purl.obolibrary.org/obo/CHEBI_18059
T84660 119472-119477 Chemical denotes group http://purl.obolibrary.org/obo/CHEBI_24433
T408 119511-119519 Chemical denotes solution http://purl.obolibrary.org/obo/CHEBI_75958
T409 119536-119541 Chemical denotes group http://purl.obolibrary.org/obo/CHEBI_24433
T85666 119618-119623 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208
T27617 119742-119744 Chemical denotes Li http://purl.obolibrary.org/obo/CHEBI_30145
T29637 119746-119748 Chemical denotes Li http://purl.obolibrary.org/obo/CHEBI_30145
T14169 119752-119754 Chemical denotes Li http://purl.obolibrary.org/obo/CHEBI_30145
T414 119855-119860 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208
T65948 120030-120033 Chemical denotes EPA http://purl.obolibrary.org/obo/CHEBI_28364
T58104 120038-120041 Chemical denotes DHA http://purl.obolibrary.org/obo/CHEBI_16016|http://purl.obolibrary.org/obo/CHEBI_28125|http://purl.obolibrary.org/obo/CHEBI_28689|http://purl.obolibrary.org/obo/CHEBI_36005
T87320 120459-120464 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208
T82196 120592-120597 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208
T30589 120731-120736 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208
T35844 121465-121470 Chemical denotes drugs http://purl.obolibrary.org/obo/CHEBI_23888
T26493 121491-121493 Chemical denotes II http://purl.obolibrary.org/obo/CHEBI_74067
T81572 121690-121695 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208
T45964 121799-121801 Chemical denotes II http://purl.obolibrary.org/obo/CHEBI_74067
T427 122039-122044 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208
T90785 122181-122186 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208
T34260 122303-122308 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208
T58511 122342-122353 Chemical denotes metabolites http://purl.obolibrary.org/obo/CHEBI_25212
T431 122457-122462 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208
T66399 122496-122507 Chemical denotes metabolites http://purl.obolibrary.org/obo/CHEBI_25212
T60416 122765-122770 Chemical denotes lipid http://purl.obolibrary.org/obo/CHEBI_18059
T68319 122771-122782 Chemical denotes metabolites http://purl.obolibrary.org/obo/CHEBI_25212
T54954 122844-122854 Chemical denotes metabolite http://purl.obolibrary.org/obo/CHEBI_25212
T36317 122956-122961 Chemical denotes PUFAs http://purl.obolibrary.org/obo/CHEBI_26208

LitCovid-PD-GO-BP

Id Subject Object Predicate Lexical cue
T1 98923-98934 http://purl.obolibrary.org/obo/GO_0035815 denotes natriuresis
T2 99263-99279 http://purl.obolibrary.org/obo/GO_0042310 denotes vasoconstriction
T3 100088-100100 http://purl.obolibrary.org/obo/GO_0006954 denotes inflammation
T4 100296-100312 http://purl.obolibrary.org/obo/GO_0006955 denotes immune responses
T5 100542-100564 http://purl.obolibrary.org/obo/GO_0006954 denotes inflammatory responses
T6 100718-100734 http://purl.obolibrary.org/obo/GO_0042310 denotes vasoconstriction
T7 100743-100752 http://purl.obolibrary.org/obo/GO_0051235 denotes retention
T8 101564-101586 http://purl.obolibrary.org/obo/GO_0006954 denotes inflammatory responses
T9 101870-101882 http://purl.obolibrary.org/obo/GO_0006954 denotes inflammation
T10 101884-101900 http://purl.obolibrary.org/obo/GO_0042310 denotes vasoconstriction
T11 103686-103695 http://purl.obolibrary.org/obo/GO_0009058 denotes formation
T12 103910-103920 http://purl.obolibrary.org/obo/GO_0065007 denotes regulation
T13 105888-105909 http://purl.obolibrary.org/obo/GO_0006954 denotes inflammatory response
T14 105914-105930 http://purl.obolibrary.org/obo/GO_0042310 denotes vasoconstriction
T15 106174-106185 http://purl.obolibrary.org/obo/GO_0009056 denotes degradation
T16 106421-106430 http://purl.obolibrary.org/obo/GO_0046903 denotes secretion
T17 106512-106521 http://purl.obolibrary.org/obo/GO_0009058 denotes formation
T18 106930-106940 http://purl.obolibrary.org/obo/GO_0008152 denotes metabolism
T19 106966-106978 http://purl.obolibrary.org/obo/GO_0006113 denotes fermentation
T20 107293-107323 http://purl.obolibrary.org/obo/GO_0002253 denotes activation of immune responses
T21 109160-109172 http://purl.obolibrary.org/obo/GO_0006954 denotes inflammation
T22 109268-109282 http://purl.obolibrary.org/obo/GO_1903409 denotes ROS generation
T23 109486-109498 http://purl.obolibrary.org/obo/GO_0006954 denotes inflammation
T24 109768-109779 http://purl.obolibrary.org/obo/GO_0050817 denotes coagulation
T25 109910-109921 http://purl.obolibrary.org/obo/GO_0009056 denotes degradation
T26 110074-110088 http://purl.obolibrary.org/obo/GO_0007596 denotes blood clotting
T27 110080-110088 http://purl.obolibrary.org/obo/GO_0050817 denotes clotting
T28 110916-110935 http://purl.obolibrary.org/obo/GO_0030168 denotes platelet-activating
T29 111411-111431 http://purl.obolibrary.org/obo/GO_0070527 denotes platelet aggregation
T30 111585-111595 http://purl.obolibrary.org/obo/GO_0065007 denotes regulation
T31 111620-111630 http://purl.obolibrary.org/obo/GO_0007599 denotes hemostasis
T32 111799-111818 http://purl.obolibrary.org/obo/GO_0030168 denotes platelet activation
T33 111837-111857 http://purl.obolibrary.org/obo/GO_0070527 denotes platelet aggregation
T34 112173-112192 http://purl.obolibrary.org/obo/GO_0030168 denotes platelet activation
T35 112448-112468 http://purl.obolibrary.org/obo/GO_0070527 denotes platelet aggregation
T36 117341-117362 http://purl.obolibrary.org/obo/GO_0006954 denotes inflammatory response
T37 117630-117642 http://purl.obolibrary.org/obo/GO_0006954 denotes inflammation
T38 118489-118501 http://purl.obolibrary.org/obo/GO_0006954 denotes inflammation
T39 118516-118524 http://purl.obolibrary.org/obo/GO_0015297 denotes exchange
T40 121342-121363 http://purl.obolibrary.org/obo/GO_0006954 denotes inflammatory response
T41 121822-121831 http://purl.obolibrary.org/obo/GO_0023052 denotes signaling
T42 122585-122600 http://purl.obolibrary.org/obo/GO_0006955 denotes immune response
T43 122709-122718 http://purl.obolibrary.org/obo/GO_0023052 denotes signaling
T44 122723-122738 http://purl.obolibrary.org/obo/GO_0010467 denotes gene expression
T43168 615-630 http://purl.obolibrary.org/obo/GO_0016032 denotes viral infection
T50540 655-670 http://purl.obolibrary.org/obo/GO_0006955 denotes immune response
T57624 1796-1808 http://purl.obolibrary.org/obo/GO_0009405 denotes pathogenesis
T4456 5899-5908 http://purl.obolibrary.org/obo/GO_0023052 denotes signaling
T38785 6400-6409 http://purl.obolibrary.org/obo/GO_0023052 denotes signaling
T79378 7328-7340 http://purl.obolibrary.org/obo/GO_0006954 denotes inflammation
T50858 7371-7383 http://purl.obolibrary.org/obo/GO_0006954 denotes inflammation
T54320 7520-7523 http://purl.obolibrary.org/obo/GO_0033885 denotes sEH
T86858 7672-7675 http://purl.obolibrary.org/obo/GO_0033885 denotes sEH
T99650 7827-7839 http://purl.obolibrary.org/obo/GO_0006954 denotes inflammation
T10292 7921-7924 http://purl.obolibrary.org/obo/GO_0033885 denotes sEH
T33009 8195-8203 http://purl.obolibrary.org/obo/GO_0015297 denotes exchange
T13750 12147-12168 http://purl.obolibrary.org/obo/GO_0006954 denotes inflammatory response
T63260 12226-12247 http://purl.obolibrary.org/obo/GO_0006954 denotes inflammatory response
T84655 12316-12326 http://purl.obolibrary.org/obo/GO_0008152 denotes metabolism
T47167 12367-12377 http://purl.obolibrary.org/obo/GO_0070269 denotes Pyroptosis
T50684 12958-12980 http://purl.obolibrary.org/obo/GO_0006954 denotes inflammatory responses
T29310 13711-13727 http://purl.obolibrary.org/obo/GO_0006955 denotes immune responses
T28779 13871-13893 http://purl.obolibrary.org/obo/GO_0045087 denotes innate immune response
T84577 13878-13893 http://purl.obolibrary.org/obo/GO_0006955 denotes immune response
T84552 14174-14185 http://purl.obolibrary.org/obo/GO_0042592 denotes homeostasis
T31599 14350-14366 http://purl.obolibrary.org/obo/GO_0042310 denotes vasoconstriction
T74952 14574-14594 http://purl.obolibrary.org/obo/GO_0070527 denotes platelet aggregation
T61815 14815-14821 http://purl.obolibrary.org/obo/GO_0040007 denotes growth
T64045 15148-15156 http://purl.obolibrary.org/obo/GO_0070265 denotes necrosis
T41562 15148-15156 http://purl.obolibrary.org/obo/GO_0019835 denotes necrosis
T38342 15148-15156 http://purl.obolibrary.org/obo/GO_0008219 denotes necrosis
T85159 15148-15156 http://purl.obolibrary.org/obo/GO_0001906 denotes necrosis
T12536 15194-15200 http://purl.obolibrary.org/obo/GO_0040007 denotes growth
T84805 16860-16881 http://purl.obolibrary.org/obo/GO_0006954 denotes inflammatory response
T88676 16899-16911 http://purl.obolibrary.org/obo/GO_0006954 denotes Inflammation
T68807 17109-17125 http://purl.obolibrary.org/obo/GO_0006955 denotes immune responses
T37930 17334-17349 http://purl.obolibrary.org/obo/GO_0006955 denotes immune response
T72413 17392-17408 http://purl.obolibrary.org/obo/GO_0016032 denotes viral infections
T89994 17494-17510 http://purl.obolibrary.org/obo/GO_0006955 denotes immune responses
T54249 17818-17824 http://purl.obolibrary.org/obo/GO_0005152 denotes IL-1RA
T41521 17832-17840 http://purl.obolibrary.org/obo/GO_0070265 denotes necrosis
T45355 17832-17840 http://purl.obolibrary.org/obo/GO_0019835 denotes necrosis
T64556 17832-17840 http://purl.obolibrary.org/obo/GO_0008219 denotes necrosis
T11287 17832-17840 http://purl.obolibrary.org/obo/GO_0001906 denotes necrosis
T1274 17924-17930 http://purl.obolibrary.org/obo/GO_0040007 denotes growth
T6678 17997-18003 http://purl.obolibrary.org/obo/GO_0040007 denotes growth
T31306 18070-18076 http://purl.obolibrary.org/obo/GO_0040007 denotes growth
T6978 18423-18444 http://purl.obolibrary.org/obo/GO_0006954 denotes inflammatory response
T45 18462-18471 http://purl.obolibrary.org/obo/GO_0097194 denotes apoptosis
T46 18462-18471 http://purl.obolibrary.org/obo/GO_0006915 denotes apoptosis
T47 18475-18483 http://purl.obolibrary.org/obo/GO_0070265 denotes necrosis
T48 18475-18483 http://purl.obolibrary.org/obo/GO_0019835 denotes necrosis
T49 18475-18483 http://purl.obolibrary.org/obo/GO_0008219 denotes necrosis
T50 18475-18483 http://purl.obolibrary.org/obo/GO_0001906 denotes necrosis
T51 18836-18865 http://purl.obolibrary.org/obo/GO_0050776 denotes regulation of immune response
T52 18836-18846 http://purl.obolibrary.org/obo/GO_0065007 denotes regulation
T53 18850-18865 http://purl.obolibrary.org/obo/GO_0006955 denotes immune response
T54 18954-18975 http://purl.obolibrary.org/obo/GO_0006954 denotes inflammatory response
T55 19123-19138 http://purl.obolibrary.org/obo/GO_0006955 denotes immune response
T56 22648-22669 http://purl.obolibrary.org/obo/GO_0006954 denotes inflammatory response
T57 23187-23199 http://purl.obolibrary.org/obo/GO_0006954 denotes inflammation
T58 24593-24606 http://purl.obolibrary.org/obo/GO_0045087 denotes innate immune
T59 24622-24638 http://purl.obolibrary.org/obo/GO_0016032 denotes viral infections
T60 24916-24937 http://purl.obolibrary.org/obo/GO_0000981 denotes transcription factors
T61 24916-24929 http://purl.obolibrary.org/obo/GO_0006351 denotes transcription
T62 25280-25293 http://purl.obolibrary.org/obo/GO_0006351 denotes transcription
T63 25588-25597 http://purl.obolibrary.org/obo/GO_0097194 denotes apoptosis
T64 25588-25597 http://purl.obolibrary.org/obo/GO_0006915 denotes apoptosis
T65 25639-25657 http://purl.obolibrary.org/obo/GO_0006919 denotes caspase activation
T66 26161-26173 http://purl.obolibrary.org/obo/GO_0006954 denotes inflammation
T67 26341-26362 http://purl.obolibrary.org/obo/GO_0006954 denotes inflammatory response
T68 26525-26537 http://purl.obolibrary.org/obo/GO_0006954 denotes inflammation
T69 26565-26577 http://purl.obolibrary.org/obo/GO_0006954 denotes Inflammation
T70 26957-26968 http://purl.obolibrary.org/obo/GO_0050817 denotes coagulation
T71 27598-27610 http://purl.obolibrary.org/obo/GO_0006954 denotes inflammation
T72 29022-29043 http://purl.obolibrary.org/obo/GO_0006954 denotes inflammatory response
T73 29115-29136 http://purl.obolibrary.org/obo/GO_0006954 denotes inflammatory response
T74 29461-29481 http://purl.obolibrary.org/obo/GO_0070527 denotes platelet-aggregating
T75 29562-29573 http://purl.obolibrary.org/obo/GO_0050817 denotes coagulation
T76 29628-29649 http://purl.obolibrary.org/obo/GO_0006954 denotes inflammatory response
T77 29918-29927 http://purl.obolibrary.org/obo/GO_0009058 denotes formation
T78 30102-30114 http://purl.obolibrary.org/obo/GO_0006954 denotes inflammation
T79 30141-30152 http://purl.obolibrary.org/obo/GO_0050817 denotes coagulation
T80 30597-30616 http://purl.obolibrary.org/obo/GO_0030168 denotes platelet activation
T81 32948-32964 http://purl.obolibrary.org/obo/GO_0006629 denotes lipid metabolism
T82 32954-32964 http://purl.obolibrary.org/obo/GO_0008152 denotes metabolism
T83 33102-33120 http://purl.obolibrary.org/obo/GO_0006006 denotes glucose metabolism
T84 33110-33120 http://purl.obolibrary.org/obo/GO_0008152 denotes metabolism
T85 33574-33595 http://purl.obolibrary.org/obo/GO_0006954 denotes inflammatory response
T86 33902-33910 http://purl.obolibrary.org/obo/GO_0015297 denotes exchange
T87 34070-34081 http://purl.obolibrary.org/obo/GO_0042592 denotes homeostasis
T88 34513-34529 http://purl.obolibrary.org/obo/GO_0042310 denotes vasoconstriction
T89 34945-34955 http://purl.obolibrary.org/obo/GO_0008152 denotes metabolism
T90 35986-35998 http://purl.obolibrary.org/obo/GO_0006954 denotes inflammation
T91 36949-36961 http://purl.obolibrary.org/obo/GO_0006954 denotes inflammation
T92 38720-38732 http://purl.obolibrary.org/obo/GO_0006954 denotes inflammation
T93 43899-43909 http://purl.obolibrary.org/obo/GO_0023052 denotes signalling
T94 47876-47888 http://purl.obolibrary.org/obo/GO_0006954 denotes inflammation
T95 51456-51467 http://purl.obolibrary.org/obo/GO_0006412 denotes translation
T96 53245-53254 http://purl.obolibrary.org/obo/GO_0009058 denotes synthesis
T97 53349-53367 http://purl.obolibrary.org/obo/GO_0007165 denotes signaling pathways
T98 53349-53358 http://purl.obolibrary.org/obo/GO_0023052 denotes signaling
T99 54031-54043 http://purl.obolibrary.org/obo/GO_0006954 denotes inflammation
T100 54844-54856 http://purl.obolibrary.org/obo/GO_0006954 denotes inflammation
T101 55051-55066 http://purl.obolibrary.org/obo/GO_0006955 denotes immune response
T102 55106-55122 http://purl.obolibrary.org/obo/GO_0016032 denotes viral infections
T103 57432-57450 http://purl.obolibrary.org/obo/GO_0001816 denotes cytokine secretion
T104 57441-57450 http://purl.obolibrary.org/obo/GO_0046903 denotes secretion
T105 57468-57489 http://purl.obolibrary.org/obo/GO_0006954 denotes inflammatory response
T106 60732-60741 http://purl.obolibrary.org/obo/GO_0009058 denotes formation
T107 62004-62016 http://purl.obolibrary.org/obo/GO_0006954 denotes inflammation
T108 62371-62389 http://purl.obolibrary.org/obo/GO_0001894 denotes tissue homeostasis
T109 62378-62389 http://purl.obolibrary.org/obo/GO_0042592 denotes homeostasis
T110 62772-62788 http://purl.obolibrary.org/obo/GO_0006955 denotes immune responses
T111 62947-62962 http://purl.obolibrary.org/obo/GO_0006955 denotes immune response
T112 63011-63027 http://purl.obolibrary.org/obo/GO_0016032 denotes viral infections
T113 63598-63610 http://purl.obolibrary.org/obo/GO_0006954 denotes inflammation
T114 63867-63875 http://purl.obolibrary.org/obo/GO_0070265 denotes necrosis
T115 63867-63875 http://purl.obolibrary.org/obo/GO_0019835 denotes necrosis
T116 63867-63875 http://purl.obolibrary.org/obo/GO_0008219 denotes necrosis
T117 63867-63875 http://purl.obolibrary.org/obo/GO_0001906 denotes necrosis
T118 64036-64048 http://purl.obolibrary.org/obo/GO_0006954 denotes inflammation
T119 64584-64621 http://purl.obolibrary.org/obo/GO_1900226 denotes inhibit NLRP3 inflammasomes, activate
T120 64592-64621 http://purl.obolibrary.org/obo/GO_0044546 denotes NLRP3 inflammasomes, activate
T121 64640-64661 http://purl.obolibrary.org/obo/GO_0000981 denotes transcription factors
T122 64640-64653 http://purl.obolibrary.org/obo/GO_0006351 denotes transcription
T123 64913-64934 http://purl.obolibrary.org/obo/GO_0006954 denotes inflammatory response
T124 65005-65014 http://purl.obolibrary.org/obo/GO_0023052 denotes signaling
T125 65314-65324 http://purl.obolibrary.org/obo/GO_0045158 denotes Cytochrome
T126 65314-65324 http://purl.obolibrary.org/obo/GO_0045157 denotes Cytochrome
T127 65314-65324 http://purl.obolibrary.org/obo/GO_0045156 denotes Cytochrome
T128 65314-65324 http://purl.obolibrary.org/obo/GO_0008121 denotes Cytochrome
T129 65762-65785 http://purl.obolibrary.org/obo/GO_0016559 denotes Peroxisome proliferator
T130 65917-65925 http://purl.obolibrary.org/obo/GO_0070265 denotes necrosis
T131 65917-65925 http://purl.obolibrary.org/obo/GO_0019835 denotes necrosis
T132 65917-65925 http://purl.obolibrary.org/obo/GO_0008219 denotes necrosis
T133 65917-65925 http://purl.obolibrary.org/obo/GO_0001906 denotes necrosis
T134 66005-66018 http://purl.obolibrary.org/obo/GO_0045087 denotes innate immune
T135 66112-66125 http://purl.obolibrary.org/obo/GO_0045087 denotes innate immune
T136 66229-66241 http://purl.obolibrary.org/obo/GO_0006954 denotes inflammation
T137 67362-67374 http://purl.obolibrary.org/obo/GO_0006954 denotes inflammation
T138 67591-67604 http://purl.obolibrary.org/obo/GO_0006351 denotes transcription
T139 67992-68002 http://purl.obolibrary.org/obo/GO_0065007 denotes regulation
T140 68010-68031 http://purl.obolibrary.org/obo/GO_0000981 denotes transcription factors
T141 68010-68023 http://purl.obolibrary.org/obo/GO_0006351 denotes transcription
T142 68232-68255 http://purl.obolibrary.org/obo/GO_0016559 denotes peroxisome proliferator
T143 69260-69282 http://purl.obolibrary.org/obo/GO_0006954 denotes inflammatory responses
T144 70005-70018 http://purl.obolibrary.org/obo/GO_0042060 denotes wound healing
T145 71343-71352 http://purl.obolibrary.org/obo/GO_0046903 denotes secretion
T146 71884-71896 http://purl.obolibrary.org/obo/GO_0006954 denotes inflammation
T147 72921-72933 http://purl.obolibrary.org/obo/GO_0006954 denotes inflammation
T148 73636-73646 http://purl.obolibrary.org/obo/GO_0008152 denotes metabolism
T149 74341-74350 http://purl.obolibrary.org/obo/GO_0009058 denotes synthesis
T150 74497-74509 http://purl.obolibrary.org/obo/GO_0042311 denotes vasodilation
T151 75172-75184 http://purl.obolibrary.org/obo/GO_0006954 denotes inflammation
T152 75563-75573 http://purl.obolibrary.org/obo/GO_0008152 denotes metabolism
T153 76129-76139 http://purl.obolibrary.org/obo/GO_0008152 denotes Metabolism
T154 76528-76537 http://purl.obolibrary.org/obo/GO_0009058 denotes synthesis
T155 76720-76732 http://purl.obolibrary.org/obo/GO_0006954 denotes inflammation
T156 76861-76880 http://purl.obolibrary.org/obo/GO_0042246 denotes tissue regeneration
T157 76868-76880 http://purl.obolibrary.org/obo/GO_0031099 denotes regeneration
T158 76885-76898 http://purl.obolibrary.org/obo/GO_0042060 denotes wound healing
T159 76908-76926 http://purl.obolibrary.org/obo/GO_0001894 denotes tissue homeostasis
T160 76915-76926 http://purl.obolibrary.org/obo/GO_0042592 denotes homeostasis
T161 77333-77345 http://purl.obolibrary.org/obo/GO_0006954 denotes inflammation
T162 77439-77455 http://purl.obolibrary.org/obo/GO_0090130 denotes tissue migration
T163 77796-77815 http://purl.obolibrary.org/obo/GO_0001816 denotes cytokine production
T164 78004-78024 http://purl.obolibrary.org/obo/GO_0001781 denotes neutrophil apoptosis
T165 78015-78024 http://purl.obolibrary.org/obo/GO_0097194 denotes apoptosis
T166 78015-78024 http://purl.obolibrary.org/obo/GO_0006915 denotes apoptosis
T167 78098-78107 http://purl.obolibrary.org/obo/GO_0023052 denotes signaling
T168 78559-78597 http://purl.obolibrary.org/obo/GO_0002920 denotes regulating the humoral immune response
T169 78574-78597 http://purl.obolibrary.org/obo/GO_0006959 denotes humoral immune response
T170 78582-78597 http://purl.obolibrary.org/obo/GO_0006955 denotes immune response
T171 78758-78767 http://purl.obolibrary.org/obo/GO_0046903 denotes secretion
T172 78802-78821 http://purl.obolibrary.org/obo/GO_0002377 denotes antibody production
T173 78834-78856 http://purl.obolibrary.org/obo/GO_0030183 denotes B cell differentiation
T174 78836-78856 http://purl.obolibrary.org/obo/GO_0030154 denotes cell differentiation
T175 79369-79381 http://purl.obolibrary.org/obo/GO_0006909 denotes phagocytosis
T176 79739-79751 http://purl.obolibrary.org/obo/GO_0006954 denotes inflammation
T177 79783-79802 http://purl.obolibrary.org/obo/GO_0042246 denotes tissue regeneration
T178 79790-79802 http://purl.obolibrary.org/obo/GO_0031099 denotes regeneration
T179 79836-79848 http://purl.obolibrary.org/obo/GO_0009058 denotes biosynthesis
T180 80139-80151 http://purl.obolibrary.org/obo/GO_0006954 denotes inflammation
T181 80164-80175 http://purl.obolibrary.org/obo/GO_0042592 denotes homeostasis
T182 80520-80532 http://purl.obolibrary.org/obo/GO_0006954 denotes inflammation
T183 81534-81546 http://purl.obolibrary.org/obo/GO_0006954 denotes inflammation
T184 81906-81918 http://purl.obolibrary.org/obo/GO_0006954 denotes inflammation
T185 82222-82234 http://purl.obolibrary.org/obo/GO_0006954 denotes inflammation
T186 82290-82300 http://purl.obolibrary.org/obo/GO_0045158 denotes cytochrome
T187 82290-82300 http://purl.obolibrary.org/obo/GO_0045157 denotes cytochrome
T188 82290-82300 http://purl.obolibrary.org/obo/GO_0045156 denotes cytochrome
T189 82290-82300 http://purl.obolibrary.org/obo/GO_0008121 denotes cytochrome
T190 83551-83563 http://purl.obolibrary.org/obo/GO_0006954 denotes inflammation
T191 83950-83962 http://purl.obolibrary.org/obo/GO_0006954 denotes inflammation
T192 84102-84114 http://purl.obolibrary.org/obo/GO_0006954 denotes inflammation
T193 84243-84263 http://purl.obolibrary.org/obo/GO_0000981 denotes transcription factor
T194 84243-84256 http://purl.obolibrary.org/obo/GO_0006351 denotes transcription
T195 85253-85273 http://purl.obolibrary.org/obo/GO_0000981 denotes transcription factor
T196 85253-85266 http://purl.obolibrary.org/obo/GO_0006351 denotes transcription
T197 86246-86255 http://purl.obolibrary.org/obo/GO_0023052 denotes signaling
T198 86310-86328 http://purl.obolibrary.org/obo/GO_0001816 denotes cytokine secretion
T199 86319-86328 http://purl.obolibrary.org/obo/GO_0046903 denotes secretion
T200 86368-86393 http://purl.obolibrary.org/obo/GO_0002250 denotes adaptive immune responses
T201 86743-86762 http://purl.obolibrary.org/obo/GO_0001769 denotes B cell polarization
T202 86745-86762 http://purl.obolibrary.org/obo/GO_0030010 denotes cell polarization
T203 87553-87575 http://purl.obolibrary.org/obo/GO_0006954 denotes inflammatory responses
T204 87679-87689 http://purl.obolibrary.org/obo/GO_0008152 denotes metabolism
T205 87986-88004 http://purl.obolibrary.org/obo/GO_0006950 denotes response to stress
T206 88367-88389 http://purl.obolibrary.org/obo/GO_0006954 denotes inflammatory responses
T207 88495-88507 http://purl.obolibrary.org/obo/GO_0009405 denotes pathogenesis
T208 88908-88917 http://purl.obolibrary.org/obo/GO_0009058 denotes formation
T209 89100-89109 http://purl.obolibrary.org/obo/GO_0000423 denotes mitophagy
T210 89100-89109 http://purl.obolibrary.org/obo/GO_0000422 denotes mitophagy
T211 89238-89247 http://purl.obolibrary.org/obo/GO_0000423 denotes mitophagy
T212 89238-89247 http://purl.obolibrary.org/obo/GO_0000422 denotes mitophagy
T213 89317-89322 http://purl.obolibrary.org/obo/GO_0007568 denotes aging
T214 89543-89555 http://purl.obolibrary.org/obo/GO_0009405 denotes pathogenesis
T215 89651-89662 http://purl.obolibrary.org/obo/GO_0042592 denotes homeostasis
T216 89867-89872 http://purl.obolibrary.org/obo/GO_0030431 denotes sleep
T217 90130-90143 http://purl.obolibrary.org/obo/GO_0045087 denotes innate immune
T218 90144-90166 http://purl.obolibrary.org/obo/GO_0006954 denotes inflammatory responses
T219 90250-90272 http://purl.obolibrary.org/obo/GO_0006954 denotes inflammatory responses
T220 90438-90449 http://purl.obolibrary.org/obo/GO_0042592 denotes homeostasis
T221 90806-90816 http://purl.obolibrary.org/obo/GO_0008152 denotes metabolism
T222 90966-90991 http://purl.obolibrary.org/obo/GO_0006119 denotes oxidative phosphorylation
T223 90976-90991 http://purl.obolibrary.org/obo/GO_0016310 denotes phosphorylation
T224 91234-91258 http://purl.obolibrary.org/obo/GO_0022900 denotes electron transport chain
T225 91243-91252 http://purl.obolibrary.org/obo/GO_0006810 denotes transport
T226 91276-91315 http://purl.obolibrary.org/obo/GO_0035794 denotes mitochondrial membrane permeabilization
T227 91352-91362 http://purl.obolibrary.org/obo/GO_0008219 denotes cell death
T228 91647-91658 http://purl.obolibrary.org/obo/GO_0042592 denotes homeostasis
T229 91852-91876 http://purl.obolibrary.org/obo/GO_0051646 denotes localize to mitochondria
T230 92726-92738 http://purl.obolibrary.org/obo/GO_0006954 denotes inflammation
T231 93122-93144 http://purl.obolibrary.org/obo/GO_0006954 denotes inflammatory responses
T232 93881-93892 http://purl.obolibrary.org/obo/GO_0042592 denotes homeostasis
T233 94393-94409 http://purl.obolibrary.org/obo/GO_0006955 denotes immune responses
T234 94684-94700 http://purl.obolibrary.org/obo/GO_0016032 denotes viral infections
T235 94989-94994 http://purl.obolibrary.org/obo/GO_0019835 denotes lysis
T236 95751-95766 http://purl.obolibrary.org/obo/GO_0006955 denotes immune response
T237 96153-96169 http://purl.obolibrary.org/obo/GO_0016032 denotes viral infections
T238 96374-96400 http://purl.obolibrary.org/obo/GO_0050728 denotes anti-inflammatory response
T239 96379-96400 http://purl.obolibrary.org/obo/GO_0006954 denotes inflammatory response
T240 96782-96798 http://purl.obolibrary.org/obo/GO_0016032 denotes viral infections
T241 97024-97039 http://purl.obolibrary.org/obo/GO_0006955 denotes immune response
T242 97048-97064 http://purl.obolibrary.org/obo/GO_0016032 denotes viral infections
T243 97837-97852 http://purl.obolibrary.org/obo/GO_0006955 denotes immune response
T244 98649-98664 http://purl.obolibrary.org/obo/GO_0006955 denotes immune response
T245 98700-98716 http://purl.obolibrary.org/obo/GO_0016032 denotes viral infections

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T1 0-132 Sentence denotes Can N-3 polyunsaturated fatty acids be considered a potential adjuvant therapy for COVID-19-associated cardiovascular complications?
T2 134-142 Sentence denotes Abstract
T3 143-360 Sentence denotes Coronavirus disease 2019 (COVID-19), caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), has currently led to a global pandemic with millions of confirmed and increasing cases around the world.
T4 361-577 Sentence denotes The novel SARS-CoV-2 not only affects the lungs causing severe acute respiratory dysfunction but also leads to significant dysfunction in multiple organs and physiological systems including the cardiovascular system.
T5 578-804 Sentence denotes A plethora of studies have shown the viral infection triggers an exaggerated immune response, hypercoagulation and oxidative stress, which contribute significantly to poor cardiovascular outcomes observed in COVID-19 patients.
T6 805-871 Sentence denotes To date, there are no approved vaccines or therapies for COVID-19.
T7 872-1007 Sentence denotes Accordingly, cardiovascular protective and supportive therapies are urgent and necessary to the overall prognosis of COVID-19 patients.
T8 1008-1269 Sentence denotes Accumulating literature has demonstrated the beneficial effects of n-3 polyunsaturated fatty acids (n-3 PUFA) toward the cardiovascular system, which include ameliorating uncontrolled inflammatory reactions, reduced oxidative stress and mitigating coagulopathy.
T9 1270-1549 Sentence denotes Moreover, it has been demonstrated the n-3 PUFAs, eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), are precursors to a group of potent bioactive lipid mediators, generated endogenously, which mediate many of the beneficial effects attributed to their parent compounds.
T10 1550-1748 Sentence denotes Considering the favorable safety profile for n-3 PUFAs and their metabolites, it is reasonable to consider n-3 PUFAs as potential adjuvant therapies for the clinical management of COVID-19 patients.
T11 1749-1969 Sentence denotes In this article, we provide an overview of the pathogenesis of cardiovascular complications secondary to COVID-19 and focus on the mechanisms that may contribute to the likely benefits of n-3 PUFAs and their metabolites.
T12 1971-1986 Sentence denotes 1 Introduction
T13 1987-2227 Sentence denotes The first outbreak of the novel coronaviruses was triggered by severe and acute respiratory syndrome coronavirus (SARS-CoV) in China in 2002, which was followed in 2012 by the Middle East respiratory syndrome-related coronavirus (MERS-CoV).
T14 2228-2455 Sentence denotes Both SARS-CoV and MERS-CoV are infectious, lethal and accounted for thousands of deaths over the past two decades (de Wit, van Doremalen, Falzarano, & Munster, 2016; Zaki, van Boheemen, Bestebroer, Osterhaus, & Fouchier, 2012).
T15 2456-2958 Sentence denotes The Coronavirus Study Group of the International Committee on Taxonomy of Viruses evaluated the novelty of the coronavirus responsible for the recent outbreak in 2019 (COVID-19) and formally considered it related to SARS-CoV, as they share about 79% nucleotide identity and accordingly named it as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) or 2019-novel coronavirus (Coronaviridae Study Group of the International Committee on Taxonomy of, 2020; Ren et al., 2020; Zhou et al., 2020).
T16 2959-3148 Sentence denotes The recent eruption of COVID-19 was first reported in Wuhan, Hubei Province, China in late December 2019 when a series of pneumonia cases of unknown cause were detected (Wang et al., 2020).
T17 3149-3245 Sentence denotes Highly contagious, COVID-19 spread rapidly throughout China and most countries across the world.
T18 3246-3524 Sentence denotes On March 11th, the spread of COVID-19 was declared by the World Health Organization as a global pandemic and by October 9, 2020, the cumulative number of diagnosed patients internationally was 36,577,872 with 1,062,677 global deaths (https://coronavirus.jhu.edu/map.html, 2020).
T19 3525-3683 Sentence denotes Coronaviruses infect both animals and humans affecting their respiratory, gastrointestinal, cardiovascular and central nervous systems (Cui, Li, & Shi, 2019).
T20 3684-3914 Sentence denotes Consistently, SARS-CoV-2 primarily targets the lungs but it can affect many other organs and systems, including the kidneys, heart, blood vessels, gastrointestinal tract and brain (Wadman, Couzin-Frankel, Kaiser, & Matacic, 2020).
T21 3915-4039 Sentence denotes Symptoms of COVID-19 are manifested as myalgia, fatigue, fever and dry cough, together with lower respiratory tract disease.
T22 4040-4263 Sentence denotes In some cases, the severe progression of the disease leads to acute lung injury (ALI), acute respiratory distress syndrome (ARDS), respiratory failure, sepsis, heart failure (HF) and sudden cardiac arrest within a few days.
T23 4264-4427 Sentence denotes Importantly, there is significant morbidity and mortality in the elderly and individuals with underlying health conditions (Chen et al., 2020; Huang et al., 2020).
T24 4428-4702 Sentence denotes Although treatment with corticosteroids, antiviral therapy and mechanical respiratory support have been employed, there is still no specific treatment for COVID-19 and therefore supportive care is of paramount importance (Huang et al., 2020; Wu & McGoogan, 2020) (Table 1 ).
T25 4703-4815 Sentence denotes Table 1 Overview of some proposed pharmacological agents with potential beneficial effects in COVID-19 patients.
T26 4816-4865 Sentence denotes Pharmacological intervention Conclusion Reference
T27 4866-5021 Sentence denotes Antioxidants including Vitamin C and E • Antioxidant effects may ameliorate cardiac injuries of critically ill COVID-19 patients (Wang, Zhang, & Bai, 2020)
T28 5022-5090 Sentence denotes Melatonin • May have preventive effect against septic cardiomyopathy
T29 5091-5224 Sentence denotes • Has benefits in myocardial infarction, cardiomyopathy, hypertensive heart diseases, and pulmonary hypertension (Zhang et al., 2020)
T30 5225-5507 Sentence denotes Anti-interleukin-6 • Tocilizumab (anti-IL-6 receptor), siltuximab (anti-IL-6), and sirukumab (anti-IL-6) are proposed as possible treatments to manage cytokine storm and elevated IL-6 levels (Akhmerov & Marban, 2020; Hendren, Drazner, Bozkurt, & Cooper Jr., 2020; Rizk et al., 2020)
T31 5508-5768 Sentence denotes Anti-TNFα • Infliximab, adalimumab, etanercept, golimumab, certolizumab as TNFα neutralizing therapies suggested as potential agents for COVID-19 hyperinflammatory state which may ameliorate organ damage including acute cardiac injury (Convertino et al., 2020)
T32 5769-6041 Sentence denotes Janus kinase (JAK) inhibitors • Ruxolitinib, tofacitinib, baricitinib are proposed to be beneficial in controlling excessive IL-6 signaling through STAT-1 and STAT-3 pathways (Alijotas-Reig et al., 2020; Convertino et al., 2020; Richardson et al., 2020; Rizk et al., 2020)
T33 6042-6288 Sentence denotes Anti-interleukin-1 • Anakinra, a modified IL-1 receptor antagonist protein, is suggested to have therapeutic potential in cytokine storm, given its effectiveness on patient survival in severe sepsis (Alijotas-Reig et al., 2020; Rizk et al., 2020)
T34 6289-6424 Sentence denotes Granulocyte-macrophage-colony stimulating factor (GM-CSF) inhibition • GM-CSF can play a pro-inflammatory role signaling to macrophages
T35 6425-6498 Sentence denotes • COVID-19 patients have been demonstrated to have elevated GM-CSF levels
T36 6499-6651 Sentence denotes • Literature proposes that targeting GM-CSF upstream of inflammatory cytokines ex. gimsilumab, may be useful to blunt cytokine storm (Rizk et al., 2020)
T37 6652-6884 Sentence denotes Statins • Anti-inflammatory properties, including reduction in cytokines, may benefit in COVID-19 hyperinflammatory states in addition to their conventional cardioprotective properties (Alijotas-Reig et al., 2020; Rizk et al., 2020)
T38 6885-7078 Sentence denotes ACEi/ARBs • Proposed that treatment with RAAS antagonists may theoretically be beneficial by upregulating ACE2 and compensating for ACE2 receptors lost due to COVID-19 (Akhmerov & Marban, 2020)
T39 7079-7244 Sentence denotes N-acetylcysteine (NAC) • Anti-oxidant and anti-inflammatory properties of NAC proposed as an adjuvant therapy for COVID-19 and secondary cardiovascular complications
T40 7245-7476 Sentence denotes • Suggested role for NAC in prevention of hypertension, atherosclerosis-associated inflammation, acute heart failure, thrombo-inflammation, and myocardial ischemia (De Flora, Balansky, & La Maestra, 2020; Guglielmetti et al., 2020)
T41 7477-7628 Sentence denotes Eicosanoids and soluble epoxide hydrolase (sEH) inhibitors • Epoxyeicosatrienoic acids (EETs) are cardioprotective, anti-inflammatory and pro-resolving
T42 7629-7774 Sentence denotes • Inhibition of their metabolizing enzyme, sEH, may be beneficial by maintaining eicosanoid levels and reducing endoplasmic reticulum (ER) stress
T43 7775-7900 Sentence denotes • Potential to limit inflammatory storm and resolve inflammation in addition to their established cardioprotective properties
T44 7901-8036 Sentence denotes • Co-treatment with sEH inhibitors and omega-3 fatty acids may provide synergistic effects (Hammock, Wang, Gilligan, & Panigrahy, 2020)
T45 8038-8082 Sentence denotes 2 COVID-19 and cardiovascular complications
T46 8083-8315 Sentence denotes The correlation between pneumonia, an inflammatory condition of lung alveoli with a compromised ability for gas exchange, and cardiovascular complications has been well established (Cilli et al., 2018; Corrales-Medina et al., 2011).
T47 8316-8598 Sentence denotes For example, patients with underlying cardiovascular disease are more likely to develop community-acquired pneumonia (Corrales-Medina et al., 2015) and about 8 to 25% of patients with community acquired pneumonia develop at least one cardiac complication during their hospital stay.
T48 8599-8753 Sentence denotes The exaggerated cardiovascular episodes after pneumonia have been associated with increased mortality (Corrales-Medina et al., 2012; Viasus et al., 2013).
T49 8754-8945 Sentence denotes In line with these observations, cardiac complications have been reported in patients with novel coronavirus infections such as tachycardia and hypotension, which are common in SARS patients.
T50 8946-9078 Sentence denotes Moreover, arrhythmia, cardiomegaly and diastolic dysfunction have been reported in SARS patients (Li et al., 2003; Yu et al., 2006).
T51 9079-9230 Sentence denotes In addition, infection with MERS-CoV was associated with acute myocarditis, myocardial edema and severe left ventricular dysfunction (Alhogbani, 2016).
T52 9231-9405 Sentence denotes In the context of COVID-19, both patients with and without underlying cardiovascular comorbidities can develop cardiovascular complications secondary to SARS-CoV-2 infection.
T53 9406-9769 Sentence denotes For example, Wang et al., reported that among 138 hospitalized patients with COVID-19 in Wuhan, China, cardiac injury, as evidenced by new ECG or echocardiographic abnormalities or elevated high-sensitivity cardiac troponin I, was present in 7.2% of all patients and 22% of patients who required intensive care unit (ICU) hospitalization (Wang, Hu, et al., 2020).
T54 9770-10112 Sentence denotes Moreover, the National Health Commission of China reported that 12% of patients infected with SARS-CoV-2 and without known cardiovascular disease (CVD) had elevated troponin levels or cardiac arrest during hospitalization, 17% had coronary heart disease and 35% of patients had hypertension (Zheng, Ma, Zhang, & Xie, 2020; Zhou et al., 2020).
T55 10113-10296 Sentence denotes However, there is accumulating evidence that COVID-19 patients with underlying CVD are at higher risk for developing severe complications (Huang et al., 2020; Wang, Hu, et al., 2020).
T56 10297-10504 Sentence denotes For instance, older patients with underlying CVD who are infected with SARS-CoV-2 are more prone to become severely ill, develop cardiac injury or require intensive care (Guo et al., 2020; Shi et al., 2020).
T57 10505-10734 Sentence denotes The death rate among patients with underlying CVD has been stated as 10.5%, which is much higher than that of the general population (Epidemiology Working Group for Ncip Epidemic Response & Prevention, 2020; Wu & McGoogan, 2020).
T58 10735-10968 Sentence denotes Furthermore, according to an epidemiological study conducted in China, 4.2% of the confirmed cases and 22.7% of mortalities have cardiovascular comorbidities (Epidemiology Working Group for Ncip Epidemic Response & Prevention, 2020).
T59 10969-11194 Sentence denotes Many COVID-19 patients suffer from persistent hypotension, myocardial injury, myocarditis, left ventricular dysfunction, arrhythmia and HF (Guan, et al., 2020; Guo et al., 2020; Inciardi et al., 2020; Zhou, Yu, et al., 2020).
T60 11195-11431 Sentence denotes Importantly, cardiac biopsy samples collected from patients with COVID-19 demonstrated increased interstitial infiltration of mononuclear inflammatory cells providing extra evidence of myocarditis in COVID-19 patients (Xu et al., 2020).
T61 11432-11723 Sentence denotes Therefore, cardiovascular damage secondary to COVID-19 is now drawing growing attention in clinical practice (Table 2 ) and the American College of Cardiology recently issued a clinical report to address the cardiovascular consequences of SARS-CoV-2 infection (Mohammad Madjid et al., 2020).
T62 11724-11793 Sentence denotes Table 2 Overview of COVID-19-associated cardiovascular complications.
T63 11794-11861 Sentence denotes COVID-19-induced cardiovascular injury Proposed mechanism of injury
T64 11862-11908 Sentence denotes • Acute myocarditis • Direct pathogen invasion
T65 11909-11934 Sentence denotes • Indirect cytokine storm
T66 11935-11984 Sentence denotes • Instability of coronary atherosclerotic plaques
T67 11985-11999 Sentence denotes • Coagulopathy
T68 12000-12010 Sentence denotes • Acute MI
T69 12011-12025 Sentence denotes • Hypertension
T70 12026-12082 Sentence denotes • Left ventricular dilation, hypertrophy and dysfunction
T71 12083-12185 Sentence denotes • Arrhythmias (long QT-syndrome, torsade de pointes) • Indirect inflammatory response (Cytokine storm)
T72 12186-12264 Sentence denotes • Worsening of heart failure • Indirect inflammatory response (Cytokine storm)
T73 12265-12326 Sentence denotes • Volume overload due to impaired sodium and water metabolism
T74 12327-12364 Sentence denotes • Disturbance of endothelial function
T75 12365-12407 Sentence denotes • Pyroptosis of cardiomyocytes • Hypoxemia
T76 12408-12446 Sentence denotes • Activation of the NLRP3 inflammasome
T77 12447-12622 Sentence denotes • Severe tachycardia, increased peripheral resistance, hypertension, increased myocardial oxygen requirements and ischemia • Pneumonia-induced increase in sympathetic activity
T78 12624-12700 Sentence denotes 3 Potential mechanisms of cardiovascular complications in COVID-19 patients
T79 12701-12895 Sentence denotes To date, there have been few reports about the pathologic features of COVID-19 and consequently the exact pathophysiological mechanisms of myocardial injury secondary to COVID-19 remain elusive.
T80 12896-13143 Sentence denotes However, direct damage by the virus, exaggerated uncontrolled inflammatory responses, instability of coronary plaques, thrombosis and hypoxia have been proposed as possible mechanisms (Guo et al., 2020; Zheng et al., 2020; Zhou, Yu, et al., 2020).
T81 13144-13286 Sentence denotes Importantly, the severity of infection, patient characteristics and host reaction all participate in the development of cardiac complications.
T82 13287-13414 Sentence denotes The main proposed mechanisms for cardiovascular deterioration in patients with COVID-19 can be summarized as follows (Fig. 1 ).
T83 13415-13494 Sentence denotes Fig. 1 Potential mechanisms of SARS-CoV-2-induced cardiovascular complications.
T84 13495-13620 Sentence denotes SARS-Cov-2 may be taken up by cardiac cells using different routes, such as via ACE2 receptors expressed on the cell surface.
T85 13621-13843 Sentence denotes Following entry, SARS-CoV-2 may exert cardiac injury by direct action and/or induction of immune responses resulting in release of pro-inflammatory cytokines (‘Cytokine storm’) such as IL, TNF-α, INF-γ, FGF, MCP1 and VEGF.
T86 13844-14082 Sentence denotes SARS-CoV-2 can trigger the innate immune response involving NLRP3 inflammasomes which lead to activation of pro-inflammatory cytokines, IL-1β and IL-18 and the inflammatory cascade (IL-6 and TNF-α) resulting in tissue damage and fibrosis.
T87 14083-14270 Sentence denotes SARS-CoV-2-induced pneumonia results in the development of hypoxemia which can impair Ca2+ homeostasis, increase ROS production and activate NLRP3 inflammasomes leading to cardiac damage.
T88 14271-14415 Sentence denotes Activation of the sympathetic nervous system in response to pneumonia leads to vasoconstriction and tachycardia compromising coronary perfusion.
T89 14416-14501 Sentence denotes This results in a mismatch of myocardial O2 demand and supply precipitating ischemia.
T90 14502-14639 Sentence denotes SARS-CoV-2 can destabilize coronary atherosclerotic plaques and mediate platelet aggregation resulting in arterial and venous thrombosis.
T91 14640-14744 Sentence denotes Altogether, these SARS-CoV-2 mediated effects may be contributing to the observed cardiovascular injury.
T92 14745-15208 Sentence denotes ACE2, Angiotensin-converting enzyme-2; Ca2+, Calcium; FGF, Fibroblast growth factor; IL, Interleukin; INF, Interferon; MCP-1, Monocyte chemoattractant protein-1; NFκB, Nuclear factor kappa-light-chain enhancer activated B-cells; NLRP3, NACHT, LRR and PYD domains-containing protein 3; O2, Oxygen; ROS, Reactive oxygen species; SARS-CoV-2, Severe and acute respiratory syndrome coronavirus; TNF-α, Tumor necrosis factor-α; VEGF, Vascular endothelial growth factor.
T93 15210-15239 Sentence denotes 3.1 Direct pathogen invasion
T94 15240-15344 Sentence denotes Direct invasion of pathogens to the cardiac tissue has been confirmed in patients with severe pneumonia.
T95 15345-15558 Sentence denotes For example, Streptococcus pneumoniae was identified in the myocardium of patients with severe pneumococcal disease, leading to local inflammatory reactions and consequently cardiac injury (Xu, Shi, et al., 2020).
T96 15559-15811 Sentence denotes Oudit et al. reported SARS-CoV RNA was detected in 35% (7/20) of autopsied human heart samples obtained from SARS patients during the Toronto SARS outbreak, suggesting the likelihood of direct damage to cardiomyocytes by the virus (Oudit et al., 2009).
T97 15812-16007 Sentence denotes In the same report, a study in mice infected with the human strain of the SARS-CoV demonstrated that pulmonary infection with SARS-CoV also precipitated myocardial infection (Oudit et al., 2009).
T98 16008-16241 Sentence denotes As SARS-CoV-2 is genetically related to SARS-CoV, there is a high potential that it shares a similar mechanism and the same functional host-cell receptor, angiotensin-converting enzyme 2 (ACE2) for cell entry (Gheblawi et al., 2020).
T99 16242-16603 Sentence denotes Importantly, ACE2 is highly expressed in both the heart and the lung (Patel, Zhong, Grant, & Oudit, 2016) and evidence indicates the affinity of SARS-CoV-2 to ACE2 is approximately 10- to 20-fold higher than that for SARS-CoV which may account for both the greater pathogenicity of SARS-CoV-2 and the rapid spread (Gheblawi et al., 2020; Hoffmann et al., 2020).
T100 16604-16722 Sentence denotes Altogether, SARS-CoV-2 might directly infect the myocardial tissue leading to severe cardiac injury (Wu et al., 2020).
T101 16723-16844 Sentence denotes However, large-scale biopsy studies are still warranted to further confirm the direct myocardial infection by SARS-CoV-2.
T102 16846-16898 Sentence denotes 3.2 Indirect inflammatory response - cytokine storm
T103 16899-17011 Sentence denotes Inflammation plays an important role in the development of cardiovascular impairment in the setting of COVID-19.
T104 17012-17296 Sentence denotes Similar to SARS-CoV and MERS-CoV infection, SARS-CoV-2 infection can also trigger excessive host immune responses, leading to extensive and uncontrolled release of proinflammatory cytokines termed as cytokine storm (Restrepo & Reyes, 2018; Zumla, Hui, Azhar, Memish, & Maeurer, 2020).
T105 17297-17409 Sentence denotes Cytokines play a pivotal role in the immune response to defend against different bacterial and viral infections.
T106 17410-17690 Sentence denotes However, it has also been established that dysregulated, amplified and uncontrolled immune responses may cause immunopathology leading to systematic self-attack contributing to multiple organ damage and cardiovascular injury secondary to SARS-CoV-2 infection (Zhang et al., 2020).
T107 17691-18271 Sentence denotes A plethora of studies have shown increased amounts of cytokines, such as interleukin-6 (IL-6), IL-7, IL-8, IL-9, IL-10, IL-1β, IL-1RA, tumor necrosis factor-alpha (TNF-α), granulocyte-macrophage colony-stimulating factor, fibroblast growth factor, macrophage inflammatory protein 1 alpha, platelet-derived growth factor, monocyte chemoattractant protein and vascular endothelial growth factor in the serum of COVID-19 patients, especially in ICU patients (Chen, Zhou, et al., 2020; Conti et al., 2020; Huang et al., 2020; Wang, Hu, et al., 2020; Zhang, Zhao, Zhang, et al., 2020).
T108 18272-18391 Sentence denotes Importantly, there is a strong correlation between serum cytokine levels and mortality rates in patients with COVID-19.
T109 18392-18506 Sentence denotes The amplified and uncontrolled inflammatory response induces cellular apoptosis or necrosis of the affected cells.
T110 18507-18738 Sentence denotes This is followed by increased permeability of blood vessels leading to the accumulation of inflammatory monocytes, macrophages and neutrophils in different body organs fueling the inflammatory cascade (Channappanavar et al., 2016).
T111 18739-18907 Sentence denotes The vicious circle intensifies the situation as the cytokine storm is further stimulated and the regulation of immune response is lost resulting in severe consequences.
T112 18908-19048 Sentence denotes Collectively, this indicates the uncontrolled inflammatory response is a major factor in the adverse response observed in COVID-19 patients.
T113 19049-19212 Sentence denotes In that sense, it would seem reasonable that ameliorating the exaggerated immune response would improve the clinical outcomes in patients with COVID-19 (Table 3 ).
T114 19213-19411 Sentence denotes Table 3 Overview of the pharmacological approaches under investigation for ameliorating cytokine storm, hyperinflammatory state and the associated secondary organ complications in COVID-19 patients.
T115 19412-19518 Sentence denotes Pharmacological intervention Sample size and criteria Treatment protocol Key findings Conclusion Reference
T116 19519-19615 Sentence denotes • Tocilizumab for IL-6 cytokine release syndrome • Multicenter Randomized controlled trial (RCT)
T117 19616-19644 Sentence denotes • Severe COVID-19 infections
T118 19645-19665 Sentence denotes • 18–85 years of age
T119 19666-19687 Sentence denotes • Elevated serum IL-6
T120 19688-19728 Sentence denotes • N = 94 standard therapy + tocilizumab
T121 19729-19789 Sentence denotes • N = 94 standard therapy • 4–8 mg/kg tocilizumab i.v. once
T122 19790-19921 Sentence denotes • Additional dose if fever persists in 24 h after first dose • First phase showed normalization of fever within 24 h of tocilizumab
T123 19922-20027 Sentence denotes • Improved respiratory function, oxygenation, and pulmonary lesions • Phase 4 study completed in May 2020
T124 20028-20045 Sentence denotes • Results pending
T125 20046-20195 Sentence denotes • Tocilizumab may be a promising investigative therapy to reduce cytokine release syndrome and associated multi-organ damage (ChiCTR2000029765, 2020)
T126 20196-20294 Sentence denotes • Tocilizumab to mitigate cytokine storm and associated complications • Retrospective cohort study
T127 20295-20313 Sentence denotes • >18 years of age
T128 20314-20366 Sentence denotes • Intensive care unit (ICU) COVID-19 hospitalization
T129 20367-20415 Sentence denotes • Primary endpoint of hospital-related mortality
T130 20416-20454 Sentence denotes • N = 210 standard care + tocilizumab
T131 20455-20523 Sentence denotes • N = 420 standard care • 400 mg single dose or 8 mg/kg tocilizumab
T132 20524-20678 Sentence denotes • 88% required 1 infusion, 12% received a second infusion • Hazard ratio (HR) 0.71 for hospital related mortality (95% confidence interval (CI) 0.56–0.89)
T133 20679-20761 Sentence denotes • Treatment was more effective in patients with C-reactive protein (CRP) >15 mg/dL
T134 20762-20972 Sentence denotes • HR 0.48 (95% CI 0.30–0.77) than those with CRP <15 mg/dL HR 0.92 (95% CI 0.57–1.48) • Tocilizumab treatment is associated with a lower rate of mortality, particularly in those with enhanced inflammatory state
T135 20973-21064 Sentence denotes • Double blind RCT recently completed with results pending NCT04320615 (Biran et al., 2020)
T136 21065-21139 Sentence denotes • Tocilizumab to mitigate cytokine storm • Prospective observational study
T137 21140-21179 Sentence denotes • Severe or critical COVID-19 infection
T138 21180-21203 Sentence denotes • 25 to 88 years of age
T139 21204-21244 Sentence denotes • N = 21 tocilizumab + standard therapy
T140 21245-21304 Sentence denotes • 42.9% had CVD • 4–8 mg/kg or 400 mg tocilizumab i.v. once
T141 21305-21433 Sentence denotes • 85.7% received single dose of tocilizumab, 14.3% required second dose within 12 h of first dose • Fever normalized within 24 h
T142 21434-21467 Sentence denotes • Reduced O2 therapy requirements
T143 21468-21504 Sentence denotes • Minimal improvement in IL-6 levels
T144 21505-21533 Sentence denotes • CT lung lesion improvement
T145 21534-21602 Sentence denotes • All patients discharged • Limited sample size and no control group
T146 21603-21726 Sentence denotes • Tocilizumab treatment in severe COVID-19 cases may improve clinical symptoms in hyperinflammatory state (Xu et al., 2020)
T147 21727-21848 Sentence denotes • Intensive methylprednisolone regimen +/− tocilizumab for management of cytokine storm • Prospective observational study
T148 21849-21904 Sentence denotes • O2 sat ≤ 94% OR tachypnea, elevated CRP, high D-dimer
T149 21905-21968 Sentence denotes • Primary outcome of hospital discharge or clinical improvement
T150 21969-22013 Sentence denotes • N = 86 methylprednisolone +/− tocilizumab
T151 22014-22047 Sentence denotes • N = 86 standard care • Stage 1:
T152 22048-22121 Sentence denotes Immediate methylprednisolone 250 mg i.v. on day 1, then 80 mg on days 2–5
T153 22122-22195 Sentence denotes • Stage 2 (lack of clinical improvement or worsening respiratory status):
T154 22196-22309 Sentence denotes Add tocilizumab 8 mg/kg i.v. once between days 2–5 • Improvement in respiratory status HR 1.79 (95% CI 1.20–2.67)
T155 22310-22361 Sentence denotes • Improvement reached in a shorter time vs. control
T156 22362-22590 Sentence denotes • Reduced hospital mortality and need for mechanical ventilation • Short duration of intensive immunosuppressive therapy is associated with improved clinical outcomes in patients with hyperinflammaory state (Ramiro et al., 2020)
T157 22591-22687 Sentence denotes • Ruxolitinib treatment for elevated cytokine levels and inflammatory response • Prospective RCT
T158 22688-22733 Sentence denotes • 18 to 75 years of age with severe infection
T159 22734-22783 Sentence denotes • Primary outcome of time to clinical improvement
T160 22784-22821 Sentence denotes • N = 20 ruxolitinib + standard care
T161 22822-22886 Sentence denotes • N = 21 placebo + standard care • Ruxolitinib 5 mg twice daily
T162 22887-22991 Sentence denotes • Placebo vitamin C 100 mg twice daily • No difference in primary endpoint HR 1.669 (95% CI 0.836–3.335)
T163 22992-23048 Sentence denotes • Improvement in lung computerized tomography (CT) scans
T164 23049-23218 Sentence denotes • Significantly reduced cytokine levels and CRP by day 3 • Ruxolitinib may hasten time of chest CT scan improvement and mitigate systemic inflammation (Cao et al., 2020)
T165 23219-23324 Sentence denotes • Anakinra for targeting the cytokine inflammatory cascade through IL-1 blockade • Open label case series
T166 23325-23345 Sentence denotes • Elevated CRP N = 9
T167 23346-23393 Sentence denotes • 6/9 with CVD risk factors (diabetes, obesity)
T168 23394-23463 Sentence denotes • 3/9 with hypertension • Anakinra 100 mg every 12 h s.c. on days 1–3
T169 23464-23536 Sentence denotes • Anakinra 100 mg once daily s.c. on days 4–10 • Fever subsided by day 3
T170 23537-23577 Sentence denotes • CRP normalized in 5 patients by day 11
T171 23578-23617 Sentence denotes • Halted progression of CT lung lesions
T172 23618-23688 Sentence denotes • 100% survival • Small case series, potential for confounding factors
T173 23689-23739 Sentence denotes • Potential therapy to target inflammatory cascade
T174 23740-23836 Sentence denotes • Positive results in patients with hypertension and other CVD risk factors (Aouba et al., 2020)
T175 23837-23854 Sentence denotes • Ana-COVID study
T176 23855-23943 Sentence denotes • Anakinra for COVID-19 hyperinflammatory state • Prospective/retrospective cohort study
T177 23944-23993 Sentence denotes • Hospitalized adults with critical lung function
T178 23994-24047 Sentence denotes • Cohort with CVD (hypertension, stroke, cardiopathy)
T179 24048-24119 Sentence denotes • Primary outcome of ICU admission with mechanical ventilation or death
T180 24120-24154 Sentence denotes • N = 52 anakinra + standard care
T181 24155-24224 Sentence denotes • N = 44 standard care • Anakinra 100 mg s.c. twice daily for 3 days
T182 24225-24517 Sentence denotes • Then anakinra 100 mg s.c. once daily for 7 days • Significantly reduced need for mechanical ventilation or death HR 0.22 (0.11–0.41) • Anakinra may be associated with improved outcomes in patients with severe COVID-19 infection, including those with CVD and history of cardiovascular events
T183 24518-24588 Sentence denotes • May be due to mitigation of inflammatory cascade (Huet et al., 2020)
T184 24589-24861 Sentence denotes The innate immune system detects viral infections by using pattern recognition receptors, particularly Toll-like receptors (TLR), to recognize pathogen-associated molecular patterns of the virus including lipids, lipoproteins, proteins and nucleic acids (Li et al., 2020).
T185 24862-25177 Sentence denotes Activation of the TLR increases the expression of the transcription factors nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB), interferon (IFN) regulatory factor 3 and mitogen-activated protein kinases, which subsequently induce the expression of a myriad of inflammatory factors (Akira, 2009).
T186 25178-25452 Sentence denotes For example, the binding of SARS-CoV-2 to TLR activates the NF-κB inflammatory pathway triggering the transcription of the different components of the NLRP3 (NOD-, LRR-, and pyrin domain-containing 3) inflammasome (Chen, Moriyama, Chang, & Ichinohe, 2019; Siu et al., 2019).
T187 25453-25775 Sentence denotes The NLRP3 inflammasome is a large multiple protein platform consisting of main 3 components, the NLRP3 scaffold, the adapter component apoptosis-associated speck-like protein carrying a caspase activation and recruitment domain and the inactive zymogen procaspase-1 (Elliott & Sutterwala, 2015; Latz, Xiao, & Stutz, 2013).
T188 25776-26093 Sentence denotes Upon activation of the NLRP3 inflammasome and once assembled, procaspase-1 is converted into the active effector protease caspase-1, which then causes cleavage and maturation of proinflammatory cytokines pro-interleukin-1β (pro-IL-1β) and pro-IL-18 into their corresponding active forms, inflammatory IL-1β and IL-18.
T189 26094-26320 Sentence denotes This, in turn, triggers a cascade of other downstream mediators of inflammation such as TNF-α, IL-6, prostaglandins and leukotrienes which induces more tissue damage, fever, and fibrosis (Conti et al., 2020; Yue et al., 2018).
T190 26321-26564 Sentence denotes Based on the robust inflammatory response triggered by the NLRP3 inflammasome cascade, targeting the pathway has potential therapeutic value, which can reduce the detrimental consequences of uncontrolled inflammation from SARS-CoVs infections.
T191 26565-26726 Sentence denotes Inflammation is well known to participate in various CVDs, such as atherosclerosis, coagulopathy, coronary artery disease and HF (Libby, Ridker, & Maseri, 2002).
T192 26727-26894 Sentence denotes In the majority of severe cases of COVID-19, the cytokine storm has been coupled with elevated levels of erythematosus sedimentation rate and C-reactive protein (CRP).
T193 26895-27099 Sentence denotes Subsequently, hypercoagulation and disseminated intravascular coagulation would present as thrombosis, thrombocytopenia and gangrene of the limbs (Siddiqi & Mehra, 2020; Zhang, Zhao, Zhang, et al., 2020).
T194 27100-27367 Sentence denotes The identification of key cytokines such as TNFα in patients with HF demonstrated a strong positive correlation between cytokines and the severity of left ventricular dilation/hypertrophy and left ventricular dysfunction (Dibbs et al., 2003; Janczewski et al., 2003).
T195 27368-27506 Sentence denotes Other evidence indicates increased IL-1β and IL-6 levels detected in patients with acute myocarditis and acute MI (Xu, Shi, et al., 2020).
T196 27507-27705 Sentence denotes Increased IL-6 levels have been associated with long QT-syndrome in patients with systemic inflammation, leading to higher risks for arrhythmias such as torsade de pointes (Aromolaran et al., 2018).
T197 27706-27879 Sentence denotes As well, the level of IL-6 can be used as a predictor of adverse cardiovascular events after acute coronary syndrome and chronic HF (Fanola et al., 2017; Held et al., 2017).
T198 27880-28016 Sentence denotes The serum levels of IL-8 are increased in patients with acute MI and is associated with higher mortality rates (Cavusoglu et al., 2015).
T199 28017-28298 Sentence denotes Collectively, we can conclude there is a strong correlation between elevated inflammatory markers and the adverse cardiovascular outcomes observed in patients with COVID-19 suggesting the potential role of an inflammatory storm in the development and progression of cardiac injury.
T200 28299-28530 Sentence denotes Importantly, it has been reported that populations at high risk to develop the more severe forms of cardiac complications secondary to COVID-19 are patients with advanced age, obesity, metabolic syndrome, hypertension and diabetes.
T201 28531-28757 Sentence denotes These conditions share a common feature where immune changes favour a hyperinflammatory state and compromised inflammatory resolution (Bruunsgaard & Pedersen, 2003; Goldstein, 2010; Lawrence & Gilroy, 2007; Rius et al., 2012).
T202 28758-29014 Sentence denotes Therefore, traditional cardiovascular treatment plus anti-inflammatory therapy targeting key steps and components of the cytokine storm could be hypothesized as a therapeutic strategy and management of cardiovascular impairment in severe cases of COVID-19.
T203 29015-29223 Sentence denotes As the inflammatory response in different organs share common pathways, ameliorating the systematic inflammatory response will benefit the cardiovascular system and have potential advantages for other organs.
T204 29225-29254 Sentence denotes 3.3 Miscellaneous mechanisms
T205 29255-29614 Sentence denotes Other proposed mechanisms of COVID-19–associated cardiovascular impairment include instability of coronary atherosclerotic plaques (Madjid, Vela, Khalili-Tabrizi, Casscells, & Litovsky, 2007) and increased platelet-aggregating activity (Modica, Karlsson, & Mooe, 2007) leading to excessive and uncontrolled coagulation and thrombosis (Milbrandt et al., 2009).
T206 29615-29883 Sentence denotes The systemic inflammatory response to pneumonia induces endothelial dysfunction, increases the procoagulant activity of the blood and consequently triggers inflammatory reactions within coronary atherosclerotic plaques, making them unstable and susceptible to rupture.
T207 29884-29985 Sentence denotes Together, this contributes to the formation of an occlusive thrombus over a ruptured coronary plaque.
T208 29986-30153 Sentence denotes It is documented that COVID-19 patients are prone to arterial and venous thromboembolisms due to hypoxia, excessive inflammation and diffuse intravascular coagulation.
T209 30154-30296 Sentence denotes In a Dutch study of 184 ICU patients with proven COVID-19 pneumonia, one-third of patients exhibited blood clots and thrombotic complications.
T210 30297-30489 Sentence denotes These findings, consequently, reinforced the recommendation to use antiplatelets and other pharmacological thrombosis prophylaxis drugs in all COVID-19 patients (Klok et al., 2020) (Table 4 ).
T211 30490-30638 Sentence denotes Table 4 Overview of the pharmacological interventions under investigation targeting hypercoagulability and platelet activation in COVID-19 patients.
T212 30639-30745 Sentence denotes Pharmacological intervention Sample size and criteria Treatment protocol Key findings Conclusion Reference
T213 30746-30839 Sentence denotes • Heparin anticoagulant treatment in sepsis-induced coagulopathy • Retrospective cohort study
T214 30840-30859 Sentence denotes • ≥ 18 years of age
T215 30860-30887 Sentence denotes • Severe COVID-19 infection
T216 30888-30953 Sentence denotes • Evaluation of 28-day mortality in heparin and non-heparin users
T217 30954-31004 Sentence denotes • 48.5% comorbid hypertension and/or heart disease
T218 31005-31022 Sentence denotes • N = 99 heparin
T219 31023-31248 Sentence denotes • N = 350 no heparin • Unfractionated (10, 000–15, 000 U/day) or low molecular weight heparin (40–60 mg enoxaparin/day) for 7 days or longer • No difference in 28-day mortality endpoint between heparin and non-heparin users.
T220 31249-31359 Sentence denotes • Lower 28-day mortality in patients with sepsis-induced coagulopathy (SIC) score of ≥4 in stratified analysis
T221 31360-31575 Sentence denotes • Odd Ratio (OR) 0.372 (95% CI 0.154–0.901) • Heparin may be associated with a lower 28-day mortality rate only in patients with enhanced coagulopathy risk such as SIC score of 4 or greater (Tang, Bai, et al., 2020)
T222 31576-31730 Sentence denotes • Antiplatelet and anticoagulant combination therapy for hypoxemia, respiratory failure, and cardiac adverse events • Case control, proof-of-concept study
T223 31731-31782 Sentence denotes • Adult patients with hypoxemic respiratory failure
T224 31783-31851 Sentence denotes • N = 5 ASA + clopidogrel + tirofiban + fondaparinux + standard care
T225 31852-31912 Sentence denotes • N = 5 matched controls given low molecular weight heparin
T226 31913-31983 Sentence denotes • Secondary outcome included major and minor cardiac adverse events 1.
T227 31984-32090 Sentence denotes Single dose of acetylsalicylic acid (ASA) 250 mg i.v. and single loading dose of oral clopidogrel 300 mg2.
T228 32091-32150 Sentence denotes ASA and clopidogrel continued at 75 mg orally for 30 days3.
T229 32151-32250 Sentence denotes Tirofiban 25 μg/kg as bolus i.v. injection, then 0.15 μg/kg/min continuous i.v. infusion for 48 h4.
T230 32251-32380 Sentence denotes Fondaparinux 2.5 mg/day s.c. for the duration of the hospital stay • Significant improvement in alveolar-arterial oxygen gradient
T231 32381-32434 Sentence denotes • Significant improvement in CRP and lymphocyte count
T232 32435-32568 Sentence denotes • Patients in treatment group did not experience any cardiac adverse events • Small study and not a randomized controlled trial (RCT)
T233 32569-32766 Sentence denotes • Intensive antithrombotic therapy may be useful in patients with severe respiratory distress with prothrombotic state at risk for acute cardiac events (Viecca, Radovanovic, Forleo, & Santus, 2020)
T234 32767-32995 Sentence denotes A 12-year follow-up study conducted by Wu et al. of 25 patients who recovered from SARS-CoV infection demonstrated patients were affected by various metabolic disturbances altering lipid metabolism and the cardiovascular system.
T235 32996-33178 Sentence denotes These patients suffered from hyperlipidemia, increased serum concentrations of free fatty acids, abnormal glucose metabolism and other cardiovascular abnormalities (Wu et al., 2017).
T236 33179-33419 Sentence denotes Considering the genetic similarities between SARS-CoV and SARS-CoV-2, Zhang et al. recently proposed the use of the lipid-lowering statins, which also possess anti-inflammatory properties, as a therapeutic option for patients with COVID-19.
T237 33420-33658 Sentence denotes This study reported that amongst 13,981 cases of COVID-19, in-hospital use of statins was associated with a lower risk of death and a significantly lower inflammatory response during the entire hospitalization period (Zhang et al., 2020).
T238 33659-33808 Sentence denotes Thus, suggesting the use of lipid-lowering drugs with anti-inflammatory properties can improve the cardiovascular outcomes in patients with COVID-19.
T239 33809-33974 Sentence denotes COVID-19 patients are susceptible to hypoxemia due to reduced lung performance, impaired gas exchange across the inflamed alveoli and abnormal ventilation/perfusion.
T240 33975-34082 Sentence denotes This will lead to decreased myocardial oxygen supply, myocardial ischemia and impaired calcium homeostasis.
T241 34083-34307 Sentence denotes The disturbance in calcium balance will trigger the activation of the NLRP3 inflammasome and different inflammatory components which consequently lead to the death of cardiomyocytes (Moccia et al., 2020; Zheng et al., 2020).
T242 34308-34465 Sentence denotes Additionally, the systemic response to pneumonia includes an increase in sympathetic activity causing severe tachycardia and increased peripheral resistance.
T243 34466-34670 Sentence denotes Subsequently, a rapid heart rate together with vasoconstriction may result in elevated myocardial oxygen requirements and a shortened diastolic interval, the period during which coronary perfusion occurs.
T244 34671-34895 Sentence denotes The mismatch between myocardial oxygen demand and supply can lead to cardiac ischemia and infarction, especially in the presence of pre-existing coronary artery disease (Corrales-Medina, Musher, Shachkina, & Chirinos, 2013).
T245 34896-35318 Sentence denotes Volume overload due to impaired sodium and water metabolism (Dreyfuss, Leviel, Paillard, Rahmani, & Coste, 1988), transient disturbance of endothelial function and vascular tone (Benson, Akbarian, Adler, & Abelmann, 1970; Kumar, Wallace, Ramirez, Benson, & Abelmann, 1970) and cardiac arrhythmias (Cilli et al., 2018) may also contribute to decreased left ventricular function or worsening of HF in patients with COVID-19.
T246 35319-35513 Sentence denotes Collectively, these effects can all result in the aggravation of existing CVDs and trigger severe events, such as acute coronary syndromes, thrombosis, myocardial ischemia or exacerbation of HF.
T247 35514-35710 Sentence denotes Indeed, cardiovascular protective strategies are needed for the prevention and management of severe adverse cardiovascular events to improve the prognosis of COVID-19 patients (Table 5, Table 6 ).
T248 35711-35822 Sentence denotes Table 5 Overview of proposed pharmacological approaches to attenuate COVID-19 associated cardiovascular injury.
T249 35823-35929 Sentence denotes Pharmacological intervention Sample size and criteria Treatment protocol Key findings Conclusion Reference
T250 35930-36081 Sentence denotes • Colchicine for the improvement of cardiac biomarkers, inflammation, and clinical outcomes • Prospective, open-label randomized controlled trial (RCT)
T251 36082-36118 Sentence denotes • N = 55 colchicine + standard care
T252 36119-36142 Sentence denotes • N = 50 standard care
T253 36143-36504 Sentence denotes • Primary endpoints included maximum cardiac troponin level, time for C-reactive protein (CRP) to reach 3× upper limit normal, time to deterioration by at least 2 points on clinical status scale • Colchicine 1.5 mg loading dose, 0.5 mg after 60 min, and then 0.5 mg twice daily + standard care for up to 3 weeks • No difference in cardiac troponin or CRP levels
T254 36505-36606 Sentence denotes • Clinical deterioration less common with colchicine treatment odd ratio (OR) 0.11 (95% CI 0.01–0.96)
T255 36607-36917 Sentence denotes • Abdominal pain and diarrhea significantly more common with colchicine treatment • Colchicine may not have a significant effect on cardiac or inflammatory biomarkers, however it may be useful in stabilizing patients with severe COVID-19 infection and preventing clinical deterioration (Deftereos et al., 2020)
T256 36918-37012 Sentence denotes • Statin therapy and impact on inflammation and patient prognosis • Retrospective cohort study
T257 37013-37061 Sentence denotes • Primary endpoint of 28-day all-cause mortality
T258 37062-37112 Sentence denotes • Secondary endpoint included acute cardiac injury
T259 37113-37135 Sentence denotes • N = 1219 statin use
T260 37136-37185 Sentence denotes • N = 12, 762 no statin • In-hospital statin use
T261 37186-37207 Sentence denotes • Atorvastatin 83.2%,
T262 37208-37228 Sentence denotes • Rosuvastatin 15.6%
T263 37229-37439 Sentence denotes • Dose differences between statins were converted to a daily equivalent dose of atorvastatin ranging from 18.9–20.0 mg/day • Reduced all-cause mortality with statin use hazard ratio (HR) 0.63 (95% CI 0.48–0.84)
T264 37440-37550 Sentence denotes • Patients on ACEi/ARB therapy in addition to statin did not have increased mortality compared to statin alone
T265 37551-37608 Sentence denotes • Statin therapy not associated with acute cardiac injury
T266 37609-37889 Sentence denotes • Inflammatory markers CRP, IL-6 were lower in statin treated patients while in hospital • Reduced mortality and improved prognosis associated with in-hospital statin use may be due to the anti-inflammatory and immunomodulatory effects of statins (Zhang, Qin, Cheng, et al., 2020)
T267 37890-38014 Sentence denotes • ACEi/ARB impact on mortality in COVID-19 patients with concomitant hypertension • Retrospective, multi-centre cohort study
T268 38015-38079 Sentence denotes • Patients with comorbid hypertension hospitalized with COVID-19
T269 38080-38100 Sentence denotes • Age 18 to 74 years
T270 38101-38149 Sentence denotes • Primary endpoint of 28-day all-cause mortality
T271 38150-38177 Sentence denotes • N = 188 ACEi/ARB therapy
T272 38178-38241 Sentence denotes • N = 940 no ACEi/ARB • ACEi/ARB for treatment of hypertension
T273 38242-38382 Sentence denotes • individual patient dosing regimens not specified • Risk of all-cause mortality lower in ACEi/ARB treated group HR 0.42 (95% CI 0.19–0.92).
T274 38383-38515 Sentence denotes • Use of ACEi/ARB in comparison to other anti-hypertension therapies was associated with lower mortality HR 0.30 (95% CI 0.12–0.70).
T275 38516-38653 Sentence denotes • No difference in acute cardiac injury outcome between groups • Chronic ACEi/ARB therapy may not increase mortality of COVID-19 patients
T276 38654-38764 Sentence denotes • May not have much benefit in acute heart injury due to COVID-19 inflammation (Zhang, Zhu, Cai, et al., 2020)
T277 38765-38871 Sentence denotes • Statin use impact on acute myocardial injury patient outcomes • Retrospective observational cohort study
T278 38872-38905 Sentence denotes • Patients with elevated troponin
T279 38906-38941 Sentence denotes • History of CVD in 24% of patients
T280 38942-38953 Sentence denotes • N = 3069
T281 38954-39055 Sentence denotes • Objective to characterize myocardial injury and associated outcomes • 36% of patients using statins
T282 39056-39325 Sentence denotes • Doses and regimens not specified • Statin use amongst patients with acute myocardial injury was associated with improved survival HR 0.57 (95% CI 0.47–0.69) • Statin treatment may be associated with a survival benefit in patients with CVD and elevated troponin levels
T283 39326-39434 Sentence denotes • Exact beneficial mechanism(s) associated with statins in COVID-19 remain to be studied (Lala et al., 2020)
T284 39435-39596 Sentence denotes Table 6 Summary of the ongoing trials investigating pharmacological agents targeting a cytokine storm and acute cardiac injury secondary to SARS-CoV-2 infection.
T285 39597-39679 Sentence denotes Pharmacological intervention Sample size and criteria Treatment protocol Reference
T286 39680-39696 Sentence denotes • TACTIC-E Trial
T287 39697-39751 Sentence denotes • Immunomodulatory agents • Multi-arm randomized trial
T288 39752-39801 Sentence denotes • Pre-intensive care unit (ICU) COVID-19 patients
T289 39802-39883 Sentence denotes • Immunomodulatory drug EDP1815 vs. dapagliflozin + ambrisentan vs. standard care
T290 39884-40020 Sentence denotes • Primary outcome includes need for cardiovascular organ support • EDP1815 as 2 capsules twice daily (1.6 × 1011 cells) for up to 7 days
T291 40021-40092 Sentence denotes • Dapagliflozin 10 mg + ambrisentan 5 mg once daily (NCT04393246, 2020)
T292 40093-40246 Sentence denotes • High dose IV Vitamin C to ameliorate cytokine storm and associated organ dysfunction • Prospective placebo controlled randomized controlled trial (RCT)
T293 40247-40257 Sentence denotes • N = 308
T294 40258-40303 Sentence denotes • High dose i.v. vitamin C (HIVC) vs. placebo
T295 40304-40501 Sentence denotes • Primary outcome of ventilator-free days • 12 g/50 ml vitamin C infusion 12 ml/h twice daily for 7 days vs. 50 ml sterile water for injection infused at 12 ml/h (Liu, Zhu, Zhang, Li, & Peng, 2020)
T296 40502-40556 Sentence denotes • TOC-COVID Trial • Prospective placebo controlled RCT
T297 40557-40599 Sentence denotes • N = 100 tocilizumab + standard treatment
T298 40600-40639 Sentence denotes • N = 100 placebo + standard treatment
T299 40640-40745 Sentence denotes • Primary outcome of ventilation-free days • Tocilizumab 8 mg/kg single i.v. dose (Rilinger et al., 2020)
T300 40746-40762 Sentence denotes • TACTIC-R Trial
T301 40763-40833 Sentence denotes • Immunomodulatory agents • Randomized parallel 3-arm open label trial
T302 40834-40856 Sentence denotes • N = 125 Baricitinib
T303 40857-40879 Sentence denotes • N = 125 Ravulizumab
T304 40880-40906 Sentence denotes • N = 125 standard of care
T305 40907-41021 Sentence denotes • Primary outcome includes need for cardiovascular organ support • Baricitinib 4 mg orally once daily on days 1–14
T306 41022-41097 Sentence denotes • Ravulizumab single i.v. weight-based dose regimen (Kulkarni et al., 2020)
T307 41098-41114 Sentence denotes • CytoResc Trial
T308 41115-41201 Sentence denotes • Cytokine storm in hyperinflammation and shock • Prospective, open-label, pilot study
T309 41202-41277 Sentence denotes • ‘CytoSorb’ polystyrene-based hemoadsorber to adsorb circulating cytokines
T310 41278-41301 Sentence denotes • N = 40–50 ‘CytoSorb’
T311 41302-41327 Sentence denotes • N = 40–50 standard care
T312 41328-41482 Sentence denotes • Primary outcome is time to resolution of vasoplegic shock • ‘CytoSorb’ therapy administered via a shaldon catheter for 3–7 days (Stockmann et al., 2020)
T313 41483-41537 Sentence denotes • MelCOVID Trial • Double blind placebo controlled RCT
T314 41538-41561 Sentence denotes • ICU COVID-19 patients
T315 41562-41599 Sentence denotes • N = 12 melatonin + standard of care
T316 41600-41640 Sentence denotes • N = 6 placebo control + standard care
T317 41641-41744 Sentence denotes • Secondary outcome includes CRP, IL-6 levels • Melatonin 5 mg/kg/day i.v. divided every 6 h for 7 days
T318 41745-41839 Sentence denotes • Placebo dose of 5 mg/kg/day i.v. divided every 6 h for 7 days (Rodriguez-Rubio et al., 2020)
T319 41840-41929 Sentence denotes • Siltuximab for patients diagnosed with severe respiratory complications due to COVID-19
T320 41930-42013 Sentence denotes • Anti-IL-6 mitigation of cytokine storm • Observational retrospective cohort study
T321 42014-42084 Sentence denotes • Cohort A: continuous positive airway pressure followed by siltuximab
T322 42085-42130 Sentence denotes • Cohort B: intubation followed by siltuximab
T323 42131-42211 Sentence denotes • Control group receiving continuous positive airway pressure or intubation only
T324 42212-42222 Sentence denotes • N = 220
T325 42223-42318 Sentence denotes • Primary outcome of mortality over 30 days • Detailed siltuximab dosing regimen not specified.
T326 42319-42374 Sentence denotes • Treatment procedure was based on clinicians judgement
T327 42375-42405 Sentence denotes • Study completed May 8, 2020.
T328 42406-42441 Sentence denotes Results pending (NCT04322188, 2020)
T329 42442-42457 Sentence denotes • COV-AID Trial
T330 42458-42535 Sentence denotes • Use of anti-interleukin agents for cytokine storm • Phase 3 prospective RCT
T331 42536-42575 Sentence denotes • Patients with signs of cytokine storm
T332 42576-42620 Sentence denotes • N = 38 Anakinra alone (anti-IL-1 receptor)
T333 42621-42659 Sentence denotes • N = 76 Siltuximab alone (anti-IL-6)
T334 42660-42691 Sentence denotes • N = 38 Anakinra + siltuximab
T335 42692-42739 Sentence denotes • N = 76 Tocilizumab alone (anti-IL-6 receptor)
T336 42740-42771 Sentence denotes • N = 38 Anakinra + tocilizumab
T337 42772-42800 Sentence denotes • N = 76 standard care alone
T338 42801-42891 Sentence denotes • Primary outcome as time to clinical improvement • Anakinra 100 mg s.c. daily for 28 days
T339 42892-42934 Sentence denotes • Siltuximab single i.v. infusion 11 mg/kg
T340 42935-43008 Sentence denotes • Tocilizumab single i.v. infusion 8 mg/kg max 800 mg (Maes et al., 2020)
T341 43009-43057 Sentence denotes • Sarilumab for hospitalized COVID-19 infections
T342 43058-43099 Sentence denotes • Cytokine storm syndrome • Phase 2/3 RCT
T343 43100-43110 Sentence denotes • Phase 2:
T344 43111-43188 Sentence denotes Sarilumab in hospitalized patients regardless of disease severity vs. placebo
T345 43189-43274 Sentence denotes • Primary outcome of % change in CRP in patients with serum IL-6 > upper limit normal
T346 43275-43294 Sentence denotes • Phase 3 Cohort 1:
T347 43295-43384 Sentence denotes Sarilumab in hospitalized critical infection receiving mechanical ventilation vs. placebo
T348 43385-43396 Sentence denotes • Cohort 2:
T349 43397-43477 Sentence denotes Sarilumab in hospitalized infection receiving mechanical ventilation vs. placebo
T350 43478-43489 Sentence denotes • N = 1912
T351 43490-43576 Sentence denotes • Primary outcome of at least 1 point improvement on 7 point clinical scale • Phase 2:
T352 43577-43600 Sentence denotes Low dose sarilumab i.v.
T353 43601-43611 Sentence denotes • Phase 2:
T354 43612-43635 Sentence denotes Mid-dose sarilumab i.v.
T355 43636-43655 Sentence denotes • Phase 3 Cohort 1:
T356 43656-43679 Sentence denotes Low dose sarilumab i.v.
T357 43680-43699 Sentence denotes • Phase 3 Cohort 1:
T358 43700-43723 Sentence denotes Mid-dose sarilumab i.v.
T359 43724-43743 Sentence denotes • Phase 3 Cohort 2:
T360 43744-43768 Sentence denotes High dose sarilumab i.v.
T361 43769-43838 Sentence denotes • Placebo given to match sarilumab administration (NCT04315298, 2020)
T362 43839-43860 Sentence denotes • CORIMUNO-SARI Trial
T363 43861-43915 Sentence denotes • Sarilumab to mitigate enhanced IL-6 signalling • RCT
T364 43916-43966 Sentence denotes • Moderate, severe, or critical COVID-19 pneumonia
T365 43967-43999 Sentence denotes • Sarilumab vs. standard of care
T366 44000-44088 Sentence denotes • N = 239 • Sarilumab 400 mg single i.v. infusion over 1 h on day 1 (NCT04324073, 2020)
T367 44089-44168 Sentence denotes • Barcitinib for hospitalized COVID-19 patients • Non-randomized clinical trial
T368 44169-44231 Sentence denotes • Any adult patient hospitalized with moderate/severe COVID-19
T369 44232-44284 Sentence denotes • Barcitinib + standard care vs. standard care alone
T370 44285-44398 Sentence denotes • Primary outcome of clinical status after 15 days • Barcitinib 2 mg orally daily for 10 days (NCT04321993, 2020)
T371 44399-44448 Sentence denotes • RUXCOVID Trial • Phase 3 placebo-controlled RCT
T372 44449-44488 Sentence denotes • Patients age ≥ 12 with cytokine storm
T373 44489-44546 Sentence denotes • Ruxolitinib + standard care vs. placebo + standard care
T374 44547-44581 Sentence denotes • N = 402 randomized in 2:1 ratio
T375 44582-44652 Sentence denotes • treatment: placebo • Ruxolitinib 5 mg orally twice daily for 14 days
T376 44653-44706 Sentence denotes • May extend treatment to 28 days (NCT04362137, 2020)
T377 44707-44775 Sentence denotes • Losartan (ARB) in patients hospitalized for COVID-19 • Phase 2 RCT
T378 44776-44814 Sentence denotes • Losartan vs. placebo + standard care
T379 44815-44825 Sentence denotes • N = 200
T380 44826-44950 Sentence denotes • Secondary outcome includes cardiovascular organ failure/dysfunction • Losartan 50 mg orally once daily (NCT04312009, 2020)
T381 44951-45036 Sentence denotes • Losartan (ARB) in patients not requiring hospitalization for COVID-19 • Phase 2 RCT
T382 45037-45075 Sentence denotes • Losartan vs. placebo + standard care
T383 45076-45086 Sentence denotes • N = 500
T384 45087-45224 Sentence denotes • Primary outcome of patients admitted to hospital within 15 days of randomization • Losartan 25 mg orally once daily (NCT04311177, 2020)
T385 45225-45336 Sentence denotes • Eicosapentaenoic acid (EPA) free fatty acid for hospitalized COVID-19 patients • Phase 3 interventional trial
T386 45337-45401 Sentence denotes • Treatment with EPA gastro-resistant capsules vs. standard care
T387 45402-45427 Sentence denotes • 28-day treatment period
T388 45428-45546 Sentence denotes • Primary outcome of time to treatment failure i.e. need for additional therapy, intubation, transfer to ICU, or death
T389 45547-45724 Sentence denotes • Secondary outcome includes reduction of IL-6 levels • Eicosapentaenoic acid free fatty acid (EPA-FFA) 1 g gastro-resistant capsules twice daily (2 g total) (NCT04335032, 2020)
T390 45725-45742 Sentence denotes • COLCORONA Trial
T391 45743-45863 Sentence denotes • Colchicine and inflammatory cytokine storm • Phase 3 multi-centre placebo-controlled randomized controlled trial (RCT)
T392 45864-45887 Sentence denotes • Age 40 years or older
T393 45888-46029 Sentence denotes • Patients must have at least one high-risk factor i.e. uncontrolled hypertension, HF, coronary artery disease (CAD), diabetes, obesity, etc.
T394 46030-46054 Sentence denotes • Colchicine vs. placebo
T395 46055-46073 Sentence denotes • 30-day treatment
T396 46074-46085 Sentence denotes • N = 6000
T397 46086-46237 Sentence denotes • Primary composite endpoint of need for hospitalization or death • Colchicine 0.5 mg orally twice daily for 3 days, then 0.5 mg once daily for 27 days
T398 46238-46304 Sentence denotes • Placebo will match colchicine administration (NCT04322682, 2020)
T399 46306-46387 Sentence denotes 4 Adverse cardiovascular effects of the proposed empirical/supportive treatments
T400 46388-46570 Sentence denotes Currently, there is no approved vaccination or effective drug for protecting against or treating COVID-19; only symptomatic therapy and empirical/supportive treatments are available.
T401 46571-46721 Sentence denotes Many of the mortalities related to COVID-19 have been primarily attributed to original patient comorbidities instead of pneumonia (Wang et al., 2020).
T402 46722-46865 Sentence denotes This highlights the importance of focusing on pre-existing comorbidities of COVID-19 patients, particularly those of the cardiovascular system.
T403 46866-47026 Sentence denotes Attention to therapies with cardiovascular side effects being proposed and applied to patients with COVID-19, especially those with underlying CVD is important.
T404 47027-47172 Sentence denotes Notably, many of the therapies proposed to ameliorate the poor prognosis of COVID-19 patients are associated with cardiovascular adverse effects.
T405 47173-47452 Sentence denotes For example, treatment of patients with COVID-19 with non-steroidal anti-inflammatory drugs, glucocorticoids and anti-viral agents, such as ribavirin, lopinavir/ritonavir, INF-α and the antibiotic azithromycin, could further increase the cardiovascular risk of COVID-19 patients.
T406 47453-47737 Sentence denotes Excessive use of non-steroidal anti-inflammatory drugs and glucocorticoids is associated with deleterious effects on the cardiovascular system increasing the risk of events including, ischemia, MI, arrhythmias and HF (England, Thiele, Anderson, & Mikuls, 2018; Roubille et al., 2015).
T407 47738-48092 Sentence denotes Although corticosteroids are sometimes prescribed for the treatment of patients with severe SARS-CoV infection for the possible relief of inflammation (Wong et al., 2004), recent evidence suggests corticosteroids may exacerbate lung injury associated with SARS-CoV-2 due to delayed viral clearance (Mehta, et al., 2020; Russell, Millar, & Baillie, 2020).
T408 48093-48344 Sentence denotes The antiviral agents lopinavir and ritonavir have been tested in a randomized controlled, open-label trial in hospitalized adult patients with COVID-19 and concluded that no benefit was observed with lopinavir–ritonavir treatment beyond standard care.
T409 48345-48558 Sentence denotes Moreover, about 14% of lopinavir–ritonavir recipients were unable to complete the full 14-day course of administration due primarily to the adverse events including the risks of QT prolongation (Cao et al., 2020).
T410 48559-48858 Sentence denotes It is important to highlight that the adverse effects of these antivirals involve altering the cardiac electrical conduction system causing QTc and/or PR interval prolongation, which can lead to atrioventricular block and torsade de pointes arrhythmias increasing the risk of MI (Worm et al., 2010).
T411 48859-49135 Sentence denotes Further, the use of these protease inhibitors can lead to metabolic disturbances such as hyperglycemia, hyperlipidemia and lipodystrophy, which may also contribute to adverse cardiovascular outcomes (Hill, Sawyer, & Gazzard, 2009; Tsiodras, Mantzoros, Hammer, & Samore, 2000).
T412 49136-49293 Sentence denotes Recently, IFN-α2b was used in an uncontrolled exploratory study including 77 hospitalized adults with confirmed COVID-19 in Wuhan, China (Zhou et al., 2020).
T413 49294-49515 Sentence denotes The trial showed that treatment with IFN-α2b markedly decreased the duration of detectable virus in the upper respiratory tract and also reduced the interval of the elevated inflammatory markers IL-6 and CRP in the blood.
T414 49516-49759 Sentence denotes However, treatment with IFN-α has been associated with hypertension, hypertriglyceridemia and direct cardiotoxicities, including arrhythmias, MI and cardiomyopathy, which could exacerbate underlying cardiac dysfunction (Page 2nd et al., 2016).
T415 49760-50132 Sentence denotes An open-label randomized trial has been conducted to test the efficacy of IFN beta-1b, lopinavir–ritonavir and ribavirin for treating patients admitted to hospital with COVID-19 and concluded early triple antiviral therapy was effective in alleviating symptoms and shortening the duration of hospital stay in patients with mild to moderate infections (Hung, et al., 2020).
T416 50133-50351 Sentence denotes However, it is worth noting ribavirin has a US boxed warning issued for hemolytic anemia associated with use that may worsen underlying cardiac disease and lead to fatal and non-fatal MI (Durante-Mangoni et al., 2011).
T417 50352-50637 Sentence denotes Numerous recent studies proposed the use of hydroxychloroquine and azithromycin as a treatment of COVID-19 in open-label non-randomized clinical trials, however, no positive results were produced (Arshad et al., 2020; Cavalcanti, et al., 2020; Gautret et al., 2020; Tang et al., 2020).
T418 50638-50942 Sentence denotes Well known adverse effects associated with azithromycin or hydroxychloroquine include development of severe QT prolongation (Gibson et al., 2017), which worsened when azithromycin is combined with hydroxychloroquine to treat COVID-19 patients (Choi, Lim, Chung, Choi, & Yoon, 2018; Mercuro et al., 2020).
T419 50943-51131 Sentence denotes Currently, there are multiple in vitro experiments and preclinical studies being performed around the world to test novel COVID-19 therapies, which are quickly moving into clinical trials.
T420 51132-51281 Sentence denotes Importantly, the early efficacy results have been limited to small-scale clinical studies in which the safety profiles have not been well-identified.
T421 51282-51406 Sentence denotes The safety profiles will be critical for COVID-19 patients with underlying comorbidities such as cardiovascular dysfunction.
T422 51407-51568 Sentence denotes Therefore, as there is a need for rapid clinical translation and a wide use of novel therapies for COVID-19, continued attention to safety profiles is important.
T423 51569-51720 Sentence denotes The rapid spread of COVID-19 globally continues to impact susceptible populations, like elderly patients and individuals with underlying comorbidities.
T424 51721-51970 Sentence denotes While underlying cardiovascular issues are impacted by COVID-19 infection, many existing and novel therapeutic strategies have direct adverse cardiovascular effects, highlighting the importance for consideration in new drug research and development.
T425 51972-52022 Sentence denotes 5 Overview of the n-3 polyunsaturated fatty acids
T426 52023-52159 Sentence denotes The long-chain n-3 polyunsaturated fatty acids (n-3 PUFAs) are essential fatty acids obtained from both dietary and non-dietary sources.
T427 52160-52218 Sentence denotes The simplest n-3 PUFA is α-linolenic acid (ALA, 18:3 n-3).
T428 52219-52341 Sentence denotes Once inside the body, ALA can be converted through a series of elongation and desaturation reactions into other n-3 PUFAs.
T429 52342-52597 Sentence denotes For instance, ALA is metabolized into eicosapentaenoic acid (EPA, C20:5n-3) which can be further metabolized into docosahexaenoic acid (DHA, C22:6n-3), the two most abundant n-3 PUFAs in mammalian tissues (Wiktorowska-Owczarek, Berezinska, & Nowak, 2015).
T430 52598-52703 Sentence denotes Mammals lack the necessary enzymes (delta-12 and delta-15 desaturase) required to synthesize ALA de novo.
T431 52704-52893 Sentence denotes As such, these fatty acids are described as “essential” and must be obtained from the diet such as fish, other marine sources, plants or supplements (Burdge & Calder, 2015; Sprecher, 1981).
T432 52894-52995 Sentence denotes Conversely, linoleic acid (LA, 18:2 n-6) is considered the primary source of the essential n-6 PUFAs.
T433 52996-53130 Sentence denotes LA can be further metabolized into arachidonic acid (AA, 20:4n-6) by the same series of elongase and delta-4,-5,-6 desaturase enzymes.
T434 53131-53475 Sentence denotes As n-3 PUFAs can compete for the same metabolic pathways with n-6 PUFAs, n-3 PUFAs supplementation may reduce the synthesis of n-6 PUFA-derived metabolites, thus, altering the metabolite profile and impacting numerous signaling pathways within the body, including the immune system, leading to disparate effects (Arterburn, Hall, & Oken, 2006).
T435 53477-53573 Sentence denotes 6 Role of n-3 polyunsaturated fatty acids in patients with respiratory infections and/or sepsis
T436 53574-53887 Sentence denotes A plethora of human and animal studies have investigated the beneficial effects of EPA and DHA in patients with ALI and ARDS which are common characteristics observed in severe SARS-CoV-2 patients (Messina et al., 2020; Nelson et al., 2003; Shirai, Yoshida, Matsumaru, Toyoda, & Ogura, 2015; Singer et al., 2006).
T437 53888-54103 Sentence denotes Mancuso et al. demonstrated Long-Evans rats fed enteral diets containing fish oil as a source of n-3 PUFAs for 21 days were subjected to acute inflammation caused by an intravenous injection of Salmonella endotoxin.
T438 54104-54334 Sentence denotes N-3 PUFA fed rats had a lower severity of pulmonary microvascular protein permeability and decreased pulmonary neutrophil accumulation compared to rats fed the n-6 PUFA enriched diet (Mancuso et al., 1997a; Mancuso et al., 1997b).
T439 54335-54618 Sentence denotes Furthermore, stimulated alveolar macrophages had lower concentrations of AA-derived metabolites, such as thromboxane B2 (TxB2) and prostaglandin E2 (PGE2) suggesting a beneficial effect of n-3 PUFAs over n-6 PUFAs in attenuation of ALI (Mancuso et al., 1997a; Mancuso et al., 1997b).
T440 54619-54907 Sentence denotes Saedisomeolia et al. demonstrated in Calu-3 epithelial cells infected with Rhinovirus RV-43 and RV-1B that pre-incubating with DHA significantly reduced the release of IL-6 and IFN-γ-inducible protein, suppressing RV-induced inflammation (Saedisomeolia, Wood, Garg, Gibson, & Wark, 2009).
T441 54908-55173 Sentence denotes Collectively, these studies demonstrate that the anti-inflammatory properties of n-3 PUFAs play a pivotal role in attenuating the uncontrolled immune response in the lungs secondary to bacterial or viral infections which could be helpful in the setting of COVID-19.
T442 55174-55290 Sentence denotes Clinical evidence from trials assessing the role of n-3 PUFAs in ameliorating ALI, ARDS and sepsis has been limited.
T443 55291-55527 Sentence denotes Pontes-Arruda et al. investigated the effect of a diet enriched with EPA, γ-linolenic acid and antioxidants in patients with severe sepsis or septic shock who required mechanical ventilation (Pontes-Arruda, Aragao, & Albuquerque, 2006).
T444 55528-55697 Sentence denotes The data suggested the diet contributed to improved ICU and hospital clinical outcomes and was associated with lower mortality rates when compared to the control groups.
T445 55698-56012 Sentence denotes Meta-analysis reported a significant reduction in ventilator-free days, organ failures, length of stay in ICU, mortality rates as well as relevant improvements in oxygenation and clinical outcomes of ventilated patients with ALI/ARDS given EPA and γ-linolenic acid (Pontes-Arruda, Demichele, Seth, & Singer, 2008).
T446 56013-56233 Sentence denotes The efficacy and safety of a diet supplemented with a high-dose EPA and DHA (9 g/d added to 1 g/d ascorbic acid, 400UI/12 h α-tocopherol and 100 μg/d selenium) was assessed in patients with early-stage sepsis for 7 days.
T447 56234-56451 Sentence denotes The investigators found patients had lower levels of CRP, IL-6 and procalcitonin, as well as less need for mechanical ventilation and reduced development of severe sepsis (Hosny, Nahas, Ali, Elshafei, & Khaled, 2013).
T448 56452-56716 Sentence denotes Evidence for beneficial effects of n-3 PUFA-containing diets in patients with severe ARDS demonstrated similar outcomes such as reduced duration of mechanical ventilation, shorter ICU length and improved oxygenation (Langlois, D'Aragon, Hardy, & Manzanares, 2019).
T449 56717-57069 Sentence denotes These effects are highlighted in a recent systematic review with a meta-analysis demonstrated critically ill patients receiving parenteral nutrition therapy enriched with fish oil lipid emulsion had reduced risk for infection and sepsis (40% and 56%, respectively) as well a reduction of hospital and ICU stay by about two days (Pradelli et al., 2020).
T450 57070-57222 Sentence denotes Together, these studies demonstrate n-3 PUFA supplementation has favorable results in terms of multiple inflammatory, respiratory and clinical outcomes.
T451 57223-57507 Sentence denotes Recently, Bristrian proposed the use of parenteral supplementation of fish-oil emulsions, containing substantial amounts of EPA and DHA (4–6 g/d), to treat patients with severe SARS-CoV-2, in order to inhibit cytokine secretion and mitigate the inflammatory response (Bistrian, 2020).
T452 57508-57897 Sentence denotes In agreement with this idea, Torrinhas et al. suggested the immune modulatory properties of n-3 PUFAs will provide important and beneficial effects to improve clinical outcomes of COVID-19 particularly in hospitalized high-risk populations with severe underlying conditions including the elderly, obese, hypertensive, oncologic and diabetic patients (Torrinhas, Calder, & Waitzberg, 2020).
T453 57898-58166 Sentence denotes Furthermore, they suggested n-3 PUFAs could provide additional benefits by attenuating the aggravated inflammatory state observed with pre-existing health conditions which might have a role in triggering detrimental outcomes associated with severe COVID-19 phenotypes.
T454 58167-58351 Sentence denotes Currently, there is an open-label, randomized control study to investigate the effect of n-3 PUFAs in hospitalized subjects with confirmed SARS-CoV-2 (NCT04335032) (NCT04335032, 2020).
T455 58352-58494 Sentence denotes The study comprises 240 participants, with one group receiving standard care, the other additionally being provided 2 g daily of EPA capsules.
T456 58495-58764 Sentence denotes Interventions will be carried out between 28 and 90 days and the efficacy of EPA in the treatment of the disease, oxygen saturation, levels of pro-inflammatory IL-6, mortality rate, ICU stays, hospitalization days and need for mechanical ventilation will be determined.
T457 58765-59006 Sentence denotes While the results from this study are not available, the evidence suggests oral or intravenous administration of bioactive lipids could potentially reduce the severity and/or enhance the recovery of those infected with COVID-19 (Das, 2020a).
T458 59007-59057 Sentence denotes However, further research is undoubtedly required.
T459 59059-59120 Sentence denotes 7 Cardiovascular benefits of n-3 polyunsaturated fatty acids
T460 59121-59430 Sentence denotes N-3 PUFAs and many of the their endogenously generated metabolites act as bioactive lipid molecules with a wide array of properties against numerous disorders including CVD (Lordan, Redfern, Tsoupras, & Zabetakis, 2020; Lordan, Tsoupras, & Zabetakis, 2017; Moro, Nagahashi, Ramanathan, Takabe, & Wakai, 2016).
T461 59431-59714 Sentence denotes Numerous studies have suggested higher consumption of n-3 PUFAs lowers the number of mortalities related to CVD (Darwesh, Sosnowski, Lee, Keshavarz-Bahaghighat, & Seubert, 2019; Kris-Etherton, Harris, Appel, & Nutrition, 2003; Lee, O'Keefe, Lavie, & Harris, 2009; Mozaffarian, 2007).
T462 59715-59981 Sentence denotes For instance, Mozaffarian et al. demonstrated higher plasma levels of n-3 PUFA biomarkers in a U.S. adults cohort study was associated with lower total mortality attributable with fewer cardiovascular compared to non-cardiovascular deaths (Mozaffarian et al., 2013).
T463 59982-60344 Sentence denotes Currently, the intake of n-3 PUFAs is still recommended by the American Heart Association to prevent clinical CVD episodes in individuals with predominant coronary heart disease, such as a recent MI, to reduce death rates as well as individuals with prevalent HF to reduce hospitalizations and number of mortalities (Sacks et al., 2017; Siscovick, et al., 2017).
T464 60345-60490 Sentence denotes The cardiovascular benefits of n-3 PUFAs could be attributed to their pleiotropic effects on the different elements of the cardiovascular system.
T465 60491-60778 Sentence denotes Evidence suggests a higher intake of n-3 PUFAs has a beneficial effect on lipid profiles by replacing saturated fatty acids and lowering triglyceride levels, thereby stabilizing atherosclerotic plaques and reducing the incidence of thrombus formation (Plutzky, 1999; Thies et al., 2003).
T466 60779-61245 Sentence denotes Furthermore, n-3 PUFAs can enrich cell membranes and alter the lipid raft structure and function leading to improved organelle and cellular function (Din et al., 2008), autonomic tone (Abuissa, O'Keefe Jr., Harris, & Lavie, 2005; O'Keefe Jr., Abuissa, Sastre, Steinhaus, & Harris, 2006), elevated arrhythmic thresholds (Anand, Alkadri, Lavie, & Milani, 2008) and ameliorating hypertension (Geleijnse, Giltay, Grobbee, Donders, & Kok, 2002; O'Keefe Jr. et al., 2006).
T467 61246-61458 Sentence denotes Importantly, several experimental, clinical and epidemiological studies hypothesize that the cardioprotective effects of n-3 PUFAs and their metabolites are attributed mainly to their immunomodulatory properties.
T468 61459-61681 Sentence denotes Notably, emerging evidence demonstrates the ability of n-3 PUFAs to reduce circulating levels of inflammatory chemokines, cytokines, and the pro-inflammatory metabolites derived from n-6 PUFAs (Calder, 2013, Calder, 2017).
T469 61683-61763 Sentence denotes 8 Potential cardioprotective mechanisms of n-3 PUFAs in the setting of COVID-19
T470 61764-61924 Sentence denotes Based on several clinical reports, COVID-19 patients with severe ALI/ARDS may also suffer from increased risk of sepsis and cardiac arrest (Huang et al., 2020).
T471 61925-62133 Sentence denotes Accumulating reports have indicated that n-3 PUFAs could improve resolution of inflammation, sepsis survival and precondition the heart against septic cardiomyopathy (Korner et al., 2018; Leger et al., 2019).
T472 62134-62390 Sentence denotes In this review, we propose that n-3 PUFAs can protect against and ameliorate cardiovascular complications associated with COVID-19 mainly due to their immunomodulatory features, antioxidant potential as well as their ability to maintain tissue homeostasis.
T473 62391-62647 Sentence denotes This section will highlight the cardioprotective mechanisms of n-3 PUFAs and their metabolites hypothesizing how n-3 PUFAs might have a supportive adjuvant utility in treating and protecting against cardiac complications associated with COVID-19 (Fig. 2 ).
T474 62648-63646 Sentence denotes Fig. 2 Potential cardioprotective mechanisms of n-3 PUFAs in the setting of COVID-19. (A) N-3 PUFAs ameliorate uncontrolled immune responses and exert anti-inflammatory effects via several mechanisms. (B) N-3 PUFAs attenuate the vicious cycle/interaction of mitochondrial dysfunction and aggravated immune response. (C) N-3 PUFAs have the capability to attenuate viral infections via both direct effects on membrane integrity and indirect mechanisms through activating the humoral response to decrease overall viral load. (D) N-3 PUFAs have the ability to regulate the RAAS system in the favor of the vasodilatory, the anti-inflammatory and the cardioprotective ACE2/Ang (1–7) effectors. (E) N-3 PUFAs enhance antioxidant capacity and attenuate oxidative stress in the tissue. (F) N-3 PUFAs ameliorate coagulopathy by exerting anti-thrombotic effects. (G) The triglyceride-lowering effect of n-3 PUFAs may play a key role in blunting the exaggerated inflammation observed in patients with COVID-19.
T475 63647-63906 Sentence denotes ACE, Angiotensin-converting enzyme; Ang, Angiotensin; CRP, C-reactive protein; IL, Interleukin; mtDNA, Mitochondrial DNA; PUFA, Poly unsaturated fatty acid; ROS, Reactive oxygen species; TGs, Triglycerides; TNF-α, Tumor necrosis factor alpha; TX, Thromboxane.
T476 63908-63958 Sentence denotes 8.1 The anti-inflammatory properties of n-3 PUFAs
T477 63959-64150 Sentence denotes As mentioned earlier, an exacerbated immune system response and uncontrolled inflammation are fundamental mechanisms in the development of cardiovascular impairment in patients with COVID-19.
T478 64151-64416 Sentence denotes Accordingly, a plethora of experimental studies and clinical trials demonstrate that targeting different inflammatory components may be considered promising strategies to control cardiovascular impairment during the acute and remission phases of COVID-19 (Fig. 3 ).
T479 64417-64935 Sentence denotes Fig. 3 A summary of the anti-inflammatory mechanisms of n-3 PUFAs. (A) N-3 PUFAs can regulate expression of inflammatory cytokines, chemokines and adhesion molecules, inhibit NLRP3 inflammasomes, activate anti-inflammatory transcription factors (PPARα/γ) and activate GPR120 receptors which inhibit TLR4-mediated activation of NF-κB. (B) N-3 PUFAs are metabolized by COX/5-LOX into 5-series LTs which exert anti-inflammatory effects. (C) N-3 PUFAs can replace n-6 PUFAs, such as AA, altering the inflammatory response.
T480 64936-65242 Sentence denotes N-3 PUFA will alter cell membrane composition, fluidity and mediated signaling. (D) N-3 PUFAs, DHA and EPA, are metabolized by CYP epoxygenases into bioactive epoxylipids with anti-inflammatory properties. (E) N-3 PUFAs are metabolized by COX/LOX into SPMs which act as potent anti-inflammatory modulators.
T481 65243-65935 Sentence denotes AA, Arachidonic acid; CCL, Chemokine ligand; COX, Cyclooxygenase; CYP, Cytochrome P450; DHA, Docosahexaenoic acid; EDP, Epoxydocosapentaenoic acid; EEQ, Epoxyeicosatetraenoic acid; EPA, Eicosapentaenoic acid; GRP, G-protein coupled receptor; IL, Interleukin; LOX, Lipoxygenase; LT, Leukotriene; PUFA, Poly unsaturated fatty acid; NFκB, Nuclear factor kappa-light-chain enhancer activated B-cells; NLRP3, NACHT, LRR and PYD domains-containing protein 3; PLA2, Phospholipase A2; PMN, Polymorphonuclear neutrophils; PPAR, Peroxisome proliferator-activated receptor; ROS, Reactive oxygen species; SPMs, Specialized pro-resolving mediators; TLR, Toll like receptor; TNF-α, Tumor necrosis factor-α.
T482 65937-66062 Sentence denotes 8.1.1 N-3 PUFAs regulate the expression of several proinflammatory innate immune components and modulate macrophage response
T483 66063-66309 Sentence denotes A ‘cytokine storm’ and activation of the central innate immune pathway linking the NLRP3 inflammasome, IL-1β, TNF-α and IL-6 response is a primary cause of excessive inflammation reported in COVID-19 that negatively impacts cardiovascular system.
T484 66310-66459 Sentence denotes Therefore, targeting the different components is a promising approach to ameliorate cardiac complications secondary to COVID-19 (Huang et al., 2020).
T485 66460-66765 Sentence denotes While there is no direct clinical evidence related to the use of n-3 PUFAs in COVID-19 patients, the application of n-3 PUFAs in several inflammatory settings, including cardiovascular disorders, has been demonstrated to ameliorate detrimental immune reactions by several mechanisms (Rogero et al., 2020).
T486 66766-66984 Sentence denotes The anti-inflammatory effect of n-3 PUFAs seems to be consistent across several previous clinical findings (Calder, Carr, Gombart, & Eggersdorfer, 2020; Fritsche, 2006; Kiecolt-Glaser et al., 2012; Vedin et al., 2008).
T487 66985-67422 Sentence denotes Intriguingly, Tan et al. recently demonstrated in a randomized controlled study that high-dose n-3 PUFA supplementation (1.5 g/day EPA and 1.0 g/day DHA) markedly reduces plasma levels of IL-6, IL-1β and TNF-α after 4 weeks of therapy in middle or late-aged patients with chronic venous leg ulcers suggesting n-3 PUFAs as an effective low-risk dietary intervention to modulate inflammation (Tan, Sullenbarger, Prakash, & McDaniel, 2018).
T488 67423-67563 Sentence denotes This study indicates that n-3 PUFAs could have direct modulatory effects on the main components of the cytokine storm IL-6, IL-1β and TNF-α.
T489 67564-67952 Sentence denotes N-3 PUFAs can modulate the transcription and expression of inflammatory genes including cytokines, chemokines and adhesion molecules in cardiomyocytes, fibroblasts, endothelial cells, monocytes and macrophages (Collie-Duguid & Wahle, 1996; De Caterina, Cybulsky, Clinton, Gimbrone, & Libby, 1994; Hughes, Southon, & Pinder, 1996; Miles, Wallace, & Calder, 2000; Sanderson & Calder, 1998).
T490 67953-68341 Sentence denotes This is primarily achieved through the regulation of key transcription factors, such as inhibiting NF-κB (Kumar, Takada, Boriek, & Aggarwal, 2004; Lo, Chiu, Fu, Lo, & Helton, 1999; Novak, Babcock, Jho, Helton, & Espat, 2003; Zhao, Joshi-Barve, Barve, & Chen, 2004) or activating peroxisome proliferator-activated receptors-α/γ (PPARα/γ) (Gani & Sylte, 2008; Zapata-Gonzalez et al., 2008).
T491 68342-68637 Sentence denotes Activation of PPARα/γ can directly interfere with the activation of NF-κB and prevent its shuttling to the nucleus reducing the inflammatory burst (Matsumoto et al., 2008; Mishra, Chaudhary, & Sethi, 2004; Poynter & Daynes, 1998; Ricote, Huang, Welch, & Glass, 1999; Vanden Berghe et al., 2003).
T492 68638-68903 Sentence denotes Interestingly, direct activation of PPAR, using PPAR agonists, was proposed as a therapeutic target for blunting and regulating cytokine storm in COVID-19 patients suggesting n-3 PUFAs could have a promising effect (Ciavarella, Motta, Valente, & Pasquinelli, 2020).
T493 68904-69099 Sentence denotes Another important immunomodulatory mechanism induced by n-3 PUFAs involves activation of G protein-coupled receptor 120 (GPR120), which mediates strong and wide-ranging anti-inflammatory effects.
T494 69100-69283 Sentence denotes Research from Oh et al. indicates n-3 PUFAs stimulate GPR120 in both monocytic RAW 264.7 cells and primary intraperitoneal macrophages inhibiting TLR4-mediated inflammatory responses.
T495 69284-69391 Sentence denotes Knockdown of GPR120 attenuates the protective effects attributed to n-3 PUFA consumption (Oh et al., 2010).
T496 69392-69520 Sentence denotes These studies together provide evidence that n-3 PUFAs mediate anti-inflammatory effects through different mechanistic pathways.
T497 69521-69680 Sentence denotes Cardiac macrophages are primarily derived and replenished from inflammatory monocytes in response to an infection with resident macrophages also having a role.
T498 69681-69817 Sentence denotes Briefly, macrophages will differentiate into classical M1 inflammatory cells to clean cellular and matrix debris (Epelman et al., 2014).
T499 69818-70052 Sentence denotes Subsequently, M1 macrophages may undergo polarization and transformation to the alternatively activated or reparatory M2 stage which secrete IL-10 to promote resolution and contribute to wound healing and tissue repair (Murray, 2017).
T500 70053-70351 Sentence denotes Controlling the migration and the polarization of macrophages to the myocardium in the context of COVID-19 is a tentative approach to limit cardiac injury (Frantz & Nahrendorf, 2014; Fujiu, Wang, & Nagai, 2014; Leblond et al., 2015; van Amerongen, Harmsen, van Rooijen, Petersen, & van Luyn, 2007).
T501 70352-70495 Sentence denotes In COVID-19, an excessive cardiac recruitment and accumulation of pro-inflammatory M1 macrophages potentially aggravates cardiovascular injury.
T502 70496-70694 Sentence denotes Notably, as M1 macrophages secrete a large variety of chemokines and cytokines such as TNF-α and IL-1β to recruit and activate other immune cells from both the innate and the adaptive immune system.
T503 70695-70926 Sentence denotes The effect will impede the reparative phase mediated by M2 macrophages and thus aggravates adverse cardiac remodeling (Dewald et al., 2005; Gordon, Pluddemann, & Martinez Estrada, 2014; Murray & Wynn, 2011; ter Horst et al., 2015).
T504 70927-71219 Sentence denotes Interestingly, evidence demonstrates n-3 PUFAs and/or their biologically active metabolites have the ability to blunt the expression, production and release of IL-1β, TNF-α, and IL-6 by M1 macrophages (Allam-Ndoul, Guenard, Barbier, & Vohl, 2017; Liu et al., 2014; Mildenberger et al., 2017).
T505 71220-71515 Sentence denotes Schoeniger et al., showed n-3 PUFAs have the ability to down-regulate inflammatory processes and reduce the production and secretion of pro-inflammatory cytokines from RAW 264.7 macrophages infected with microorganisms, R. equi and P. aeruginosa (Schoeniger, Adolph, Fuhrmann, & Schumann, 2011).
T506 71516-71763 Sentence denotes Moreover, the inhibitory effects of EPA and DHA on the pro-inflammatory NLRP3 inflammasome pathway has also been well-documented in macrophage cell lines as well as in primary human and mouse macrophages (Iverson et al., 2018; Kumar et al., 2016).
T507 71764-71943 Sentence denotes Kumar et al., investigated the effects of 15-lipoxygenase (LOX) metabolites of ALA on lipopolysaccharide (LPS) -induced inflammation in RAW 264.7 cells and peritoneal macrophages.
T508 71944-72120 Sentence denotes The findings revealed the anti-inflammatory effects of these metabolites involve inactivation of the NLRP3 inflammasome complex through the PPAR-γ pathway (Kumar et al., 2016).
T509 72121-72448 Sentence denotes N-3 PUFAs can increase the phagocytic capacity of macrophages, which has been shown through the engulfment of zymosan particles (Chang, Lee, Kim, & Surh, 2015), Pseudomonas aeruginosa, Rhodococcus equi (Adolph, Fuhrmann, & Schumann, 2012), E.coli (Davidson, Kerr, Guy, & Rotondo, 1998) and apoptotic cells (Chang et al., 2015).
T510 72449-72775 Sentence denotes It has been suggested the increase in phagocytic capacity of macrophages upon n-3 PUFA treatment could be attributed to changes in the cellular membrane composition and structure caused by the incorporation of the n-3 PUFAs (Hellwing, Tigistu-Sahle, Fuhrmann, Kakela, & Schumann, 2018; Schoeniger, Fuhrmann, & Schumann, 2016).
T511 72776-73015 Sentence denotes Importantly, n-3 PUFAs have been found to promote M2 polarization in macrophage cell lines and primary mouse macrophages enhancing resolution of inflammation and tissue repair after infection (Chang et al., 2015; Ohue-Kitano et al., 2018).
T512 73016-73275 Sentence denotes Collectively, the modulatory properties of n-3 PUFAs on the immune system could impart a promising beneficial effect on the cardiovascular system in the context of COVID-19, an effect which needs further exploration and confirmation in larger clinical trials.
T513 73277-73363 Sentence denotes 8.1.2 Shifting to the anti-inflammatory COX- and LOX-derived metabolites of n-3 PUFAs
T514 73364-73631 Sentence denotes Accumulating literature demonstrates potent immunomodulatory properties of metabolites generated from n-3 PUFAs and consequently their impact on cardiovascular health (Jamieson, Endo, Darwesh, Samokhvalov, & Seubert, 2017; Schunck, Konkel, Fischer, & Weylandt, 2018).
T515 73632-73846 Sentence denotes The metabolism of n-3 and n-6 PUFAs is closely interconnected as parent compounds compete for the same metabolic enzymes but result in the production of a wide array of either pro- or anti-inflammatory metabolites.
T516 73847-74123 Sentence denotes For example, cyclooxygenase (COX) converts the n-6 PUFA arachidonic acid (AA) to the 2-series of prostaglandins (PGs) and the 2-series of thromboxanes (TX), while lipoxygenase (LOX) enzymes metabolize AA to the 4-series leukotrienes (LTs) and the hydroxyicosatetraenoic acids.
T517 74124-74336 Sentence denotes These lipid mediators are considered pro-inflammatory and are involved in various pathological processes including cardiovascular disorders (Innes & Calder, 2018; Kalinski, 2012; Lewis, Austen, & Soberman, 1990).
T518 74337-74473 Sentence denotes The synthesis and production of PGE2 occurs in several cells, including dendritic cells, macrophages, fibroblasts and endothelial cells.
T519 74474-74740 Sentence denotes PGE2 not only mediates vasodilation, endothelial permeability and increase of pain (Ricciotti & FitzGerald, 2011) but also contributes to the tissue influx of neutrophils, mast cells and macrophages and can affect the differentiation of these cells (Kalinski, 2012).
T520 74741-75080 Sentence denotes N-3 PUFAs can also act as a substrate for COX and 5-LOX enzymes resulting in production of the 3-series of PGs and TxAs as well as 5-series LTs, which are a set of less inflammatory or even anti-inflammatory metabolites in comparison to the metabolite family derived from AA (Corey, Shih, & Cashman, 1983; Lee et al., 1984; Surette, 2008).
T521 75081-75279 Sentence denotes These eicosanoids are responsible for producing several physiological responses related to inflammation, and their imbalance has been observed in several diseases (Calder, 2006; Falck et al., 2011).
T522 75280-75547 Sentence denotes For example, the production of PGE2 and LTB4 by human inflammatory cells was significantly decreased in a diet rich in fish oil (Caughey, Mantzioris, Gibson, Cleland, & James, 1996; Lee et al., 1985; Prescott, 1984; von Schacky, Kiefl, Jendraschak, & Kaminski, 1993).
T523 75548-75855 Sentence denotes Therefore, the metabolism of n-3 PUFAs by COX and LOX enzymes not only reduce the AA-derived pro-inflammatory metabolites but also alter the metabolic profile towards more biologically active anti-inflammatory mediators (Goldman, Pickett, & Goetzl, 1983; Lee et al., 1984; Lee, Mencia-Huerta, et al., 1984).
T524 75856-76025 Sentence denotes This may represent one of the central anti-inflammatory and consequently cardioprotective mechanisms of n-3 PUFAs against cardiac complications associated with COVID-19.
T525 76027-76128 Sentence denotes 8.1.3 Anti-inflammatory features of the n-3 PUFAs-derived specialized pro-resolving mediators (SPMs)
T526 76129-76477 Sentence denotes Metabolism of n-3 PUFAs also generates another group of highly specialized pro-resolving mediators (SPMs) which include resolvins ‘resolution phase interaction products’ produced from both EPA (E-series, RvE1-2) and DHA (D-series, RvD1-6) as well as protectins and maresins produced from DHA (Serhan et al., 2002; Serhan, Chiang, & Van Dyke, 2008).
T527 76478-76677 Sentence denotes Both the COX and LOX pathways are involved in the synthesis of these metabolites with distinct epimers being produced in the presence and absence of aspirin (Mas, Croft, Zahra, Barden, & Mori, 2012).
T528 76678-77020 Sentence denotes SPMs possess potent anti-inflammatory and inflammation resolving properties which is essential to terminate ongoing inflammatory processes, accelerate the cleaning process and aid in tissue regeneration and wound healing allowing tissue homeostasis to return (Serhan et al., 2000; Serhan et al., 2002; Spite et al., 2009; Titos et al., 2011).
T529 77021-77132 Sentence denotes Several mechanistic pathways contribute to the anti-inflammatory effects of resolvins, protectins and maresins.
T530 77133-77391 Sentence denotes This includes preventing the migration of neutrophils and monocytes across epithelial cells and promoting clearance of polymorphonuclear (PMNs) leukocytes, apoptotic cells and debris from the site of inflammation (Campbell et al., 2007; Serhan et al., 2002).
T531 77392-77647 Sentence denotes Krishnamoorthy et al. showed resolvins inhibit tissue migration of neutrophils by lowering the expression of surface adhesion receptors on neutrophils, such as CD11b or CD18, and reducing the production of the chemokine IL-8 (Krishnamoorthy et al., 2010).
T532 77648-77917 Sentence denotes Additionally, the partial agonist/antagonist activity of RvE1 toward LTB4 receptors on PMNs will inhibit NF-κB activation, abolish pro-inflammatory cytokine production and reduce PMN leukocyte infiltration (Arita et al., 2007; Serhan et al., 2002; Serhan et al., 2008).
T533 77918-78191 Sentence denotes Resolvins can blunt reactive oxygen species (ROS) production from neutrophils, induce neutrophil apoptosis and clearance by macrophages, as well contribute to inhibiting chemokine signaling (Ariel et al., 2006; Schwab, Chiang, Arita, & Serhan, 2007; Serhan & Chiang, 2004).
T534 78192-78496 Sentence denotes Furthermore, Morin et al. demonstrated a diet enriched with DHA and monoglycerides can significantly increase the levels of RvD2 and RvD3, which correlate with reduced levels of proinflammatory mediators CRP, IL-6, TNF-α, and IL-1β in a rat model of hypertension (Morin, Rousseau, Blier, & Fortin, 2015).
T535 78497-78598 Sentence denotes Additionally, there is growing evidence for a role of SPMs in regulating the humoral immune response.
T536 78599-78924 Sentence denotes A study conducted by Ramon et al., showed 17-hydroxydocosahexaenoic acid (17-HDHA), the precursor of the D-series SPMs (RvD1, 17R-RvD1, RvD2), can reduce IL-6 secretion in human B cells, increase B cell antibody production and promote B cell differentiation to an antibody secreting cell (Ramon, Gao, Serhan, & Phipps, 2012).
T537 78925-79128 Sentence denotes These new findings highlight the potential applications of SPMs as non-toxic, supportive adjuvants and as anti-inflammatory therapeutic molecules particularly during infection as in the case of COVID-19.
T538 79129-79223 Sentence denotes Resolvins, protectins and maresins play a pivotal role regulating the function of macrophages.
T539 79224-79401 Sentence denotes Sulciner et al. demonstrates RvD1, RvD2 or RvE1 can inhibit debris-stimulated cancer progression by enhancing clearance of debris via macrophage phagocytosis in multiple tumors.
T540 79402-79637 Sentence denotes These resolvins suppressed the release of the proinflammatory cytokines/chemokines, including TNFα, IL-6, IL-8, chemokine ligand 4, and chemokine ligand 5, by human macrophages cocultured with tumor cell debris (Sulciner et al., 2018).
T541 79638-79825 Sentence denotes Maresins are conjugates of sulfides synthetized by macrophages, which are also participants in acute inflammation resolution and seem to promote tissue regeneration (Serhan et al., 2009).
T542 79826-80048 Sentence denotes Maresin-1 biosynthesis involves an active intermediate (13S,14S-epoxi-DHA) that stimulates macrophage conversion from M1 (pro-inflammatory) to M2 (anti-inflammatory) phenotype (Dalli, Ramon, Norris, Colas, & Serhan, 2015).
T543 80049-80476 Sentence denotes It is noteworthy that M2 macrophages secrete resolvins, protectins and maresins to dampen inflammation and restore homeostasis (Bouchery & Harris, 2017; Ramon et al., 2016) and at the same time augment phagocytic capacity of macrophages and other cells to remove debris from the site(s) of infection and injury and enhance microbial clearance (Dalli et al., 2013; Norris et al., 2018; Poorani, Bhatt, Dwarakanath, & Das, 2016).
T544 80477-80684 Sentence denotes The role of resolvins in the resolution of inflammation has been demonstrated in several animal models of ALI and ARDS (Gao et al., 2017; Uddin & Levy, 2011; Wang, Yan, Hao, & Jin, 2018; Zhang et al., 2019).
T545 80685-81049 Sentence denotes These studies carried out using rat and mouse models infected with the E.coli endotoxin, LPS, suggested the pro-resolving effects of these molecules could be attributed, for example, to the suppression of neutrophil infiltration due to reduced expression and release of pro-inflammatory cytokines from alveolar macrophages (Uddin & Levy, 2011; Zhang et al., 2019).
T546 81050-81269 Sentence denotes Further, it has been demonstrated protectins may reduce the replication of influenza (Morita et al., 2013) and potentially affect the inflammatory manifestations of respiratory viral diseases (Russell & Schwarze, 2014).
T547 81270-81474 Sentence denotes Importantly, pro-inflammatory cytokines, TNF-α and IL-6, will inhibit the activities of desaturases, which are essential for the generation of AA, EPA and DHA from their precursors LA and ALA (Das, 2013).
T548 81475-81747 Sentence denotes Hence, in instances where there is a substantial degree of inflammation due to high levels of IL-6 and TNF-α, such as following COVID-19 infection, a deficiency of EPA and DHA and subsequent decreased generation of resolvins, protectins and maresins can occur (Das, 2018).
T549 81748-81986 Sentence denotes Thus, administration of PUFAs and/or their metabolites, resolvins, protectins and maresins can suppress inappropriate production of IL-6 and TNF-α to resolve inflammation, enhance recovery and limit cytokine storm (Das, 2019) in COVID-19.
T550 81987-82164 Sentence denotes Together, the studies imply administration of n-3 PUFA may enhance recovery from infections and further, if present in adequate amounts, may modulate the response to infections.
T551 82166-82234 Sentence denotes 8.1.4 Role of CYP-mediated metabolites in ameliorating inflammation
T552 82235-82651 Sentence denotes CYP2J and CYP2C isoforms, the constitutively expressed cytochrome P450 (CYP) epoxygenases found in the cardiovascular system, metabolize EPA into 5 regioisomeric epoxyeicosatetraenoic acids (5,6-, 8,9-, 11,12-, 14,15-, 17,18-EEQ) and DHA into 6 regioisomeric epoxydocosapentaenoic acids (4,5-, 7,8-, 10,11-, 13,14-, 16,17-, 19,20-EDP) (Arnold et al., 2010; Konkel & Schunck, 2011; Westphal, Konkel, & Schunck, 2015).
T553 82652-82865 Sentence denotes Recent evidence suggests that 17,18-EEQ and 19,20-EDP mediate several anti-inflammatory effects of n-3 PUFAs in various models of tissue injury (Arnold et al., 2010; Ulu et al., 2014; Wang, Chai, Lu, & Lee, 2011).
T554 82866-83200 Sentence denotes For example, Fang et al. demonstrated a n-3 PUFA-rich diet attenuates MI injury in mice by producing a protective eicosanoid pattern, which results in shifting the metabolite profile to a more anti-inflammatory state by increasing the levels of the 19,20-EDP and 17,18-EEQ and decreasing the pro-inflammatory PGE2 (Fang et al., 2018).
T555 83201-83388 Sentence denotes The cardioprotective effects of n-3 PUFAs are also attributed to their ability to attenuate the NLRP3 inflammasome complex cascade (Darwesh, Jamieson, Wang, Samokhvalov, & Seubert, 2019).
T556 83389-83504 Sentence denotes Importantly, the anti-inflammatory features of CYP-derived epoxy metabolites have been reported in numerous models.
T557 83505-83824 Sentence denotes For example, in TNFα-induced retinal vascular inflammation, Capozzi et al. demonstrated 19,20-EDP can ameliorate vascular adhesion molecule and intracellular adhesion molecule expression and reduce leukocyte adherence to human retinal microvascular endothelial cell monolayers (Capozzi, Hammer, McCollum, & Penn, 2016).
T558 83825-84058 Sentence denotes Additionally, evidence demonstrates intraperitoneal infusions of 17,18-EEQ and 19,20-EDP protect against allergic intestinal inflammation and kidney fibrosis in corresponding mouse models (Kunisawa et al., 2015; Sharma et al., 2016).
T559 84059-84323 Sentence denotes 17,18-EEQ was able to inhibit TNFα-induced inflammation in human lung tissue obtained from patients undergoing surgery for lung carcinoma via inhibition of NF-κB and activation of the transcription factor PPAR-γ (Morin, Sirois, Echave, Albadine, & Rousseau, 2010).
T560 84324-84442 Sentence denotes The anti-inflammatory properties of DHA epoxides were also well demonstrated using animal models of inflammatory pain.
T561 84443-84688 Sentence denotes For example, Morisseau et al. demonstrated that direct injection of the DHA epoxides, EDPs, together with the pro-inflammatory carrageenan into the paw or spinal cord of male Sprague-Dawley rats resulted in significant antihyperalgesic activity.
T562 84689-84917 Sentence denotes Surprisingly, both the parent free fatty acid DHA and the corresponding diols were inactive, supporting the hypothesis that the epoxylipids mediate many of the beneficial effects of the parent compounds (Morisseau et al., 2010).
T563 84918-85057 Sentence denotes The bacterial endotoxin, LPS, has a marked role in triggering inflammatory injury which can result in several cardiovascular complications.
T564 85058-85335 Sentence denotes In a study using HL-1 cardiac cells, 19,20-EDP protected against LPS-stimulated inflammatory injury by activating the histone deacetylase Sirtuin-1 inhibiting the activation the pro-inflammatory transcription factor NF-κB (Samokhvalov, Jamieson, Vriend, Quan, & Seubert, 2015).
T565 85336-85542 Sentence denotes The accumulating evidence suggests the anti-inflammatory properties of CYP-epoxygenase metabolites of n-3 PUFAs have a substantial role in activating protective responses in models of cardiovascular injury.
T566 85543-85693 Sentence denotes However, further investigation is required to elucidate whether the protective properties limit cardiovascular injury secondary to COVID-19 infection.
T567 85695-85785 Sentence denotes 8.1.5 N-3 PUFAs alter cell membrane structure and function - modulation of the lipid raft
T568 85786-86026 Sentence denotes Within a cell, n-3 PUFAs can be found incorporated into phospholipid membranes where elevating levels will replace existing n-6 PUFAs thereby altering the composition and properties of lipid rafts (Lordan et al., 2017; Lordan et al., 2020).
T569 86027-86201 Sentence denotes The increased incorporation of n-3 PUFAs into membrane bilayers can have a role in mediating immunomodulatory effects by altering membrane composition, fluidity and function.
T570 86202-86394 Sentence denotes These changes will impact membrane-mediated signaling, protein trafficking, generation of bioactive lipids, cytokine secretion and gene activation in both innate and adaptive immune responses.
T571 86395-86605 Sentence denotes For example, a change in fluidity can interfere with the dimerization and expression of the TLR4 subunits, blocking the downstream inflammatory reaction (Ciesielska & Kwiatkowska, 2015; Takashima et al., 2016).
T572 86606-86971 Sentence denotes Evidence of these effects by n-3 PUFAs have been demonstrated to impact the maturation of dendritic cells, macrophage function and T and B cell polarization/activation (Katagiri, Kiyokawa, & Fujimoto, 2001; Kim et al., 2010; McMurray, Bonilla, & Chapkin, 2011; Rockett, Salameh, Carraway, Morrison, & Shaikh, 2010; Shaikh and Edidin, 2006, Shaikh and Edidin, 2008).
T573 86972-87217 Sentence denotes Interestingly, DHA appears to be better than EPA in replacing n-6 PUFAs and cholesterol in plasma membranes of aortic endothelial cells enhancing the fluidity of the phospholipid membrane (Hashimoto, Hossain, Yamasaki, Yazawa, & Masumura, 1999).
T574 87218-87352 Sentence denotes In most cell types, AA is the predominant n-6 PUFA in membrane phospholipids (Yaqoob, Pala, Cortina-Borja, Newsholme, & Calder, 2000).
T575 87353-87492 Sentence denotes Inflammatory immune cells such as monocytes, neutrophils, macrophages and lymphocytes often contain a large amount of AA in their membrane.
T576 87493-87576 Sentence denotes The high membrane AA composition is important during normal inflammatory responses.
T577 87577-87844 Sentence denotes Under stress conditions activation of phospholipase A2 liberates AA from the cell membrane leading to metabolism and production of many pro-inflammatory metabolites (Ford, Hazen, Saffitz, & Gross, 1991; Hazen, Ford, & Gross, 1991; Leslie, 2015; Mancuso et al., 2003).
T578 87845-88211 Sentence denotes Supplementation with n-3 PUFAs leads to the substitution of AA with EPA and DHA in the cell membrane which can alter immune cell reaction in response to stress stimuli by shifting the metabolic profile to less proinflammatory or even anti-inflammatory metabolite predominance (Brouard & Pascaud, 1990; Faber et al., 2011; Gibney & Hunter, 1993; Grando et al., 2009).
T579 88212-88412 Sentence denotes Therefore, increasing n-3 PUFAs, such as EPA and DHA, in the phospholipids has a potential benefit of ameliorating detrimental effects during uncontrolled inflammatory responses (Lordan et al., 2020).
T580 88414-88519 Sentence denotes 8.2 N-3 PUFAs have the potential to ameliorate mitochondrial dysfunction in the pathogenesis of COVID-19
T581 88520-88820 Sentence denotes Under normal physiological conditions, it is essential for all body organs and physiological systems, particularly the cardiovascular system, to maintain a large number of functional mitochondria to provide energy, as well as preserve and regulate different cellular functions (Murphy, et al., 2016).
T582 88821-89181 Sentence denotes Maintaining a healthy pool of mitochondria depends upon a delicate balance between the formation of newly generated mitochondria termed as “mitochondrial biogenesis”, to meet the increased energy demand, and the efficient elimination of irreversibly damaged mitochondria through mitophagy (Bayeva, Gheorghiade, & Ardehali, 2013; Meyers, Basha, & Koenig, 2013).
T583 89182-89493 Sentence denotes Mitochondrial damage, decreased biogenesis and impaired mitophagy has been implicated in several pathologies including diabetes, CVDs, aging, as well as viral and bacterial infections (Cho, Kim, & Jo, 2020; Kim, Ahn, Syed, & Siddiqui, 2018; Rovira-Llopis et al., 2017; Srivastava, 2017; Wu, Zhang, & Ren, 2019).
T584 89494-89840 Sentence denotes While the intrinsic mechanism(s) involved in the pathogenesis of cardiovascular insult secondary to COVID-19 are not fully understood, altered mitochondrial homeostasis could be a major contributing factor (Grivennikova, Kareyeva, & Vinogradov, 2010; Melser, Lavie, & Benard, 2015; Murphy, et al., 2016; Saleh, Peyssonnaux, Singh, & Edeas, 2020).
T585 89841-90042 Sentence denotes Notably, symptoms such as sleep and appetite disturbance, loss of energy, fatigue and muscle weakness, observed in COVID-19 patients, are cardinal signs of mitochondrial distress (Filler et al., 2014).
T586 90043-90167 Sentence denotes Recent studies identified a level of interaction or interplay between mitochondria and innate immune inflammatory responses.
T587 90168-90367 Sentence denotes Mitochondrial dysfunction is considered both a trigger and target of uncontrolled inflammatory responses (Gurung, Lukens, & Kanneganti, 2015; Mohanty, Tiwari-Pandey, & Pandey, 2019; Yu et al., 2014).
T588 90368-90695 Sentence denotes As such, this implicates the potential role of impaired mitochondrial homeostasis in the aggravation of cardiovascular injury secondary to COVID-19 (Darwesh, Jamieson, et al., 2019; Darwesh, Keshavarz-Bahaghighat, Jamieson, & Seubert, 2019; Keshavarz-Bahaghighat, Darwesh, Sosnowski, & Seubert, 2020; Samokhvalov et al., 2018).
T589 90696-90830 Sentence denotes Inflammatory mediators are well documented to trigger several intracellular cascades that alter mitochondrial metabolism and function.
T590 90831-91123 Sentence denotes For example, the pro-inflammatory cytokines TNF-α, IL-1β and IL-6, found in the serum from COVID-19 patients, can impede mitochondrial oxidative phosphorylation, inhibit ATP production and mitochondrial ROS production exacerbating injury (Jo, Kim, Shin, & Sasakawa, 2016; Naik & Dixit, 2011).
T591 91124-91381 Sentence denotes Furthermore, IFN-γ and IL-6 can increase mitochondrial ROS production and directly affect the activity of the electron transport chain, which may cause mitochondrial membrane permeabilization, altered mitochondrial dynamics and cell death (Li et al., 2013).
T592 91382-91518 Sentence denotes Conversely, direct mitochondrial damage was found to aggravate the production of proinflammatory cytokines and worsen disease prognosis.
T593 91519-91707 Sentence denotes Briefly, the pathological changes observed in patients infected with SARS-CoV-2 such as pneumonia, hypoxia and impaired calcium homeostasis can indirectly induce mitochondrial dysfunction.
T594 91708-91989 Sentence denotes Moreover, a very recent study conducted by Singh et al. interestingly showed both RNA and RNA transcripts of SARS-CoV-2 can directly target and localize to mitochondria hijacking the host cell's mitochondrial function to viral advantage (Singh, Chaubey, Chen, & Suravajhala, 2020).
T595 91990-92136 Sentence denotes Subsequently, SARS-CoV-2 will manipulate the host cell's mitochondrial function to evade removal and facilitate virus replication and progression.
T596 92137-92662 Sentence denotes These effects lead to the release of mitochondrial DNA and ROS in the cytosol (Herst, Rowe, Carson, & Berridge, 2017; Kozlov, Lancaster Jr., Meszaros, & Weidinger, 2017; Mittal, Siddiqui, Tran, Reddy, & Malik, 2014; Starkov, 2008; Twig & Shirihai, 2011; West et al., 2015), which drives the activation and release of central pro-inflammatory cytokines such as NLRP3 inflammasomes, IL-1β and IL-6 (Jo et al., 2016; Naik & Dixit, 2011; Nakahira et al., 2011; West et al., 2015), the hallmark cytokines of the COVID-19 severity.
T597 92663-92801 Sentence denotes Thus, highlighting a vicious cycle of mitochondrial damage and inflammation that has a critical role in aggravating cardiovascular injury.
T598 92802-92925 Sentence denotes Accordingly, mitochondria are considered a strategic therapeutic target to improve the outcomes in the context of COVID-19.
T599 92926-93169 Sentence denotes Numerous studies have demonstrated cardioprotective properties of n-3 PUFA, and their epoxylipid metabolites, involve an ability to preserve a healthy mitochondrial pool and attenuate exaggerated inflammatory responses under stress conditions.
T600 93170-93455 Sentence denotes For example, n-3 PUFAs could impart a cardioprotective effect via enriching mitochondrial membrane phospholipid composition, which enhances mitochondrial function promoting efficient ATP generation (Duda, O'Shea, & Stanley, 2009; Samokhvalov, Jamieson, Fedotov, Endo, & Seubert, 2016).
T601 93456-93720 Sentence denotes In a mouse model of ischemia reperfusion injury, both DHA and its epoxy metabolite, 19,20-EDP, were able to improve postischemic functional recovery by preserving mitochondrial function and attenuating NLRP3 inflammasome response (Darwesh, Jamieson, et al., 2019).
T602 93721-94006 Sentence denotes Moreover, recent data indicates a synthetic EDP analogue imparts cardioprotective effects against ischemia reperfusion injury via preservation of mitochondrial homeostasis and anti-oxidant defenses, which blunted a detrimental innate NLRP3 inflammasome response (Darwesh et al., 2020).
T603 94007-94199 Sentence denotes Earlier data demonstrated 19,20-EDP protected HL-1 cardiac cells from the bacterial endotoxin, LPS, cell injury by preserving mitochondrial biogenesis and integrity (Samokhvalov et al., 2015).
T604 94200-94410 Sentence denotes These data suggest n-3 PUFAs and their metabolites provide beneficial protective responses in models of cardiovascular injury via maintaining mitochondrial quality and ameliorating detrimental immune responses.
T605 94411-94515 Sentence denotes However, further research is required to investigate the proposed hypothesis in the context of COVID-19.
T606 94517-94580 Sentence denotes 8.3 Direct and indirect effects of n-3 PUFAs on the viral load
T607 94581-94859 Sentence denotes Although EPA and DHA have been widely used to ameliorate chronic inflammatory diseases their effect on viral infections remains limited (Das, 2018; Husson et al., 2016; Ingram, Eaton, Erdos, Tedder, & Vreeland, 1982; Juers, Rogers, McCurdy, & Cook, 1976; Territo & Golde, 1979).
T608 94860-95239 Sentence denotes Some evidence indicates EPA, DHA and other dietary unsaturated fatty acids can inactivate viruses by directly causing leakage or lysis of the viral envelopes, which will disrupt the membrane integrity or activate the humoral immune system to produce antibodies against these pathogens (Das, 2018, Das, 2020a; Hilmarsson, Larusson, & Thormar, 2006; Kohn, Gitelman, & Inbar, 1980).
T609 95240-95467 Sentence denotes Morita et al. demonstrated n-3 PUFA-derived lipid mediator, protectin D1, exhibits antiviral activity, markedly attenuates influenza A virus replication and improves survival in severe influenza infection in male C57Bl/6J mice.
T610 95468-95643 Sentence denotes This study highlighted the importance of the endogenous protectin D1 as an innate suppressor of influenza virus replication attenuating lethal infection (Morita et al., 2013).
T611 95644-95791 Sentence denotes In another study, Ramon et al. evaluated the ability of 17-HDHA, a SPM derived from DHA, for improving the immune response to H1N1 influenza virus.
T612 95792-96068 Sentence denotes The results showed 17-HDHA was able to enhance the humoral immunity against viruses by increasing the number of antibody-secreting cells and the levels of H1N1 antibodies, which resulted in greater protection against live H1N1 influenza infection in mice (Ramon et al., 2014).
T613 96069-96500 Sentence denotes More recently, Braz-De-Melo highlighted the beneficial effects of n-3 PUFAs against viral infections by showing that DHA pre-treatment to neuroblastoma SH-SY5Y cells infected with Zika virus increased their viability and proliferation, restored mitochondrial function, reduced viral load and triggered an anti-inflammatory response identifying n-3 PUFAs as useful therapeutic tools in combating viruses (Braz-De-Melo et al., 2019).
T614 96501-96703 Sentence denotes Additionally, Yan et al. has shown that EPA and DHA can inhibit the replication of both enterovirus A71 and coxsackievirus A16 the most common causes of hand, foot, and mouth disease (Yan et al., 2019).
T615 96704-96932 Sentence denotes Collectively, we can conclude that n-3 PUFAs have the capability to attenuate viral infections via both direct effects on membrane integrity and indirect mechanisms activating the humoral response to decrease overall viral load.
T616 96933-97109 Sentence denotes In contrast, the immunosuppressive effects of EPA and DHA supplementation can decrease the immune response against viral infections and thus compromising removal from the body.
T617 97110-97289 Sentence denotes C57BL/6J mice supplemented with fish oil and infected with H1N1 influenza virus showed a 40% higher mortality rate and 70% higher viral load compared to the corresponding control.
T618 97290-97490 Sentence denotes Moreover, the treated mice had markedly reduced numbers of CD8+ T lymphocytes and reduced mRNA expression of inflammatory mediators IL-6 and TNF-α (Schwerbrock, Karlsson, Shi, Sheridan, & Beck, 2009).
T619 97491-97751 Sentence denotes Similarly, BALB/c mice fed a high-fat diet rich in EPA and DHA had reduced levels of IFN-γ, serum immunoglobulin G and lung immunoglobulin A-specific antibodies following infection with the influenza virus, indicating a virus-specific lung T cell cytotoxicity.
T620 97752-97881 Sentence denotes These results suggested supplementation with a diet rich in EPA and DHA could impair immune response by delaying virus clearance.
T621 97882-98211 Sentence denotes However, differences noticed during the course of infection did not affect the ultimate outcome as n-3 PUFA-fed mice were finally able to clear the virus and returned to pre-infection food consumption and body weight similar to the control group (Byleveld, Pang, Clancy, & Roberts, 1999; Byleveld, Pang, Clancy, & Roberts, 2000).
T622 98212-98400 Sentence denotes Importantly, other factors contribute to these opposite results, for example, an initial weight loss is typically observed when mice are supplemented with fish oil (Byleveld et al., 1999).
T623 98401-98565 Sentence denotes In addition, thoroughly controlled animal studies have not been conducted with the SARS-CoV-2 virus and significant variations between viruses should be considered.
T624 98566-98717 Sentence denotes Therefore, further research is needed to understand the role of EPA and DHA in the immune response related specifically to SARS-CoV-2 viral infections.
T625 98719-98823 Sentence denotes 8.4 Role of n-3 PUFAs in modulating the renin-angiotensin aldosterone system in the setting of COVID-19
T626 98824-98968 Sentence denotes The renin-angiotensin aldosterone system (RAAS) is a key regulator of vascular function modulating natriuresis, blood volume and blood pressure.
T627 98969-99106 Sentence denotes Briefly, angiotensin I (Ang I) is metabolized by angiotensin-converting enzyme (ACE) to form the vasoconstrictor angiotensin II (Ang II).
T628 99107-99430 Sentence denotes Accumulation, prolonged and excessive binding of Ang II to the angiotensin 1 receptor in the heart and blood vessels mediates several effects which include vasoconstriction, hypertension, cardiac hypertrophy, increased ROS production and adverse fibrosis (Fyhrquist, Metsarinne, & Tikkanen, 1995; Perazella & Setaro, 2003).
T629 99431-99652 Sentence denotes Earlier literature demonstrated Ang II may act as a proinflammatory cytokine potentially having a significant role in cardiac remodeling (Gibbons, Pratt, & Dzau, 1992; Griendling, Minieri, Ollerenshaw, & Alexander, 1994).
T630 99653-100018 Sentence denotes Conversely, the master regulator ACE2, a type 1 integral membrane glycoprotein expressed in most tissues including the lungs, kidneys, heart and vascular endothelium layers, can metabolize Ang II to produce the vasodilator angiotensin (Ang 1–7) which protects the cardiovascular system against the actions of Ang II (Das, 2018; Kumar & Das, 1997; Yan et al., 2020).
T631 100019-100388 Sentence denotes Beside its vasodilatory properties, Ang-(1–7) promotes resolution of inflammation by decreasing TNF-α, IL-6, vascular adhesion molecule, monocyte chemoattractant protein-1 and macrophage infiltration enhancing the survival of cardiomyocytes and endothelial cells during severe immune responses (Simoes e Silva, Silveira, Ferreira, & Teixeira, 2013; Zhang et al., 2015).
T632 100389-100607 Sentence denotes Accordingly, several clinical and experimental studies reported dysregulation of RAAS due to increased Ang II and decreased ACE2 can lead to detrimental inflammatory responses and worsening of cardiovascular disorders.
T633 100608-100920 Sentence denotes Therefore, maintaining the activity of ACE2 is essential in preserving the balance of the RAAS and effects on vasoconstriction, sodium retention and fibrosis and may elicit protective effects against hypertension, HF, MI and other CVDs (Crackower et al., 2002; Patel et al., 2016; Wang, Gheblawi, & Oudit, 2020).
T634 100921-101032 Sentence denotes Recent evidence has demonstrated SARS-CoV-2 uses ACE2 as an internalization receptor to enter the target cells.
T635 101033-101254 Sentence denotes The spike (S) glycoprotein of SARS-CoV-2 recognizes and interacts with its target ACE2 receptor on the host cell surface, mediating viral entry during the infection cycle (Letko, Marzi, & Munster, 2020; Yan et al., 2020).
T636 101255-101363 Sentence denotes Excessive binding of spike protein to ACE2 leads to downregulation of the ACE2 receptor (Jung et al., 2020).
T637 101364-101511 Sentence denotes This finding is consistent with reports in the animal models infected with SARS-CoV (Crackower et al., 2002; Imai et al., 2005; Kuba et al., 2005).
T638 101512-101707 Sentence denotes The reduction in ACE2 levels leads to excessive pro-inflammatory responses adversely affecting both lung and cardiovascular systems (Crackower et al., 2002; Imai et al., 2005; Kuba et al., 2005).
T639 101708-101935 Sentence denotes These detrimental effects can be explained as the partial decrease in ACE2 function leads to dominant angiotensin II effects, including augmented cytokine storm, inflammation, vasoconstriction and susceptibility for thrombosis.
T640 101936-102133 Sentence denotes These effects further increase the cardiovascular burden by worsening hypertension, HF and other cardiovascular disorders in predisposed patients (Liu, Blet, Smyth, & Li, 2020; Oudit et al., 2009).
T641 102134-102249 Sentence denotes Importantly, the accumulation of Ang II was positively associated to viral load and lung injury (Liu et al., 2020).
T642 102250-102522 Sentence denotes Moreover, reduction in the activity and/or number of ACE2 leads to deficiency of Ang-(1–7) production and consequently loss of its anti-inflammatory, vasodilatory, and cardiovascular protective effects (Lelis, Freitas, Machado, Crespo, & Santos, 2019; Patel et al., 2016).
T643 102523-102660 Sentence denotes Therefore, it is hypothesized that inhibition of RAAS may be helpful to attenuate the inflammatory storm and ameliorate end-organ damage.
T644 102661-102943 Sentence denotes Interestingly, recent data indicates individuals with COVID-19 who are being treated with ACE inhibitors or ARBs, for pre-existing conditions, are at lower risk of 28-day all-cause mortality than those not treated with ACE inhibitors or ARBs (Wang et al., 2020; Zhang et al., 2020).
T645 102944-103190 Sentence denotes Although ARBs and ACE inhibitors do not directly impact ACE2, they indirectly elevate ACE2 activity and the beneficial Ang-(1–7) production and counter the excessive production of the harmful Ang II (Hanff, Harhay, Brown, Cohen, & Mohareb, 2020).
T646 103191-103373 Sentence denotes Therefore, it was proposed that maintaining the levels of ACE2 and its downstream effector Ang-(1–7) may limit cardiovascular damage secondary to COVID-19 (Wang, Edin, et al., 2020).
T647 103374-103498 Sentence denotes Interestingly, several reports showed that n-3 PUFAs can regulate the RAAS system by modulating both Ang II and ACE2 levels.
T648 103499-103742 Sentence denotes For instance, emerging literature indicates n-3 PUFAs and their endogenously generated metabolites can directly reduce the expression and activity of ACE, thereby reducing angiotensin II formation and cardiovascular burden (Kumar & Das, 1997).
T649 103743-103948 Sentence denotes Moreover, it has been demonstrated that supplementation of mice with an n-3 PUFA rich diet for three weeks resulted in attenuated Ang-II-induced blood pressure via up-regulation of ACE2 (Ulu et al., 2013).
T650 103949-104225 Sentence denotes Alternatively, as previously discussed, incorporation of n-3 PUFAs into the cell membranes will alter key properties, which can consequently affect protein number and affinity of SARS-CoV-2 to ACE2 (Candelario & Chachisvilis, 2013; Das, 1999, Das, 2020b; Glende et al., 2008).
T651 104226-104519 Sentence denotes Together, these studies suggest a novel role for n-3 PUFAs in regulating SARS-CoV-2 infection where the potential benefit as an adjuvant therapy involves increasing the production of Ang-(1–7) and reducing the levels of Ang II, thereby limiting COVID-19-triggered cardiovascular complications.
T652 104520-104689 Sentence denotes Importantly, evidence demonstrating upregulation and enhanced activity of ACE2 suggested it will facilitate the infectivity of SARS-CoV-2 (South, Diz, & Chappell, 2020).
T653 104690-104836 Sentence denotes Accordingly, some researchers proposed that ACE inhibitors and ARBs should be discontinued in COVID-19 patients (Diaz, 2020; Esler & Esler, 2020).
T654 104837-105041 Sentence denotes However, in addition to the direct effects on cardiac ACE2 other mechanisms such as triggering a cytokine storm will markedly contribute to SARS-CoV-2-induced injury (Chen, Li, Chen, Feng, & Xiong, 2020).
T655 105042-105277 Sentence denotes A recent study conducted by Yang et al., demonstrated COVID-19 patients with hypertension using ACE inhibitors/ARBs had lower mortality rates than hypertensive COVID-19 patients that were not on ACE inhibitors/ARBs (Yang et al., 2020).
T656 105278-105474 Sentence denotes Moreover, Mancia et al. examined 6272 patients and found no association between RAAS inhibitor use and susceptibility or development of COVID-19 (Mancia, Rea, Ludergnani, Apolone, & Corrao, 2020).
T657 105475-105719 Sentence denotes In that sense, a published statement by American Heart Association (AHA), the American College of Cardiology (ACC) and the Heart Failure Society of America strongly recommended continuation of ACE inhibitor/ARBs (Zhang, Zhu, Cai, et al., 2020).
T658 105720-105999 Sentence denotes Together, these data suggest therapies targeting ACE and Ang II do not appear to increase the likelihood of SARS-CoV-2 infection, but may have a role in abrogating the inflammatory response and vasoconstriction that contributes to the clinical deterioration in COVID-19 patients.
T659 106000-106196 Sentence denotes In summary, evidence has demonstrated infection with SARS-CoV-2 induces internalization and downregulation of ACE2, which may aggravate a patient's condition by limiting the degradation of Ang II.
T660 106197-106461 Sentence denotes Elevated Ang II levels induce several detrimental effects on the cardiovascular system including elevated blood pressure, excessive recruitment and infiltration of inflammatory immune cells to the heart as well as increased secretion of pro-inflammatory cytokines.
T661 106462-106615 Sentence denotes Reduced ACE2 levels are associated with decreased formation of Ang-(1–7) and thus loss of its vasodilatory, anti-inflammatory and CVD-protective effects.
T662 106616-106778 Sentence denotes Therefore, intervention with treatments to correct an imbalance in the RAAS system, such as ACE inhibitors, ARBs and n-3 PUFAs, can possibly improve the outcomes.
T663 106780-106826 Sentence denotes 8.5 N-3 PUFAs possess anti-oxidant properties
T664 106827-107047 Sentence denotes The pneumonia-induced hypoxemia caused by RNA virus infections reduces the energy production from cell metabolism, increases the anaerobic fermentation, intracellular acidosis and the generation of ROS (Li et al., 2020).
T665 107048-107174 Sentence denotes The subsequent increased ROS production causes damage to different cellular components including the DNA, lipids and proteins.
T666 107175-107434 Sentence denotes The increased ROS levels will deplete the antioxidant defense system resulting in severe oxidative stress and chronic activation of immune responses, aggravating tissue injury and damage (Khomich, Kochetkov, Bartosch, & Ivanov, 2018; Reshi, Su, & Hong, 2014).
T667 107435-107712 Sentence denotes Several studies reveal n-3 PUFAs possess anti-oxidant properties attributable to their ability to up-regulate anti-oxidant enzymes (e.g. superoxide dismutase), down-regulate pro-oxidant enzymes (e.g. nitric oxide synthase) and potential to interact directly with free radicals.
T668 107713-107989 Sentence denotes Antioxidant effects of n-3 PUFAs have been demonstrated in different organs including lungs, kidneys and the cardiovascular system (Darwesh et al., 2020; Darwesh, Jamieson, et al., 2019; Darwesh, Keshavarz-Bahaghighat, et al., 2019; De Caterina, 2011; Mozaffarian & Wu, 2011).
T669 107990-108258 Sentence denotes Anderson et al. reported patients were administered a moderately high dose of n-3 PUFAs (3.4 g/day EPA and DHA ethyl-esters) for a period of 2–3 weeks before having elective cardiac surgery and then myocardial tissue was dissected from the right atrium during surgery.
T670 108259-108595 Sentence denotes Intriguingly, myocardial tissues obtained from patients displayed improved antioxidant capacity attributed to increased expression and activity of key antioxidants such as glutathione peroxidase-1, glutathione peroxidase-4, NADPH-quinone oxido-reductase-1, thioredoxin reductase-2 and total glutathione compared to the control patients.
T671 108596-108845 Sentence denotes Moreover, the mitochondrial outer membrane-bound enzyme monoamine oxidase, a substantial generator of ROS, was also determined to have significantly lower activity in myocardial tissue obtained from n-3 PUFA-treated patients (Anderson et al., 2014).
T672 108846-109082 Sentence denotes Interestingly, isolated mouse hearts perfused with DHA derived epoxylipids had improved postischemic recovery which correlated with better activities of the antioxidants thioredoxin-1 and thioredoxin-2 (Darwesh, Jamieson, et al., 2019).
T673 109083-109347 Sentence denotes Importantly, with COVID-19, especially in advanced stages and in ICU, severe inflammation, hypoxemia and mechanical ventilation with high oxygen concentrations will inevitably increase ROS generation locally and systemically notably within the lungs and the heart.
T674 109348-109518 Sentence denotes Thus, it can be hypothesized that increased n-3 PUFAs and their corresponding metabolites would provide beneficial control of exaggerated inflammation and ROS production.
T675 109520-109580 Sentence denotes 8.6 N-3 PUFAs have the potential to ameliorate coagulopathy
T676 109581-109691 Sentence denotes Laboratory examinations from COVID-19 patients indicate serious coagulopathy has occurred in some individuals.
T677 109692-109989 Sentence denotes This is reflected by widespread microvascular thrombosis and consumption of coagulation factors as evidenced by markers such as thrombocytopenia, prolongation of the prothrombin, elevation of D-dimer, increased fibrin degradation product levels and decreased fibrinogen levels (Tang et al., 2020).
T678 109990-110139 Sentence denotes In a study with 184 Dutch ICU COVID-19 patients, 38% were reported to have abnormal blood clotting and 33% with identified clots (Klok et al., 2020).
T679 110140-110227 Sentence denotes Importantly, blood clots may cause lung emboli, cardiovascular complications or stroke.
T680 110228-110399 Sentence denotes In addition, long-term bed rest has been linked to increased risk of venous thromboembolism in severe SARS-CoV-2 infected patients (Iba, et al., 2019; Zhang et al., 2020).
T681 110400-110616 Sentence denotes Accordingly, the active application of anticoagulants (such as heparin) for patients with severe SARS-CoV-2 infection has been recommended and appears to be associated with better prognosis (Tang, Bai, et al., 2020).
T682 110617-110833 Sentence denotes Tang et al. recently published a study indicating anticoagulant therapy, mainly with low molecular weight heparin, is associated with better prognosis in severe SARS-CoV-2 infected patients (Tang, Bai, et al., 2020).
T683 110834-111134 Sentence denotes N-3 PUFAs contain polar lipids that exhibit potent antithrombotic effects against platelet-activating factor and other prothrombotic pathways, including thrombin, collagen, and adenosine diphosphate (Lordan et al., 2020; Tsoupras et al., 2019; Tsoupras, O'Keeffe, Lordan, Redfern, & Zabetakis, 2019).
T684 111135-111332 Sentence denotes Increased levels of n-3 PUFAs may alter platelet phospholipid membrane composition and affect platelet function, which can be predicted to alter the progression and thrombotic complications of CVD.
T685 111333-111681 Sentence denotes Adili et al. outlined that EPA and DHA act on the platelet membrane to reduce platelet aggregation and TX release via COX-1 and 12-LOX, which metabolize fatty acids into a group of beneficial oxylipins in platelets that contribute significantly to the regulation of platelet function in hemostasis and thrombosis (Adili, Hawley, & Holinstat, 2018).
T686 111682-111880 Sentence denotes This is supported by Park and Harris who demonstrated healthy subjects supplemented with EPA for 4 weeks had reduced platelet activation, an early step in platelet aggregation (Park & Harris, 2002).
T687 111881-112011 Sentence denotes While the evidence is limited, it appears EPA is more active than DHA in altering platelet function because it is a COX substrate.
T688 112012-112099 Sentence denotes However, DHA appears to decrease TxA2 and PGH2 receptor affinity (Park & Harris, 2002).
T689 112100-112370 Sentence denotes Although dietary supplementation of EPA and DHA has been shown to reduce platelet activation and aggregation in healthy subjects, a higher recommended dose of n-3 PUFAs may be needed in platelet hyperactivity prothrombotic conditions such as in CVD (Adili et al., 2018).
T690 112371-112517 Sentence denotes These anticoagulant properties of n-3 PUFAs suggest potential effects on the platelet aggregation in severe cases of SARS-CoV-2 infected subjects.
T691 112518-112657 Sentence denotes Our current level of knowledge only permits speculation on whether n-3 PUFAs can mitigate the coagulopathy associated with severe COVID-19.
T692 112659-112729 Sentence denotes 8.7 Lipid-lowering properties of n-3 PUFAs in the context of COVID-19
T693 112730-113081 Sentence denotes Patients with comorbidities such as diabetes, dyslipidemia, aberrations in plasma cholesterol and triglycerides and coronary heart disease are more susceptible to severe COVID-19 outcomes such as cardiac complications, sepsis, ARDS and death (Chen et al., 2020; Petersen et al., 2020; Shi et al., 2020; Wang, Hu, et al., 2020; Zhou, Yu, et al., 2020).
T694 113082-113236 Sentence denotes The acute inflammatory syndrome associated with COVID-19 has the capacity to destabilize plaques, which can lead to ischemic events (Madjid et al., 2007).
T695 113237-113533 Sentence denotes Recent studies indicated serum triglyceride concentrations were significantly higher in individuals who died as a result of COVID-19 likely due to augmented inflammatory TNF-α levels causing reduced lipoprotein lipase activity (Chen, Wu, et al., 2020; Skevaki, Fragkou, Cheng, Xie, & Renz, 2020).
T696 113534-113703 Sentence denotes Triglyceride-glucose index, a product of fasting triglyceride and fasting plasma glucose levels, is used as a surrogate marker for insulin resistance (Ren et al., 2020).
T697 113704-113834 Sentence denotes COVID-19 patients with a higher triglyceride-glucose index have been shown to experience more severe COVID-19 infection and death.
T698 113835-114038 Sentence denotes Furthermore, levels of high density lipoprotein cholesterol (HDL-c) are also reduced in COVID-19 patients with the magnitude of reduction correlating with disease severity (Hu, Chen, Wu, He, & Ye, 2020).
T699 114039-114178 Sentence denotes Generally, HDL-c is considered to be anti-inflammatory and antithrombotic (Suzuki et al., 2010; van der Stoep, Korporaal, & Van Eck, 2014).
T700 114179-114392 Sentence denotes So, the robust, maladaptive inflammatory and hypercoagulability responses observed in more severe COVID-19 cases could possibly be attributed– in part – to reduced levels of HLD-c and a dysregulated lipid profile.
T701 114393-114693 Sentence denotes Given the potential for COVID-19 infection to alter the lipid profile acutely and the association of dyslipidemia with conditions such as diabetes, coronary artery disease, and obesity raises the question whether normalization of plasma lipid profiles in COVID-19 patients can offer clinical benefit.
T702 114694-115000 Sentence denotes Use of statins and other lipid-modulating therapies can reduce the risk of primary or secondary cardiovascular events in at-risk individuals, including those with diabetes, metabolic syndrome, and coronary artery disease – conditions that are risk factors for severe COVID-19 outcomes (Stone et al., 2013).
T703 115001-115286 Sentence denotes A large retrospective study of over 13,000 COVID-19 patients has shown the in-hospital use of statin therapy, potent lipid-lowering agents with anti-inflammatory properties, was associated with a reduced rate of mortality compared to non-statin users (Zhang, Qin, Cheng, et al., 2020).
T704 115287-115484 Sentence denotes This important study disrupts the previous dogma that statins may enhance the COVID-19 virus pathology via ACE2 expression and may in fact be overwhelmingly beneficial in the treatment of COVID-19.
T705 115485-115791 Sentence denotes However, despite statin monotherapy, many patients with dyslipidemia still suffer from persistently elevated triglyceride levels which may continue to be a risk factor for coronary artery disease, cardiac events and more severe COVID-19 infection outcomes (Ballantyne et al., 2012; Davidson, et al., 2007).
T706 115792-116036 Sentence denotes The triglyceride-lowering effect of n-3 PUFA supplementation has been demonstrated in a plethora of clinical trials (Abdelhamid et al., 2020; Ballantyne et al., 2012; Chan et al., 2003; Maki et al., 2013; Yanai et al., 2018; Zhou et al., 2019).
T707 116037-116238 Sentence denotes Lower levels of triglycerides present a lower risk of developing a cytokine storm based on the score from the available secondary haemophagocytic lymphohistiocytosis score system (Mehta, et al., 2020).
T708 116239-116370 Sentence denotes Additionally, n-3 PUFAs have been shown to significantly lower CRP in patients with hypertriglyceridemia (Ballantyne et al., 2012).
T709 116371-116641 Sentence denotes Thus, the rationale for the use of n-3 PUFAs in COVID-19 patients not only focuses on the attenuation of the infection-induced respiratory disorders but also on an overall improvement of patients' wellbeing and prevention of potential complications due to comorbidities.
T710 116643-116713 Sentence denotes 9 When and how to intervene with n-3 PUFAs in the context of COVID-19
T711 116714-116935 Sentence denotes An important aspect in considering n-3 PUFAs as adjunctive therapy in critically or severe ill patients is the time of intervention, duration of treatment, dose, composition of the preparation and route of administration.
T712 116936-117089 Sentence denotes The type and intensity of supportive treatment required by a patient is dependent upon the severity of disease and the possible need for hospitalization.
T713 117090-117256 Sentence denotes Existing literature demonstrates it may take weeks or months for standard doses of n-3 PUFAs to exert a biological effect due to a gradual replacement of membrane AA.
T714 117257-117446 Sentence denotes It has been hypothesized the acute supplementation with n-3 PUFAs may influence the inflammatory response in critically ill patients, particularly those with ALI (Martin & Stapleton, 2010).
T715 117447-117678 Sentence denotes For example, a randomized clinical trial showed daily enteral feeding of critically ill ALI patients with elevated levels EPA, DHA and gamma-linolenic acid significantly reduced lung inflammation and improved oxygenation by 4 days.
T716 117679-117827 Sentence denotes This was associated with a decreased duration of mechanical ventilation, ICU length of stay and mortality (Gadek et al., 1999; Singer et al., 2006).
T717 117828-118238 Sentence denotes In a trial conducted by Pontes-Arruda et al. who studied patients with sepsis requiring mechanical ventilation, a diet enriched with EPA, gamma-linolenic acid and antioxidants delivered at a constant rate during a minimum of 4 days contributed to better ICU and hospital outcomes, oxygenation status, ventilator-free days and was associated with lower mortality at 28-day interval (Pontes-Arruda et al., 2006).
T718 118239-118356 Sentence denotes There are many studies suggesting the beneficial effects of parenteral fish oil emulsions in critically ill patients.
T719 118357-118589 Sentence denotes For example, parenteral supplementation of severe ill patients with lipid emulsions containing fish oil was associated with reduced inflammation, improved gas exchange and shorter length of ICU and hospital stay (Zhao & Wang, 2018).
T720 118590-118776 Sentence denotes In a study by Mayer et al., patients with sepsis were randomized in an open-label trial to receive an omega-3 FA rich lipid emulsion or a standard omega-6 rich lipid emulsion for 5 days.
T721 118777-119049 Sentence denotes Within 2 days of fish oil infusion, free n-3 fatty acids increased and the n-3/n-6 ratio was reversed favoring EPA and DHA over AA, with rapid incorporation of n-3 fatty acids into mononuclear leukocyte membranes and reaching maximum effect in 3 days (Mayer et al., 2003).
T722 119050-119201 Sentence denotes Furthermore, a parenteral lipid emulsion enriched in n-3 PUFA for 7 days was found to reduce acetic acid-induced colitis in rats (Campos et al., 2002).
T723 119202-119560 Sentence denotes In a randomized controlled trial conducted by Wang et al., patients with severe acute pancreatitis were randomly assigned to receive parenteral nutrition for 5 days containing similar amounts of amino acids, glucose and fat but different lipid compositions: the control group received a soybean oil-based fat solution and the omega-3 group received fish oil.
T724 119561-119762 Sentence denotes Interestingly, patients treated with the fish oil or n-3 PUFAs had a markedly lower inflammatory marker CRP and better oxygenation index after 5 days of parenteral nutrition (Wang, Li, Li, & Li, 2008).
T725 119763-119944 Sentence denotes Together, these studies demonstrated that acute enteral or parenteral administration of n-3 PUFAs in the setting of severe illness could significantly improve the clinical outcomes.
T726 119945-120277 Sentence denotes Notably, it has been shown that fish oil emulsions containing substantial amounts of EPA and DHA have an excellent safety record in both critically ill adults and children (Calder, 2009, Calder, 2019; Nandivada, Fell, Gura, & Puder, 2016) making them a suitable candidate for use in severe stress conditions as in COVID-19 patients.
T727 120278-120492 Sentence denotes However, with the research that has been completed to date, it is not possible to definitively determine the dose, route of administration and the best timing to intervene with n-3 PUFAs in the setting of COVID-19.
T728 120493-120799 Sentence denotes More research is undoubtedly needed before definitive recommendations about the routine use of n-3 PUFAs in the context of COVID-19 can be made particularly that dosing data and pharmacokinetics studies of both enteral and parenteral n-3 PUFAs in critically ill patients are highly variable and incomplete.
T729 120801-120827 Sentence denotes 10 Summary and conclusion
T730 120828-120933 Sentence denotes In summary, COVID-19 is rapidly spreading around the globe and our understanding of the virus is limited.
T731 120934-121056 Sentence denotes To date, there is no effective, approved therapy or vaccination to treat the disease or protect against its complications.
T732 121057-121201 Sentence denotes Although the lungs are considered the main target organ of SARS-CoV-2, the virus can affect many other organs, leading to multiple organ damage.
T733 121202-121293 Sentence denotes Cardiovascular injury has been noted as a protruding clinical feature in COVID-19 patients.
T734 121294-121435 Sentence denotes The dysregulation of RAAS can lead to a harmful inflammatory response and worsening of cardiovascular consequences in patients with COVID-19.
T735 121436-121574 Sentence denotes Therefore, intervention with drugs that counteract Ang II may have a potential role in preventing the deleterious cardiovascular outcomes.
T736 121575-121881 Sentence denotes Although increased ACE2 levels may raise the concern of increased SARS-CoV-2 infectivity, we propose here that n-3 PUFAs may be beneficial rather than harmful for cardiovascular outcomes in COVID-19 patients by limiting Ang II-induced detrimental signaling and enhancing Ang (1-7) cardioprotective effects.
T737 121882-122094 Sentence denotes In this review we highlight the different mechanisms of cardiovascular complications secondary to COVID-19 and draw attention toward the potential roles n-3 PUFAs in mitigating these cardiovascular complications.
T738 122095-122208 Sentence denotes Currently, there is no direct evidence of any beneficial or deleterious effect of n-3 PUFAs in COVID-19 patients.
T739 122209-122452 Sentence denotes However, it is evident from the preceding discussion the dietary or non-dietary intake of n-3 PUFAs and/or their biologically active metabolites have many beneficial actions leading to prevention and management of cardiovascular complications.
T740 122453-122916 Sentence denotes N-3 PUFAs and/or their biologically active metabolites have the potential to modulate many of the adverse effects of an exaggerated immune response, inactivate enveloped viruses, enhance macrophage phagocytic capacity, ameliorate coagulopathy, modify cell signaling and gene expression, shift the pattern of the lipid metabolites produced under stress conditions to a more anti-inflammatory metabolite profile and enhance the anti-oxidative capacity of the heart.
T741 122917-123134 Sentence denotes Despite these promising effects of n-3 PUFAs, more experimental, randomized control trials and epidemiological research is warranted to test and translate these proposed effects in the setting of SARS-CoV-2 infection.
T742 123136-123157 Sentence denotes Authors contributions
T743 123158-123281 Sentence denotes A.D. and J.M.S. designed the outline of the review, A.D. screened the studies, extracted the data and wrote the manuscript.
T744 123282-123359 Sentence denotes W.B. and D.S. provided significant contribution to the content of the review.
T745 123360-123402 Sentence denotes J.M.S. reviewed and edited the manuscript.
T746 123404-123411 Sentence denotes Funding
T747 123412-123534 Sentence denotes This work was supported by a grant from 10.13039/501100000024Canadian Institutes of Health Research (FRN 156393) to J.M.S.
T748 123535-123697 Sentence denotes A.D. is supported by both an 10.13039/501100009192Alberta Innovates Graduate Studentship in Health Innovation and by the Izaak Walton Killam Memorial Scholarship.
T749 123698-123790 Sentence denotes W.B. is supported by an 10.13039/501100009192Alberta Innovates Graduate Student Scholarship.
T750 123792-123825 Sentence denotes Declaration of Competing Interest
T751 123826-123886 Sentence denotes The authors declare that there are no conflicts of interest.

LitCovid-PD-HP

Id Subject Object Predicate Lexical cue hp_id
T1 580-588 Phenotype denotes plethora http://purl.obolibrary.org/obo/HP_0001050
T2 693-709 Phenotype denotes oxidative stress http://purl.obolibrary.org/obo/HP_0025464
T3 1224-1240 Phenotype denotes oxidative stress http://purl.obolibrary.org/obo/HP_0025464
T4 1256-1268 Phenotype denotes coagulopathy http://purl.obolibrary.org/obo/HP_0003256
T5 3081-3090 Phenotype denotes pneumonia http://purl.obolibrary.org/obo/HP_0002090
T6 3954-3961 Phenotype denotes myalgia http://purl.obolibrary.org/obo/HP_0003326
T7 3963-3970 Phenotype denotes fatigue http://purl.obolibrary.org/obo/HP_0012378
T8 3972-3977 Phenotype denotes fever http://purl.obolibrary.org/obo/HP_0001945
T9 3982-3991 Phenotype denotes dry cough http://purl.obolibrary.org/obo/HP_0031246
T10 4102-4119 Phenotype denotes acute lung injury http://www.orpha.net/ORDO/Orphanet_178320
T11 4121-4124 Phenotype denotes ALI http://www.orpha.net/ORDO/Orphanet_178320
T12 4133-4153 Phenotype denotes respiratory distress http://purl.obolibrary.org/obo/HP_0002098
T13 4171-4190 Phenotype denotes respiratory failure http://purl.obolibrary.org/obo/HP_0002878
T14 4192-4198 Phenotype denotes sepsis http://purl.obolibrary.org/obo/HP_0100806
T15 4200-4213 Phenotype denotes heart failure http://purl.obolibrary.org/obo/HP_0001635
T16 4215-4217 Phenotype denotes HF http://purl.obolibrary.org/obo/HP_0001635
T17 4223-4244 Phenotype denotes sudden cardiac arrest http://purl.obolibrary.org/obo/HP_0031628
T18 5076-5090 Phenotype denotes cardiomyopathy http://purl.obolibrary.org/obo/HP_0001638
T19 5109-5130 Phenotype denotes myocardial infarction http://purl.obolibrary.org/obo/HP_0001658
T20 5132-5146 Phenotype denotes cardiomyopathy http://purl.obolibrary.org/obo/HP_0001638
T21 5191-5203 Phenotype denotes hypertension http://purl.obolibrary.org/obo/HP_0000822
T22 5376-5390 Phenotype denotes cytokine storm http://purl.obolibrary.org/obo/HP_0033041
T23 6164-6178 Phenotype denotes cytokine storm http://purl.obolibrary.org/obo/HP_0033041
T24 6234-6240 Phenotype denotes sepsis http://purl.obolibrary.org/obo/HP_0100806
T25 6617-6631 Phenotype denotes cytokine storm http://purl.obolibrary.org/obo/HP_0033041
T26 7287-7299 Phenotype denotes hypertension http://purl.obolibrary.org/obo/HP_0000822
T27 7301-7316 Phenotype denotes atherosclerosis http://purl.obolibrary.org/obo/HP_0002621
T28 7348-7361 Phenotype denotes heart failure http://purl.obolibrary.org/obo/HP_0001635
T29 8107-8116 Phenotype denotes pneumonia http://purl.obolibrary.org/obo/HP_0002090
T30 8354-8376 Phenotype denotes cardiovascular disease http://purl.obolibrary.org/obo/HP_0001626
T31 8423-8432 Phenotype denotes pneumonia http://purl.obolibrary.org/obo/HP_0002090
T32 8519-8528 Phenotype denotes pneumonia http://purl.obolibrary.org/obo/HP_0002090
T33 8645-8654 Phenotype denotes pneumonia http://purl.obolibrary.org/obo/HP_0002090
T34 8882-8893 Phenotype denotes tachycardia http://purl.obolibrary.org/obo/HP_0001649
T35 8898-8909 Phenotype denotes hypotension http://purl.obolibrary.org/obo/HP_0002615
T36 8956-8966 Phenotype denotes arrhythmia http://purl.obolibrary.org/obo/HP_0011675
T37 8968-8980 Phenotype denotes cardiomegaly http://purl.obolibrary.org/obo/HP_0001640
T38 9142-9153 Phenotype denotes myocarditis http://purl.obolibrary.org/obo/HP_0012819
T39 9166-9171 Phenotype denotes edema http://purl.obolibrary.org/obo/HP_0000969
T40 9183-9211 Phenotype denotes left ventricular dysfunction http://purl.obolibrary.org/obo/HP_0005162
T41 9893-9915 Phenotype denotes cardiovascular disease http://purl.obolibrary.org/obo/HP_0001626
T42 9954-9968 Phenotype denotes cardiac arrest http://purl.obolibrary.org/obo/HP_0001695
T43 10048-10060 Phenotype denotes hypertension http://purl.obolibrary.org/obo/HP_0000822
T44 11015-11026 Phenotype denotes hypotension http://purl.obolibrary.org/obo/HP_0002615
T45 11047-11058 Phenotype denotes myocarditis http://purl.obolibrary.org/obo/HP_0012819
T46 11060-11088 Phenotype denotes left ventricular dysfunction http://purl.obolibrary.org/obo/HP_0005162
T47 11090-11100 Phenotype denotes arrhythmia http://purl.obolibrary.org/obo/HP_0011675
T48 11105-11107 Phenotype denotes HF http://purl.obolibrary.org/obo/HP_0001635
T49 11380-11391 Phenotype denotes myocarditis http://purl.obolibrary.org/obo/HP_0012819
T50 11870-11881 Phenotype denotes myocarditis http://purl.obolibrary.org/obo/HP_0012819
T51 11920-11934 Phenotype denotes cytokine storm http://purl.obolibrary.org/obo/HP_0033041
T52 11987-11999 Phenotype denotes Coagulopathy http://purl.obolibrary.org/obo/HP_0003256
T53 12013-12025 Phenotype denotes Hypertension http://purl.obolibrary.org/obo/HP_0000822
T54 12033-12053 Phenotype denotes ventricular dilation http://purl.obolibrary.org/obo/HP_0002119
T55 12085-12096 Phenotype denotes Arrhythmias http://purl.obolibrary.org/obo/HP_0011675
T56 12098-12114 Phenotype denotes long QT-syndrome http://purl.obolibrary.org/obo/HP_0001657
T57 12116-12134 Phenotype denotes torsade de pointes http://purl.obolibrary.org/obo/HP_0001664
T58 12170-12184 Phenotype denotes Cytokine storm http://purl.obolibrary.org/obo/HP_0033041
T59 12201-12214 Phenotype denotes heart failure http://purl.obolibrary.org/obo/HP_0001635
T60 12249-12263 Phenotype denotes Cytokine storm http://purl.obolibrary.org/obo/HP_0033041
T61 12398-12407 Phenotype denotes Hypoxemia http://purl.obolibrary.org/obo/HP_0012418
T62 12456-12467 Phenotype denotes tachycardia http://purl.obolibrary.org/obo/HP_0001649
T63 12502-12514 Phenotype denotes hypertension http://purl.obolibrary.org/obo/HP_0000822
T64 12572-12581 Phenotype denotes Pneumonia http://purl.obolibrary.org/obo/HP_0002090
T65 13030-13037 Phenotype denotes hypoxia http://purl.obolibrary.org/obo/HP_0012418
T66 13781-13795 Phenotype denotes Cytokine storm http://purl.obolibrary.org/obo/HP_0033041
T67 14102-14111 Phenotype denotes pneumonia http://purl.obolibrary.org/obo/HP_0002090
T68 14142-14151 Phenotype denotes hypoxemia http://purl.obolibrary.org/obo/HP_0012418
T69 14187-14210 Phenotype denotes increase ROS production http://purl.obolibrary.org/obo/HP_0025464
T70 14331-14340 Phenotype denotes pneumonia http://purl.obolibrary.org/obo/HP_0002090
T71 14371-14382 Phenotype denotes tachycardia http://purl.obolibrary.org/obo/HP_0001649
T72 14621-14638 Phenotype denotes venous thrombosis http://purl.obolibrary.org/obo/HP_0004936
T73 15142-15147 Phenotype denotes Tumor http://purl.obolibrary.org/obo/HP_0002664
T74 15334-15343 Phenotype denotes pneumonia http://purl.obolibrary.org/obo/HP_0002090
T75 15372-15382 Phenotype denotes pneumoniae http://purl.obolibrary.org/obo/HP_0002090
T76 15913-15932 Phenotype denotes pulmonary infection http://purl.obolibrary.org/obo/HP_0006532
T77 16884-16898 Phenotype denotes cytokine storm http://purl.obolibrary.org/obo/HP_0033041
T78 17212-17226 Phenotype denotes cytokine storm http://purl.obolibrary.org/obo/HP_0033041
T79 17693-17701 Phenotype denotes plethora http://purl.obolibrary.org/obo/HP_0001050
T80 17826-17831 Phenotype denotes tumor http://purl.obolibrary.org/obo/HP_0002664
T81 18791-18805 Phenotype denotes cytokine storm http://purl.obolibrary.org/obo/HP_0033041
T82 19301-19315 Phenotype denotes cytokine storm http://purl.obolibrary.org/obo/HP_0033041
T83 19542-19567 Phenotype denotes cytokine release syndrome http://purl.obolibrary.org/obo/HP_0033041
T84 19811-19816 Phenotype denotes fever http://purl.obolibrary.org/obo/HP_0001945
T85 19889-19894 Phenotype denotes fever http://purl.obolibrary.org/obo/HP_0001945
T86 20111-20136 Phenotype denotes cytokine release syndrome http://purl.obolibrary.org/obo/HP_0033041
T87 20222-20236 Phenotype denotes cytokine storm http://purl.obolibrary.org/obo/HP_0033041
T88 21091-21105 Phenotype denotes cytokine storm http://purl.obolibrary.org/obo/HP_0033041
T89 21405-21410 Phenotype denotes Fever http://purl.obolibrary.org/obo/HP_0001945
T90 21800-21814 Phenotype denotes cytokine storm http://purl.obolibrary.org/obo/HP_0033041
T91 21867-21876 Phenotype denotes tachypnea http://purl.obolibrary.org/obo/HP_0002789
T92 21878-21890 Phenotype denotes elevated CRP http://purl.obolibrary.org/obo/HP_0011227
T93 22717-22733 Phenotype denotes severe infection http://purl.obolibrary.org/obo/HP_0032169
T94 23327-23339 Phenotype denotes Elevated CRP http://purl.obolibrary.org/obo/HP_0011227
T95 23385-23392 Phenotype denotes obesity http://purl.obolibrary.org/obo/HP_0001513
T96 23405-23417 Phenotype denotes hypertension http://purl.obolibrary.org/obo/HP_0000822
T97 23513-23518 Phenotype denotes Fever http://purl.obolibrary.org/obo/HP_0001945
T98 23776-23788 Phenotype denotes hypertension http://purl.obolibrary.org/obo/HP_0000822
T99 24013-24025 Phenotype denotes hypertension http://purl.obolibrary.org/obo/HP_0000822
T100 24027-24033 Phenotype denotes stroke http://purl.obolibrary.org/obo/HP_0001297
T101 26261-26266 Phenotype denotes fever http://purl.obolibrary.org/obo/HP_0001945
T102 26632-26647 Phenotype denotes atherosclerosis http://purl.obolibrary.org/obo/HP_0002621
T103 26649-26661 Phenotype denotes coagulopathy http://purl.obolibrary.org/obo/HP_0003256
T104 26691-26693 Phenotype denotes HF http://purl.obolibrary.org/obo/HP_0001635
T105 26776-26790 Phenotype denotes cytokine storm http://purl.obolibrary.org/obo/HP_0033041
T106 26930-26968 Phenotype denotes disseminated intravascular coagulation http://purl.obolibrary.org/obo/HP_0005521
T107 26998-27014 Phenotype denotes thrombocytopenia http://purl.obolibrary.org/obo/HP_0001873
T108 27019-27027 Phenotype denotes gangrene http://purl.obolibrary.org/obo/HP_0100758
T109 27166-27168 Phenotype denotes HF http://purl.obolibrary.org/obo/HP_0001635
T110 27255-27275 Phenotype denotes ventricular dilation http://purl.obolibrary.org/obo/HP_0002119
T111 27292-27320 Phenotype denotes left ventricular dysfunction http://purl.obolibrary.org/obo/HP_0005162
T112 27457-27468 Phenotype denotes myocarditis http://purl.obolibrary.org/obo/HP_0012819
T113 27555-27571 Phenotype denotes long QT-syndrome http://purl.obolibrary.org/obo/HP_0001657
T114 27640-27651 Phenotype denotes arrhythmias http://purl.obolibrary.org/obo/HP_0011675
T115 27660-27678 Phenotype denotes torsade de pointes http://purl.obolibrary.org/obo/HP_0001664
T116 27835-27837 Phenotype denotes HF http://purl.obolibrary.org/obo/HP_0001635
T117 28475-28482 Phenotype denotes obesity http://purl.obolibrary.org/obo/HP_0001513
T118 28504-28516 Phenotype denotes hypertension http://purl.obolibrary.org/obo/HP_0000822
T119 28879-28893 Phenotype denotes cytokine storm http://purl.obolibrary.org/obo/HP_0033041
T120 29653-29662 Phenotype denotes pneumonia http://purl.obolibrary.org/obo/HP_0002090
T121 29671-29694 Phenotype denotes endothelial dysfunction http://purl.obolibrary.org/obo/HP_0032654
T122 30059-30075 Phenotype denotes thromboembolisms http://purl.obolibrary.org/obo/HP_0001907
T123 30083-30090 Phenotype denotes hypoxia http://purl.obolibrary.org/obo/HP_0012418
T124 30212-30221 Phenotype denotes pneumonia http://purl.obolibrary.org/obo/HP_0002090
T125 30574-30592 Phenotype denotes hypercoagulability http://purl.obolibrary.org/obo/HP_0100724
T126 30783-30789 Phenotype denotes sepsis http://purl.obolibrary.org/obo/HP_0100806
T127 30798-30810 Phenotype denotes coagulopathy http://purl.obolibrary.org/obo/HP_0003256
T128 30971-30983 Phenotype denotes hypertension http://purl.obolibrary.org/obo/HP_0000822
T129 31291-31297 Phenotype denotes sepsis http://purl.obolibrary.org/obo/HP_0100806
T130 31306-31318 Phenotype denotes coagulopathy http://purl.obolibrary.org/obo/HP_0003256
T131 31498-31510 Phenotype denotes coagulopathy http://purl.obolibrary.org/obo/HP_0003256
T132 31633-31642 Phenotype denotes hypoxemia http://purl.obolibrary.org/obo/HP_0012418
T133 31644-31663 Phenotype denotes respiratory failure http://purl.obolibrary.org/obo/HP_0002878
T134 31763-31782 Phenotype denotes respiratory failure http://purl.obolibrary.org/obo/HP_0002878
T135 32642-32662 Phenotype denotes respiratory distress http://purl.obolibrary.org/obo/HP_0002098
T136 33025-33039 Phenotype denotes hyperlipidemia http://purl.obolibrary.org/obo/HP_0003077
T137 33080-33101 Phenotype denotes fatty acids, abnormal http://purl.obolibrary.org/obo/HP_0004359
T138 33131-33159 Phenotype denotes cardiovascular abnormalities http://purl.obolibrary.org/obo/HP_0001626
T139 33846-33855 Phenotype denotes hypoxemia http://purl.obolibrary.org/obo/HP_0012418
T140 34347-34356 Phenotype denotes pneumonia http://purl.obolibrary.org/obo/HP_0002090
T141 34417-34428 Phenotype denotes tachycardia http://purl.obolibrary.org/obo/HP_0001649
T142 35173-35192 Phenotype denotes cardiac arrhythmias http://purl.obolibrary.org/obo/HP_0011675
T143 35289-35291 Phenotype denotes HF http://purl.obolibrary.org/obo/HP_0001635
T144 35510-35512 Phenotype denotes HF http://purl.obolibrary.org/obo/HP_0001635
T145 36609-36623 Phenotype denotes Abdominal pain http://purl.obolibrary.org/obo/HP_0002027
T146 36628-36636 Phenotype denotes diarrhea http://purl.obolibrary.org/obo/HP_0002014
T147 37959-37971 Phenotype denotes hypertension http://purl.obolibrary.org/obo/HP_0000822
T148 38040-38052 Phenotype denotes hypertension http://purl.obolibrary.org/obo/HP_0000822
T149 38229-38241 Phenotype denotes hypertension http://purl.obolibrary.org/obo/HP_0000822
T150 38429-38441 Phenotype denotes hypertension http://purl.obolibrary.org/obo/HP_0000822
T151 39522-39536 Phenotype denotes cytokine storm http://purl.obolibrary.org/obo/HP_0033041
T152 40132-40146 Phenotype denotes cytokine storm http://purl.obolibrary.org/obo/HP_0033041
T153 41117-41131 Phenotype denotes Cytokine storm http://purl.obolibrary.org/obo/HP_0033041
T154 41157-41162 Phenotype denotes shock http://purl.obolibrary.org/obo/HP_0031273
T155 41382-41387 Phenotype denotes shock http://purl.obolibrary.org/obo/HP_0031273
T156 41956-41970 Phenotype denotes cytokine storm http://purl.obolibrary.org/obo/HP_0033041
T157 42495-42509 Phenotype denotes cytokine storm http://purl.obolibrary.org/obo/HP_0033041
T158 42561-42575 Phenotype denotes cytokine storm http://purl.obolibrary.org/obo/HP_0033041
T159 43060-43074 Phenotype denotes Cytokine storm http://purl.obolibrary.org/obo/HP_0033041
T160 43957-43966 Phenotype denotes pneumonia http://purl.obolibrary.org/obo/HP_0002090
T161 44474-44488 Phenotype denotes cytokine storm http://purl.obolibrary.org/obo/HP_0033041
T162 45773-45787 Phenotype denotes cytokine storm http://purl.obolibrary.org/obo/HP_0033041
T163 45957-45969 Phenotype denotes hypertension http://purl.obolibrary.org/obo/HP_0000822
T164 45971-45973 Phenotype denotes HF http://purl.obolibrary.org/obo/HP_0001635
T165 46016-46023 Phenotype denotes obesity http://purl.obolibrary.org/obo/HP_0001513
T166 46691-46700 Phenotype denotes pneumonia http://purl.obolibrary.org/obo/HP_0002090
T167 47651-47662 Phenotype denotes arrhythmias http://purl.obolibrary.org/obo/HP_0011675
T168 47667-47669 Phenotype denotes HF http://purl.obolibrary.org/obo/HP_0001635
T169 48754-48776 Phenotype denotes atrioventricular block http://purl.obolibrary.org/obo/HP_0001678
T170 48781-48799 Phenotype denotes torsade de pointes http://purl.obolibrary.org/obo/HP_0001664
T171 48800-48811 Phenotype denotes arrhythmias http://purl.obolibrary.org/obo/HP_0011675
T172 48948-48961 Phenotype denotes hyperglycemia http://purl.obolibrary.org/obo/HP_0003074
T173 48963-48977 Phenotype denotes hyperlipidemia http://purl.obolibrary.org/obo/HP_0003077
T174 48982-48995 Phenotype denotes lipodystrophy http://purl.obolibrary.org/obo/HP_0009125
T175 49571-49583 Phenotype denotes hypertension http://purl.obolibrary.org/obo/HP_0000822
T176 49585-49605 Phenotype denotes hypertriglyceridemia http://purl.obolibrary.org/obo/HP_0002155
T177 49645-49656 Phenotype denotes arrhythmias http://purl.obolibrary.org/obo/HP_0011675
T178 49665-49679 Phenotype denotes cardiomyopathy http://purl.obolibrary.org/obo/HP_0001638
T179 50205-50221 Phenotype denotes hemolytic anemia http://purl.obolibrary.org/obo/HP_0001878
T180 53537-53559 Phenotype denotes respiratory infections http://purl.obolibrary.org/obo/HP_0011947
T181 53567-53573 Phenotype denotes sepsis http://purl.obolibrary.org/obo/HP_0100806
T182 53576-53584 Phenotype denotes plethora http://purl.obolibrary.org/obo/HP_0001050
T183 53686-53689 Phenotype denotes ALI http://www.orpha.net/ORDO/Orphanet_178320
T184 54567-54570 Phenotype denotes ALI http://www.orpha.net/ORDO/Orphanet_178320
T185 55252-55255 Phenotype denotes ALI http://www.orpha.net/ORDO/Orphanet_178320
T186 55266-55272 Phenotype denotes sepsis http://purl.obolibrary.org/obo/HP_0100806
T187 55423-55429 Phenotype denotes sepsis http://purl.obolibrary.org/obo/HP_0100806
T188 55440-55445 Phenotype denotes shock http://purl.obolibrary.org/obo/HP_0031273
T189 55923-55926 Phenotype denotes ALI http://www.orpha.net/ORDO/Orphanet_178320
T190 56215-56221 Phenotype denotes sepsis http://purl.obolibrary.org/obo/HP_0100806
T191 56398-56404 Phenotype denotes sepsis http://purl.obolibrary.org/obo/HP_0100806
T192 56947-56953 Phenotype denotes sepsis http://purl.obolibrary.org/obo/HP_0100806
T193 60242-60244 Phenotype denotes HF http://purl.obolibrary.org/obo/HP_0001635
T194 61155-61167 Phenotype denotes hypertension http://purl.obolibrary.org/obo/HP_0000822
T195 61829-61832 Phenotype denotes ALI http://www.orpha.net/ORDO/Orphanet_178320
T196 61877-61883 Phenotype denotes sepsis http://purl.obolibrary.org/obo/HP_0100806
T197 61888-61902 Phenotype denotes cardiac arrest http://purl.obolibrary.org/obo/HP_0001695
T198 62018-62024 Phenotype denotes sepsis http://purl.obolibrary.org/obo/HP_0100806
T199 62076-62090 Phenotype denotes cardiomyopathy http://purl.obolibrary.org/obo/HP_0001638
T200 62906-62931 Phenotype denotes mitochondrial dysfunction http://purl.obolibrary.org/obo/HP_0003287
T201 63393-63409 Phenotype denotes oxidative stress http://purl.obolibrary.org/obo/HP_0025464
T202 63450-63462 Phenotype denotes coagulopathy http://purl.obolibrary.org/obo/HP_0003256
T203 63861-63866 Phenotype denotes Tumor http://purl.obolibrary.org/obo/HP_0002664
T204 64166-64174 Phenotype denotes plethora http://purl.obolibrary.org/obo/HP_0001050
T205 65911-65916 Phenotype denotes Tumor http://purl.obolibrary.org/obo/HP_0002664
T206 66066-66080 Phenotype denotes cytokine storm http://purl.obolibrary.org/obo/HP_0033041
T207 67526-67540 Phenotype denotes cytokine storm http://purl.obolibrary.org/obo/HP_0033041
T208 68766-68780 Phenotype denotes cytokine storm http://purl.obolibrary.org/obo/HP_0033041
T209 74552-74556 Phenotype denotes pain http://purl.obolibrary.org/obo/HP_0012531
T210 78442-78454 Phenotype denotes hypertension http://purl.obolibrary.org/obo/HP_0000822
T211 79302-79308 Phenotype denotes cancer http://purl.obolibrary.org/obo/HP_0002664
T212 79595-79600 Phenotype denotes tumor http://purl.obolibrary.org/obo/HP_0002664
T213 80583-80586 Phenotype denotes ALI http://www.orpha.net/ORDO/Orphanet_178320
T214 81947-81961 Phenotype denotes cytokine storm http://purl.obolibrary.org/obo/HP_0033041
T215 83967-83982 Phenotype denotes kidney fibrosis http://purl.obolibrary.org/obo/HP_0030760
T216 84187-84196 Phenotype denotes carcinoma http://purl.obolibrary.org/obo/HP_0030731
T217 84437-84441 Phenotype denotes pain http://purl.obolibrary.org/obo/HP_0012531
T218 88462-88487 Phenotype denotes mitochondrial dysfunction http://purl.obolibrary.org/obo/HP_0003287
T219 89915-89922 Phenotype denotes fatigue http://purl.obolibrary.org/obo/HP_0012378
T220 89927-89942 Phenotype denotes muscle weakness http://purl.obolibrary.org/obo/HP_0001324
T221 90168-90193 Phenotype denotes Mitochondrial dysfunction http://purl.obolibrary.org/obo/HP_0003287
T222 91607-91616 Phenotype denotes pneumonia http://purl.obolibrary.org/obo/HP_0002090
T223 91618-91625 Phenotype denotes hypoxia http://purl.obolibrary.org/obo/HP_0012418
T224 91681-91706 Phenotype denotes mitochondrial dysfunction http://purl.obolibrary.org/obo/HP_0003287
T225 96207-96220 Phenotype denotes neuroblastoma http://purl.obolibrary.org/obo/HP_0003006
T226 98301-98312 Phenotype denotes weight loss http://purl.obolibrary.org/obo/HP_0001824
T227 99281-99293 Phenotype denotes hypertension http://purl.obolibrary.org/obo/HP_0000822
T228 99316-99340 Phenotype denotes increased ROS production http://purl.obolibrary.org/obo/HP_0025464
T229 100808-100820 Phenotype denotes hypertension http://purl.obolibrary.org/obo/HP_0000822
T230 100822-100824 Phenotype denotes HF http://purl.obolibrary.org/obo/HP_0001635
T231 101854-101868 Phenotype denotes cytokine storm http://purl.obolibrary.org/obo/HP_0033041
T232 102006-102018 Phenotype denotes hypertension http://purl.obolibrary.org/obo/HP_0000822
T233 102020-102022 Phenotype denotes HF http://purl.obolibrary.org/obo/HP_0001635
T234 104934-104948 Phenotype denotes cytokine storm http://purl.obolibrary.org/obo/HP_0033041
T235 105119-105131 Phenotype denotes hypertension http://purl.obolibrary.org/obo/HP_0000822
T236 105598-105611 Phenotype denotes Heart Failure http://purl.obolibrary.org/obo/HP_0001635
T237 106831-106840 Phenotype denotes pneumonia http://purl.obolibrary.org/obo/HP_0002090
T238 106849-106858 Phenotype denotes hypoxemia http://purl.obolibrary.org/obo/HP_0012418
T239 106994-107002 Phenotype denotes acidosis http://purl.obolibrary.org/obo/HP_0001941
T240 107063-107087 Phenotype denotes increased ROS production http://purl.obolibrary.org/obo/HP_0025464
T241 107264-107280 Phenotype denotes oxidative stress http://purl.obolibrary.org/obo/HP_0025464
T242 109174-109183 Phenotype denotes hypoxemia http://purl.obolibrary.org/obo/HP_0012418
T243 109568-109580 Phenotype denotes coagulopathy http://purl.obolibrary.org/obo/HP_0003256
T244 109645-109657 Phenotype denotes coagulopathy http://purl.obolibrary.org/obo/HP_0003256
T245 109820-109836 Phenotype denotes thrombocytopenia http://purl.obolibrary.org/obo/HP_0001873
T246 110065-110088 Phenotype denotes abnormal blood clotting http://purl.obolibrary.org/obo/HP_0001977
T247 110220-110226 Phenotype denotes stroke http://purl.obolibrary.org/obo/HP_0001297
T248 110304-110319 Phenotype denotes thromboembolism http://purl.obolibrary.org/obo/HP_0001907
T249 110323-110349 Phenotype denotes severe SARS-CoV-2 infected http://purl.obolibrary.org/obo/HP_0033141
T250 110490-110517 Phenotype denotes severe SARS-CoV-2 infection http://purl.obolibrary.org/obo/HP_0033141
T251 110771-110797 Phenotype denotes severe SARS-CoV-2 infected http://purl.obolibrary.org/obo/HP_0033141
T252 112295-112308 Phenotype denotes hyperactivity http://purl.obolibrary.org/obo/HP_0000752
T253 112612-112624 Phenotype denotes coagulopathy http://purl.obolibrary.org/obo/HP_0003256
T254 112776-112788 Phenotype denotes dyslipidemia http://purl.obolibrary.org/obo/HP_0003119
T255 112949-112955 Phenotype denotes sepsis http://purl.obolibrary.org/obo/HP_0100806
T256 113665-113683 Phenotype denotes insulin resistance http://purl.obolibrary.org/obo/HP_0000855
T257 114224-114242 Phenotype denotes hypercoagulability http://purl.obolibrary.org/obo/HP_0100724
T258 114494-114506 Phenotype denotes dyslipidemia http://purl.obolibrary.org/obo/HP_0003119
T259 114570-114577 Phenotype denotes obesity http://purl.obolibrary.org/obo/HP_0001513
T260 115541-115553 Phenotype denotes dyslipidemia http://purl.obolibrary.org/obo/HP_0003119
T261 115880-115888 Phenotype denotes plethora http://purl.obolibrary.org/obo/HP_0001050
T262 116104-116118 Phenotype denotes cytokine storm http://purl.obolibrary.org/obo/HP_0033041
T263 116323-116343 Phenotype denotes hypertriglyceridemia http://purl.obolibrary.org/obo/HP_0002155
T264 117415-117418 Phenotype denotes ALI http://www.orpha.net/ORDO/Orphanet_178320
T265 117535-117538 Phenotype denotes ALI http://www.orpha.net/ORDO/Orphanet_178320
T266 117899-117905 Phenotype denotes sepsis http://purl.obolibrary.org/obo/HP_0100806
T267 118632-118638 Phenotype denotes sepsis http://purl.obolibrary.org/obo/HP_0100806
T268 119163-119170 Phenotype denotes colitis http://purl.obolibrary.org/obo/HP_0002583
T269 119282-119300 Phenotype denotes acute pancreatitis http://purl.obolibrary.org/obo/HP_0001735
T270 122683-122695 Phenotype denotes coagulopathy http://purl.obolibrary.org/obo/HP_0003256

2_test

Id Subject Object Predicate Lexical cue
33031856-27344959-84038790 2388-2392 27344959 denotes 2016
33031856-23075143-84038791 2449-2453 23075143 denotes 2012
33031856-32004165-84038792 2933-2937 32004165 denotes 2020
33031856-32015507-84038793 2952-2956 32015507 denotes 2020
33031856-32031570-84038794 3142-3146 32031570 denotes 2020
33031856-30531947-84038795 3677-3681 30531947 denotes 2019
33031856-32327580-84038796 3908-3912 32327580 denotes 2020
33031856-32007143-84038797 4401-4405 32007143 denotes 2020
33031856-31986264-84038798 4421-4425 31986264 denotes 2020
33031856-31986264-84038799 4664-4668 31986264 denotes 2020
33031856-32091533-84038800 4685-4689 32091533 denotes 2020
33031856-32321655-84038801 5016-5020 32321655 denotes 2020
33031856-32252591-84038802 5436-5440 32252591 denotes 2020
33031856-32297796-84038803 5483-5487 32297796 denotes 2020
33031856-32696108-84038804 5502-5506 32696108 denotes 2020
33031856-32527304-84038805 5763-5767 32527304 denotes 2020
33031856-32527304-84038806 5992-5996 32527304 denotes 2020
33031856-32032529-84038807 6017-6021 32032529 denotes 2020
33031856-32696108-84038808 6036-6040 32696108 denotes 2020
33031856-32696108-84038809 6283-6287 32696108 denotes 2020
33031856-32696108-84038810 6646-6650 32696108 denotes 2020
33031856-32696108-84038811 6283-6287 32696108 denotes 2020
33031856-32252591-84038812 7073-7077 32252591 denotes 2020
33031856-32560665-84038813 7471-7475 32560665 denotes 2020
33031856-32650004-84038814 8031-8035 32650004 denotes 2020
33031856-29570241-84038815 8279-8283 29570241 denotes 2018
33031856-25602997-84038816 8458-8462 25602997 denotes 2015
33031856-22219349-84038817 8726-8730 22219349 denotes 2012
33031856-22981899-84038818 8747-8751 22981899 denotes 2013
33031856-14504188-84038819 9055-9059 14504188 denotes 2003
33031856-16461478-84038820 9072-9076 16461478 denotes 2006
33031856-26922692-84038821 9224-9228 26922692 denotes 2016
33031856-32031570-84038822 9763-9767 32031570 denotes 2020
33031856-32171076-84038823 10106-10110 32171076 denotes 2020
33031856-31986264-84038824 10266-10270 31986264 denotes 2020
33031856-32031570-84038825 10290-10294 32031570 denotes 2020
33031856-32211816-84038826 10498-10502 32211816 denotes 2020
33031856-32064853-84038827 10707-10711 32064853 denotes 2020
33031856-32091533-84038828 10728-10732 32091533 denotes 2020
33031856-32064853-84038829 10962-10966 32064853 denotes 2020
33031856-32109013-84038830 11123-11127 32109013 denotes 2020
33031856-32219357-84038831 11164-11168 32219357 denotes 2020
33031856-32171076-84038832 11188-11192 32171076 denotes 2020
33031856-32085846-84038833 11425-11429 32085846 denotes 2020
33031856-32171076-84038834 13137-13141 32171076 denotes 2020
33031856-32085846-84038835 15552-15556 32085846 denotes 2020
33031856-19453650-84038836 15805-15809 19453650 denotes 2009
33031856-19453650-84038837 16001-16005 19453650 denotes 2009
33031856-32264791-84038838 16235-16239 32264791 denotes 2020
33031856-27081112-84038839 16342-16346 27081112 denotes 2016
33031856-32264791-84038840 16574-16578 32264791 denotes 2020
33031856-32015508-84038841 16716-16720 32015508 denotes 2020
33031856-29325222-84038842 17246-17250 29325222 denotes 2018
33031856-32035018-84038843 17290-17294 32035018 denotes 2020
33031856-32007143-84038844 18167-18171 32007143 denotes 2020
33031856-31986264-84038845 18207-18211 31986264 denotes 2020
33031856-32031570-84038846 18231-18235 32031570 denotes 2020
33031856-26867177-84038847 18732-18736 26867177 denotes 2016
33031856-32838323-84038848 21059-21063 32838323 denotes 2020
33031856-32350134-84038849 11425-11429 32350134 denotes 2020
33031856-32719045-84038850 22585-22589 32719045 denotes 2020
33031856-32376597-84038851 23831-23835 32376597 denotes 2020
33031856-32835245-84038852 24583-24587 32835245 denotes 2020
33031856-31981224-84038853 24855-24859 31981224 denotes 2020
33031856-30761102-84038854 25428-25432 30761102 denotes 2019
33031856-31034780-84038855 25446-25450 31034780 denotes 2019
33031856-25879282-84038856 25742-25746 25879282 denotes 2015
33031856-30185776-84038857 26314-26318 30185776 denotes 2018
33031856-11877368-84038858 26720-26724 11877368 denotes 2002
33031856-32362390-84038859 27059-27063 32362390 denotes 2020
33031856-12912811-84038860 27336-27340 12912811 denotes 2003
33031856-12578819-84038861 27361-27365 12578819 denotes 2003
33031856-32085846-84038862 27500-27504 32085846 denotes 2020
33031856-26318109-84038863 28010-28014 26318109 denotes 2015
33031856-12645876-84038864 28690-28694 12645876 denotes 2003
33031856-21178458-84038865 28707-28711 21178458 denotes 2010
33031856-17408451-84038866 28732-28736 17408451 denotes 2007
33031856-22934096-84038867 28751-28755 22934096 denotes 2012
33031856-17420787-84038868 29441-29445 17420787 denotes 2007
33031856-17319905-84038869 29518-29522 17319905 denotes 2007
33031856-19753144-84038870 29608-29612 19753144 denotes 2009
33031856-32291094-84038871 30472-30476 32291094 denotes 2020
33031856-32220112-84038872 31570-31574 32220112 denotes 2020
33031856-28831119-84038873 33172-33176 28831119 denotes 2017
33031856-32430627-84038874 34281-34285 32430627 denotes 2020
33031856-23332146-84038875 34889-34893 23332146 denotes 2013
33031856-3059874-84038876 35003-35007 3059874 denotes 1988
33031856-5443179-84038877 35112-35116 5443179 denotes 1970
33031856-5443180-84038878 35163-35167 5443180 denotes 1970
33031856-29570241-84038879 35208-35212 29570241 denotes 2018
33031856-32302265-84038880 38759-38763 32302265 denotes 2020
33031856-32517963-84038881 39429-39433 32517963 denotes 2020
33031856-32493514-84038882 40740-40744 32493514 denotes 2020
33031856-32641154-84038883 41092-41096 32641154 denotes 2020
33031856-32586396-84038884 41477-41481 32586396 denotes 2020
33031856-32758298-84038885 41834-41838 32758298 denotes 2020
33031856-32493441-84038886 43003-43007 32493441 denotes 2020
33031856-32171074-84038887 46715-46719 32171074 denotes 2020
33031856-29685876-84038888 47708-47712 29685876 denotes 2018
33031856-25561362-84038889 47731-47735 25561362 denotes 2015
33031856-15030519-84038890 47903-47907 15030519 denotes 2004
33031856-32192578-84038891 48052-48056 32192578 denotes 2020
33031856-32043983-84038892 48086-48090 32043983 denotes 2020
33031856-32187464-84038893 48552-48556 32187464 denotes 2020
33031856-20039804-84038894 48852-48856 20039804 denotes 2010
33031856-19362991-84038895 49084-49088 19362991 denotes 2009
33031856-10888979-84038896 49129-49133 10888979 denotes 2000
33031856-32574262-84038897 49287-49291 32574262 denotes 2020
33031856-27400984-84038898 49753-49757 27400984 denotes 2016
33031856-21310673-84038899 50345-50349 21310673 denotes 2011
33031856-32623082-84038900 50564-50568 32623082 denotes 2020
33031856-32409561-84038901 50631-50635 32409561 denotes 2020
33031856-28687413-84038902 50778-50782 28687413 denotes 2017
33031856-32936252-84038903 50936-50940 32936252 denotes 2020
33031856-26771963-84038904 52591-52595 26771963 denotes 2015
33031856-25471798-84038905 52871-52875 25471798 denotes 2015
33031856-7342077-84038906 52887-52891 7342077 denotes 1981
33031856-16841856-84038907 53469-53473 16841856 denotes 2006
33031856-12665164-84038908 53809-53813 12665164 denotes 2003
33031856-26015869-84038909 53860-53864 26015869 denotes 2015
33031856-16484911-84038910 53881-53885 16484911 denotes 2006
33031856-18631417-84038915 54901-54905 18631417 denotes 2009
33031856-16850002-84038916 55521-55525 16850002 denotes 2006
33031856-18974237-84038917 56006-56010 18974237 denotes 2008
33031856-23983421-84038918 56445-56449 23983421 denotes 2013
33031856-30703574-84038919 56710-56714 30703574 denotes 2019
33031856-31250474-84038920 57063-57067 31250474 denotes 2020
33031856-32270798-84038922 59335-59339 32270798 denotes 2020
33031856-27458590-84038923 59424-59428 27458590 denotes 2016
33031856-31067438-84038924 59603-59607 31067438 denotes 2019
33031856-19859067-84038925 59689-59693 19859067 denotes 2009
33031856-17398290-84038926 59708-59712 17398290 denotes 2007
33031856-23546563-84038927 59975-59979 23546563 denotes 2013
33031856-28620111-84038928 60313-60317 28620111 denotes 2017
33031856-28289069-84038929 60338-60342 28289069 denotes 2017
33031856-17575985-84038930 60941-60945 17575985 denotes 2008
33031856-15821175-84038931 61003-61007 15821175 denotes 2005
33031856-16616012-84038932 61060-61064 16616012 denotes 2006
33031856-18360184-84038933 61132-61136 18360184 denotes 2008
33031856-12172309-84038934 61213-61217 12172309 denotes 2002
33031856-16616012-84038935 61239-61243 16616012 denotes 2006
33031856-22765297-84038936 61661-61665 22765297 denotes 2013
33031856-28900017-84038937 61675-61679 28900017 denotes 2017
33031856-31986264-84038938 61918-61922 31986264 denotes 2020
33031856-29053142-84038939 62107-62111 29053142 denotes 2018
33031856-31986264-84038940 66453-66457 31986264 denotes 2020
33031856-32653511-84038941 66759-66763 32653511 denotes 2020
33031856-18541548-84038942 66978-66982 18541548 denotes 2008
33031856-8607877-84038943 67798-67802 8607877 denotes 1996
33031856-7524649-84038944 67855-67859 7524649 denotes 1994
33031856-8598544-84038945 67888-67892 8598544 denotes 1996
33031856-10996338-84038946 67920-67924 10996338 denotes 2000
33031856-9708190-84038947 67946-67950 9708190 denotes 1998
33031856-10090832-84038948 68128-68132 10090832 denotes 1999
33031856-12388359-84038949 68172-68176 12388359 denotes 2003
33031856-14963056-84038950 68212-68216 14963056 denotes 2004
33031856-18547851-84038951 68305-68309 18547851 denotes 2008
33031856-18632990-84038952 68335-68339 18632990 denotes 2008
33031856-17765904-84038953 68508-68512 17765904 denotes 2008
33031856-9830030-84038954 68566-68570 9830030 denotes 1998
33031856-10577502-84038955 68603-68607 10577502 denotes 1999
33031856-14713228-84038956 68631-68635 14713228 denotes 2003
33031856-20813258-84038957 69385-69389 20813258 denotes 2010
33031856-24439267-84038958 69811-69815 24439267 denotes 2014
33031856-24501331-84038959 70230-70234 24501331 denotes 2014
33031856-24675722-84038960 70258-70262 24675722 denotes 2014
33031856-17322368-84038961 70345-70349 17322368 denotes 2007
33031856-15774854-84038962 70829-70833 15774854 denotes 2005
33031856-25319326-84038963 70875-70879 25319326 denotes 2014
33031856-26690421-84038964 70920-70924 26690421 denotes 2015
33031856-24673159-84038965 71186-71190 24673159 denotes 2014
33031856-28820283-84038966 71213-71217 28820283 denotes 2017
33031856-22174614-84038967 71509-71513 22174614 denotes 2011
33031856-29352206-84038968 71737-71741 29352206 denotes 2018
33031856-27535180-84038969 71757-71761 27535180 denotes 2016
33031856-27535180-84038970 72114-72118 27535180 denotes 2016
33031856-25445227-84038971 72275-72279 25445227 denotes 2015
33031856-22903555-84038972 72354-72358 22903555 denotes 2012
33031856-9741345-84038973 72401-72405 9741345 denotes 1998
33031856-25445227-84038974 72442-72446 25445227 denotes 2015
33031856-28782808-84038975 72729-72733 28782808 denotes 2018
33031856-25445227-84038976 72983-72987 25445227 denotes 2015
33031856-28904023-84038977 73009-73013 28904023 denotes 2018
33031856-28551025-84038978 73581-73585 28551025 denotes 2017
33031856-29080699-84038979 73625-73629 29080699 denotes 2018
33031856-2166915-84038980 74330-74334 2166915 denotes 1990
33031856-6304720-84038981 75041-75045 6304720 denotes 1983
33031856-6096400-84038982 75059-75063 6096400 denotes 1984
33031856-18195292-84038983 75074-75078 18195292 denotes 2008
33031856-16841861-84038984 75253-75257 16841861 denotes 2006
33031856-21591683-84038985 75273-75277 21591683 denotes 2011
33031856-8604658-84038986 75456-75460 8604658 denotes 1996
33031856-2985986-84038987 75474-75478 2985986 denotes 1985
33031856-6330066-84038988 75490-75494 6330066 denotes 1984
33031856-8381847-84038989 75541-75545 8381847 denotes 1993
33031856-6318749-84038990 75797-75801 6318749 denotes 1983
33031856-6321468-84038991 75815-75819 6321468 denotes 1984
33031856-6096400-84038992 75849-75853 6096400 denotes 1984
33031856-12391014-84038993 76437-76441 12391014 denotes 2002
33031856-22912397-84038994 76671-76675 22912397 denotes 2012
33031856-11034610-84038995 76953-76957 11034610 denotes 2000
33031856-12391014-84038996 76974-76978 12391014 denotes 2002
33031856-19865173-84038997 76994-76998 19865173 denotes 2009
33031856-17496159-84038998 77364-77368 17496159 denotes 2007
33031856-12391014-84038999 77385-77389 12391014 denotes 2002
33031856-20080636-84039000 77641-77645 20080636 denotes 2010
33031856-12391014-84039001 77890-77894 12391014 denotes 2002
33031856-17013391-84039002 78123-78127 17013391 denotes 2006
33031856-17568749-84039003 78162-78166 17568749 denotes 2007
33031856-15061569-84039004 78185-78189 15061569 denotes 2004
33031856-25910811-84039005 78490-78494 25910811 denotes 2015
33031856-29191914-84039006 79631-79635 29191914 denotes 2018
33031856-19103881-84039007 79819-79823 19103881 denotes 2009
33031856-25713027-84039008 80042-80046 25713027 denotes 2015
33031856-28596328-84039009 80196-80200 28596328 denotes 2017
33031856-26878209-84039010 80216-80220 26878209 denotes 2016
33031856-23438748-84039011 80407-80411 23438748 denotes 2013
33031856-26335394-84039012 80470-80474 26335394 denotes 2016
33031856-20887750-84039013 80629-80633 20887750 denotes 2011
33031856-29664060-84039014 80658-80662 29664060 denotes 2018
33031856-20887750-84039015 81023-81027 20887750 denotes 2011
33031856-23477864-84039016 81151-81155 23477864 denotes 2013
33031856-24400794-84039017 81263-81267 24400794 denotes 2014
33031856-23273709-84039018 81468-81472 23273709 denotes 2013
33031856-30034876-84039019 81741-81745 30034876 denotes 2018
33031856-31677539-84039020 81968-81972 31677539 denotes 2019
33031856-20732876-84039021 82586-82590 20732876 denotes 2010
33031856-20869469-84039022 82610-82614 20869469 denotes 2011
33031856-26002735-84039023 82645-82649 26002735 denotes 2015
33031856-20732876-84039024 82812-82816 20732876 denotes 2010
33031856-24691274-84039025 82830-82834 24691274 denotes 2014
33031856-21187320-84039026 82859-82863 21187320 denotes 2011
33031856-30223037-84039027 83194-83198 30223037 denotes 2018
33031856-30326194-84039028 83382-83386 30326194 denotes 2019
33031856-26065911-84039029 84031-84035 26065911 denotes 2015
33031856-20008283-84039030 84317-84321 20008283 denotes 2010
33031856-20664072-84039031 84911-84915 20664072 denotes 2010
33031856-32270798-84039032 86020-86024 32270798 denotes 2020
33031856-25966354-84039033 86575-86579 25966354 denotes 2015
33031856-27744130-84039034 86599-86603 27744130 denotes 2016
33031856-11270600-84039035 86807-86811 11270600 denotes 2001
33031856-20176053-84039036 86825-86829 20176053 denotes 2010
33031856-21798252-84039037 86861-86865 21798252 denotes 2011
33031856-20071694-84039038 86915-86919 20071694 denotes 2010
33031856-17158407-84039039 86940-86944 17158407 denotes 2006
33031856-18346461-84039040 86965-86969 18346461 denotes 2008
33031856-10652989-84039041 87211-87215 10652989 denotes 1999
33031856-10692004-84039042 87346-87350 10692004 denotes 2000
33031856-2056126-84039043 87774-87778 2056126 denotes 1991
33031856-2005103-84039044 87802-87806 2005103 denotes 1991
33031856-25838312-84039045 87816-87820 25838312 denotes 2015
33031856-12719436-84039046 87838-87842 12719436 denotes 2003
33031856-2123401-84039047 88141-88145 2123401 denotes 1990
33031856-21430245-84039048 88161-88165 21430245 denotes 2011
33031856-8491162-84039049 88184-88188 8491162 denotes 1993
33031856-19466285-84039050 88205-88209 19466285 denotes 2009
33031856-32270798-84039051 88406-88410 32270798 denotes 2020
33031856-27126807-84039052 88814-88818 27126807 denotes 2016
33031856-23219298-84039053 89144-89148 23219298 denotes 2013
33031856-31999918-84039054 89383-89387 31999918 denotes 2020
33031856-29246869-84039055 89417-89421 29246869 denotes 2018
33031856-28131082-84039056 89445-89449 28131082 denotes 2017
33031856-20170624-84039057 89739-89743 20170624 denotes 2010
33031856-25979837-84039058 89770-89774 25979837 denotes 2015
33031856-27126807-84039059 89792-89796 27126807 denotes 2016
33031856-32574708-84039060 89834-89838 32574708 denotes 2020
33031856-25500014-84039061 90304-90308 25500014 denotes 2015
33031856-30719617-84039062 90344-90348 30719617 denotes 2019
33031856-25313054-84039063 90361-90365 25313054 denotes 2014
33031856-30326194-84039064 90544-90548 30326194 denotes 2019
33031856-30692927-84039065 90689-90693 30692927 denotes 2018
33031856-26549800-84039066 91097-91101 26549800 denotes 2016
33031856-21357740-84039067 91117-91121 21357740 denotes 2011
33031856-23442817-84039068 91375-91379 23442817 denotes 2013
33031856-32510973-84039069 91983-91987 32510973 denotes 2020
33031856-28578275-84039070 92301-92305 28578275 denotes 2017
33031856-23991888-84039071 92347-92351 23991888 denotes 2014
33031856-19076429-84039072 92362-92366 19076429 denotes 2008
33031856-21128700-84039073 92385-92389 21128700 denotes 2011
33031856-25642965-84039074 92404-92408 25642965 denotes 2015
33031856-26549800-84039075 92545-92549 26549800 denotes 2016
33031856-21357740-84039076 92565-92569 21357740 denotes 2011
33031856-21151103-84039077 92588-92592 21151103 denotes 2011
33031856-25642965-84039078 92607-92611 25642965 denotes 2015
33031856-19474179-84039079 93394-93398 19474179 denotes 2009
33031856-27242531-84039080 93449-93453 27242531 denotes 2016
33031856-30326194-84039081 93714-93718 30326194 denotes 2019
33031856-30034876-84039082 94723-94727 30034876 denotes 2018
33031856-27746159-84039083 94744-94748 27746159 denotes 2016
33031856-7035675-84039084 94792-94796 7035675 denotes 1982
33031856-956366-84039085 94830-94834 956366 denotes 1976
33031856-430467-84039086 94853-94857 430467 denotes 1979
33031856-30034876-84039087 95151-95155 30034876 denotes 2018
33031856-16388394-84039089 95202-95206 16388394 denotes 2006
33031856-7447706-84039090 95233-95237 7447706 denotes 1980
33031856-23477864-84039091 95637-95641 23477864 denotes 2013
33031856-31882804-84039092 96494-96498 31882804 denotes 2019
33031856-19549756-84039093 97484-97488 19549756 denotes 2009
33031856-10024609-84039094 98164-98168 10024609 denotes 1999
33031856-10632664-84039095 98205-98209 10632664 denotes 2000
33031856-10024609-84039096 98394-98398 10024609 denotes 1999
33031856-12673184-84039097 99424-99428 12673184 denotes 2003
33031856-1644917-84039098 99593-99597 1644917 denotes 1992
33031856-8187280-84039099 99646-99650 8187280 denotes 1994
33031856-30034876-84039100 99975-99979 30034876 denotes 2018
33031856-9111529-84039101 99994-99998 9111529 denotes 1997
33031856-32132184-84039102 100012-100016 32132184 denotes 2020
33031856-23488800-84039103 100362-100366 23488800 denotes 2013
33031856-25721616-84039104 100382-100386 25721616 denotes 2015
33031856-12075344-84039105 100863-100867 12075344 denotes 2002
33031856-27081112-84039106 100883-100887 27081112 denotes 2016
33031856-32132184-84039107 101248-101252 32132184 denotes 2020
33031856-12075344-84039108 101467-101471 12075344 denotes 2002
33031856-16001071-84039109 101486-101490 16001071 denotes 2005
33031856-12075344-84039110 101663-101667 12075344 denotes 2002
33031856-16001071-84039111 101682-101686 16001071 denotes 2005
33031856-32293910-84039112 102107-102111 32293910 denotes 2020
33031856-19453650-84039113 102127-102131 19453650 denotes 2009
33031856-32048163-84039114 102243-102247 32048163 denotes 2020
33031856-30905634-84039115 102496-102500 30905634 denotes 2019
33031856-27081112-84039116 102516-102520 27081112 denotes 2016
33031856-32302265-84039117 102937-102941 32302265 denotes 2020
33031856-32215613-84039118 103184-103188 32215613 denotes 2020
33031856-9111529-84039119 103736-103740 9111529 denotes 1997
33031856-23676336-84039120 103942-103946 23676336 denotes 2013
33031856-23826374-84039121 104175-104179 23826374 denotes 2013
33031856-18814896-84039123 104219-104223 18814896 denotes 2008
33031856-32228252-84039124 104683-104687 32228252 denotes 2020
33031856-32195824-84039125 104830-104834 32195824 denotes 2020
33031856-32227090-84039126 105035-105039 32227090 denotes 2020
33031856-32348166-84039127 105271-105275 32348166 denotes 2020
33031856-32356627-84039128 105468-105472 32356627 denotes 2020
33031856-32302265-84039129 105713-105717 32302265 denotes 2020
33031856-32161990-84039130 107041-107045 32161990 denotes 2020
33031856-30326194-84039131 107894-107898 30326194 denotes 2019
33031856-21696310-84039132 107959-107963 21696310 denotes 2011
33031856-22051327-84039133 107983-107987 22051327 denotes 2011
33031856-24597798-84039134 108839-108843 24597798 denotes 2014
33031856-30326194-84039135 109076-109080 30326194 denotes 2019
33031856-32220112-84039136 109983-109987 32220112 denotes 2020
33031856-32291094-84039137 110133-110137 32291094 denotes 2020
33031856-31410983-84039138 110373-110377 31410983 denotes 2019
33031856-32164091-84039139 110393-110397 32164091 denotes 2020
33031856-32220112-84039140 110610-110614 32220112 denotes 2020
33031856-32220112-84039141 110827-110831 32220112 denotes 2020
33031856-32270798-84039142 111049-111053 32270798 denotes 2020
33031856-30266534-84039143 111675-111679 30266534 denotes 2018
33031856-12530552-84039144 111874-111878 12530552 denotes 2002
33031856-12530552-84039145 112093-112097 12530552 denotes 2002
33031856-30266534-84039146 112364-112368 30266534 denotes 2018
33031856-32217556-84039147 112986-112990 32217556 denotes 2020
33031856-32211816-84039148 113027-113031 32211816 denotes 2020
33031856-32031570-84039149 113051-113055 32031570 denotes 2020
33031856-32171076-84039150 113075-113079 32171076 denotes 2020
33031856-17420787-84039151 113230-113234 17420787 denotes 2007
33031856-32217556-84039152 113483-113487 32217556 denotes 2020
33031856-32579986-84039153 113527-113531 32579986 denotes 2020
33031856-32393351-84039154 113697-113701 32393351 denotes 2020
33031856-20974999-84039155 114129-114133 20974999 denotes 2010
33031856-24891399-84039156 114172-114176 24891399 denotes 2014
33031856-24239923-84039157 114994-114998 24239923 denotes 2013
33031856-22819432-84039158 115761-115765 22819432 denotes 2012
33031856-17825687-84039159 115785-115789 17825687 denotes 2007
33031856-22819432-84039160 115953-115957 22819432 denotes 2012
33031856-12540386-84039161 115972-115976 12540386 denotes 2003
33031856-32192578-84039162 116232-116236 32192578 denotes 2020
33031856-22819432-84039163 116364-116368 22819432 denotes 2012
33031856-20796218-84039164 117440-117444 20796218 denotes 2010
33031856-10470743-84039165 117800-117804 10470743 denotes 1999
33031856-16484911-84039166 117821-117825 16484911 denotes 2006
33031856-16850002-84039167 118232-118236 16850002 denotes 2006
33031856-12615625-84039168 119043-119047 12615625 denotes 2003
33031856-11898774-84039169 119195-119199 11898774 denotes 2002
33031856-18443134-84039170 119756-119760 18443134 denotes 2008
33031856-19426581-84039171 120126-120130 19426581 denotes 2009
33031856-26791189-84039172 120178-120182 26791189 denotes 2016

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
3 4-35 Chemical denotes N-3 polyunsaturated fatty acids MESH:D015525
4 83-91 Disease denotes COVID-19 MESH:C000657245
5 103-131 Disease denotes cardiovascular complications MESH:D002318
35 1112-1116 Gene denotes PUFA Gene:9933
36 194-241 Species denotes Severe Acute Respiratory Syndrome Coronavirus 2 Tax:2697049
37 243-253 Species denotes SARS-CoV-2 Tax:2697049
38 371-381 Species denotes SARS-CoV-2 Tax:2697049
39 795-803 Species denotes patients Tax:9606
40 998-1006 Species denotes patients Tax:9606
41 1739-1747 Species denotes patients Tax:9606
42 1075-1106 Chemical denotes n-3 polyunsaturated fatty acids MESH:D015525
43 1309-1318 Chemical denotes n-3 PUFAs MESH:D015525
44 1320-1341 Chemical denotes eicosapentaenoic acid MESH:D015118
45 1343-1346 Chemical denotes EPA MESH:D015118
46 1352-1372 Chemical denotes docosahexaenoic acid MESH:D004281
47 1374-1377 Chemical denotes DHA MESH:D004281
48 1426-1431 Chemical denotes lipid MESH:D008055
49 1595-1604 Chemical denotes n-3 PUFAs MESH:D015525
50 1657-1666 Chemical denotes n-3 PUFAs MESH:D015525
51 1937-1938 Chemical denotes n MESH:D009584
52 143-167 Disease denotes Coronavirus disease 2019 MESH:C000657245
53 169-177 Disease denotes COVID-19 MESH:C000657245
54 430-453 Disease denotes respiratory dysfunction MESH:D012131
55 615-630 Disease denotes viral infection MESH:D001102
56 672-688 Disease denotes hypercoagulation MESH:D019851
57 786-794 Disease denotes COVID-19 MESH:C000657245
58 862-870 Disease denotes COVID-19 MESH:C000657245
59 989-997 Disease denotes COVID-19 MESH:C000657245
60 1256-1268 Disease denotes coagulopathy MESH:D001778
61 1730-1738 Disease denotes COVID-19 MESH:C000657245
62 1812-1840 Disease denotes cardiovascular complications MESH:D002318
63 1854-1862 Disease denotes COVID-19 MESH:C000657245
85 2013-2032 Species denotes novel coronaviruses Tax:2697049
86 2088-2099 Species denotes coronavirus Tax:11118
87 2101-2109 Species denotes SARS-CoV Tax:694009
88 2163-2215 Species denotes Middle East respiratory syndrome-related coronavirus Tax:1335626
89 2217-2225 Species denotes MERS-CoV Tax:1335626
90 2233-2241 Species denotes SARS-CoV Tax:694009
91 2246-2254 Species denotes MERS-CoV Tax:1335626
92 2460-2471 Species denotes Coronavirus Tax:11118
93 2567-2578 Species denotes coronavirus Tax:11118
94 2672-2680 Species denotes SARS-CoV Tax:694009
95 2754-2801 Species denotes severe acute respiratory syndrome coronavirus 2 Tax:2697049
96 2803-2813 Species denotes SARS-CoV-2 Tax:2697049
97 2818-2840 Species denotes 2019-novel coronavirus Tax:2697049
98 3410-3418 Species denotes patients Tax:9606
99 2309-2315 Disease denotes deaths MESH:D003643
100 2624-2632 Disease denotes COVID-19 MESH:C000657245
101 2982-2990 Disease denotes COVID-19 MESH:C000657245
102 3081-3090 Disease denotes pneumonia MESH:D011014
103 3168-3176 Disease denotes COVID-19 MESH:C000657245
104 3275-3283 Disease denotes COVID-19 MESH:C000657245
156 5230-5243 Gene denotes interleukin-6 Gene:3569
157 5297-5301 Gene denotes IL-6 Gene:3569
158 5324-5328 Gene denotes IL-6 Gene:3569
159 5404-5408 Gene denotes IL-6 Gene:3569
160 5513-5517 Gene denotes TNFα Gene:7124
161 5583-5587 Gene denotes TNFα Gene:7124
162 5894-5898 Gene denotes IL-6 Gene:3569
163 5917-5923 Gene denotes STAT-1 Gene:6772
164 5928-5934 Gene denotes STAT-3 Gene:6774
165 6084-6108 Gene denotes IL-1 receptor antagonist Gene:3557
166 6289-6337 Gene denotes Granulocyte-macrophage-colony stimulating factor Gene:1437
167 6339-6345 Gene denotes GM-CSF Gene:1437
168 6485-6491 Gene denotes GM-CSF Gene:1437
169 6536-6542 Gene denotes GM-CSF Gene:1437
176 6047-6060 Gene denotes interleukin-1 Gene:3552
177 4986-4994 Species denotes patients Tax:9606
178 6207-6214 Species denotes patient Tax:9606
179 6436-6444 Species denotes patients Tax:9606
180 6360-6366 Gene denotes GM-CSF Gene:1437
181 4889-4898 Chemical denotes Vitamin C MESH:D001205
182 5022-5031 Chemical denotes Melatonin MESH:D008550
183 4942-4958 Disease denotes cardiac injuries MESH:D006331
184 4962-4976 Disease denotes critically ill MESH:D016638
185 4977-4985 Disease denotes COVID-19 MESH:C000657245
186 5069-5090 Disease denotes septic cardiomyopathy MESH:D009202
187 5109-5130 Disease denotes myocardial infarction MESH:D009203
188 5132-5146 Disease denotes cardiomyopathy MESH:D009202
189 5148-5175 Disease denotes hypertensive heart diseases MESH:D006973
190 5181-5203 Disease denotes pulmonary hypertension MESH:D006976
191 5645-5653 Disease denotes COVID-19 MESH:C000657245
192 5728-5774 Disease denotes cardiac injury (Convertino et al., 2020) Janus MESH:D006331
193 6234-6240 Disease denotes sepsis MESH:D018805
194 6413-6435 Disease denotes macrophages • COVID-19 MESH:C000657245
195 6582-6592 Disease denotes gimsilumab
208 4806-4814 Species denotes patients Tax:9606
209 4797-4805 Disease denotes COVID-19 MESH:C000657245
228 3525-3538 Species denotes Coronaviruses Tax:11118
229 3563-3569 Species denotes humans Tax:9606
230 3698-3708 Species denotes SARS-CoV-2 Tax:2697049
231 3927-3935 Disease denotes COVID-19 MESH:C000657245
232 3954-3961 Disease denotes myalgia MESH:D063806
233 3963-3970 Disease denotes fatigue MESH:D005221
234 3972-3977 Disease denotes fever MESH:D005334
235 3982-3991 Disease denotes dry cough MESH:D003371
236 4013-4038 Disease denotes respiratory tract disease MESH:D012140
237 4108-4119 Disease denotes lung injury MESH:D055370
238 4127-4162 Disease denotes acute respiratory distress syndrome MESH:D012128
239 4164-4168 Disease denotes ARDS MESH:D012128
240 4171-4190 Disease denotes respiratory failure MESH:D012131
241 4192-4198 Disease denotes sepsis MESH:D018805
242 4200-4213 Disease denotes heart failure MESH:D006333
243 4230-4244 Disease denotes cardiac arrest MESH:D006323
244 4312-4321 Disease denotes mortality MESH:D003643
245 4583-4591 Disease denotes COVID-19 MESH:C000657245
248 8041-8049 Disease denotes COVID-19 MESH:C000657245
249 8054-8082 Disease denotes cardiovascular complications MESH:D002318
274 8329-8337 Species denotes patients Tax:9606
275 8486-8494 Species denotes patients Tax:9606
276 8831-8839 Species denotes patients Tax:9606
277 8936-8944 Species denotes patients Tax:9606
278 9034-9042 Species denotes patients Tax:9606
279 9107-9115 Species denotes MERS-CoV Tax:1335626
280 8107-8116 Disease denotes pneumonia MESH:D011014
281 8209-8237 Disease denotes cardiovascular complications MESH:D002318
282 8354-8376 Disease denotes cardiovascular disease MESH:D002318
283 8423-8432 Disease denotes pneumonia MESH:D011014
284 8519-8528 Disease denotes pneumonia MESH:D011014
285 8645-8654 Disease denotes pneumonia MESH:D011014
286 8691-8700 Disease denotes mortality MESH:D003643
287 8787-8808 Disease denotes cardiac complications MESH:D005117
288 8845-8873 Disease denotes novel coronavirus infections MESH:C000657245
289 8882-8893 Disease denotes tachycardia MESH:D013610
290 8898-8909 Disease denotes hypotension MESH:D007022
291 8956-8966 Disease denotes arrhythmia MESH:D001145
292 8968-8980 Disease denotes cardiomegaly MESH:D006332
293 8985-9006 Disease denotes diastolic dysfunction MESH:D007022
294 9092-9101 Disease denotes infection MESH:D007239
295 9142-9153 Disease denotes myocarditis MESH:D009205
296 9155-9171 Disease denotes myocardial edema MESH:D004487
297 9183-9211 Disease denotes left ventricular dysfunction MESH:D018487
310 12428-12433 Gene denotes NLRP3 Gene:114548
311 12299-12305 Chemical denotes sodium MESH:D012964
312 12310-12315 Chemical denotes water MESH:D014867
313 12537-12543 Chemical denotes oxygen MESH:D010100
314 11794-11802 Disease denotes COVID-19 MESH:C000657245
315 11811-11832 Disease denotes cardiovascular injury MESH:D002318
316 11855-11881 Disease denotes injury • Acute myocarditis MESH:D009205
317 12116-12134 Disease denotes torsade de pointes MESH:D016171
318 12201-12214 Disease denotes heart failure MESH:D006333
319 12456-12467 Disease denotes tachycardia MESH:D013610
320 12502-12514 Disease denotes hypertension MESH:D006973
321 12561-12581 Disease denotes ischemia • Pneumonia MESH:D007511
324 11744-11752 Disease denotes COVID-19 MESH:C000657245
325 11764-11792 Disease denotes cardiovascular complications MESH:D002318
371 9264-9272 Species denotes patients Tax:9606
372 9469-9477 Species denotes patients Tax:9606
373 9660-9668 Species denotes patients Tax:9606
374 9680-9688 Species denotes patients Tax:9606
375 9841-9849 Species denotes patients Tax:9606
376 9864-9874 Species denotes SARS-CoV-2 Tax:2697049
377 10035-10043 Species denotes patients Tax:9606
378 10167-10175 Species denotes patients Tax:9606
379 10317-10325 Species denotes patients Tax:9606
380 10368-10378 Species denotes SARS-CoV-2 Tax:2697049
381 10526-10534 Species denotes patients Tax:9606
382 10983-10991 Species denotes patients Tax:9606
383 11246-11254 Species denotes patients Tax:9606
384 11404-11412 Species denotes patients Tax:9606
385 9249-9257 Disease denotes COVID-19 MESH:C000657245
386 9342-9370 Disease denotes cardiovascular complications MESH:D002318
387 9384-9404 Disease denotes SARS-CoV-2 infection MESH:C000657245
388 9483-9491 Disease denotes COVID-19 MESH:C000657245
389 9509-9523 Disease denotes cardiac injury MESH:D006331
390 9850-9858 Disease denotes infected MESH:D007239
391 9893-9915 Disease denotes cardiovascular disease MESH:D002318
392 9917-9920 Disease denotes CVD MESH:D002318
393 9954-9968 Disease denotes cardiac arrest MESH:D006323
394 10001-10023 Disease denotes coronary heart disease MESH:D003324
395 10048-10060 Disease denotes hypertension MESH:D006973
396 10158-10166 Disease denotes COVID-19 MESH:C000657245
397 10192-10195 Disease denotes CVD MESH:D002318
398 10342-10345 Disease denotes CVD MESH:D002318
399 10354-10362 Disease denotes infected MESH:D007239
400 10426-10440 Disease denotes cardiac injury MESH:D006331
401 10509-10514 Disease denotes death MESH:D003643
402 10551-10554 Disease denotes CVD MESH:D002318
403 10847-10858 Disease denotes mortalities MESH:D003643
404 10974-10982 Disease denotes COVID-19 MESH:C000657245
405 11015-11026 Disease denotes hypotension MESH:D007022
406 11028-11045 Disease denotes myocardial injury MESH:D009202
407 11047-11058 Disease denotes myocarditis MESH:D009205
408 11065-11088 Disease denotes ventricular dysfunction MESH:D018754
409 11090-11100 Disease denotes arrhythmia MESH:D001145
410 11260-11268 Disease denotes COVID-19 MESH:C000657245
411 11380-11391 Disease denotes myocarditis MESH:D009205
412 11395-11403 Disease denotes COVID-19 MESH:C000657245
413 11443-11464 Disease denotes cardiovascular damage MESH:D002318
414 11478-11486 Disease denotes COVID-19 MESH:C000657245
415 11671-11691 Disease denotes SARS-CoV-2 infection MESH:C000657245
418 12651-12679 Disease denotes cardiovascular complications MESH:D002318
419 12683-12691 Disease denotes COVID-19 MESH:C000657245
465 13575-13579 Gene denotes ACE2 Gene:59272
466 13810-13815 Gene denotes TNF-α Gene:7124
467 13829-13833 Gene denotes MCP1 Gene:6347
468 13838-13842 Gene denotes VEGF Gene:7422
469 13904-13909 Gene denotes NLRP3 Gene:114548
470 13980-13985 Gene denotes IL-1β Gene:3552
471 13990-13995 Gene denotes IL-18 Gene:3606
472 14026-14030 Gene denotes IL-6 Gene:3569
473 14035-14040 Gene denotes TNF-α Gene:7124
474 14224-14229 Gene denotes NLRP3 Gene:114548
475 14745-14749 Gene denotes ACE2 Gene:59272
476 14751-14782 Gene denotes Angiotensin-converting enzyme-2 Gene:59272
477 14864-14869 Gene denotes MCP-1 Gene:6347
478 14871-14905 Gene denotes Monocyte chemoattractant protein-1 Gene:6347
479 14974-14979 Gene denotes NLRP3 Gene:114548
480 14981-15028 Gene denotes NACHT, LRR and PYD domains-containing protein 3 Gene:114548
481 15135-15140 Gene denotes TNF-α Gene:7124
482 15142-15165 Gene denotes Tumor necrosis factor-α Gene:7124
483 15167-15171 Gene denotes VEGF Gene:7422
484 15173-15207 Gene denotes Vascular endothelial growth factor Gene:7422
485 13446-13456 Species denotes SARS-CoV-2 Tax:2697049
486 13495-13505 Species denotes SARS-Cov-2 Tax:2697049
487 13638-13648 Species denotes SARS-CoV-2 Tax:2697049
488 13844-13854 Species denotes SARS-CoV-2 Tax:2697049
489 14083-14093 Species denotes SARS-CoV-2 Tax:2697049
490 14502-14512 Species denotes SARS-CoV-2 Tax:2697049
491 14658-14668 Species denotes SARS-CoV-2 Tax:2697049
492 15072-15082 Species denotes SARS-CoV-2 Tax:2697049
493 15122-15133 Species denotes coronavirus Tax:11118
494 14169-14173 Chemical denotes Ca2+ MESH:D000069285
495 14196-14199 Chemical denotes ROS MESH:D017382
496 14457-14459 Chemical denotes O2 MESH:D010100
497 13465-13493 Disease denotes cardiovascular complications MESH:D002318
498 13659-13673 Disease denotes cardiac injury MESH:D006331
499 14073-14081 Disease denotes fibrosis MESH:D005355
500 14102-14111 Disease denotes pneumonia MESH:D011014
501 14142-14151 Disease denotes hypoxemia MESH:D000860
502 14255-14269 Disease denotes cardiac damage MESH:D006331
503 14331-14340 Disease denotes pneumonia MESH:D011014
504 14371-14382 Disease denotes tachycardia MESH:D013610
505 14492-14500 Disease denotes ischemia MESH:D007511
506 14529-14561 Disease denotes coronary atherosclerotic plaques MESH:D003324
507 14574-14594 Disease denotes platelet aggregation MESH:D001791
508 14621-14638 Disease denotes venous thrombosis MESH:D020246
509 14722-14743 Disease denotes cardiovascular injury MESH:D002318
521 13184-13191 Species denotes patient Tax:9606
522 13352-13360 Species denotes patients Tax:9606
523 12771-12779 Disease denotes COVID-19 MESH:C000657245
524 12840-12857 Disease denotes myocardial injury MESH:D009202
525 12871-12879 Disease denotes COVID-19 MESH:C000657245
526 13015-13025 Disease denotes thrombosis MESH:D013927
527 13030-13037 Disease denotes hypoxia MESH:D000860
528 13173-13182 Disease denotes infection MESH:D007239
529 13264-13285 Disease denotes cardiac complications MESH:D005117
530 13320-13348 Disease denotes cardiovascular deterioration MESH:D002318
531 13366-13374 Disease denotes COVID-19 MESH:C000657245
561 16163-16194 Gene denotes angiotensin-converting enzyme 2 Gene:59272
562 16196-16200 Gene denotes ACE2 Gene:59272
563 16255-16259 Gene denotes ACE2 Gene:59272
564 16401-16405 Gene denotes ACE2 Gene:59272
565 15313-15321 Species denotes patients Tax:9606
566 15358-15382 Species denotes Streptococcus pneumoniae Tax:1313
567 15419-15427 Species denotes patients Tax:9606
568 15581-15589 Species denotes SARS-CoV Tax:694009
569 15634-15639 Species denotes human Tax:9606
570 15673-15681 Species denotes patients Tax:9606
571 15843-15847 Species denotes mice Tax:10090
572 15866-15871 Species denotes human Tax:9606
573 15886-15894 Species denotes SARS-CoV Tax:694009
574 15938-15946 Species denotes SARS-CoV Tax:694009
575 16011-16021 Species denotes SARS-CoV-2 Tax:2697049
576 16048-16056 Species denotes SARS-CoV Tax:694009
577 16387-16397 Species denotes SARS-CoV-2 Tax:2697049
578 16459-16467 Species denotes SARS-CoV Tax:694009
579 16524-16534 Species denotes SARS-CoV-2 Tax:2697049
580 16616-16626 Species denotes SARS-CoV-2 Tax:2697049
581 16833-16843 Species denotes SARS-CoV-2 Tax:2697049
582 15334-15343 Disease denotes pneumonia MESH:D011014
583 15440-15460 Disease denotes pneumococcal disease MESH:D011008
584 15519-15533 Disease denotes cardiac injury MESH:D006331
585 15848-15856 Disease denotes infected MESH:D007239
586 15913-15932 Disease denotes pulmonary infection MESH:D012141
587 15965-15985 Disease denotes myocardial infection MESH:D009202
588 16689-16703 Disease denotes cardiac injury MESH:D006331
589 16809-16829 Disease denotes myocardial infection MESH:D009202
651 19537-19541 Gene denotes IL-6 Gene:3569
652 20727-20745 Gene denotes C-reactive protein Gene:1401
653 20747-20750 Gene denotes CRP Gene:1401
654 21493-21497 Gene denotes IL-6 Gene:3569
655 21887-21890 Gene denotes CRP Gene:1401
656 23093-23096 Gene denotes CRP Gene:1401
657 23286-23290 Gene denotes IL-1 Gene:3553
658 20807-20810 Gene denotes CRP Gene:1401
659 20713-20721 Species denotes patients Tax:9606
660 21540-21548 Species denotes patients Tax:9606
661 22532-22540 Species denotes patients Tax:9606
662 23559-23567 Species denotes patients Tax:9606
663 23762-23770 Species denotes patients Tax:9606
664 24415-24423 Species denotes patients Tax:9606
665 19521-19532 Chemical denotes Tocilizumab MESH:C502936
666 19717-19733 Chemical denotes tocilizumab • N
667 19768-19779 Chemical denotes tocilizumab MESH:C502936
668 21337-21348 Chemical denotes tocilizumab MESH:C502936
669 21444-21446 Chemical denotes O2 MESH:D010100
670 21597-21616 Chemical denotes group • Tocilizumab
671 21739-21757 Chemical denotes methylprednisolone MESH:D008775
672 21770-21781 Chemical denotes tocilizumab MESH:C502936
673 21979-21997 Chemical denotes methylprednisolone MESH:D008775
674 22002-22017 Chemical denotes tocilizumab • N
675 22058-22076 Chemical denotes methylprednisolone MESH:D008775
676 22200-22211 Chemical denotes tocilizumab MESH:C502936
677 23460-23474 Chemical denotes 1–3 • Anakinra
678 19625-19633 Disease denotes COVID-19 MESH:C000657245
679 19811-19816 Disease denotes fever MESH:D005334
680 19889-19894 Disease denotes fever MESH:D005334
681 19972-19989 Disease denotes pulmonary lesions MESH:D008171
682 20038-20059 Disease denotes pending • Tocilizumab
683 20152-20209 Disease denotes multi-organ damage (ChiCTR2000029765, 2020) • Tocilizumab MESH:C564969
684 20342-20350 Disease denotes COVID-19 MESH:C000657245
685 20628-20637 Disease denotes mortality MESH:D003643
686 20907-20916 Disease denotes mortality MESH:D003643
687 21161-21169 Disease denotes COVID-19 MESH:C000657245
688 21257-21260 Disease denotes CVD MESH:D002318
689 21405-21410 Disease denotes Fever MESH:D005334
690 21510-21539 Disease denotes lung lesion improvement • All MESH:D008171
691 21637-21645 Disease denotes COVID-19 MESH:C000657245
692 21867-21876 Disease denotes tachypnea MESH:D059246
693 22381-22390 Disease denotes mortality MESH:D003643
694 23187-23199 Disease denotes inflammation MESH:D007249
695 23357-23360 Disease denotes CVD MESH:D002318
696 23375-23383 Disease denotes diabetes MESH:D003920
697 23385-23392 Disease denotes obesity MESH:D009765
698 23405-23428 Disease denotes hypertension • Anakinra MESH:D006973
699 23513-23518 Disease denotes Fever MESH:D005334
700 23776-23788 Disease denotes hypertension MESH:D006973
701 23799-23802 Disease denotes CVD MESH:D002318
702 23839-23865 Disease denotes Ana-COVID study • Anakinra MESH:C000657245
703 23870-23878 Disease denotes COVID-19 MESH:C000657245
704 24008-24011 Disease denotes CVD MESH:D002318
705 24013-24025 Disease denotes hypertension MESH:D006973
706 24027-24033 Disease denotes stroke MESH:D020521
707 24035-24046 Disease denotes cardiopathy MESH:C536187
708 24334-24342 Disease denotes death HR MESH:D003643
709 24436-24444 Disease denotes COVID-19 MESH:C000657245
710 24445-24454 Disease denotes infection MESH:D007239
711 24477-24480 Disease denotes CVD MESH:D002318
714 19402-19410 Species denotes patients Tax:9606
715 19393-19401 Disease denotes COVID-19 MESH:C000657245
749 17764-17777 Gene denotes interleukin-6 Gene:3569
750 17779-17783 Gene denotes IL-6 Gene:3569
751 17786-17790 Gene denotes IL-7 Gene:3574
752 17792-17796 Gene denotes IL-8 Gene:3576
753 17798-17802 Gene denotes IL-9 Gene:3578
754 17804-17809 Gene denotes IL-10 Gene:3586
755 17811-17816 Gene denotes IL-1β Gene:3552
756 17818-17824 Gene denotes IL-1RA Gene:3557
757 17826-17853 Gene denotes tumor necrosis factor-alpha Gene:7124
758 17855-17860 Gene denotes TNF-α Gene:7124
759 17863-17911 Gene denotes granulocyte-macrophage colony-stimulating factor Gene:1437
760 17939-17978 Gene denotes macrophage inflammatory protein 1 alpha Gene:1230
761 18049-18083 Gene denotes vascular endothelial growth factor Gene:7422
762 17023-17031 Species denotes SARS-CoV Tax:694009
763 18109-18117 Species denotes patients Tax:9606
764 18137-18145 Species denotes patients Tax:9606
765 18368-18376 Species denotes patients Tax:9606
766 19039-19047 Species denotes patients Tax:9606
767 19178-19186 Species denotes patients Tax:9606
768 16899-16911 Disease denotes Inflammation MESH:D007249
769 16958-16983 Disease denotes cardiovascular impairment MESH:D002318
770 17002-17010 Disease denotes COVID-19 MESH:C000657245
771 17036-17054 Disease denotes MERS-CoV infection MESH:D018352
772 17061-17076 Disease denotes CoV-2 infection MESH:C000657245
773 17392-17408 Disease denotes viral infections MESH:D001102
774 17613-17634 Disease denotes cardiovascular injury MESH:D002318
775 17648-17668 Disease denotes SARS-CoV-2 infection MESH:C000657245
776 18100-18108 Disease denotes COVID-19 MESH:C000657245
777 18349-18358 Disease denotes mortality MESH:D003643
778 18382-18390 Disease denotes COVID-19 MESH:C000657245
779 18475-18483 Disease denotes necrosis MESH:D009336
780 19030-19038 Disease denotes COVID-19 MESH:C000657245
781 19192-19200 Disease denotes COVID-19 MESH:C000657245
808 25002-25007 Gene denotes NF-κB Gene:4790
809 25010-25046 Gene denotes interferon (IFN) regulatory factor 3 Gene:3661
810 25238-25243 Gene denotes NF-κB Gene:4790
811 25329-25334 Gene denotes NLRP3 Gene:114548
812 25336-25339 Gene denotes NOD Gene:1822
813 25342-25377 Gene denotes LRR-, and pyrin domain-containing 3
814 25457-25462 Gene denotes NLRP3 Gene:114548
815 25550-25555 Gene denotes NLRP3 Gene:114548
816 25799-25804 Gene denotes NLRP3 Gene:114548
817 25898-25907 Gene denotes caspase-1 Gene:834
818 25980-25998 Gene denotes pro-interleukin-1β Gene:3553
819 26004-26009 Gene denotes IL-1β Gene:3552
820 26077-26082 Gene denotes IL-1β Gene:3552
821 26087-26092 Gene denotes IL-18 Gene:3606
822 26182-26187 Gene denotes TNF-α Gene:7124
823 26189-26193 Gene denotes IL-6 Gene:3569
824 26380-26385 Gene denotes NLRP3 Gene:114548
825 25206-25216 Species denotes SARS-CoV-2 Tax:2697049
826 26195-26209 Chemical denotes prostaglandins MESH:D011453
827 26214-26226 Chemical denotes leukotrienes MESH:D015289
828 24622-24638 Disease denotes viral infections MESH:D001102
829 26161-26173 Disease denotes inflammation MESH:D007249
830 26261-26266 Disease denotes fever MESH:D005334
831 26272-26280 Disease denotes fibrosis MESH:D005355
832 26525-26537 Disease denotes inflammation MESH:D007249
833 26543-26563 Disease denotes SARS-CoVs infections MESH:C000657245
871 26869-26887 Gene denotes C-reactive protein Gene:1401
872 26889-26892 Gene denotes CRP Gene:1401
873 27144-27148 Gene denotes TNFα Gene:7124
874 27403-27408 Gene denotes IL-1β Gene:3552
875 27413-27417 Gene denotes IL-6 Gene:3569
876 27517-27521 Gene denotes IL-6 Gene:3569
877 27728-27732 Gene denotes IL-6 Gene:3569
878 27900-27904 Gene denotes IL-8 Gene:3576
879 27152-27160 Species denotes patients Tax:9606
880 27437-27445 Species denotes patients Tax:9606
881 27575-27583 Species denotes patients Tax:9606
882 27922-27930 Species denotes patients Tax:9606
883 28167-28175 Species denotes patients Tax:9606
884 26565-26577 Disease denotes Inflammation MESH:D007249
885 26618-26622 Disease denotes CVDs
886 26632-26647 Disease denotes atherosclerosis MESH:D050197
887 26649-26661 Disease denotes coagulopathy MESH:D001778
888 26663-26686 Disease denotes coronary artery disease MESH:D003324
889 26762-26770 Disease denotes COVID-19 MESH:C000657245
890 26832-26845 Disease denotes erythematosus MESH:D008180
891 26909-26925 Disease denotes hypercoagulation MESH:D019851
892 26930-26968 Disease denotes disseminated intravascular coagulation MESH:D004211
893 26986-26996 Disease denotes thrombosis MESH:D013927
894 26998-27014 Disease denotes thrombocytopenia MESH:D013921
895 27019-27027 Disease denotes gangrene MESH:D005734
896 27255-27287 Disease denotes ventricular dilation/hypertrophy MESH:D002312
897 27297-27320 Disease denotes ventricular dysfunction MESH:D018754
898 27457-27468 Disease denotes myocarditis MESH:D009205
899 27555-27571 Disease denotes long QT-syndrome MESH:D008133
900 27598-27610 Disease denotes inflammation MESH:D007249
901 27640-27651 Disease denotes arrhythmias MESH:D001145
902 27660-27678 Disease denotes torsade de pointes MESH:D016171
903 27805-27822 Disease denotes coronary syndrome MESH:D054058
904 27827-27837 Disease denotes chronic HF MESH:D002908
905 27975-27984 Disease denotes mortality MESH:D003643
906 28181-28189 Disease denotes COVID-19 MESH:C000657245
907 28283-28297 Disease denotes cardiac injury MESH:D006331
917 28447-28455 Species denotes patients Tax:9606
918 28399-28420 Disease denotes cardiac complications MESH:D005117
919 28434-28442 Disease denotes COVID-19 MESH:C000657245
920 28475-28482 Disease denotes obesity MESH:D009765
921 28484-28502 Disease denotes metabolic syndrome MESH:D024821
922 28504-28516 Disease denotes hypertension MESH:D006973
923 28521-28529 Disease denotes diabetes MESH:D003920
924 28960-28985 Disease denotes cardiovascular impairment MESH:D002318
925 29005-29013 Disease denotes COVID-19 MESH:C000657245
965 32410-32413 Gene denotes CRP Gene:1401
966 31277-31285 Species denotes patients Tax:9606
967 31475-31483 Species denotes patients Tax:9606
968 31739-31747 Species denotes patients Tax:9606
969 32621-32629 Species denotes patients Tax:9606
970 30748-30755 Chemical denotes Heparin MESH:D006493
971 30924-30931 Chemical denotes heparin MESH:D006493
972 30940-30947 Chemical denotes heparin MESH:D006493
973 31037-31044 Chemical denotes heparin MESH:D006493
974 31089-31117 Chemical denotes low molecular weight heparin MESH:D006495
975 31218-31225 Chemical denotes heparin MESH:D006493
976 31234-31241 Chemical denotes heparin MESH:D006493
977 31406-31413 Chemical denotes Heparin MESH:D006493
978 31999-32019 Chemical denotes acetylsalicylic acid MESH:D001241
979 32021-32024 Chemical denotes ASA MESH:D001241
980 32070-32081 Chemical denotes clopidogrel MESH:D000077144
981 32091-32094 Chemical denotes ASA MESH:D001241
982 32099-32110 Chemical denotes clopidogrel MESH:D000077144
983 32151-32160 Chemical denotes Tirofiban MESH:D000077466
984 32251-32263 Chemical denotes Fondaparinux MESH:D000077425
985 32365-32371 Chemical denotes oxygen MESH:D010100
986 30783-30789 Disease denotes sepsis MESH:D018805
987 30798-30810 Disease denotes coagulopathy MESH:D001778
988 30869-30877 Disease denotes COVID-19 MESH:C000657245
989 30911-30920 Disease denotes mortality MESH:D003643
990 30971-30983 Disease denotes hypertension MESH:D006973
991 30991-31009 Disease denotes heart disease • N MESH:D006331
992 31191-31200 Disease denotes mortality MESH:D003643
993 31264-31273 Disease denotes mortality MESH:D003643
994 31291-31297 Disease denotes sepsis MESH:D018805
995 31306-31318 Disease denotes coagulopathy MESH:D001778
996 31320-31323 Disease denotes SIC MESH:D018805
997 31452-31461 Disease denotes mortality MESH:D003643
998 31498-31510 Disease denotes coagulopathy MESH:D001778
999 31524-31527 Disease denotes SIC MESH:D018805
1000 31633-31642 Disease denotes hypoxemia MESH:D000860
1001 31644-31663 Disease denotes respiratory failure MESH:D012131
1002 31763-31786 Disease denotes respiratory failure • N MESH:D012131
1003 32642-32662 Disease denotes respiratory distress MESH:D012128
1007 30629-30637 Species denotes patients Tax:9606
1008 30574-30592 Disease denotes hypercoagulability MESH:D019851
1009 30620-30628 Disease denotes COVID-19 MESH:C000657245
1031 30017-30025 Species denotes patients Tax:9606
1032 30182-30190 Species denotes patients Tax:9606
1033 30236-30244 Species denotes patients Tax:9606
1034 30449-30457 Species denotes patients Tax:9606
1035 29284-29292 Disease denotes COVID-19 MESH:C000657245
1036 29304-29329 Disease denotes cardiovascular impairment MESH:D002318
1037 29353-29377 Disease denotes coronary atherosclerotic MESH:D003324
1038 29578-29588 Disease denotes thrombosis MESH:D013927
1039 29653-29662 Disease denotes pneumonia MESH:D011014
1040 29801-29825 Disease denotes coronary atherosclerotic MESH:D003324
1041 29875-29882 Disease denotes rupture MESH:D012421
1042 29934-29952 Disease denotes occlusive thrombus MESH:D013927
1043 30008-30016 Disease denotes COVID-19 MESH:C000657245
1044 30052-30075 Disease denotes venous thromboembolisms MESH:D054556
1045 30083-30090 Disease denotes hypoxia MESH:D000860
1046 30102-30114 Disease denotes inflammation MESH:D007249
1047 30127-30152 Disease denotes intravascular coagulation MESH:D004211
1048 30203-30221 Disease denotes COVID-19 pneumonia MESH:C000657245
1049 30271-30295 Disease denotes thrombotic complications MESH:D013927
1050 30404-30414 Disease denotes thrombosis MESH:D013927
1051 30440-30448 Disease denotes COVID-19 MESH:C000657245
1070 32822-32830 Species denotes patients Tax:9606
1071 32882-32890 Species denotes patients Tax:9606
1072 33002-33010 Species denotes patients Tax:9606
1073 33224-33232 Species denotes SARS-CoV Tax:694009
1074 33237-33247 Species denotes SARS-CoV-2 Tax:2697049
1075 121412-121420 Species denotes patients Tax:9606
1077 32948-32953 Chemical denotes lipid MESH:D008055
1078 33080-33091 Chemical denotes fatty acids MESH:D005227
1079 33295-33300 Chemical denotes lipid MESH:D008055
1080 32850-32868 Disease denotes SARS-CoV infection MESH:C000657245
1081 33025-33039 Disease denotes hyperlipidemia MESH:D006949
1082 33093-33120 Disease denotes abnormal glucose metabolism MESH:D044882
1083 33131-33159 Disease denotes cardiovascular abnormalities MESH:D002318
1084 121426-121434 Disease denotes COVID-19 MESH:C000657245
1110 34153-34158 Gene denotes NLRP3 Gene:114548
1111 33818-33826 Species denotes patients Tax:9606
1112 35295-35303 Species denotes patients Tax:9606
1113 34014-34020 Chemical denotes oxygen MESH:D010100
1114 34062-34069 Chemical denotes calcium MESH:D002118
1115 34102-34109 Chemical denotes calcium MESH:D002118
1116 34564-34570 Chemical denotes oxygen MESH:D010100
1117 34703-34709 Chemical denotes oxygen MESH:D010100
1118 34928-34934 Chemical denotes sodium MESH:D012964
1119 34939-34944 Chemical denotes water MESH:D014867
1120 33809-33817 Disease denotes COVID-19 MESH:C000657245
1121 33846-33855 Disease denotes hypoxemia MESH:D000860
1122 34029-34048 Disease denotes myocardial ischemia MESH:D003324
1123 34241-34264 Disease denotes death of cardiomyocytes MESH:D003643
1124 34347-34356 Disease denotes pneumonia MESH:D011014
1125 34417-34428 Disease denotes tachycardia MESH:D013610
1126 34740-34756 Disease denotes cardiac ischemia MESH:D006331
1127 34761-34771 Disease denotes infarction MESH:D007238
1128 34816-34839 Disease denotes coronary artery disease MESH:D003324
1129 35173-35192 Disease denotes cardiac arrhythmias MESH:D001145
1130 35237-35272 Disease denotes decreased left ventricular function MESH:D018487
1131 35309-35317 Disease denotes COVID-19 MESH:C000657245
1180 36213-36231 Gene denotes C-reactive protein Gene:1401
1181 36233-36236 Gene denotes CRP Gene:1401
1182 36494-36497 Gene denotes CRP Gene:1401
1183 37632-37635 Gene denotes CRP Gene:1401
1184 37637-37641 Gene denotes IL-6 Gene:3569
1185 36815-36823 Species denotes patients Tax:9606
1186 36966-36973 Species denotes patient Tax:9606
1187 37442-37450 Species denotes Patients Tax:9606
1188 37671-37679 Species denotes patients Tax:9606
1189 37933-37941 Species denotes patients Tax:9606
1190 38255-38262 Species denotes patient Tax:9606
1191 38279-38292 Species denotes not specified Tax:32644
1192 38812-38819 Species denotes patient Tax:9606
1193 39033-39041 Species denotes patients Tax:9606
1194 39077-39090 Species denotes not specified Tax:32644
1195 39112-39120 Species denotes patients Tax:9606
1196 39279-39287 Species denotes patients Tax:9606
1197 35986-35998 Disease denotes inflammation MESH:D007249
1198 36609-36623 Disease denotes Abdominal pain MESH:D015746
1199 36628-36636 Disease denotes diarrhea MESH:D003967
1200 36836-36844 Disease denotes COVID-19 MESH:C000657245
1201 36845-36854 Disease denotes infection MESH:D007239
1202 36949-36961 Disease denotes inflammation MESH:D007249
1203 37098-37117 Disease denotes cardiac injury • N MESH:D006331
1204 37372-37381 Disease denotes mortality MESH:D003643
1205 37516-37525 Disease denotes mortality MESH:D003643
1206 37594-37623 Disease denotes cardiac injury • Inflammatory MESH:D006331
1207 37708-37717 Disease denotes mortality MESH:D003643
1208 37911-37920 Disease denotes mortality MESH:D003643
1209 37924-37932 Disease denotes COVID-19 MESH:C000657245
1210 37959-37971 Disease denotes hypertension MESH:D006973
1211 38040-38052 Disease denotes hypertension MESH:D006973
1212 38071-38076 Disease denotes COVID MESH:C000657245
1213 38313-38322 Disease denotes mortality MESH:D003643
1214 38429-38441 Disease denotes hypertension MESH:D006973
1215 38478-38487 Disease denotes mortality MESH:D003643
1216 38541-38555 Disease denotes cardiac injury MESH:D006331
1217 38623-38632 Disease denotes mortality MESH:D003643
1218 38636-38644 Disease denotes COVID-19 MESH:C000657245
1219 38691-38703 Disease denotes heart injury MESH:D006335
1220 38711-38719 Disease denotes COVID-19 MESH:C000657245
1221 38720-38732 Disease denotes inflammation MESH:D007249
1222 38794-38811 Disease denotes myocardial injury MESH:D009202
1223 38919-38922 Disease denotes CVD MESH:D002318
1224 38982-38999 Disease denotes myocardial injury MESH:D009202
1225 39132-39149 Disease denotes myocardial injury MESH:D009202
1226 39293-39296 Disease denotes CVD MESH:D002318
1227 39385-39393 Disease denotes COVID-19 MESH:C000657245
1230 35780-35788 Disease denotes COVID-19 MESH:C000657245
1231 35800-35821 Disease denotes cardiovascular injury MESH:D002318
1297 41670-41673 Gene denotes CRP Gene:1401
1298 41675-41679 Gene denotes IL-6 Gene:3569
1299 41937-41941 Gene denotes IL-6 Gene:3569
1300 42654-42658 Gene denotes IL-6 Gene:3569
1301 43222-43225 Gene denotes CRP Gene:1401
1302 43249-43253 Gene denotes IL-6 Gene:3569
1303 43894-43898 Gene denotes IL-6 Gene:3569
1304 45589-45593 Gene denotes IL-6 Gene:3569
1305 42448-42451 Gene denotes AID Gene:57379
1306 41857-41865 Species denotes patients Tax:9606
1307 42304-42317 Species denotes not specified Tax:32644
1308 42444-42447 Species denotes COV Tax:11118
1309 43137-43145 Species denotes patients Tax:9606
1310 44128-44136 Species denotes patients Tax:9606
1311 44181-44188 Species denotes patient Tax:9606
1312 44727-44735 Species denotes patients Tax:9606
1313 44971-44979 Species denotes patients Tax:9606
1314 45108-45116 Species denotes patients Tax:9606
1315 45297-45305 Species denotes patients Tax:9606
1316 43229-43237 Species denotes patients Tax:9606
1317 40275-40284 Chemical denotes vitamin C MESH:D001205
1318 40359-40368 Chemical denotes vitamin C MESH:D001205
1319 40427-40432 Chemical denotes water MESH:D014867
1320 40567-40578 Chemical denotes tocilizumab MESH:C502936
1321 40685-40696 Chemical denotes Tocilizumab MESH:C502936
1322 40845-40861 Chemical denotes Baricitinib • N
1323 40974-40985 Chemical denotes Baricitinib MESH:C000596027
1324 41017-41035 Chemical denotes 1–14 • Ravulizumab
1325 41842-41852 Chemical denotes Siltuximab MESH:C504234
1326 42278-42288 Chemical denotes siltuximab MESH:C504234
1327 42932-42948 Chemical denotes kg • Tocilizumab
1328 43621-43630 Chemical denotes sarilumab MESH:C000592401
1329 43665-43674 Chemical denotes sarilumab MESH:C000592401
1330 43709-43718 Chemical denotes sarilumab MESH:C000592401
1331 43754-43763 Chemical denotes sarilumab MESH:C000592401
1332 43794-43803 Chemical denotes sarilumab MESH:C000592401
1333 44013-44022 Chemical denotes Sarilumab MESH:C000592401
1334 46032-46042 Chemical denotes Colchicine MESH:D003078
1335 46154-46164 Chemical denotes Colchicine MESH:D003078
1336 46259-46269 Chemical denotes colchicine MESH:D003078
1337 39784-39792 Disease denotes COVID-19 MESH:C000657245
1338 40162-40179 Disease denotes organ dysfunction MESH:D009102
1339 40508-40513 Disease denotes COVID MESH:C000657245
1340 41544-41552 Disease denotes COVID-19 MESH:C000657245
1341 41888-41913 Disease denotes respiratory complications MESH:D012131
1342 41921-41926 Disease denotes COVID MESH:C000657245
1343 42244-42253 Disease denotes mortality MESH:D003643
1344 43038-43046 Disease denotes COVID-19 MESH:C000657245
1345 43330-43339 Disease denotes infection MESH:D007239
1346 43423-43432 Disease denotes infection MESH:D007239
1347 43948-43956 Disease denotes COVID-19 MESH:C000657245
1348 43957-43978 Disease denotes pneumonia • Sarilumab
1349 44119-44127 Disease denotes COVID-19 MESH:C000657245
1350 44223-44228 Disease denotes COVID MESH:C000657245
1351 44401-44409 Disease denotes RUXCOVID
1352 44753-44761 Disease denotes COVID-19 MESH:C000657245
1353 44855-44883 Disease denotes cardiovascular organ failure MESH:D002318
1354 45014-45022 Disease denotes COVID-19 MESH:C000657245
1355 45288-45296 Disease denotes COVID-19 MESH:C000657245
1356 45957-45969 Disease denotes hypertension MESH:D006973
1357 45975-45998 Disease denotes coronary artery disease MESH:D003324
1358 46000-46003 Disease denotes CAD
1359 46006-46014 Disease denotes diabetes MESH:D003920
1360 46016-46023 Disease denotes obesity MESH:D009765
1361 46146-46151 Disease denotes death MESH:D003643
1364 39547-39561 Disease denotes cardiac injury MESH:D006331
1365 39575-39595 Disease denotes SARS-CoV-2 infection MESH:C000657245
1371 35681-35689 Species denotes patients Tax:9606
1372 35393-35397 Disease denotes CVDs
1373 35459-35469 Disease denotes thrombosis MESH:D013927
1374 35471-35490 Disease denotes myocardial ischemia MESH:D003324
1375 35672-35680 Disease denotes COVID-19 MESH:C000657245
1396 47345-47350 Gene denotes INF-α Gene:3451
1397 46658-46665 Species denotes patient Tax:9606
1398 46807-46815 Species denotes patients Tax:9606
1399 46952-46960 Species denotes patients Tax:9606
1400 47112-47120 Species denotes patients Tax:9606
1401 47199-47207 Species denotes patients Tax:9606
1402 47443-47451 Species denotes patients Tax:9606
1403 47313-47322 Chemical denotes ribavirin MESH:D012254
1404 47324-47343 Chemical denotes lopinavir/ritonavir MESH:C558899
1405 47370-47382 Chemical denotes azithromycin MESH:D017963
1406 46485-46493 Disease denotes COVID-19 MESH:C000657245
1407 46583-46594 Disease denotes mortalities MESH:D003643
1408 46606-46614 Disease denotes COVID-19 MESH:C000657245
1409 46691-46700 Disease denotes pneumonia MESH:D011014
1410 46798-46806 Disease denotes COVID-19 MESH:C000657245
1411 46966-46974 Disease denotes COVID-19 MESH:C000657245
1412 47009-47012 Disease denotes CVD MESH:D002318
1413 47103-47111 Disease denotes COVID-19 MESH:C000657245
1414 47213-47221 Disease denotes COVID-19 MESH:C000657245
1415 47434-47442 Disease denotes COVID-19 MESH:C000657245
1467 49146-49153 Gene denotes IFN-α2b Gene:3440
1468 49331-49338 Gene denotes IFN-α2b Gene:3440
1469 49489-49493 Gene denotes IL-6 Gene:3569
1470 49498-49501 Gene denotes CRP Gene:1401
1471 49540-49545 Gene denotes IFN-α Gene:3451
1472 48710-48712 Gene denotes PR Gene:140738
1473 47809-47817 Species denotes patients Tax:9606
1474 47994-48004 Species denotes SARS-CoV-2 Tax:2697049
1475 48222-48230 Species denotes patients Tax:9606
1476 49894-49902 Species denotes patients Tax:9606
1477 50069-50077 Species denotes patients Tax:9606
1478 50872-50880 Species denotes patients Tax:9606
1479 48114-48123 Chemical denotes lopinavir MESH:D061466
1480 48128-48137 Chemical denotes ritonavir MESH:D019438
1481 48293-48312 Chemical denotes lopinavir–ritonavir MESH:C558899
1482 48368-48387 Chemical denotes lopinavir–ritonavir MESH:C558899
1483 49847-49866 Chemical denotes lopinavir–ritonavir MESH:C558899
1484 49871-49880 Chemical denotes ribavirin MESH:D012254
1485 50161-50170 Chemical denotes ribavirin MESH:D012254
1486 50396-50414 Chemical denotes hydroxychloroquine MESH:D006886
1487 50419-50431 Chemical denotes azithromycin MESH:D017963
1488 50681-50693 Chemical denotes azithromycin MESH:D017963
1489 50697-50715 Chemical denotes hydroxychloroquine MESH:D006886
1490 50805-50817 Chemical denotes azithromycin MESH:D017963
1491 50835-50853 Chemical denotes hydroxychloroquine MESH:D006886
1492 47637-47645 Disease denotes ischemia MESH:D007511
1493 47651-47662 Disease denotes arrhythmias MESH:D001145
1494 47830-47848 Disease denotes SARS-CoV infection MESH:C000657245
1495 47876-47888 Disease denotes inflammation MESH:D007249
1496 47966-47977 Disease denotes lung injury MESH:D055370
1497 48236-48244 Disease denotes COVID-19 MESH:C000657245
1498 48523-48538 Disease denotes QT prolongation MESH:D008133
1499 48754-48776 Disease denotes atrioventricular block MESH:D054537
1500 48781-48811 Disease denotes torsade de pointes arrhythmias MESH:D016171
1501 48948-48961 Disease denotes hyperglycemia MESH:D006943
1502 48963-48977 Disease denotes hyperlipidemia MESH:D006949
1503 48982-48995 Disease denotes lipodystrophy MESH:D008060
1504 49248-49256 Disease denotes COVID-19 MESH:C000657245
1505 49571-49583 Disease denotes hypertension MESH:D006973
1506 49585-49605 Disease denotes hypertriglyceridemia MESH:D015228
1507 49617-49633 Disease denotes cardiotoxicities MESH:D066126
1508 49645-49656 Disease denotes arrhythmias MESH:D001145
1509 49665-49679 Disease denotes cardiomyopathy MESH:D009202
1510 49715-49734 Disease denotes cardiac dysfunction MESH:D006331
1511 49929-49937 Disease denotes COVID-19 MESH:C000657245
1512 50100-50110 Disease denotes infections MESH:D007239
1513 50205-50221 Disease denotes hemolytic anemia MESH:D000743
1514 50269-50284 Disease denotes cardiac disease MESH:D006331
1515 50450-50458 Disease denotes COVID-19 MESH:C000657245
1516 50746-50761 Disease denotes QT prolongation MESH:D008133
1517 50863-50871 Disease denotes COVID-19 MESH:C000657245
1527 51332-51340 Species denotes patients Tax:9606
1528 51665-51673 Species denotes patients Tax:9606
1529 51065-51073 Disease denotes COVID-19 MESH:C000657245
1530 51323-51331 Disease denotes COVID-19 MESH:C000657245
1531 51379-51405 Disease denotes cardiovascular dysfunction MESH:D002318
1532 51506-51514 Disease denotes COVID-19 MESH:C000657245
1533 51589-51597 Disease denotes COVID-19 MESH:C000657245
1534 51776-51784 Disease denotes COVID-19 MESH:C000657245
1535 51785-51794 Disease denotes infection MESH:D007239
1537 51991-52022 Chemical denotes n-3 polyunsaturated fatty acids MESH:D015525
1563 53097-53121 Gene denotes delta-4,-5,-6 desaturase Gene:3992
1564 52177-52181 Gene denotes PUFA Gene:9933
1565 52529-52538 Species denotes mammalian Tax:9606
1566 53262-53266 Gene denotes PUFA Gene:9933
1567 52038-52069 Chemical denotes n-3 polyunsaturated fatty acids MESH:D015525
1568 52071-52080 Chemical denotes n-3 PUFAs MESH:D015525
1569 52086-52107 Chemical denotes essential fatty acids MESH:D005228
1570 52185-52201 Chemical denotes α-linolenic acid MESH:D017962
1571 52203-52206 Chemical denotes ALA MESH:D017962
1572 52241-52244 Chemical denotes ALA MESH:D017962
1573 52331-52340 Chemical denotes n-3 PUFAs MESH:D015525
1574 52356-52359 Chemical denotes ALA MESH:D017962
1575 52380-52401 Chemical denotes eicosapentaenoic acid MESH:D015118
1576 52403-52406 Chemical denotes EPA MESH:D015118
1577 52456-52476 Chemical denotes docosahexaenoic acid MESH:D004281
1578 52478-52481 Chemical denotes DHA MESH:D004281
1579 52691-52694 Chemical denotes ALA MESH:D017962
1580 52719-52730 Chemical denotes fatty acids MESH:D005227
1581 52906-52919 Chemical denotes linoleic acid MESH:D019787
1582 52930-52931 Chemical denotes n MESH:D009584
1583 52985-52994 Chemical denotes n-6 PUFAs
1584 53031-53047 Chemical denotes arachidonic acid MESH:D016718
1585 53134-53143 Chemical denotes n-3 PUFAs MESH:D015525
1586 53193-53202 Chemical denotes n-6 PUFAs
1587 53204-53213 Chemical denotes n-3 PUFAs MESH:D015525
1592 53523-53531 Species denotes patients Tax:9606
1593 53488-53519 Chemical denotes n-3 polyunsaturated fatty acids MESH:D015525
1594 53537-53559 Disease denotes respiratory infections MESH:D012141
1595 53567-53573 Disease denotes sepsis MESH:D018805
1624 54268-54272 Gene denotes PUFA Gene:9933
1625 54787-54791 Gene denotes IL-6 Gene:3569
1626 54796-54801 Gene denotes IFN-γ Gene:15978
1627 54108-54112 Gene denotes PUFA Gene:9933
1628 53588-53593 Species denotes human Tax:9606
1629 53672-53680 Species denotes patients Tax:9606
1630 53751-53761 Species denotes SARS-CoV-2 Tax:2697049
1631 53762-53770 Species denotes patients Tax:9606
1632 53927-53931 Species denotes rats Tax:10116
1633 54117-54121 Species denotes rats Tax:10116
1634 54251-54255 Species denotes rats Tax:10116
1635 54694-54704 Species denotes Rhinovirus Tax:12059
1636 53657-53660 Chemical denotes EPA MESH:D015118
1637 53665-53668 Chemical denotes DHA MESH:D004281
1638 53961-53969 Chemical denotes fish oil MESH:D005395
1639 53985-53994 Chemical denotes n-3 PUFAs MESH:D015525
1640 54440-54454 Chemical denotes thromboxane B2 MESH:D013929
1641 54456-54460 Chemical denotes TxB2 MESH:D013929
1642 54466-54482 Chemical denotes prostaglandin E2 MESH:D015232
1643 54484-54488 Chemical denotes PGE2 MESH:D015232
1644 54746-54749 Chemical denotes DHA MESH:D004281
1645 54989-54998 Chemical denotes n-3 PUFAs MESH:D015525
1646 53694-53698 Disease denotes ARDS MESH:D012128
1647 54031-54043 Disease denotes inflammation MESH:D007249
1648 54680-54688 Disease denotes infected MESH:D007239
1649 54844-54856 Disease denotes inflammation MESH:D007249
1650 55106-55122 Disease denotes viral infections MESH:D001102
1651 55164-55172 Disease denotes COVID-19 MESH:C000657245
1687 56287-56290 Gene denotes CRP Gene:1401
1688 56292-56296 Gene denotes IL-6 Gene:3569
1689 57110-57114 Gene denotes PUFA Gene:9933
1690 56491-56495 Gene denotes PUFA Gene:9933
1691 55402-55410 Species denotes patients Tax:9606
1692 55909-55917 Species denotes patients Tax:9606
1693 56189-56197 Species denotes patients Tax:9606
1694 56258-56266 Species denotes patients Tax:9606
1695 56516-56524 Species denotes patients Tax:9606
1696 56826-56834 Species denotes patients Tax:9606
1697 55226-55235 Chemical denotes n-3 PUFAs MESH:D015525
1698 55360-55363 Chemical denotes EPA MESH:D015118
1699 55365-55381 Chemical denotes γ-linolenic acid MESH:D017965
1700 55938-55941 Chemical denotes EPA MESH:D015118
1701 55946-55962 Chemical denotes γ-linolenic acid MESH:D017965
1702 56077-56080 Chemical denotes EPA MESH:D015118
1703 56085-56088 Chemical denotes DHA MESH:D004281
1704 56111-56124 Chemical denotes ascorbic acid MESH:D001205
1705 56137-56149 Chemical denotes α-tocopherol MESH:D024502
1706 56163-56171 Chemical denotes selenium MESH:D012643
1707 56888-56902 Chemical denotes fish oil lipid
1708 57106-57107 Chemical denotes n MESH:D009584
1709 55257-55261 Disease denotes ARDS MESH:D012128
1710 55266-55272 Disease denotes sepsis MESH:D018805
1711 55423-55429 Disease denotes sepsis MESH:D018805
1712 55433-55445 Disease denotes septic shock MESH:D012772
1713 55645-55654 Disease denotes mortality MESH:D003643
1714 55809-55818 Disease denotes mortality MESH:D003643
1715 55927-55931 Disease denotes ARDS MESH:D012128
1716 56215-56221 Disease denotes sepsis MESH:D018805
1717 56398-56404 Disease denotes sepsis MESH:D018805
1718 56537-56541 Disease denotes ARDS MESH:D012128
1719 56811-56825 Disease denotes critically ill MESH:D016638
1720 56933-56942 Disease denotes infection MESH:D007239
1721 56947-56953 Disease denotes sepsis MESH:D018805
1733 57379-57387 Species denotes patients Tax:9606
1734 57400-57410 Species denotes SARS-CoV-2 Tax:2697049
1735 57849-57857 Species denotes patients Tax:9606
1736 57293-57301 Chemical denotes fish-oil MESH:D005395
1737 57347-57350 Chemical denotes EPA MESH:D015118
1738 57355-57358 Chemical denotes DHA MESH:D004281
1739 57688-57696 Disease denotes COVID-19 MESH:C000657245
1740 57805-57810 Disease denotes obese MESH:D009765
1741 57812-57824 Disease denotes hypertensive MESH:D006973
1742 57840-57848 Disease denotes diabetic MESH:D003920
1743 58146-58154 Disease denotes COVID-19 MESH:C000657245
1755 58655-58659 Gene denotes IL-6 Gene:3569
1756 58306-58316 Species denotes SARS-CoV-2 Tax:2697049
1757 58376-58388 Species denotes participants Tax:9606
1758 58256-58265 Chemical denotes n-3 PUFAs MESH:D015525
1759 58481-58484 Chemical denotes EPA MESH:D015118
1760 58572-58575 Chemical denotes EPA MESH:D015118
1761 58609-58615 Chemical denotes oxygen MESH:D010100
1762 58888-58894 Chemical denotes lipids MESH:D008055
1763 58661-58670 Disease denotes mortality MESH:D003643
1764 58970-58978 Disease denotes infected MESH:D007239
1765 58984-58992 Disease denotes COVID-19 MESH:C000657245
1767 59089-59120 Chemical denotes n-3 polyunsaturated fatty acids MESH:D015525
1780 59789-59793 Gene denotes PUFA Gene:9933
1781 59205-59210 Chemical denotes lipid MESH:D008055
1782 59261-59279 Disease denotes numerous disorders MESH:D030342
1783 59290-59293 Disease denotes CVD MESH:D002318
1784 59516-59527 Disease denotes mortalities MESH:D003643
1785 59539-59542 Disease denotes CVD MESH:D002318
1786 59867-59876 Disease denotes mortality MESH:D003643
1787 59947-59953 Disease denotes deaths MESH:D003643
1788 60092-60095 Disease denotes CVD MESH:D002318
1789 60137-60159 Disease denotes coronary heart disease MESH:D003324
1790 60192-60197 Disease denotes death MESH:D003643
1791 60286-60297 Disease denotes mortalities MESH:D003643
1805 60376-60385 Chemical denotes n-3 PUFAs MESH:D015525
1806 60565-60570 Chemical denotes lipid MESH:D008055
1807 60593-60614 Chemical denotes saturated fatty acids MESH:D005227
1808 60628-60640 Chemical denotes triglyceride MESH:D014280
1809 60792-60801 Chemical denotes n-3 PUFAs MESH:D015525
1810 60842-60847 Chemical denotes lipid MESH:D008055
1811 61367-61376 Chemical denotes n-3 PUFAs MESH:D015525
1812 61514-61523 Chemical denotes n-3 PUFAs MESH:D015525
1813 61642-61651 Chemical denotes n-6 PUFAs
1814 60349-60372 Disease denotes cardiovascular benefits MESH:D002318
1815 60669-60684 Disease denotes atherosclerotic MESH:D050197
1816 60723-60731 Disease denotes thrombus MESH:D013927
1817 61155-61167 Disease denotes hypertension MESH:D006973
1819 61755-61763 Disease denotes COVID-19 MESH:C000657245
1848 63310-63314 Gene denotes ACE2 Gene:59272
1849 63647-63650 Gene denotes ACE Gene:1636
1850 63652-63681 Gene denotes Angiotensin-converting enzyme Gene:1636
1851 63683-63686 Gene denotes Ang Gene:283
1852 63701-63704 Gene denotes CRP Gene:1401
1853 63706-63724 Gene denotes C-reactive protein Gene:1401
1854 63769-63773 Gene denotes PUFA Gene:9933
1855 63854-63859 Gene denotes TNF-α Gene:7124
1856 63861-63888 Gene denotes Tumor necrosis factor alpha Gene:7124
1857 63623-63631 Species denotes patients Tax:9606
1858 62738-62747 Chemical denotes N-3 PUFAs MESH:D015525
1859 62853-62862 Chemical denotes N-3 PUFAs MESH:D015525
1860 63174-63183 Chemical denotes N-3 PUFAs MESH:D015525
1861 63340-63349 Chemical denotes N-3 PUFAs MESH:D015525
1862 63429-63438 Chemical denotes N-3 PUFAs MESH:D015525
1863 63508-63520 Chemical denotes triglyceride MESH:D014280
1864 63775-63802 Chemical denotes Poly unsaturated fatty acid MESH:D005231
1865 63804-63807 Chemical denotes ROS MESH:D017382
1866 63809-63832 Chemical denotes Reactive oxygen species MESH:D017382
1867 63834-63837 Chemical denotes TGs MESH:C026285
1868 63839-63852 Chemical denotes Triglycerides MESH:D014280
1869 63894-63905 Chemical denotes Thromboxane MESH:D013931
1870 62724-62732 Disease denotes COVID-19 MESH:C000657245
1871 62906-62931 Disease denotes mitochondrial dysfunction MESH:D028361
1872 63011-63027 Disease denotes viral infections MESH:D001102
1873 63450-63462 Disease denotes coagulopathy MESH:D001778
1874 63598-63610 Disease denotes inflammation MESH:D007249
1875 63637-63645 Disease denotes COVID-19 MESH:C000657245
1891 61808-61816 Species denotes patients Tax:9606
1892 61966-61975 Chemical denotes n-3 PUFAs MESH:D015525
1893 62454-62463 Chemical denotes n-3 PUFAs MESH:D015525
1894 62504-62513 Chemical denotes n-3 PUFAs MESH:D015525
1895 61799-61807 Disease denotes COVID-19 MESH:C000657245
1896 61833-61837 Disease denotes ARDS MESH:D012128
1897 61877-61883 Disease denotes sepsis MESH:D018805
1898 61888-61902 Disease denotes cardiac arrest MESH:D006323
1899 62004-62016 Disease denotes inflammation MESH:D007249
1900 62018-62024 Disease denotes sepsis MESH:D018805
1901 62069-62090 Disease denotes septic cardiomyopathy MESH:D009202
1902 62211-62239 Disease denotes cardiovascular complications MESH:D002318
1903 62256-62264 Disease denotes COVID-19 MESH:C000657245
1904 62590-62611 Disease denotes cardiac complications MESH:D005117
1905 62628-62636 Disease denotes COVID-19 MESH:C000657245
1907 63949-63958 Chemical denotes n-3 PUFAs MESH:D015525
1931 64592-64597 Gene denotes NLRP3 Gene:114548
1932 64663-64668 Gene denotes PPARα Gene:5465
1933 64685-64691 Gene denotes GPR120 Gene:338557
1934 64716-64720 Gene denotes TLR4 Gene:7099
1935 64744-64749 Gene denotes NF-κB Gene:4790
1936 65309-65312 Gene denotes CYP Gene:4051
1937 65314-65329 Gene denotes Cytochrome P450 Gene:4051
1938 65452-65455 Gene denotes GRP Gene:2922
1939 65538-65542 Gene denotes PUFA Gene:9933
1940 65640-65645 Gene denotes NLRP3 Gene:114548
1941 65647-65694 Gene denotes NACHT, LRR and PYD domains-containing protein 3 Gene:114548
1942 65696-65700 Gene denotes PLA2 Gene:5320
1943 65702-65718 Gene denotes Phospholipase A2 Gene:5319
1944 65756-65760 Gene denotes PPAR Gene:5465
1945 65904-65909 Gene denotes TNF-α Gene:7124
1946 65911-65934 Gene denotes Tumor necrosis factor-α Gene:7124
1947 64940-64944 Gene denotes PUFA Gene:9933
1948 65063-65066 Gene denotes CYP Gene:4051
1949 64855-64857 Chemical denotes N- MESH:D009584
1950 65020-65029 Chemical denotes N-3 PUFAs MESH:D015525
1951 65031-65034 Chemical denotes DHA MESH:D004281
1952 65039-65042 Chemical denotes EPA MESH:D015118
1953 65146-65155 Chemical denotes N-3 PUFAs MESH:D015525
1960 64127-64135 Species denotes patients Tax:9606
1961 64036-64048 Disease denotes inflammation MESH:D007249
1962 64098-64123 Disease denotes cardiovascular impairment MESH:D002318
1963 64141-64149 Disease denotes COVID-19 MESH:C000657245
1964 64330-64355 Disease denotes cardiovascular impairment MESH:D002318
1965 64397-64405 Disease denotes COVID-19 MESH:C000657245
1991 66146-66151 Gene denotes NLRP3 Gene:114548
1992 66166-66171 Gene denotes IL-1β Gene:3552
1993 66173-66178 Gene denotes TNF-α Gene:7124
1994 66183-66187 Gene denotes IL-6 Gene:3569
1995 67173-67177 Gene denotes IL-6 Gene:3569
1996 67179-67184 Gene denotes IL-1β Gene:3552
1997 67189-67194 Gene denotes TNF-α Gene:7124
1998 67541-67545 Gene denotes IL-6 Gene:3569
1999 67547-67552 Gene denotes IL-1β Gene:3552
2000 67557-67562 Gene denotes TNF-α Gene:7124
2001 67084-67088 Gene denotes PUFA Gene:9933
2002 66547-66555 Species denotes patients Tax:9606
2003 67243-67251 Species denotes patients Tax:9606
2004 67116-67119 Chemical denotes EPA MESH:D015118
2005 67134-67137 Chemical denotes DHA MESH:D004281
2006 67449-67458 Chemical denotes n-3 PUFAs MESH:D015525
2007 66229-66241 Disease denotes inflammation MESH:D007249
2008 66254-66262 Disease denotes COVID-19 MESH:C000657245
2009 66279-66308 Disease denotes impacts cardiovascular system MESH:D002318
2010 66394-66415 Disease denotes cardiac complications MESH:D005117
2011 66429-66437 Disease denotes COVID-19 MESH:C000657245
2012 66538-66546 Disease denotes COVID-19 MESH:C000657245
2013 66630-66654 Disease denotes cardiovascular disorders MESH:D002318
2014 67265-67282 Disease denotes venous leg ulcers MESH:D007871
2015 67362-67374 Disease denotes inflammation MESH:D007249
2033 68052-68057 Gene denotes NF-κB Gene:4790
2034 68232-68288 Gene denotes peroxisome proliferator-activated receptors-α/γ (PPARα/γ Gene:5465
2035 68356-68361 Gene denotes PPARα Gene:5465
2036 68410-68415 Gene denotes NF-κB Gene:4790
2037 68674-68678 Gene denotes PPAR Gene:5465
2038 68686-68690 Gene denotes PPAR Gene:5465
2039 68993-69023 Gene denotes G protein-coupled receptor 120 Gene:338557
2040 69025-69031 Gene denotes GPR120 Gene:338557
2041 69154-69160 Gene denotes GPR120 Gene:107221
2042 69246-69250 Gene denotes TLR4 Gene:21898
2043 69297-69303 Gene denotes GPR120 Gene:107221
2044 69356-69360 Gene denotes PUFA Gene:9933
2045 68793-68801 Species denotes patients Tax:9606
2046 69134-69135 Chemical denotes n MESH:D009584
2047 69437-69446 Chemical denotes n-3 PUFAs MESH:D015525
2048 68784-68792 Disease denotes COVID-19 MESH:C000657245
2049 69179-69188 CellLine denotes RAW 264.7 CVCL:0493
2058 69959-69964 Gene denotes IL-10 Gene:3586
2059 70583-70588 Gene denotes TNF-α Gene:7124
2060 70593-70598 Gene denotes IL-1β Gene:3552
2061 69625-69634 Disease denotes infection MESH:D007239
2062 70151-70159 Disease denotes COVID-19 MESH:C000657245
2063 70193-70207 Disease denotes cardiac injury MESH:D006331
2064 70355-70363 Disease denotes COVID-19 MESH:C000657245
2065 70473-70494 Disease denotes cardiovascular injury MESH:D002318
2095 71087-71092 Gene denotes IL-1β Gene:3552
2096 71094-71099 Gene denotes TNF-α Gene:7124
2097 71105-71109 Gene denotes IL-6 Gene:3569
2098 71588-71593 Gene denotes NLRP3 Gene:114548
2099 71806-71821 Gene denotes 15-lipoxygenase Gene:246
2100 72045-72050 Gene denotes NLRP3 Gene:216799
2101 72084-72090 Gene denotes PPAR-γ Gene:5468
2102 71440-71447 Species denotes R. equi Tax:43767
2103 71452-71465 Species denotes P. aeruginosa Tax:287
2104 71692-71697 Species denotes human Tax:9606
2105 71702-71707 Species denotes mouse Tax:10090
2106 72282-72304 Species denotes Pseudomonas aeruginosa Tax:287
2107 72306-72322 Species denotes Rhodococcus equi Tax:43767
2109 72879-72884 Species denotes mouse Tax:10090
2110 72531-72535 Gene denotes PUFA Gene:9933
2111 71552-71555 Chemical denotes EPA MESH:D015118
2112 71560-71563 Chemical denotes DHA MESH:D004281
2113 71843-71846 Chemical denotes ALA MESH:D017962
2114 71850-71868 Chemical denotes lipopolysaccharide MESH:D008070
2115 71870-71873 Chemical denotes LPS MESH:D008070
2116 73059-73068 Chemical denotes n-3 PUFAs MESH:D015525
2117 71410-71418 Disease denotes infected MESH:D007239
2118 71884-71896 Disease denotes inflammation MESH:D007249
2119 72921-72933 Disease denotes inflammation MESH:D007249
2120 72958-72967 Disease denotes infection MESH:D007239
2121 73180-73188 Disease denotes COVID-19 MESH:C000657245
2122 71388-71397 CellLine denotes RAW 264.7 CVCL:0493
2123 71900-71909 CellLine denotes RAW 264.7 CVCL:0493
2125 73354-73363 Chemical denotes n-3 PUFAs MESH:D015525
2140 73898-73902 Gene denotes PUFA Gene:9933
2141 73466-73475 Chemical denotes n-3 PUFAs MESH:D015525
2142 73658-73667 Chemical denotes n-6 PUFAs
2143 73903-73919 Chemical denotes arachidonic acid MESH:D016718
2144 73944-73958 Chemical denotes prostaglandins MESH:D011453
2145 73960-73963 Chemical denotes PGs MESH:D011453
2146 73985-73997 Chemical denotes thromboxanes MESH:D013931
2147 74067-74079 Chemical denotes leukotrienes MESH:D015289
2148 74081-74084 Chemical denotes LTs MESH:D015289
2149 74130-74135 Chemical denotes lipid MESH:D008055
2150 74369-74373 Chemical denotes PGE2 MESH:D015232
2151 74474-74478 Chemical denotes PGE2 MESH:D015232
2152 74239-74263 Disease denotes cardiovascular disorders MESH:D002318
2153 74552-74556 Disease denotes pain MESH:D010146
2167 74856-74860 Gene denotes TxAs Gene:6916
2168 75328-75333 Species denotes human Tax:9606
2169 74741-74750 Chemical denotes N-3 PUFAs MESH:D015525
2170 74848-74851 Chemical denotes PGs MESH:D011453
2171 74881-74884 Chemical denotes LTs MESH:D015289
2172 75087-75098 Chemical denotes eicosanoids MESH:D015777
2173 75311-75315 Chemical denotes PGE2 MESH:D015232
2174 75320-75324 Chemical denotes LTB4 MESH:D007975
2175 75399-75407 Chemical denotes fish oil MESH:D005395
2176 75577-75586 Chemical denotes n-3 PUFAs MESH:D015525
2177 75172-75184 Disease denotes inflammation MESH:D007249
2178 75978-75999 Disease denotes cardiac complications MESH:D005117
2179 76016-76024 Disease denotes COVID-19 MESH:C000657245
2181 76068-76077 Chemical denotes n-3 PUFAs MESH:D015525
2189 76143-76152 Chemical denotes n-3 PUFAs MESH:D015525
2190 76318-76321 Chemical denotes EPA MESH:D015118
2191 76345-76348 Chemical denotes DHA MESH:D004281
2192 76394-76402 Chemical denotes maresins
2193 76417-76420 Chemical denotes DHA MESH:D004281
2194 76627-76634 Chemical denotes aspirin MESH:D001241
2195 76333-76339 CellLine denotes RvE1-2 CVCL:1045
2219 77552-77557 Gene denotes CD11b Gene:3684
2220 77561-77565 Gene denotes CD18 Gene:4055
2221 77612-77616 Gene denotes IL-8 Gene:3576
2222 77753-77758 Gene denotes NF-κB Gene:4790
2223 78396-78399 Gene denotes CRP Gene:25419
2224 78401-78405 Gene denotes IL-6 Gene:24498
2225 78407-78412 Gene denotes TNF-α Gene:24835
2226 78418-78423 Gene denotes IL-1β Gene:24493
2227 78753-78757 Gene denotes IL-6 Gene:3569
2228 76854-76857 Gene denotes aid Gene:57379
2229 78429-78432 Species denotes rat Tax:10116
2230 78771-78776 Species denotes human Tax:9606
2231 77938-77961 Chemical denotes reactive oxygen species MESH:D017382
2232 77963-77966 Chemical denotes ROS MESH:D017382
2233 78252-78255 Chemical denotes DHA MESH:D004281
2234 78260-78274 Chemical denotes monoglycerides MESH:D050178
2235 78643-78671 Chemical denotes -hydroxydocosahexaenoic acid
2236 78673-78680 Chemical denotes 17-HDHA MESH:C062894
2237 76720-76732 Disease denotes inflammation MESH:D007249
2238 77333-77345 Disease denotes inflammation MESH:D007249
2239 78442-78454 Disease denotes hypertension MESH:D006973
2240 79091-79100 Disease denotes infection MESH:D007239
2241 79119-79127 Disease denotes COVID-19 MESH:C000657245
2255 79496-79500 Gene denotes TNFα Gene:7124
2256 79502-79506 Gene denotes IL-6 Gene:3569
2257 79508-79512 Gene denotes IL-8 Gene:3576
2258 79561-79566 Species denotes human Tax:9606
2259 79717-79729 Species denotes participants Tax:9606
2260 79665-79673 Chemical denotes sulfides MESH:D013440
2261 79882-79899 Chemical denotes 13S,14S-epoxi-DHA
2262 79302-79308 Disease denotes cancer MESH:D009369
2263 79394-79400 Disease denotes tumors MESH:D009369
2264 79595-79600 Disease denotes tumor MESH:D009369
2265 79739-79751 Disease denotes inflammation MESH:D007249
2266 80139-80151 Disease denotes inflammation MESH:D007249
2267 80339-80348 Disease denotes infection MESH:D007239
2277 80717-80720 Species denotes rat Tax:10116
2278 80725-80730 Species denotes mouse Tax:10090
2279 80756-80762 Species denotes E.coli Tax:562
2280 81125-81134 Species denotes influenza Tax:11320
2281 80774-80777 Chemical denotes LPS MESH:D008070
2282 80520-80532 Disease denotes inflammation MESH:D007249
2283 80591-80595 Disease denotes ARDS MESH:D012128
2284 80738-80746 Disease denotes infected MESH:D007239
2285 81215-81241 Disease denotes respiratory viral diseases
2305 81311-81316 Gene denotes TNF-α Gene:7124
2306 81321-81325 Gene denotes IL-6 Gene:3569
2307 81569-81573 Gene denotes IL-6 Gene:3569
2308 81578-81583 Gene denotes TNF-α Gene:7124
2309 81880-81884 Gene denotes IL-6 Gene:3569
2310 81889-81894 Gene denotes TNF-α Gene:7124
2311 82037-82041 Gene denotes PUFA Gene:9933
2312 81417-81420 Chemical denotes EPA MESH:D015118
2313 81425-81428 Chemical denotes DHA MESH:D004281
2314 81458-81461 Chemical denotes ALA MESH:D017962
2315 81639-81642 Chemical denotes EPA MESH:D015118
2316 81647-81650 Chemical denotes DHA MESH:D004281
2317 81534-81546 Disease denotes inflammation MESH:D007249
2318 81603-81611 Disease denotes COVID-19 MESH:C000657245
2319 81612-81621 Disease denotes infection MESH:D007239
2320 81906-81918 Disease denotes inflammation MESH:D007249
2321 81977-81985 Disease denotes COVID-19 MESH:C000657245
2322 82068-82078 Disease denotes infections MESH:D007239
2323 82153-82163 Disease denotes infections MESH:D007239
2326 82181-82184 Gene denotes CYP Gene:4051
2327 82222-82234 Disease denotes inflammation MESH:D007249
2386 83297-83302 Gene denotes NLRP3 Gene:114548
2387 83436-83439 Gene denotes CYP Gene:4051
2388 83521-83525 Gene denotes TNFα Gene:7124
2389 84089-84093 Gene denotes TNFα Gene:21926
2390 84215-84220 Gene denotes NF-κB Gene:4790
2391 84264-84270 Gene denotes PPAR-γ Gene:5468
2392 85196-85205 Gene denotes Sirtuin-1 Gene:23411
2393 85274-85279 Gene denotes NF-κB Gene:4790
2394 85407-85410 Gene denotes CYP Gene:4051
2395 82910-82914 Gene denotes PUFA Gene:9933
2396 82949-82953 Species denotes mice Tax:10090
2397 83726-83731 Species denotes human Tax:9606
2398 84000-84005 Species denotes mouse Tax:10090
2399 84118-84123 Species denotes human Tax:9606
2400 84150-84158 Species denotes patients Tax:9606
2401 84618-84637 Species denotes Sprague-Dawley rats Tax:10116
2402 82307-82310 Gene denotes CYP Gene:4051
2403 82290-82305 Gene denotes cytochrome P450 Gene:4051
2404 82682-82691 Chemical denotes 17,18-EEQ
2405 82696-82705 Chemical denotes 19,20-EDP
2406 82751-82760 Chemical denotes n-3 PUFAs MESH:D015525
2407 82980-82990 Chemical denotes eicosanoid MESH:D015777
2408 83115-83124 Chemical denotes 19,20-EDP
2409 83129-83138 Chemical denotes 17,18-EEQ
2410 83175-83179 Chemical denotes PGE2 MESH:D015232
2411 83233-83242 Chemical denotes n-3 PUFAs MESH:D015525
2412 83598-83602 Chemical denotes -EDP
2413 83890-83899 Chemical denotes 17,18-EEQ
2414 83904-83913 Chemical denotes 19,20-EDP
2415 84059-84068 Chemical denotes 17,18-EEQ
2416 84360-84372 Chemical denotes DHA epoxides
2417 84515-84527 Chemical denotes DHA epoxides
2418 84529-84533 Chemical denotes EDPs
2419 84570-84581 Chemical denotes carrageenan MESH:D002351
2420 84724-84734 Chemical denotes fatty acid MESH:D005227
2421 84735-84738 Chemical denotes DHA MESH:D004281
2422 84761-84766 Chemical denotes diols MESH:D011276
2423 84817-84828 Chemical denotes epoxylipids
2424 84943-84946 Chemical denotes LPS MESH:D008070
2425 85097-85104 Chemical denotes ,20-EDP
2426 85123-85126 Chemical denotes LPS MESH:D008070
2427 85438-85447 Chemical denotes n-3 PUFAs MESH:D015525
2428 82782-82795 Disease denotes tissue injury MESH:D017695
2429 82936-82945 Disease denotes MI injury MESH:D009203
2430 83534-83563 Disease denotes retinal vascular inflammation MESH:D007249
2431 83930-83962 Disease denotes allergic intestinal inflammation MESH:D007249
2432 83967-83982 Disease denotes kidney fibrosis MESH:D005355
2433 84102-84114 Disease denotes inflammation MESH:D007249
2434 84182-84196 Disease denotes lung carcinoma MESH:D008175
2435 84424-84441 Disease denotes inflammatory pain MESH:D010146
2436 84980-84999 Disease denotes inflammatory injury MESH:D007249
2437 85028-85056 Disease denotes cardiovascular complications MESH:D002318
2438 85138-85157 Disease denotes inflammatory injury MESH:D007249
2439 85520-85541 Disease denotes cardiovascular injury MESH:D002318
2440 85639-85660 Disease denotes cardiovascular injury MESH:D002318
2441 85674-85682 Disease denotes COVID-19 MESH:C000657245
2442 85683-85692 Disease denotes infection MESH:D007239
2443 85075-85079 CellLine denotes HL-1 CVCL:0303
2446 85702-85711 Chemical denotes N-3 PUFAs MESH:D015525
2447 85775-85780 Chemical denotes lipid MESH:D008055
2459 86487-86491 Gene denotes TLR4 Gene:7099
2460 85801-85810 Chemical denotes n-3 PUFAs MESH:D015525
2461 85910-85919 Chemical denotes n-6 PUFAs
2462 85971-85976 Chemical denotes lipid MESH:D008055
2463 86058-86067 Chemical denotes n-3 PUFAs MESH:D015525
2464 86302-86308 Chemical denotes lipids MESH:D008055
2465 86635-86644 Chemical denotes n-3 PUFAs MESH:D015525
2466 86987-86990 Chemical denotes DHA MESH:D004281
2467 87017-87020 Chemical denotes EPA MESH:D015118
2468 87035-87043 Chemical denotes -6 PUFAs
2469 87048-87059 Chemical denotes cholesterol MESH:D002784
2480 87615-87631 Gene denotes phospholipase A2 Gene:5319
2481 87264-87268 Gene denotes PUFA Gene:9933
2482 87281-87294 Chemical denotes phospholipids MESH:D010743
2483 87866-87875 Chemical denotes n-3 PUFAs MESH:D015525
2484 87913-87916 Chemical denotes EPA MESH:D015118
2485 87921-87924 Chemical denotes DHA MESH:D004281
2486 88234-88243 Chemical denotes n-3 PUFAs MESH:D015525
2487 88253-88256 Chemical denotes EPA MESH:D015118
2488 88261-88264 Chemical denotes DHA MESH:D004281
2489 88273-88286 Chemical denotes phospholipids MESH:D010743
2492 88462-88487 Disease denotes mitochondrial dysfunction MESH:D028361
2493 88511-88519 Disease denotes COVID-19 MESH:C000657245
2505 89965-89973 Species denotes patients Tax:9606
2506 89301-89309 Disease denotes diabetes MESH:D003920
2507 89311-89315 Disease denotes CVDs
2508 89345-89365 Disease denotes bacterial infections MESH:D001424
2509 89559-89580 Disease denotes cardiovascular insult MESH:D002318
2510 89594-89602 Disease denotes COVID-19 MESH:C000657245
2511 89867-89872 Disease denotes sleep MESH:D012893
2512 89877-89897 Disease denotes appetite disturbance MESH:D001068
2513 89915-89922 Disease denotes fatigue MESH:D005221
2514 89927-89942 Disease denotes muscle weakness MESH:D018908
2515 89956-89964 Disease denotes COVID-19 MESH:C000657245
2530 90875-90880 Gene denotes TNF-α Gene:7124
2531 90882-90887 Gene denotes IL-1β Gene:3552
2532 90892-90896 Gene denotes IL-6 Gene:3569
2533 91137-91142 Gene denotes IFN-γ Gene:3458
2534 91147-91151 Gene denotes IL-6 Gene:3569
2535 90931-90939 Species denotes patients Tax:9606
2536 91001-91004 Chemical denotes ATP MESH:D000255
2537 91034-91037 Chemical denotes ROS MESH:D017382
2538 91179-91182 Chemical denotes ROS MESH:D017382
2539 90168-90193 Disease denotes Mitochondrial dysfunction MESH:D028361
2540 90472-90493 Disease denotes cardiovascular injury MESH:D002318
2541 90507-90515 Disease denotes COVID-19 MESH:C000657245
2542 90922-90930 Disease denotes COVID-19 MESH:C000657245
2543 91357-91362 Disease denotes death MESH:D003643
2563 92497-92502 Gene denotes NLRP3 Gene:114548
2564 92518-92523 Gene denotes IL-1β Gene:3552
2565 92528-92532 Gene denotes IL-6 Gene:3569
2566 91565-91573 Species denotes patients Tax:9606
2567 91588-91598 Species denotes SARS-CoV-2 Tax:2697049
2568 91817-91827 Species denotes SARS-CoV-2 Tax:2697049
2569 92004-92014 Species denotes SARS-CoV-2 Tax:2697049
2570 91639-91646 Chemical denotes calcium MESH:D002118
2571 92196-92199 Chemical denotes ROS MESH:D017382
2572 91401-91421 Disease denotes mitochondrial damage MESH:D028361
2573 91574-91582 Disease denotes infected MESH:D007239
2574 91607-91616 Disease denotes pneumonia MESH:D011014
2575 91618-91625 Disease denotes hypoxia MESH:D000860
2576 91681-91706 Disease denotes mitochondrial dysfunction MESH:D028361
2577 92644-92652 Disease denotes COVID-19 MESH:C000657245
2578 92701-92721 Disease denotes mitochondrial damage MESH:D028361
2579 92726-92738 Disease denotes inflammation MESH:D007249
2580 92779-92800 Disease denotes cardiovascular injury MESH:D002318
2581 92916-92924 Disease denotes COVID-19 MESH:C000657245
2600 93658-93663 Gene denotes NLRP3 Gene:216799
2601 93955-93960 Gene denotes NLRP3 Gene:216799
2602 93461-93466 Species denotes mouse Tax:10090
2603 92992-93000 Chemical denotes n-3 PUFA MESH:D015525
2604 93183-93192 Chemical denotes n-3 PUFAs MESH:D015525
2605 93269-93281 Chemical denotes phospholipid MESH:D010743
2606 93353-93356 Chemical denotes ATP MESH:D000255
2607 93510-93513 Chemical denotes DHA MESH:D004281
2608 93540-93549 Chemical denotes 19,20-EDP
2609 93765-93768 Chemical denotes EDP
2610 94033-94042 Chemical denotes 19,20-EDP
2611 94102-94105 Chemical denotes LPS MESH:D008070
2612 94219-94228 Chemical denotes n-3 PUFAs MESH:D015525
2613 93476-93503 Disease denotes ischemia reperfusion injury MESH:D015427
2614 93819-93846 Disease denotes ischemia reperfusion injury MESH:D015427
2615 94304-94325 Disease denotes cardiovascular injury MESH:D002318
2616 94506-94514 Disease denotes COVID-19 MESH:C000657245
2617 94053-94057 CellLine denotes HL-1 CVCL:0303
2656 95271-95275 Gene denotes PUFA Gene:9933
2657 95363-95380 Species denotes influenza A virus Tax:11320
2658 95462-95466 Species denotes mice Tax:10090
2659 95564-95579 Species denotes influenza virus Tax:11308
2660 95770-95774 Species denotes H1N1 Tax:114727
2661 95775-95790 Species denotes influenza virus Tax:11308
2662 96014-96018 Species denotes H1N1 Tax:114727
2663 96042-96046 Species denotes mice Tax:10090
2664 96249-96259 Species denotes Zika virus Tax:64320
2665 96589-96604 Species denotes enterovirus A71 Tax:39054
2666 96609-96627 Species denotes coxsackievirus A16 Tax:31704
2667 95425-95434 Species denotes influenza Tax:11320
2668 96019-96028 Species denotes influenza Tax:11320
2669 95947-95951 Species denotes H1N1 Tax:114727
2670 94590-94593 Chemical denotes EPA MESH:D015118
2671 94598-94601 Chemical denotes DHA MESH:D004281
2672 94884-94887 Chemical denotes EPA MESH:D015118
2673 94889-94892 Chemical denotes DHA MESH:D004281
2674 94911-94934 Chemical denotes unsaturated fatty acids MESH:D005231
2675 95284-95289 Chemical denotes lipid MESH:D008055
2676 95700-95707 Chemical denotes 17-HDHA MESH:C062894
2677 95728-95731 Chemical denotes DHA MESH:D004281
2678 95811-95818 Chemical denotes 17-HDHA MESH:C062894
2679 96084-96096 Chemical denotes Braz-De-Melo
2680 96186-96189 Chemical denotes DHA MESH:D004281
2681 96541-96544 Chemical denotes EPA MESH:D015118
2682 96549-96552 Chemical denotes DHA MESH:D004281
2683 94646-94667 Disease denotes inflammatory diseases MESH:D007249
2684 94684-94700 Disease denotes viral infections MESH:D001102
2685 95435-95444 Disease denotes infection MESH:D007239
2686 95611-95620 Disease denotes infection MESH:D007239
2687 96029-96038 Disease denotes infection MESH:D007239
2688 96153-96169 Disease denotes viral infections MESH:D001102
2689 96207-96220 Disease denotes neuroblastoma MESH:D009447
2690 96235-96243 Disease denotes infected MESH:D007239
2691 96670-96683 Disease denotes mouth disease MESH:D009059
2692 96782-96798 Disease denotes viral infections MESH:D001102
2693 96221-96228 CellLine denotes SH-SY5Y CVCL:0019
2727 97422-97426 Gene denotes IL-6 Gene:16193
2728 97431-97436 Gene denotes TNF-α Gene:21926
2729 97576-97581 Gene denotes IFN-γ Gene:15978
2730 97119-97123 Species denotes mice Tax:10090
2731 97169-97173 Species denotes H1N1 Tax:114727
2732 97174-97189 Species denotes influenza virus Tax:11308
2733 97312-97316 Species denotes mice Tax:10090
2734 97509-97513 Species denotes mice Tax:10090
2735 97681-97696 Species denotes influenza virus Tax:11308
2736 97994-97998 Species denotes mice Tax:10090
2737 98340-98344 Species denotes mice Tax:10090
2738 98484-98494 Species denotes SARS-CoV-2 Tax:2697049
2739 98689-98699 Species denotes SARS-CoV-2 Tax:2697049
2740 97985-97989 Gene denotes PUFA Gene:9933
2741 96979-96982 Chemical denotes EPA MESH:D015118
2742 96987-96990 Chemical denotes DHA MESH:D004281
2743 97142-97150 Chemical denotes fish oil MESH:D005395
2744 97542-97545 Chemical denotes EPA MESH:D015118
2745 97550-97553 Chemical denotes DHA MESH:D004281
2746 97812-97815 Chemical denotes EPA MESH:D015118
2747 97820-97823 Chemical denotes DHA MESH:D004281
2748 98367-98375 Chemical denotes fish oil MESH:D005395
2749 98630-98633 Chemical denotes EPA MESH:D015118
2750 98638-98641 Chemical denotes DHA MESH:D004281
2751 97048-97064 Disease denotes viral infections MESH:D001102
2752 97155-97163 Disease denotes infected MESH:D007239
2753 97210-97219 Disease denotes mortality MESH:D003643
2754 97662-97671 Disease denotes infection MESH:D007239
2755 97726-97750 Disease denotes lung T cell cytotoxicity MESH:D064420
2756 97932-97941 Disease denotes infection MESH:D007239
2757 98056-98065 Disease denotes infection MESH:D007239
2758 98301-98312 Disease denotes weight loss MESH:D015431
2759 98706-98716 Disease denotes infections MESH:D007239
2763 98732-98741 Chemical denotes n-3 PUFAs MESH:D015525
2764 98778-98789 Chemical denotes aldosterone MESH:D000450
2765 98815-98823 Disease denotes COVID-19 MESH:C000657245
2796 98978-98991 Gene denotes angiotensin I Gene:183
2797 98993-98998 Gene denotes Ang I Gene:183
2798 99018-99047 Gene denotes angiotensin-converting enzyme Gene:1636
2799 99049-99052 Gene denotes ACE Gene:1636
2800 99098-99104 Gene denotes Ang II Gene:183
2801 99156-99162 Gene denotes Ang II Gene:183
2812 99082-99096 Gene denotes angiotensin II Gene:183
2815 98846-98857 Chemical denotes aldosterone MESH:D000450
2816 99326-99329 Chemical denotes ROS MESH:D017382
2818 99281-99293 Disease denotes hypertension MESH:D006973
2819 99295-99314 Disease denotes cardiac hypertrophy MESH:D006332
2820 99353-99361 Disease denotes fibrosis MESH:D005355
2862 100970-100974 Gene denotes ACE2 Gene:59272
2863 101115-101119 Gene denotes ACE2 Gene:59272
2864 101293-101297 Gene denotes ACE2 Gene:59272
2865 101329-101333 Gene denotes ACE2 Gene:59272
2866 101529-101533 Gene denotes ACE2 Gene:59272
2867 101778-101782 Gene denotes ACE2 Gene:59272
2868 101810-101824 Gene denotes angiotensin II Gene:183
2869 102167-102173 Gene denotes Ang II Gene:183
2870 102303-102307 Gene denotes ACE2 Gene:59272
2871 102331-102339 Gene denotes Ang-(1–7 Gene:7108
2872 102751-102754 Gene denotes ACE Gene:1636
2873 102880-102883 Gene denotes ACE Gene:1636
2874 102962-102965 Gene denotes ACE Gene:1636
2875 103000-103004 Gene denotes ACE2 Gene:59272
2876 103030-103034 Gene denotes ACE2 Gene:59272
2877 103063-103071 Gene denotes Ang-(1–7 Gene:7108
2878 103249-103253 Gene denotes ACE2 Gene:59272
2879 103282-103290 Gene denotes Ang-(1–7 Gene:7108
2880 103136-103142 Gene denotes Ang II Gene:183
2881 100954-100964 Species denotes SARS-CoV-2 Tax:2697049
2882 101063-101073 Species denotes SARS-CoV-2 Tax:2697049
2883 101439-101447 Species denotes SARS-CoV Tax:694009
2884 102073-102081 Species denotes patients Tax:9606
2885 101188-101197 Disease denotes infection MESH:D007239
2886 101425-101433 Disease denotes infected MESH:D007239
2887 101621-101643 Disease denotes cardiovascular systems MESH:D002318
2888 101870-101882 Disease denotes inflammation MESH:D007249
2889 101924-101934 Disease denotes thrombosis MESH:D013927
2890 102006-102018 Disease denotes hypertension MESH:D006973
2891 102033-102057 Disease denotes cardiovascular disorders MESH:D002318
2892 102218-102229 Disease denotes lung injury MESH:D055370
2893 102715-102723 Disease denotes COVID-19 MESH:C000657245
2894 102842-102851 Disease denotes mortality MESH:D003643
2895 103022-103029 Disease denotes elevate MESH:D006973
2896 103302-103323 Disease denotes cardiovascular damage MESH:D002318
2897 103337-103345 Disease denotes COVID-19 MESH:C000657245
2915 103475-103481 Gene denotes Ang II Gene:183
2916 103486-103490 Gene denotes ACE2 Gene:59272
2917 103649-103652 Gene denotes ACE Gene:1636
2918 103671-103685 Gene denotes angiotensin II Gene:183
2919 103873-103879 Gene denotes Ang-II Gene:11606
2920 103924-103928 Gene denotes ACE2 Gene:70008
2921 104142-104146 Gene denotes ACE2 Gene:59272
2922 104409-104417 Gene denotes Ang-(1–7 Gene:7108
2923 103819-103823 Gene denotes PUFA Gene:9933
2924 103802-103806 Species denotes mice Tax:10090
2925 104128-104138 Species denotes SARS-CoV-2 Tax:2697049
2926 103543-103552 Chemical denotes n-3 PUFAs MESH:D015525
2927 104006-104015 Chemical denotes n-3 PUFAs MESH:D015525
2928 104275-104276 Chemical denotes n MESH:D009584
2929 104299-104319 Disease denotes SARS-CoV-2 infection MESH:C000657245
2930 104471-104479 Disease denotes COVID-19 MESH:C000657245
2931 104490-104518 Disease denotes cardiovascular complications MESH:D002318
2956 104594-104598 Gene denotes ACE2 Gene:59272
2957 104734-104737 Gene denotes ACE Gene:1636
2958 104891-104895 Gene denotes ACE2 Gene:59272
2959 105138-105141 Gene denotes ACE Gene:1636
2960 105237-105240 Gene denotes ACE Gene:1636
2961 105668-105671 Gene denotes ACE Gene:1636
2962 105769-105772 Gene denotes ACE Gene:1636
2963 104647-104657 Species denotes SARS-CoV-2 Tax:2697049
2964 104793-104801 Species denotes patients Tax:9606
2965 104977-104987 Species denotes SARS-CoV-2 Tax:2697049
2966 105105-105113 Species denotes patients Tax:9606
2967 105211-105219 Species denotes patients Tax:9606
2968 105316-105324 Species denotes patients Tax:9606
2969 105990-105998 Species denotes patients Tax:9606
2970 104784-104792 Disease denotes COVID-19 MESH:C000657245
2971 105096-105104 Disease denotes COVID-19 MESH:C000657245
2972 105119-105131 Disease denotes hypertension MESH:D006973
2973 105168-105177 Disease denotes mortality MESH:D003643
2974 105189-105201 Disease denotes hypertensive MESH:D006973
2975 105202-105210 Disease denotes COVID-19 MESH:C000657245
2976 105414-105422 Disease denotes COVID-19 MESH:C000657245
2977 105543-105546 Disease denotes AHA
2978 105828-105848 Disease denotes SARS-CoV-2 infection MESH:C000657245
2979 105981-105989 Disease denotes COVID-19 MESH:C000657245
2991 106110-106114 Gene denotes ACE2 Gene:59272
2992 106189-106195 Gene denotes Ang II Gene:183
2993 106206-106212 Gene denotes Ang II Gene:183
2994 106470-106474 Gene denotes ACE2 Gene:59272
2995 106525-106533 Gene denotes Ang-(1–7 Gene:7108
2996 106708-106711 Gene denotes ACE Gene:1636
2997 106053-106063 Species denotes SARS-CoV-2 Tax:2697049
2998 106138-106145 Species denotes patient Tax:9606
2999 106733-106742 Chemical denotes n-3 PUFAs MESH:D015525
3000 106038-106047 Disease denotes infection MESH:D007239
3001 106592-106595 Disease denotes CVD MESH:D002318
3003 106785-106794 Chemical denotes N-3 PUFAs MESH:D015525
3012 107025-107028 Chemical denotes ROS MESH:D017382
3013 107073-107076 Chemical denotes ROS MESH:D017382
3014 107154-107160 Chemical denotes lipids MESH:D008055
3015 107189-107192 Chemical denotes ROS MESH:D017382
3016 106831-106840 Disease denotes pneumonia MESH:D011014
3017 106849-106858 Disease denotes hypoxemia MESH:D000860
3018 106873-106889 Disease denotes virus infections MESH:D001102
3019 106994-107002 Disease denotes acidosis MESH:D000138
3050 108431-108455 Gene denotes glutathione peroxidase-1 Gene:2876
3051 108457-108481 Gene denotes glutathione peroxidase-4 Gene:2879
3052 108483-108514 Gene denotes NADPH-quinone oxido-reductase-1 Gene:1728
3053 108516-108539 Gene denotes thioredoxin reductase-2 Gene:10587
3054 109016-109029 Gene denotes thioredoxin-1 Gene:22166
3055 109034-109047 Gene denotes thioredoxin-2 Gene:56551
3056 108799-108803 Gene denotes PUFA Gene:9933
3057 108015-108023 Species denotes patients Tax:9606
3058 108306-108314 Species denotes patients Tax:9606
3059 108586-108594 Species denotes patients Tax:9606
3060 108812-108820 Species denotes patients Tax:9606
3061 108870-108875 Species denotes mouse Tax:10090
3062 107458-107467 Chemical denotes n-3 PUFAs MESH:D015525
3063 107572-107582 Chemical denotes superoxide MESH:D013481
3064 107698-107711 Chemical denotes free radicals MESH:D005609
3065 107736-107745 Chemical denotes n-3 PUFAs MESH:D015525
3066 108068-108077 Chemical denotes n-3 PUFAs MESH:D015525
3067 108089-108092 Chemical denotes EPA MESH:D015118
3068 108097-108113 Chemical denotes DHA ethyl-esters MESH:C067518
3069 108550-108561 Chemical denotes glutathione MESH:D005978
3070 108698-108701 Chemical denotes ROS MESH:D017382
3071 108897-108900 Chemical denotes DHA MESH:D004281
3072 109221-109227 Chemical denotes oxygen MESH:D010100
3073 109268-109271 Chemical denotes ROS MESH:D017382
3074 109392-109401 Chemical denotes n-3 PUFAs MESH:D015525
3075 109503-109506 Chemical denotes ROS MESH:D017382
3076 109101-109109 Disease denotes COVID-19 MESH:C000657245
3077 109160-109172 Disease denotes inflammation MESH:D007249
3078 109174-109183 Disease denotes hypoxemia MESH:D000860
3079 109486-109498 Disease denotes inflammation MESH:D007249
3081 109568-109580 Disease denotes coagulopathy MESH:D001778
3102 109951-109961 Gene denotes fibrinogen Gene:2244
3103 109858-109869 Gene denotes prothrombin Gene:2147
3104 109619-109627 Species denotes patients Tax:9606
3105 110029-110037 Species denotes patients Tax:9606
3106 110350-110358 Species denotes patients Tax:9606
3107 110476-110484 Species denotes patients Tax:9606
3108 110798-110806 Species denotes patients Tax:9606
3109 110463-110470 Chemical denotes heparin MESH:D006493
3110 110702-110730 Chemical denotes low molecular weight heparin MESH:D006495
3111 109610-109618 Disease denotes COVID-19 MESH:C000657245
3112 109645-109657 Disease denotes coagulopathy MESH:D001778
3113 109738-109748 Disease denotes thrombosis MESH:D013927
3114 109820-109836 Disease denotes thrombocytopenia MESH:D013921
3115 110020-110028 Disease denotes COVID-19 MESH:C000657245
3116 110188-110216 Disease denotes cardiovascular complications MESH:D002318
3117 110220-110226 Disease denotes stroke MESH:D020521
3118 110297-110319 Disease denotes venous thromboembolism MESH:D054556
3119 110330-110349 Disease denotes SARS-CoV-2 infected MESH:C000657245
3120 110497-110517 Disease denotes SARS-CoV-2 infection MESH:C000657245
3121 110778-110797 Disease denotes SARS-CoV-2 infected MESH:C000657245
3149 110987-110995 Gene denotes thrombin Gene:2147
3150 111451-111456 Gene denotes COX-1 Gene:4512
3151 111461-111467 Gene denotes 12-LOX Gene:246
3152 111011-111020 Chemical denotes adenosine MESH:D000241
3153 111155-111164 Chemical denotes n-3 PUFAs MESH:D015525
3154 111360-111363 Chemical denotes EPA MESH:D015118
3155 111368-111371 Chemical denotes DHA MESH:D004281
3156 111486-111497 Chemical denotes fatty acids MESH:D005227
3157 111525-111534 Chemical denotes oxylipins MESH:D054883
3158 111771-111774 Chemical denotes EPA MESH:D015118
3159 111923-111926 Chemical denotes EPA MESH:D015118
3160 111947-111950 Chemical denotes DHA MESH:D004281
3161 112021-112024 Chemical denotes DHA MESH:D004281
3162 112136-112139 Chemical denotes EPA MESH:D015118
3163 112144-112147 Chemical denotes DHA MESH:D004281
3164 112259-112268 Chemical denotes n-3 PUFAs MESH:D015525
3165 112405-112414 Chemical denotes n-3 PUFAs MESH:D015525
3166 111300-111331 Disease denotes thrombotic complications of CVD MESH:D013927
3167 111411-111431 Disease denotes platelet aggregation MESH:D001791
3168 111635-111645 Disease denotes thrombosis MESH:D013927
3169 111837-111857 Disease denotes platelet aggregation MESH:D001791
3170 112295-112333 Disease denotes hyperactivity prothrombotic conditions MESH:D006948
3171 112345-112348 Disease denotes CVD MESH:D002318
3172 112448-112468 Disease denotes platelet aggregation MESH:D001791
3173 112488-112507 Disease denotes SARS-CoV-2 infected MESH:C000657245
3174 112612-112624 Disease denotes coagulopathy MESH:D001778
3175 112648-112656 Disease denotes COVID-19 MESH:C000657245
3178 112664-112669 Chemical denotes Lipid MESH:D008055
3179 112721-112729 Disease denotes COVID-19 MESH:C000657245
3225 113407-113412 Gene denotes TNF-α Gene:7124
3226 113665-113672 Gene denotes insulin Gene:3630
3227 112730-112738 Species denotes Patients Tax:9606
3228 113713-113721 Species denotes patients Tax:9606
3229 113932-113940 Species denotes patients Tax:9606
3230 114657-114665 Species denotes patients Tax:9606
3231 112812-112823 Chemical denotes cholesterol MESH:D002784
3232 112828-112841 Chemical denotes triglycerides MESH:D014280
3233 113268-113280 Chemical denotes triglyceride MESH:D014280
3234 113534-113546 Chemical denotes Triglyceride MESH:D014280
3235 113547-113554 Chemical denotes glucose MESH:D005947
3236 113583-113595 Chemical denotes triglyceride MESH:D014280
3237 113615-113622 Chemical denotes glucose MESH:D005947
3238 113736-113748 Chemical denotes triglyceride MESH:D014280
3239 113749-113756 Chemical denotes glucose MESH:D005947
3240 113883-113894 Chemical denotes cholesterol MESH:D002784
3241 114378-114383 Chemical denotes lipid MESH:D008055
3242 114449-114454 Chemical denotes lipid MESH:D008055
3243 114630-114635 Chemical denotes lipid MESH:D008055
3244 112766-112774 Disease denotes diabetes MESH:D003920
3245 112776-112788 Disease denotes dyslipidemia MESH:D050171
3246 112846-112868 Disease denotes coronary heart disease MESH:D003324
3247 112900-112908 Disease denotes COVID-19 MESH:C000657245
3248 112926-112947 Disease denotes cardiac complications MESH:D005117
3249 112949-112955 Disease denotes sepsis MESH:D018805
3250 112957-112961 Disease denotes ARDS MESH:D012128
3251 112966-112971 Disease denotes death MESH:D003643
3252 113130-113138 Disease denotes COVID-19 MESH:C000657245
3253 113198-113206 Disease denotes ischemic MESH:D007511
3254 113341-113345 Disease denotes died MESH:D003643
3255 113361-113369 Disease denotes COVID-19 MESH:C000657245
3256 113704-113712 Disease denotes COVID-19 MESH:C000657245
3257 113805-113813 Disease denotes COVID-19 MESH:C000657245
3258 113814-113823 Disease denotes infection MESH:D007239
3259 113828-113833 Disease denotes death MESH:D003643
3260 113923-113931 Disease denotes COVID-19 MESH:C000657245
3261 114224-114242 Disease denotes hypercoagulability MESH:D019851
3262 114277-114285 Disease denotes COVID-19 MESH:C000657245
3263 114417-114425 Disease denotes COVID-19 MESH:C000657245
3264 114426-114435 Disease denotes infection MESH:D007239
3265 114494-114506 Disease denotes dyslipidemia MESH:D050171
3266 114531-114539 Disease denotes diabetes MESH:D003920
3267 114541-114564 Disease denotes coronary artery disease MESH:D003324
3268 114570-114577 Disease denotes obesity MESH:D009765
3269 114648-114656 Disease denotes COVID-19 MESH:C000657245
3301 115394-115398 Gene denotes ACE2 Gene:59272
3302 116302-116305 Gene denotes CRP Gene:1401
3303 115832-115836 Gene denotes PUFA Gene:9933
3304 115053-115061 Species denotes patients Tax:9606
3305 115365-115379 Species denotes COVID-19 virus Tax:2697049
3306 115527-115535 Species denotes patients Tax:9606
3307 116309-116317 Species denotes patients Tax:9606
3308 116428-116436 Species denotes patients Tax:9606
3309 116558-116566 Species denotes patients Tax:9606
3310 114719-114724 Chemical denotes lipid MESH:D008055
3311 115118-115123 Chemical denotes lipid MESH:D008055
3312 115594-115606 Chemical denotes triglyceride MESH:D014280
3313 115796-115808 Chemical denotes triglyceride MESH:D014280
3314 116053-116066 Chemical denotes triglycerides MESH:D014280
3315 116253-116262 Chemical denotes n-3 PUFAs MESH:D015525
3316 114857-114865 Disease denotes diabetes MESH:D003920
3317 114867-114885 Disease denotes metabolic syndrome MESH:D024821
3318 114891-114914 Disease denotes coronary artery disease MESH:D003324
3319 114961-114969 Disease denotes COVID-19 MESH:C000657245
3320 115044-115052 Disease denotes COVID-19 MESH:C000657245
3321 115213-115222 Disease denotes mortality MESH:D003643
3322 115475-115483 Disease denotes COVID-19 MESH:C000657245
3323 115541-115553 Disease denotes dyslipidemia MESH:D050171
3324 115657-115680 Disease denotes coronary artery disease MESH:D003324
3325 115713-115721 Disease denotes COVID-19 MESH:C000657245
3326 115722-115731 Disease denotes infection MESH:D007239
3327 116167-116202 Disease denotes haemophagocytic lymphohistiocytosis MESH:D051359
3328 116323-116343 Disease denotes hypertriglyceridemia MESH:D015228
3329 116419-116427 Disease denotes COVID-19 MESH:C000657245
3330 116480-116489 Disease denotes infection MESH:D007239
3331 116498-116519 Disease denotes respiratory disorders MESH:D012131
3333 116705-116713 Disease denotes COVID-19 MESH:C000657245
3351 116809-116817 Species denotes patients Tax:9606
3352 116997-117004 Species denotes patient Tax:9606
3353 117381-117389 Species denotes patients Tax:9606
3354 117539-117547 Species denotes patients Tax:9606
3355 117885-117893 Species denotes patients Tax:9606
3356 116749-116758 Chemical denotes n-3 PUFAs MESH:D015525
3357 117569-117572 Chemical denotes EPA MESH:D015118
3358 117574-117577 Chemical denotes DHA MESH:D004281
3359 117582-117602 Chemical denotes gamma-linolenic acid MESH:D017965
3360 117961-117964 Chemical denotes EPA MESH:D015118
3361 117966-117986 Chemical denotes gamma-linolenic acid MESH:D017965
3362 117366-117380 Disease denotes critically ill MESH:D016638
3363 117520-117534 Disease denotes critically ill MESH:D016638
3364 117625-117642 Disease denotes lung inflammation MESH:D011014
3365 117775-117784 Disease denotes mortality MESH:D003643
3366 117899-117905 Disease denotes sepsis MESH:D018805
3367 118180-118189 Disease denotes mortality MESH:D003643
3398 119665-119668 Gene denotes CRP Gene:1401
3399 119107-119111 Gene denotes PUFA Gene:9933
3400 118347-118355 Species denotes patients Tax:9606
3401 118411-118419 Species denotes patients Tax:9606
3402 118618-118626 Species denotes patients Tax:9606
3403 119174-119178 Species denotes rats Tax:10116
3404 119261-119269 Species denotes patients Tax:9606
3405 119489-119496 Species denotes soybean Tax:3847
3406 119576-119584 Species denotes patients Tax:9606
3407 118310-118318 Chemical denotes fish oil MESH:D005395
3408 118452-118460 Chemical denotes fish oil MESH:D005395
3409 118692-118702 Chemical denotes omega-3 FA
3410 118794-118802 Chemical denotes fish oil MESH:D005395
3411 118818-118833 Chemical denotes n-3 fatty acids MESH:D015525
3412 118888-118891 Chemical denotes EPA MESH:D015118
3413 118896-118899 Chemical denotes DHA MESH:D004281
3414 118937-118952 Chemical denotes n-3 fatty acids MESH:D015525
3415 119143-119154 Chemical denotes acetic acid MESH:D019342
3416 119410-119417 Chemical denotes glucose MESH:D005947
3417 119440-119445 Chemical denotes lipid MESH:D008055
3418 119551-119559 Chemical denotes fish oil MESH:D005395
3419 119602-119610 Chemical denotes fish oil MESH:D005395
3420 119614-119623 Chemical denotes n-3 PUFAs MESH:D015525
3421 118332-118346 Disease denotes critically ill MESH:D016638
3422 118489-118501 Disease denotes inflammation MESH:D007249
3423 118632-118638 Disease denotes sepsis MESH:D018805
3424 118703-118722 Disease denotes rich lipid emulsion MESH:D011017
3425 118745-118764 Disease denotes rich lipid emulsion MESH:D011017
3426 119163-119170 Disease denotes colitis MESH:D003092
3427 119288-119300 Disease denotes pancreatitis MESH:D010195
3442 120108-120116 Species denotes children Tax:9606
3443 120268-120276 Species denotes patients Tax:9606
3444 120755-120763 Species denotes patients Tax:9606
3445 119851-119860 Chemical denotes n-3 PUFAs MESH:D015525
3446 119977-119985 Chemical denotes fish oil MESH:D005395
3447 120030-120033 Chemical denotes EPA MESH:D015118
3448 120038-120041 Chemical denotes DHA MESH:D004281
3449 120588-120597 Chemical denotes n-3 PUFAs MESH:D015525
3450 120727-120736 Chemical denotes n-3 PUFAs MESH:D015525
3451 120082-120096 Disease denotes critically ill MESH:D016638
3452 120259-120267 Disease denotes COVID-19 MESH:C000657245
3453 120483-120491 Disease denotes COVID-19 MESH:C000657245
3454 120616-120624 Disease denotes COVID-19 MESH:C000657245
3455 120740-120754 Disease denotes critically ill MESH:D016638
3471 121487-121493 Gene denotes Ang II Gene:183
3472 121594-121598 Gene denotes ACE2 Gene:59272
3475 121116-121126 Species denotes SARS-CoV-2 Tax:2697049
3476 121284-121292 Species denotes patients Tax:9606
3478 121641-121651 Species denotes SARS-CoV-2 Tax:2697049
3479 122199-122207 Species denotes patients Tax:9606
3480 120840-120848 Disease denotes COVID-19 MESH:C000657245
3481 121202-121223 Disease denotes Cardiovascular injury MESH:D002318
3482 121275-121283 Disease denotes COVID-19 MESH:C000657245
3484 122190-122198 Disease denotes COVID-19 MESH:C000657245
3501 122299-122308 Chemical denotes n-3 PUFAs MESH:D015525
3502 122453-122454 Chemical denotes N MESH:D009584
3503 122765-122770 Chemical denotes lipid MESH:D008055
3504 122952-122961 Chemical denotes n-3 PUFAs MESH:D015525
3505 121938-121966 Disease denotes cardiovascular complications MESH:D002318
3506 121980-121988 Disease denotes COVID-19 MESH:C000657245
3507 122065-122093 Disease denotes cardiovascular complications MESH:D002318
3509 122423-122451 Disease denotes cardiovascular complications MESH:D002318
3510 122683-122695 Disease denotes coagulopathy MESH:D001778
3511 123113-123133 Disease denotes SARS-CoV-2 infection MESH:C000657245